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ABSTRACT 
Smoking, excessive alcohol consumption and illicit drug use are prevalent within the 
Cystic Fibrosis population, with these behaviours having adverse health effects upon 
patients regardless of their treatment adherence. Previous quantitative research 
highlighting the incidence, prevalence and effects of these behaviours within the 
Cystic Fibrosis population demonstrates the need for more effective health 
promotion measures to be integrated into Cystic Fibrosis care. Therefore, attempting 
to reduce occurring risky health behaviours specifically within the Cystic Fibrosis 
population, this doctoral research aimed to identify influential factors associated with 
these behaviours. This research utilised qualitative methods to explore beliefs 
associated with risky health behaviours within the adult Cystic Fibrosis population. 
This first phase of data collection was followed by another qualitative study exploring 
Cystic Fibrosis adolescents' understanding of, and beliefs about risky health 
behaviours. Both phases of data collection highlight that a desire to be normal, 
acceptance of Cystic Fibrosis and awareness of risks are influential in initiation and 
engagement of risky health behaviours. Both adult and paediatric participants 
reported a lack of awareness regarding adverse health effects of risky behaviours, 
demonstrating the need for more effective health promotion and encouragement of 
healthier lifestyles. Accordingly, to create a corresponding intervention, the 
researcher has listened to how Cystic Fibrosis Specialist Nurses perceive the issue 
of risky health behaviours within the population, along with gaining Cystic Fibrosis 
health care professionals' views on what interventions are needed to reduce the 
occurrence of such behaviours. The researcher presently plans to collaborate with 
health care professionals to design an intervention, which would consist of 
continuous professional development for health care professionals to improve 
awareness on risky health behaviours within the Cystic Fibrosis population, and 
would inform patients regarding the Cystic Fibrosis-specific adverse effects of risky 
health behaviours via interdisciplinary collaboration and scholarship between 
psychology and technology. Overall this research has provided practical insight into 
policy change for the prevention and reduction of risky health behaviours within the 
Cystic Fibrosis population nationally and internationally by informing current advice 
and practice. 
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CHAPTER ONE: INTRODUCTION TO CYSTIC FIBROSIS  
Cystic Fibrosis (CF) is the United Kingdom’s (UK) most common life-limiting genetic 
disease (Elborn, 2016; Jackson & Pencharz, 2003), caused by defects in a recessive gene 
(CFTR) located on chromosome seven (Abbott, Hart, Morton, Gee & Conway, 2008). The 
“faulty” CFTR gene mainly impairs the functioning of the respiratory tract and the pancreas 
by allowing too much salt and water into cells, increasing the production of mucus (Kerem et 
al., 1989; Stoltz, Meyerholtz & Welsh, 2015) which impacts upon the clearance of 
microorganisms, leading to recurrent infections, inflammation of the respiratory tract, lung 
damage and in severe cases fatal respiratory failure (Abbott et al., 2008; Elborn, 2016). In 
the pancreas, CF causes the pancreatic ducts to become blocked, preventing the production 
of digestive enzymes, leading to the maldigestion and malabsorption of nutrients (Abbott et 
al., 2008; Elborn, 2016; Sinaasappel et al., 2002). CF is also associated with complications 
such as chronic liver damage, pneumothorax, haemoptysis, osteoporosis (Abbott et al., 
2008; Couce, O’Brien, Moran, Roche & Butler, 1996) and commonly CF related diabetes 
(CFRD), with nearly 20% of adolescents and 40-50% of adults with CF experiencing CFRD 
(The CF Trust, 2013a).  
Symptomology for CF varies between individuals, with symptoms typically emerging 
during the first twelve months of an individual's life; however in milder forms symptoms may 
remain undetected until adolescence or even later (NHS, 2016a). Nationwide CF newborn 
screening began to be introduced in the UK in 2003 (Super, 2003), with all newborn babies 
in the UK since 2007 being offered a newborn blood spot test to help detect CF (The CF 
Trust, 2017a). Most cases of CF today are detected soon after birth, with babies receiving 
this screening between five to eight days after birth (NHS Choices, 2016). If screening 
suggests a baby has CF two main tests can be conducted to confirm a diagnosis, a sweat 
test, to measure the amount of salt in sweat; and a genetic test, where a blood or saliva 
sample is checked for the faulty gene which causes CF (NHS Choices, 2016).  
The respiratory symptoms of CF can include breathing difficulties, shortness of 
breath, a chronic cough, which if untreated will produce thick mucus, frequent wheezing in 
the lungs and tightness of the chest (Bennett, Patrick, Lymp, Edwards, Goss, 2010; Gibson, 
Burns & Ramsey, 2003). In addition to the respiratory symptoms, a child may also present 
with pneumonia, poor growth, persistent diarrhoea and meconium ileus (an intestinal 
blockage due to mucus build-up); all of which would lead to the diagnosis of CF (NHS, 
2016a). Individuals with CF often present with a fever and report feeling tired, due to both 
physical implications and emotional implications such as worry, depression and frustration, 
with these at times being co-existing symptoms not directly as a result from CF, but as a 
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consequence from having CF, which can impact upon an individual’s ability to sleep (Goss, 
Edwards, Ramsey, Aitken & Patrick, 2009). 
CF is a serious disease which at present is incurable and progressive; however there 
are several treatments which aim to reduce the severity of symptoms and slow down CF's 
progression, consequently improving an individual’s quality of life (NHS, 2016b). CF daily 
medical regimens vary, with most CF treatments targeting the lungs, with an aim to reduce 
breathing obstructions resulting from frequent infectious exacerbations (Smyth, 2016; NHS, 
2016b). These treatments commonly consist of chest physiotherapy and exercise to assist 
the clearance of excess mucus (Kriemler, Radtke, Christen, Kerstan-Huber & Hebestreit, 
2016), oral and intravenous antibiotics to treat infectious exacerbations within an individual's 
respiratory system (Smyth, 2016); and nebulised therapies which are often used to 
administer antibiotics and Pulmozyne (an enzyme [DNase] which thins and breaks down 
mucus within the lungs, allowing the individual to remove the excess mucus easier), or 
Hypertonic saline (an alternative to DNase) (NHS, 2016b). However, as an individual’s 
disease deteriorates the above treatments may no longer be as effective in preventing 
frequent infectious exacerbations, therefore lung transplantation may become a necessity for 
people with severe lung disease whose FEV1 falls below 30% (The CF Trust, 2017b). 
Besides respiratory treatments, CF treatments also target the digestive system, with 
pancreatic insufficient patients often being prescribed pancreatic enzymes to aid with 
digestion, and vitamin supplements (typically vitamins A, D, E and K) due to the likely 
malabsorption of fat soluble vitamins (Elborn, 2016; NHS, 2016b).  
CF treatments are continuously developing, there are currently numerous trials 
leading to the development of new drugs which promise to revolutionise CF care. CF care is 
entering a period of personalised medicine with the emergence of precision medicines. 
These new drugs target the underlying cause of CF by treating and correcting specific 
genetic mutations, with the drug an individual receives being dependent upon their genome 
(CF News Today, 2016; Fajac & De Boeck, 2017; Keyte et al., 2017a; The CF Trust, 2017c). 
These new drugs are targeted at only a few different CF mutations, and work is underway to 
create drugs targeted for other mutations, specific to the genome of individuals. Whilst these 
drugs aim to increase both the quality and quantity of individuals lives with CF, not all 
individuals with CF have access to these new medications, with there currently being issues 
in getting Orkambi licensed within the UK due to the cost of the drug (Keyte et al., 2017a; 
The CF Trust, 2016a). 
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The impact of the increasing life expectancy within the Cystic Fibrosis population 
CF is associated with a reduced life expectancy, and therefore adds an emotional 
burden for people (McHugh, McFeeters, Boyda & O'Neill, 2016; Withers, 2012), with 
associated psychology sequelae which is well documented within the literature. Quittner et al 
(2014) report that symptoms of depression and anxiety are elevated within CF patients, with 
research suggesting that individuals with CF can have a preoccupation with death (Lawler, 
Nakielny & Wright, 1966). This is not just evident within adult patients; with research 
providing evidence of some paediatric patients also having a preoccupation with death 
(Lawler et al., 1966). Such preoccupation can be as a result of individuals with CF 
witnessing other CF patients experience health deteriorations, either at hospital visits or 
through friendships they have formed. Higham, Ahmed and Ahmed (2013) pointed out that 
when patients witness others with CF suffering, and passing away it is a frightening 
experience, with such individuals not only having to cope with the death of a loved one, they 
also have to deal with witnessing what their own death may entail, and the suffering they 
may encounter prior to death; as well as confronting their own mortality.  
While CF is an incurable disease, recently the CF population has experienced an 
increase in its life expectancy. In the 1980s life expectancy for CF was fourteen years; in 
2003 this increased to eighteen years (Pinkerton, 2013; Withers, 2012), and this has 
continued to increase recently, because of medical advances in managing respiratory 
infections and pancreatic insufficiency (Kettler, Sawyer, Winefield & Greville, 2002). CF is 
therefore no longer a paediatric entity, as many people are progressing well into adulthood, 
with most individuals with CF born during the 1990’s being expected to survive to more than 
forty years of age (Elborn, 2016); the current medium predicted age of survival for CF in the 
UK is 48 years (The UK CF Conference, 2016).  
This improvement in life expectancy has been coupled with an improvement in 
quality of life, with recent research suggesting there is no elevated risk for anxiety or 
depression amongst individuals with CF (Backström-Eriksson, Sorjonen, Bergsten-
Brucefors, Hjelte & Melin, 2015). Götz and Götz (2000) reported that individuals with CF 
often lead “normal lives”, with CF not appearing to be the major obstacle to school or work 
attendance. Nonetheless, CF is still an incurable and progressive disease (Gee, Abbott, 
Conway, Etherington & Webb, 2000), which does still provide individuals with emotional 
burdens (Abbott et al., 2008; McHugh et al., 2016), with the research evidence varying when 
reporting anxiety and depression within individuals with CF. Adults with CF often have to 
deal with a diminishing ability to engage in activities as they become older, due to their 
worsening health (Orenstein, 2004), which is difficult for usually active individuals to deal 
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with, and this is often coupled with serious health implications (Burker, Kazaukauskas & 
Williams, 2012). 
In addition, whilst CF health care professionals (HCPs) are skilled in helping 
individuals with CF adjust to decreased health, HCPs may be less experienced in supporting 
people whose health has shown an improvement (Horky, 2014). A parent of a CF patient at 
the UK CF Conference (2016) explained how the discourse HCPs use is hard, with HCPs 
rarely discussing hope and inspiration, despite the parent reporting that CF's increasing life 
expectancy does provide patients and families with hope and inspiration. This parent 
believed that HCPs should focus on the here and now (e.g. the patient is well), rather than 
dwelling on potential future implications. With this increasing life expectancy it is 
acknowledged HCPs may overlook "new" issues that individuals with CF are now faced with, 
such as a vulnerability to engage in risky behaviours (Horky, 2014). As a consequence of the 
anticipated improvements in CF treatment in the upcoming years, allowing individuals with 
CF to lead a more "normal" life, it is essential for HCPs to become aware of these “new” 
challenges, to effectively help patients, especially with the CF population being a growing 
population (Horky, 2014; Owen, 2016). 
With the increasing life expectancy it is acknowledged that there is a need for new 
approaches to health care within the changing CF population. Owen (2016) emphasised that 
today CF care needs to be individualised, with Cox (2015) illustrating at the UK CF 
Conference that from 2015 - 2020 the five year challenge for the CF population includes 
dealing with the growing CF population, and aiming to keep patients away from hospital due 
to the risk of cross infection and the emotional aspects of hospital visits, indicating that 
quality of life is sometimes a better measure than lung function. Cox (2015) and Owen 
(2016) both stated that in order to meet the needs of this growing population, both in terms 
of health and quality of life, research needs to be done to listen to the views of individuals 
with CF in terms of what it is like to live with CF. In an attempt to meet some of the five year 
challenges research is being conducted to investigate different ways healthcare could be 
delivered, for instance Cox (2015) states that HCPs could potentially do health checks on 
stable patients using technology e.g. via phone calls or the internet, rather than clinic visits 
(Bilton, 2015; Owen, 2016). This illustrates that the focus of CF care for clinicians and 
researchers alike, is not just on pharmacological care, with CF care heavily focusing upon 
quality of life and shifting towards a person-centred model of care (Owen, 2016).  
Whilst CF care is a changing environment, a major focus that has not changed is 
adherence, as despite the improved life expectancy, individuals with CF still require daily 
“preventative management and symptomatic treatment” (Kettler et al., 2002, p. 459) to 
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manage their progressive disease. Therefore, the increasing life expectancy is creating a 
welcomed challenge for HCPs, in supporting adolescents as they become increasingly 
responsible for their own medical regimens, with research indicating that poor adherence is 
a major concern within the CF population (Bregnballe, Schiotz, Boisen, Pressler & Thastum, 
2011).  
Poor adherence within the Cystic Fibrosis population 
Due to CF's increasing life expectancy, more individuals with CF are entering 
adolescence and adulthood in comparison to previous generations, with this creating 
manifold challenges for patients in independently maintaining their complex and time-
consuming treatment regimens (Barker, Driscoll, Modi, Light & Quittner, 2012). As a 
consequence of treatments complexity, coupled with CF's progressive nature, ongoing 
treatment adherence is a major concern (Horne, 2000; Quittner et al., 2014); with these 
medical regimens being essential as adults with CF encounter more health-related 
limitations and symptoms than they experienced during childhood and adolescence (Elborn, 
2016; Orenstein, 2004). However, despite the necessity of these medical regimens, poor 
adherence is prevalent during adolescence, with 60% of CF adolescents agreeing that the 
three main barriers preventing their adherence are a “lack of time, forgetfulness and 
unwillingness to take medication in public” (Bregnballe et al., 2011, p.512). Furthermore 
Kettler et al (2002) stated that poor adherence within CF may be a result of individuals 
having to interpret and understand their complex regimen, and having to prioritise their 
prescribed treatments within their daily lives. However, Horne, Weinman, Barber, Elliott and 
Morgan (2006) concluded that treatment complexity is not the key determinant within non-
adherence, but how well a particular treatment fits into an individual’s routine. 
In terms of CF, poor adherence is a significant predictor of pulmonary exacerbations 
during a 12-month period (Eakin, Bilderback, Boyle, Mogayzel & Riekert, 2011), with 
Quittner et al (2014) indicating through the use of medical progression ratios that poor 
adherence is associated with acute health-care use. Therefore, an obstacle HCPs have to 
overcome to successfully treat CF is poor adherence. Many HCPs do acknowledge their 
patients poor adherence, however they often underestimate the extent of this poor/non-
adherence, with CF patients often reporting their adherence rates to be higher than the 
reality (Daniels et al., 2011). As a consequence HCPs often underestimate the extent of 
patients poor/non-adherence, with Wilderman (2015) stating that CF HCPs often work 
"under the lamppost" when treating CF. For instance, Wilderman (2015) states that it often 
the case that if an individual's lung function or BMI has declined, HCPs will prescribe 
additional medical regimens; however in doing this HCPs may not take non-adherence into 
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account. When patients are not open about their adherence efforts it does create challenges 
in successfully treating their individual condition, however it has to be acknowledged that the 
difficulty lies in how to communicate with patients in order for them to be able to be honest 
about their adherence efforts. Work is therefore needed to highlight how HCPs can work with 
patients in a patient centred way to facilitate open discussions about treatment regimens, 
specifically surrounding what patients find difficult to follow in terms of their treatments, and 
why.  
Literature suggests that effort needs to be employed to improve treatment adherence 
within the CF population by creating new adherence interventions, therefore improving 
subsequent health outcomes (Eakin et al., 2011; Quittner et al., 2014). In order to create 
such interventions, factors associated with adherence need to be more clearly identified. 
There are a variety of research suggestions indicating what influences adherence within the 
CF population. Research by Kettler et al (2002) reported that individuals with CF receive little 
positive reinforcement for their adherence, as the health of an individual with CF will 
progressively deteriorate, regardless of adherence. Furthermore, research indicates that 
adherence within CF differs between treatment types, with individuals appearing to focus on 
short-term treatment benefits, without considerations for long-term benefits; with their 
adherence decisions being based on their immediate symptoms (Abbott, Dodd, Bilton & 
Webb, 1994; Keyte et al., 2017b). 
Research has also explored the roles of psychological distress and disease severity 
as potential predictors of adherence. Kettler et al (2002) suggests that an increase in 
disease severity may be associated with a decrease in adherence, possibly due to a 
reduction in positive reinforcement as CF becomes more severe. However, Abbott et al 
(1994) demonstrated no association between disease severity and adherence in an earlier 
study, and this was confirmed by Daniels et al (2011) using electronic monitoring data.  A 
concomitant increase in psychological distress as symptoms worsen may also account for a 
reduction in adherence (Kilbourne, 2005; Sundbom & Bingefors, 2013), with research 
concluding that higher depressive symptoms within individuals with CF is associated with 
less positive medication beliefs, which consequently is associated with lower medication 
adherence (Hillard, Eakin, Borrelli, Green & Riekert, 2015; Keyte et al., 2017b). Whilst 
depression has been linked to poor adherence, some individuals with CF who have 
concerns and potential anxieties towards CF remain motivated to adhere to their treatments 
(Keyte et al., 2017b). Such concerns surrounded CF's fatal nature, and the uncertain future 
this provides individuals with, with some people describing how health deteriorations can 
exacerbate their concerns (Keyte et al., 2017b). 
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Within the literature, the influence of a number of factors on adherence such as sex, 
age and time of day have been explored. Research has indicated sex differences in 
adherence within the CF population (Abbott, Havermans & Hart, 2009), with female 
adolescents displaying more non-adherent behaviours and feelings than male adolescents 
(Patterson, Wall, Berge & Milla, 2008). These findings may offer an explanation as to why 
the age of onset for progressive decline in pulmonary function is younger for females with 
CF (12-14 years) in comparison to males (19-20 years) (Cory, Edwards, Sevinson & 
Knowles, 1990; Harness-Brumley, Elliott, Rosenbluth, Raghavan & Jain, 2014; Rosenfield, 
Davis, Simmons, Pepe & Ramsey, 1997). Research indicates that the relative risk for 
survival is significantly lower for females than males with CF (Harness-Brumley et al., 2014; 
Kullich, Rosenfeld, Griss & Wilmott, 2003), potentially due to the sex differences within 
adherence affecting pulmonary function and nutritional status (Patterson et al., 2008).  
Adherence rates differ by age group during a twenty four hour period, in one study 
(McNamara, McCormack, McDonald, Heaf & Southern, 2009) paediatric CF patients were  
more adherent in the evenings in comparison to the mornings; indicating that time-pressures 
in the mornings (for both parents and children) may adversely affect adherence (Latchford, 
Duff, Quinn, Conway & Conner, 2009; McNamara et al., 2009). Another study by Ball et al 
(2013) showed that adolescents were more adherent during weekdays in comparison to 
weekends, and during term-times in comparison to holidays. This supports Horne et al's 
(2006) observation around the importance of CF care being integrated into "structured, daily 
family schedules, which act to contain treatments" (Ball et al., 2013, p.442). 
Keyte et al (2017c) investigated how adherence differs for CF adults during the 
weekend in comparison to weekdays, utilising a daily phone diary (DPD) methodology (Modi 
et al., 2006), whilst examining the roles of gender, anxiety, depression and lung function as 
predictors of adherence. In this study, adults with CF had higher reported adherence during 
the weekend in comparison to weekdays, particularly for female participants. These finding 
differed to those of Ball et al (2013) where adolescent adherence was higher during the 
weekdays, with Keyte et al's (2017c) findings supporting previous work (Kettler et al., 2002; 
Keyte et al., 2017b; Patterson et al., 2008), with sex, psychological distress and lung 
function predicting adherence. 
Although Keyte et al's (2017c) research used a different method to Ball et al (2013) 
to record adherence rates, the difference in findings suggest a difference in the adherence 
relationship between adolescents and adults with CF. There are a variety of possible 
reasons for this change; adults may have more difficulty in independently integrating their 
daily treatments within their weekday lifestyle, alongside employment or study commitments. 
18 
 
For paediatric patients, daily treatments are more likely to be managed by parents or 
guardians, with it potentially being easier for parents to organise their child's daily treatments 
during the weekdays, as CF care would be integrated into structured, daily routines (e.g. 
school) (Ball et al., 2013, p.442). 
CF adolescents and young adults may consciously choose to be non-adherent during 
the weekdays in an attempt to hide their illness identity from their peers. Individuals may 
believe their illness identity is on display when they have to engage in medical regimens, 
therefore some individuals with CF may consciously choose to be non-adherent to provide 
themselves with a degree of invisibility towards their illness, allowing them greater normalcy 
(Keyte et al., 2017b; Yates et al., 2010) and this was one of the findings in Keyte et al’s 
(2017c) research.  
The role of identity is one of the possible explanations for why the weekend / 
weekday difference in adherence was most prevalent within adult female CF patients (Keyte 
et al., 2017c), with females with CF often reporting experiencing embarrassment when their 
adherence behaviours are visible to their peers resulting in self-consciousness (Patterson et 
al., 2008). Therefore females with CF may have lower reported adherence during the 
weekdays due to their conscious efforts to avoid performing medical regimens in front of 
their peers (e.g. at work), in order to provide themselves with a degree of invisibility towards 
CF. Literature suggests that invisibility towards one's CF is often valued by patients.  
However whilst this may be associated with increasing one's quality of life, or having 
psychological benefits, such invisibility could have negative health implications if it is 
associated with avoiding medical regimens.  
Risky health behaviours within the Cystic Fibrosis population 
 Research has recently started to view non-adherence in a different way, stressing 
that non-adherence should not be viewed just in terms of medical regimens. There are other 
damaging behaviours that some chronically-ill individuals engage in, which can be viewed as 
severe forms of non-adherence, such as "risky behaviours" (Huq et al., 2011; Mays, 
Streisand, Walker, Prokhorov & Tercyak, 2012; Withers, 2012). Risky behaviours are any 
behaviours that expose an individual to harm or significant risk, which will therefore prevent 
them in reaching their potential (Richmond, 2014). Researchers often view non-adherence 
and risky behaviours within the CF population as two separate entities. However the 
relationship between risky behaviours and non-adherence within chronic illnesses was 
suggested by Mays et al (2012), who stated that type 1 diabetic adolescents are presented 
with decisions regarding risky behaviours alongside their complex treatment regimen. 
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Adolescents’ decisions surrounding risky behaviours and adherence are related, and are 
likely to be influenced by the same factors (Buller et al., 2003; Flay, 1999; Jamner et al., 
2003; Solberg, Desai, O’Connor, Bishop & Develin, 2004; Tercyak, 2004; Tercyak et al., 
2005; Tercyak, Britto, Hanna, Hollen, & Hudsen, 2008; Tyas & Pederson, 1998); with risky 
behaviour engagement being associated with poor treatment adherence (Solberg et al., 
2004).  
 Quantitative research has displayed that smoking, excessive alcohol consumption 
and illicit drug use are prevalent within the CF population, with these behaviours being a 
major concern for individuals with CF, as they are having adverse health effects on 
individuals regardless of their treatment adherence (Richmond, 2014).  
Smoking and Cystic Fibrosis 
Smoking within the general population is considered to be a risky behaviour, with it 
being reported that smoking is the primary cause of preventable illness resulting in 
premature death, accounting for 96,000 deaths a year in the UK (ASH, 2016a; Health & 
Social Care Information Centre, 2012). Smoking dramatically reduces both the quality of an 
individual's life and their life expectancy, having adverse health effects on the majority of 
organs within the body, and causing various health complications such as "lung cancer, 
respiratory disease and heart disease, as well as numerous cancers in other organs 
including mouth, throat and kidney" (ASH, 2016a, p. 2; Das, 2003). Despite these adverse 
health effects smoking is still prevalent within the general population (Verma, Clough, 
McKenna & Dodd, 2001), with the current prevalence of cigarette smoking being 19% in the 
UK (Borrelli, Bartlett, Tooley, Armitage & Wearden, 2015). Cigarette smoking prevalence 
amongst adults in the UK decreases with age, with there being more male smokers than 
female smokers within each age group (Office for National Statistics, 2013), however this 
sex gap in cigarette smoking prevalence has narrowed in recent years, with there being a 
decrease in cigarette smoking prevalence among adults in the UK since the early 1970's 
(Office for National Statistics, 2011; 2012). In terms of adolescents, the reduction in smoking 
prevalence among 11-15 year olds has been more gradual than in adults, plateuing in the 
early 2000s, but accelerating in 2007 (Amos & Hastings, 2009). Experimentation of smoking 
commonly begins during early to mid teens, with smoking prevalence and consumption 
increasing until the mid-twenties (Amos & Hastings, 2009).  
Studies of the incidence, prevalence and effects of smoking within a CF population 
(Verma et al, 2001) identified that despite CF's respiratory difficulties, active smoking is 
prevalent (Huq et al., 2011; Smyth, O’Hea, Williams, Smyth & Heaf, 1994). McEwan, 
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Hodson and Simmonds (2012) reported that 46% of CF patients at Royal Brompton CF Unit 
had tried smoking, with 3% continuing to smoke regularly. Verma et al (2001) reported that 
21% of CF patients at a Manchester Unit had tried smoking, with 11% continuing to smoke 
regularly.  
The prevalence statistics within the CF population are less than the general 
population (in the case of McEwan et al., 2012: 3 vs 21%; p<0.001), however the detrimental 
effects of smoking are well documented, and they present a particular and specific risk to 
those who have CF. Smoking decreases the lung function of individuals with CF, with their 
FEV1  scores being reduced by 4% for every 10 cigarettes they smoke, and their FVC scores 
being reduced by 3% for every 10 cigarettes they smoke (Verma et al., 2001). This evidence 
shows a dose-dependent relationship between the number of cigarettes smoked and CF's 
severity. Smoking causes growth suppression, an increase in the frequency of infectious 
exacerbations, resulting in their being an increase in the need for intravenous antibiotics 
(Verma et al., 2001). Whilst there may be halt in spirometric deterioration when an individual 
stops smoking, the lungs are an organ that do not recover (Verma et al., 2001), therefore 
emphasis needs to be placed on reducing the number of individuals with CF who admit in 
this behaviour.  
In addition, people who smoke will not be considered for lung transplantation (Aurora, 
Carby & Sweet, 2008; NHS, 2016b; Orens et al., 2006; The CF Trust, 2017b; Withers, 
2012). Therefore, smokers are decreasing their lung function, needing lung transplantation 
quicker than predicted, but failing the assessment due to their smoking behaviour (Minai & 
Budev, 2005). Smoking also has adverse health effects on CFRD (Mays et al., 2012); with 
smoking resulting in poor blood glucose regulation, elevated haemoglobin, and 
hypoglycaemia (Haire-Joshu, Glasgow & Tibbs, 2004; Mays et al., 2012). Smoking can also 
accelerate the progression of diabetes-related micro-vascular complications, as well as 
various types of diabetes neuropathy (Daneman, 2006), nerve damage and kidney disease 
(Hofer et al., 2009; Mays et al., 2012; Wadwa, 2006).  
Within the general population there are currently a variety of interventions to aid 
cessation (Aveyard & Raw, 2011; Lancaster, Stead, Silagy, & Sowden, 2000), which have 
had a degree of success, such as nicotine replacement therapies (Aveyard & Raw, 2011; 
Bollinger et al., 2000) (e.g. chewing gum, inhalers, nasal spray), and mass media 
campaigns. The mass media campaigns provide education about smokings adverse health 
effects in an attempt to modify individuals’ attitudes, to therefore increase cessation 
intentions and attempts (Lancaster et al., 2000). In addition to mass media campaigns the 
government has also implemented a number of smoking bans in an attempt to reduce the 
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occurrence of smoking within the general population. These bans include the smoke free law 
introduced in England on 1st July 2007, which banned smoking in workplaces and enclosed 
public spaces (Hawkins, Cole & Law, 2011); the illegalisation of smoking in cars and other 
vehicles with anyone present under the age of 18 years, introduced on 1st October 2015 
(Department of Health, 2015a); and the launch of smoke free zones in major outdoor spaces 
(currently implemented within Nottingham and Bristol) (Abbott, 2011; BBC, 2016; The 
Telegraph, 2014). These bans aim to reduce the normalisation of smoking within the general 
population, protecting non-smokers from the adverse health effects of passive smoke 
(Department of Health, 2015a). In terms of CF, environmental tobacco smoke is associated 
with a decreased lung function, as well as lower weight (Ong et al., 2017). In addition to non-
smokers, these bans aim to improve the health of smokers, and are associated with various 
health benefits. As a consequence of the smoke free law there have been 1200 fewer 
hospital admissions for heart attacks in England, and Scotland has experienced a 10% drop 
in premature births (Mackay, Nelson, Haw & Pell, 2012; Sims, Maxwell, Bauld & Gilmore, 
2010). Whilst the current smoking bans have had some effect, further measures are 
required.  
The use of electronic smoking devices as an aid to smoking cessation has increased 
in recent years, however they are not licensed as medicines (Department of Health 2015b). 
These devices are designed to deliver nicotine in a vapour form (ASH, 2016b), with it being 
reported that they are now the most popular smoking cessation aid (Smoking in England, 
2016), which appear to be effective (Department of Health, 2015b). Whilst electronic 
cigarettes are addictive, they are considered to be less harmful than smoking (Ash, 2016b). 
However, due to electronic cigarettes being a new intervention there is an absence of 
comprehensive scientific studies (Giroud et al., 2015), and long-term health implications are 
currently unknown (Britton & Bogdanovica, 2014; Hajek, Etter, Benowitz, Eissenberg & 
McRobbie, 2014), with Pisinger and Døssing (2014) stating that although no firm conclusions 
can be drawn on the safety of electronic cigarettes, they can hardly be considered harmless. 
Furthermore the specific effects that electronic cigarette use has upon distinct populations, 
such as the CF population, again is unknown, with fears that such engagement could result 
in respiratory infections due to cleanliness of the devices, or natural fungi that exists within 
the substances used within electronic cigarettes (Reddit, 2015). 
 Due to the normalisation of electronic cigarettes, it is reported that they are not just 
used by individuals who wish to attempt smoking cessation, they are used by individuals 
who have never smoked (Tan, 2015), with Kamerow (2015) reporting that more young 
people "vape" electronic cigarettes than smoke conventional tobacco cigarettes, with 
adolescents who have used electronic cigarettes being more likely to then smoke 
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conventional tobacco cigarettes (McCarthy, 2015). In addition, electronic cigarettes are also 
providing marijuana users with a new method of inhaling cannabinoids, with the use of 
electronic cigarettes often resulting in less detection from others (Giroud et al., 2015). Giroud 
and colleagues (2015) therefore suggested that a consequence of the normalisation of 
electronic cigarettes may be that adolescents are being provided with an alternative gateway 
to marijuana and nicotine. With individuals with CF, it has been speculated that vaping 
marijuana could be associated with an increased risk of the development of aspergillus, 
which has very severe consequences upon the health of an individual with CF (Cystic 
Fibrosis, 2015). Consequently research is needed to investigate the incidence, prevalence 
and effects of electronic cigarettes (both in terms of nicotine and marijuana) within a CF 
population, to see whether this alongside smoking is an issue within individuals with CF. 
Excessive alcohol consumption and Cystic Fibrosis 
 Excessive alcohol consumption and binge drinking are also seen to be risky 
behaviours within the general population, with the consequences of such behaviours being 
well documented. Excessive alcohol consumption and binge drinking impacts upon the 
whole body and plays a role in the development of numerous medical conditions, increasing 
an individual's risk of cancer, including mouth, oesophagus, throat, liver and breast (National 
Institute on Alcohol Abuse and Alcoholism, 2017; NHS, 2016c). Most commonly alcohol 
abuse can impact upon the heart, potentially resulting in cardiomyopathy, arrhythmias and 
high blood pressure; the liver, potentially resulting in cirrhosis, steatosis and alcoholic 
hepatitis; the pancreas resulting in pancreatitis; the immune system, potentially resulting in 
the body being vulnerable to pneumonia; and the brain, potentially resulting in Korsakoff’s 
syndrome which is characterised by persistent memory and learning impairments (NHS, 
2016c).  
 In terms of the prevalence of excessive alcohol consumption in England, it is 
reported that 29.9 million people (58% of the population) drink alcohol on a regular basis, 
with 38% of secondary school pupils reporting experimentation with alcohol (NHS Digital, 
2016). Males are more likely to drink excessive amounts of alcohol (34% of men and 27% of 
women drank more than the recommended guidelines), with elder people tending to drink 
more frequently than younger people (1% of 16-25 year olds had drunk every day of the 
previous week compared with 13% of individuals aged 65 years and above), however 
younger people tend to drink more heavily on a single occasion than older people (6% of 
men and 2% of women aged 65 years and above had drunk heavily at least one day in the 
previous week, compared to 22% of men and 18% of women aged 16-24 years) (Office for 
National Statistics, 2011). 
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Alcohol use (particularly binge drinking) within individuals with CF is problematic 
because of the impact alcohol use as well as CF can have upon the liver, with CF liver 
disease being the third leading cause of death in CF (Sakiani et al., 2017); as well as the 
increased risk of developing pancreatitis (NHS, 2015; Withers, 2012), and the possibility of 
alcohol-induced hypoglycaemia within individuals who have CFRD (The CF Trust, 2013a). 
Symptoms of alcohol-induced hypoglycaemia include abdominal pain coupled with vomiting 
(Withers, 2012); therefore these symptoms are often mistaken for being drunk (The CF 
Trust, 2013a). Despite these adverse health effects, McEwan et al (2012) found that 94% of 
males with CF and 98% of females with CF at Royal Brompton Hospital had tried alcohol, 
with 83% continuing on to drink alcohol regularly. However, McEwan et al (2012) indicated 
that overall 79% of the CF patients they investigated did not drink alcohol, or they drank 
within the recommended guidelines, which is significantly more than the general population 
(77%; p<0.001). 
There are various legislations and mass media campaigns which aim to reduce the 
occurrence of alcohol abuse. These interventions can focus upon informing society about 
the adverse health effects of drinking excessive amounts of alcohol, providing tips on how to 
reduce the amount of alcohol people consume (Change4Life, 2017). In increasing societies 
awareness regarding excessive alcohol consumption, the alcohol industry provides on 80% 
of product labels the unit information of that product, the recommended drinking guidelines, 
and a warning regarding drinking during pregnancy (Department of Health, 2015c). To 
reduce the alcohol individuals consume, the government are trying to increase the price of 
the cheapest drinks by implementing a minimum price per unit of alcohol, and banning drink 
offers (e.g. 2-for-1 offers) (Department of Health, 2015c). The government are also currently 
working with the advertising standards authority and ofcom to stop alcohol advertisements 
appealing to young people, by stopping these adverts being aired during programmes that 
appeal to younger generations (Department of Health, 2015c).  
The government have also implemented an alcohol risk assessment which is 
included within the NHS health check for adults between the ages of 40-75 years 
(Department of Health, 2016; NHS Health Check, 2017). In addition hospitals have alcohol 
liaison Nurses to assist individuals admitted with alcohol-related problems, to ensure they 
receive the appropriate treatment (e.g. treatment for alcohol dependence), with the 
government currently developing a model to specifically support young people admitted to 
hospital with alcohol-related problems (Department of Health, 2016). In addition to the 
government's efforts, within the UK there are also a number of contacts for individuals who 
feel they have an alcohol problem, such as "drinkline", "alcoholics anonymous" and 
"addactions". These contacts range from being a confidential helpline, right through to self 
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help groups and treatment agencies (Addactions, 2015; Alcoholics Anonymous, 2017; NHS, 
2016d). Despite the success of these legislations and interventions, alcohol misuse is still 
prevalent within the UK; therefore new interventions are required.  
Illicit drug use and Cystic Fibrosis 
Illicit drug use impacts upon all anatomical lung compartments, producing 
morphological changes (Glassroth, Adams & Schnoll, 1987; Tashkin, 1990; Tomashefski, 
2004). It is reported that 8.4% of adults in the UK aged between 16 - 69 years have taken an 
illicit drug, with 15% of pupils in the UK having experience with illicit drug use (Health and 
Social Care Information Centre, 2016). The prevalence of drug use increases with age 
amongst adolescents in the UK, with 6% of 11 years olds reporting that they have tried an 
illicit drug at least once, compared to 24% of 15 year olds (Health and Social Care 
Information, 2016). Common complications of drug use within the general population include 
lung infections, such as HIV, septic emboli and pneumonia (Tomashefski, 2004); all of which 
would increase the severity of an individual's lung disease with CF. Despite these pulmonary 
complications, McEwan et al (2012) found that 35% of CF patients at Royal Brompton 
Hospital had tried illicit drugs, with such drug use commonly compromising of cannabis 
(31%), cocaine (14%) and ecstasy (6%). These statistics are less than the general 
population (37%, p<0.001).  
There are a variety of legislations and interventions which aim to reduce the 
occurrence of this risky behaviour. The government aims to reduce the number of young 
people initiating in drug use by providing them with accurate information on drugs and 
alcohol through drug education (Department of Health, 2016) and the FRANK (2017) 
service, which is a website designed specifically for adolescents, to provide them with 
guidance if they feel under pressure to take drugs. The website also provides adolescents 
with contact details so they can receive confidential help about their drug use or thoughts on 
initiation (Frank, 2017). In addition, the government have recognised that drug use is multi-
factorial, therefore the government aims to help young people who are drug dependent to 
get treatment and support, with this support being offered to many areas within their life (e.g. 
housing or mental health problems) so that the young person does not relapse as a way of 
coping with other problems within their life (Department of Health, 2016). Despite these 
legislations and interventions, again illicit drug use is still prevalent within the UK; therefore 
new interventions are required in order to further reduce the occurrence of drug use.  
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Addressing risky health behaviours in the Cystic Fibrosis population 
While smoking, excessive alcohol consumption and illicit drug use are prevalent 
within the CF population, research clearly reports that prevalence for each of these risky 
behaviours is lower in the CF population than it is within the general population (McEwan et 
al., 2012). However, for each of these risky behaviours it is plausible that prevalence within 
the CF population may be higher than the data suggests, due to potential under-reporting by 
individuals with CF (Haire-Joshu et al., 2004). In addition, it is feared that risky behaviour 
prevalence within CF may increase as life expectancy also increases. Treatment advances 
within CF mean that individuals have an improved health status, consequently today 
individuals with CF are more susceptible to engaging in risky behaviours. The age of onset 
for risky behaviour initiation is commonly during adolescence (smoking initiation within CF is 
13-14 years, alcohol initiation within CF is 16.3 years; illicit drug use initiation within CF is 19 
years) (McEwan et al., 2012; Verma et al., 2001); in previous generations individuals with CF 
at that age would most likely have been too ill to consider engagement.   
 Despite the prevalence of risky behaviours within the CF population being reported to 
be less than the general population, the health consequences of engagement in such 
behaviours are far more detrimental for those with CF. Consequently information on 
prevention and cessation need to be specifically tailored to CF so individuals understand the 
CF-specific adverse health effects such behaviours can have, highlighting why individuals 
with CF should not engage in risky behaviours in order to prolong and protect their current 
and future health status. The need for interventions to be specifically tailored to CF is 
highlighted by individuals with CF, with individuals reporting that in addition to the 
interventions found within the general population to reduce the occurrence of risky 
behaviours, individuals also benefit from advice from their doctors, with generic self-help 
documents not being as helpful as personalised material (Aveyard & Raw, 2011; Lancaster 
et al., 2000; Verma et al., 2001). As risky behaviours are still prevalent within the CF 
population despite current attempts by HCPs, it suggests that more effective health 
promotion measures are required specifically within the CF population (McEwan et al., 
2012). Metse et al (2014) indicates that whilst individuals who engage in risky behaviours 
within the general population are inpatients, they are surrounded by information (both verbal 
and written information) that outlines why they should not engage in such behaviours, which 
can impact upon an individual's motivation to attempt cessation. However without post-
discharge support pre-admission risky behaviours often return (Metse et al., 2014). 
Consequently support to aid cessation should be extended into the community after 
discharge to reduce the prevalence of risky behaviours, and personalised information should 
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be provided to individuals with CF regarding how such behaviours can specifically impact 
upon their CF 
Overall, the prevalence of risky behaviours within the CF population, and the specific 
detrimental consequences such behaviours can have upon an individual with CF, 
demonstrates the need for research-informed interventions to be developed to promote 
healthy lifestyles within the CF population, by reducing the occurrence of risky behaviours. In 
order to create such interventions it was essential for the researcher to understand how UK 
CF units approach the issue of risky behaviours, exploring what awareness is provided to 
patients in an attempt to prevent initiation, and which patients receive this awareness. Insight 
into current UK practice within the CF population was essential to understand how research 
can progress current interventions, to more effectively reduce the occurrence of risky 
behaviours, specifically within the CF population. The evaluation the researcher conducted 
to investigate how the issue of risky behaviours is currently addressed within CF care, 
provided a rationale for this doctoral research, highlighting the need for more effective health 
promotion measures.  
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CHAPTER TWO: TRANSITIONING FROM PAEDIATRIC TO ADULT CARE: AN 
EVALUATION ON MATERIAL AND INFORMATION PROVIDED TO INDIVIDUALS WITH 
CYSTIC FIBROSIS REGARDING RISKY HEALTH BEHAVIOURS 
The problem of risky health behaviours and transitioning into a self-care model 
The initiation of risky behaviours within the CF population, as in the wider population, 
commonly occurs during adolescence, therefore it is timely to discuss such issues during 
transition from paediatric to adult care. The timing of transition from paediatric to adult care 
does vary between individuals, with the majority of individuals transitioning to adult care 
between the ages of 16-18 years (Great Ormond Street Hospital for Children, 2017; NHS 
Choices, 2015; University Hospital Southampton, 2014). Transitioning from paediatric to 
adult care is significant not only for HCPs, but also for patients who transition from a model 
of care-from-others to a more independent model of self-care. Whilst many young adults 
continue to be monitored and guided by parents when outside the care of professionals, this 
is not the case for all individuals with CF, and even with the most engaged supportive 
parents or carers, risky behaviours may still be prevalent in young adults with CF. It can be 
reasonably assumed that a significant number of young adults with CF are behaving as any 
other young adult, and the time of transitioning into adult care is about the time where risky 
behaviours initiate and can become a problem in the CF population (McEwan et al., 2012).  
The transition period is a time where individuals are expected to take on more 
responsibility (University Hospital of South Manchester, 2014), and have a more active 
involvement in treatment decisions (Barber, 1995). Research indicates that as the 
responsibility of regulating health behaviours shifts from the clinicians and family to the 
individual, risky behaviours within the CF population become prevalent (McEwan, et al., 
2012). Risky behaviours result in adverse health effects upon patients regardless of their 
adherence to medical regimens (Mays et al., 2012; Withers 2012), therefore additional 
support during transition is key in increasing the health and wellbeing of individuals with CF. 
Huq et al (2011) emphasised the importance of risky behaviours being explored with patients 
at periodic reviews to identify those who are more vulnerable to initiate such behaviours. The 
transition period would be an appropriate time to discuss risky behaviours with patients, as 
clinicians often talk to patients without parents or guardians, and respect patient 
confidentiality (University Hospital of South Manchester, 2014). 
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Current material and information 
The researcher conducted an evaluation on the information received by individuals 
with CF in the UK during their transition. All nineteen adult CF regional units in England (The 
CF Trust, 2017d) were contacted, and out of these sixteen units replied. Written information 
regarding risky behaviours during transition is currently provided by two CF units. These 
units administer the ready, steady, go questionnaires (University Hospital Southampton, 
2014) to paediatric patients three times prior to transition, which assists the adult medical 
team in developing an individual treatment plan. Within this questionnaire there are two 
questions which relate to risky behaviours:  
1) “I understand the risks of alcohol, drugs and smoking to my health” 
2) “I know where and how I can access information about sexual health” 
Answers are given by either ticking a “yes” or “no” box. Additional options exist, such as 
ticking a box “I would like some extra advice/help with this”; and there is the opportunity for 
individuals to write comments. When adolescents with CF are transferred to the adult unit, 
they receive the same questionnaire on three different occasions, enabling identification of 
changes in an individual’s awareness of whether or not they understand the consequences 
of risky behaviours.  
One further adult unit provides individuals with verbal information specifically on risky 
behaviours during transition, but they do not use generalised leaflets or written 
questionnaires, suggesting that all individuals are different and require support in different 
areas. It is recognised though that the consequences of risky behaviours are similarly 
detrimental for all individuals with CF. Consequently it has to be questioned whether 
standardised written information on the adverse health effects of risky behaviours should be 
incorporated, as a preventive method to the treatment of all individuals who are transitioning, 
regardless of their personal identification of being ‘at risk’ or not.  
  HCPs at this unit record such discussions with the use of a transition proforma. The 
transition proforma asks HCPs to tick "yes" or "no" to indicate whether or not smoking, 
recreational drugs and alcohol have been discussed with the CF patient, with HCPs having 
to document any concerns that were present prior to transferring. These actions are best 
practice, and understandably such discussions are not always fully undertaken due to 
competing clinical pressures. Informal communication (2015) with HCPs involved in CF care 
to inform this evaluation, suggest that discussions around risky behaviours are not prioritised 
for a number of reasons, including time pressures, other pressing clinical needs and an 
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unwillingness of young people to engage openly in such discussions. To overcome these 
issues, individuals with CF could be provided with a standardised questionnaire to attain rich 
and useful information about an individual's knowledge and attitudes towards risky 
behaviours, followed by a standardised leaflet outlining the consequences of risky 
behaviours specific to CF; this would complement any verbal information received. 
Individuals forget up to half of the information/advice that has been given within five minutes, 
and recall only 20% of the information (Entwistle & Watt, 1998; Little, Griffin, Kelly, Dickson 
& Sadler, 1998). Patient retention of information can be improved with supplemental written 
information (MacFarlane et al., 2002). 
All twenty paediatric CF regional units in England (The CF Trust, 2017e) were 
contacted, and out of these twelve units replied. Written information regarding risky 
behaviours during transition is currently provided by two paediatric CF units. One unit 
provides individuals with a questionnaire (as previously discussed), and the other unit 
provides information to patients from health education about sexual health, drugs and 
alcohol. This information is not specific to CF, however it does provide information regarding 
the effects of these behaviours. This information could be improved further by outlining the 
effects of these behaviours upon CF, and certainly provides grounds for further 
investigations. 
Issues with the current materials and information 
This evaluation of current practice in providing information and materials indicated 
the need for standardised risky behaviour advice from HCPs, and the need for research 
informed practice, which is scant in the area of CF. Specifically, the evaluation indicated that 
services address risky behaviours in different ways, with many units not incorporating risky 
behaviours as a formal part of their transition process. The majority of units approach the 
issue of risky behaviours on an individualised basis, which may involve a referral to the 
psychosocial team; however this is focusing on aiding the cessation of an already 
established behaviour, rather than preventing initiation. It is well known that risky behaviours 
are much easier to prevent than terminate once initiated, and missed opportunities appear to 
be a common phenomenon in past and current practice (Jáen, Strange, Tumiel & Nutting, 
1997).   
Furthermore, despite the positive efforts of two adult units, where they acknowledge 
the occurrence of risky behaviours, the use of questionnaires to identify patient vulnerability 
may be problematic. If an individual has ticked the box to indicate that they are aware of the 
risks of such behaviours, the individual is merely indicating that they understand the risks, 
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but they may not necessarily disclose that they have engaged or are contemplating 
engaging in these behaviours. Additionally, due to social desirability bias, it may be that 
individuals respond in a positive way, in order to be viewed favourably by their new clinicians 
at the adult unit (Krumpal, 2013; Lippitt, Masterson, Sierra, Davis & White, 2014; Sanzone et 
al., 2013).   
In conclusion, all the adult and paediatric CF units contacted do have procedures in 
place when an individual engages in a risky behaviour, but more emphasis should be placed 
on preventing initiation, and this should start when most of those risky behaviours start, that 
is, before and during transition. Therefore qualitative research is required to inform such 
interventions, by investigating individuals’ beliefs and attitudes towards risky behaviours, 
which may provide an interpretive perspective. The main conclusion drawn from this 
evaluation is that the important transition into adult care is challenging for everyone involved; 
patients, parents, HCPs, and even researchers. The importance of investigating risky 
behaviours in the CF population, and putting in place an effective standardised format for 
providing information and support, may assist in the development and provision of health 
care at a crucial time for young people to make choices that have a long-term impact on their 
future health. 
Such research is imperative within the adolescent CF population, as adolescence is 
a period associated with heightened risk-taking behaviours, with adolescents being less 
likely than adults to perceive situations as unsafe (Knoll, Magis-Weinberg, Speekenbrink & 
Blakemore, 2015). There is a positive relationship between age and risk identification 
(Halpern-Felsher & Cauffman, 2001), with individuals under the age of 25 years 
demonstrating poor risk perceptions. Whilst adolescent risk-taking largely reflects 
experimentation rather than long-term problem behaviours (Cohn, Macfarlane, Yanez & 
Imai, 1995), the CF population does not have the freedom to experiment with such 
behaviours due to the severe adverse health effects these behaviours have upon CF 
(McEwan et al., 2012). Upon those foundations the researcher suggested that effective and 
deliverable behavioural interventions should be developed to support HCPs and patients 
further.  
Forum and Twitter discussions between individuals with Cystic Fibrosis 
 Further evidence to support the conclusion that all individuals with CF need to be 
provided with information regarding the consequences of risky behaviours specific to CF, 
arises from discussions that some individuals with CF have on various forums and on 
Twitter. Many young people turn to social media for support and advice, with literature 
explaining how individuals with medical conditions often share information with others with 
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the same condition about their experiences via social media, developing their understanding 
of living with the condition (Shepherd, Sanders, Doyle & Shaw, 2015). The number of 
individuals seeking health information online within the UK has increased dramatically from 
18% in 2008, to 43% in 2013, with an increase of 58% amongst individuals aged 25 to 29 
years (Cole, Watkins & Kleine, 2016). It is reported that today, 70% of adults in the UK are 
using the internet for health advice (Massey-Chase, 2016). Social media and online forums 
provide individuals with the opportunity to disclose their engagement in risky behaviours, or 
thoughts of engagement to others and receive advice regarding these behaviours. These 
online platforms offer individuals with anonymity which is known to increase self-disclosure, 
with it being found that individuals self-disclose more in online environments than in person 
(Ma, Hancock & Naaman, 2016). In addition to anonymity, social media and online forums 
supply individuals with an audience that shares certain traits or experiences (Ma et al., 
2016), e.g. an individual with CF may seek to use a forum specifically designed for the CF 
community. Consequently, online communication can yield peer support and peer 
understanding surrounding issues that young people may feel is absent from adult HCPs.  
 The use of social media and health forums by individuals seeking medical advice 
presents an opportunity to relieve pressures on HCPs, however this does depend on the 
quality of the information found online (Cole et al., 2016). When the researcher examined the 
conversations individuals with CF were having on various forums and on Twitter, it was 
indicated that some individuals with CF are unaware of the results of both risky behaviours 
and non-adherence, for instance some individuals discuss the possibility of missing creon 
tablets to lose weight. The idea of manipulating the use of creon tablets to lose weight is 
prevalent within the CF population, with a parent of a CF adolescent stating that she has 
seen many CF patients use creon to lose weight in order to fit into sociocultural expectations 
(Richards, 2015).  
 Many of the discussions on the forums and on Twitter surround the issue of smoking; 
with CF adolescents inquiring about the adverse health effects of smoking, and asking 
whether or not any other individuals with CF smoke. These discussions indicate that many 
individuals are unaware about what they can and cannot do with their CF, potentially as they 
have not been informed about the adverse health effects of these behaviours by HCPs. 
Some individuals explain that they do not necessarily want to engage in that behaviour (e.g. 
smoking marijuana), however they would like to know what health effects it could specifically 
have upon their CF.  
 Consequently, more information needs to be offered to individuals with CF about the 
adverse health effects of risky behaviours. This information needs to be administered to 
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individuals from their HCPs, instead of individuals using the internet to seek such advice 
from peers. Whilst the internet, particularly social media, is good for patients to use for 
emotional support, in terms of medical advice parents and HCPs have no control over what 
information is displayed upon these webpage's, with this information often not being 
accurate (Massey-Chase, 2016; Richards, 2015). Consequently, CF HCPs need to supply 
individuals with standardised information regarding the adverse health effects of risky 
behaviours, allowing individuals with CF to make a more informed choice about whether or 
not they want to engage in these behaviours in light of the consequences. However, with it 
being suggested that young people favour online communications as opposed to face-to-
face communication, partially due to the anonymity online communication provides an 
individual with, health care could use the benefits of online communication when 
implementing health advice to young people. It is possible that apps and interactive 
anonymous online forums with HCPs could be created which offer individuals with CF health 
advice. This would therefore fulfil the need that is clearly there, to provide individuals with CF 
with more awareness regarding the adverse health effects of risky behaviours, in more 
innovative ways that address what young people want. 
 This doctoral research therefore explores the reasons why some individuals with CF 
engage in risky behaviours, highlighting interventions which could be used within the CF 
population to reduce the occurrence of such behaviours. This research also investigates 
HCPs views towards risky behaviours within the CF population, gaining insight into what 
interventions they believe would work. The researcher aims to collaborate with HCPs and 
patients to create a new intervention to address the issue of risky behaviours, which would 
be welcomed by both patients and HCPs alike. The transition evaluation, and the online 
communications that some individuals with CF have regarding risky behaviours, provides a 
strong rationale for this research, highlighting the need for new proactive interventions to be 
implemented within CF care, which potentially incorporate the use of technology. In order to 
conduct this research, the researcher conducted an in-depth literature review focusing on 
what influences the engagement of risky behaviours, specifically within a CF population, to 
identify any gaps within the literature where this research could be positioned.  
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CHAPTER THREE: WHAT INFLUENCES THE ENGAGEMENT IN RISKY HEALTH 
BEHAVIOURS? 
Despite risky behaviours being prevalent within the CF population and having 
adverse health effects on individuals with CF, there is a lack of research exploring what 
influences engagement in such behaviours within the CF population, with previous research 
(Huq et al., 2011; McEwan et al., 2012; Verma et al., 2001) focusing upon the incidence, 
prevalence and effects of these behaviours (Tyc & Belzer, 2006). In addition there are a lack 
of effective interventions to reduce occurring risky behaviours within the CF population, as 
highlighted within the transition evaluation.   
 Adolescence in CF is a period where individuals are most vulnerable to health 
deteriorations, with some individuals starting to engage in non-adherence, as parents power 
of responsibility over the patient starts to diminish (Bregnballe et al., 2011; Bryon, 2015). 
Despite adolescence being identified as the healthiest and most resilient period of the 
lifespan, Bryon (2015) shows that overall morbidity and mortality rates increase from 200 - 
300% from childhood to late adolescence within the general population, due to features of 
adolescent behaviour which are linked to poor health outcomes, such as an increase in risk-
taking, sensation-seeking and erratic behaviour. The primary cause of death and disability 
during adolescence is due to problems with control of behaviour and emotions, resulting in 
alcohol and substance abuse, eating disorders, reckless behaviour etc; not ill health (Bryon, 
2015; Lawrence, Appleton Gootman & Sim, 2009). 
The experimentation of risky behaviours is “normal” during adolescence; however 
there is a line which causes these normal experimental behaviours to escalate to become 
extremely risky behaviours (Richmond, 2014); and this is also the case for the CF 
population. Bryon (2015) explains that adolescents with CF will behave like their peers 
without CF, and engage in these normal experimental behaviours. Therefore, if the 
contributory causes of adolescent and early adulthood morbidity in CF are related to 
problems with control of behaviour and emotion resulting in risky behaviours, then the focus 
of support, assessments and treatments during adolescence should not just be medical, but 
it also needs to acknowledge that during adolescence an individual's behaviour may be 
changing rapidly. 
 As normal experimental behaviours can escalate to become extremely risky 
behaviours, it is accepted that increasing adherence, and decreasing the initiation of risky 
behaviours is a positive outcome (Abbott, Dodd & Webb, 1996), whilst acknowledging that 
avoidance of regimens and the initiation in risky behaviours may represent an active choice 
(Mitchell & Selmes, 2007) which should be respected. However, individuals cannot make an 
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informed choice if they have not been presented with enough information about the 
consequences of such behaviours. Consequently, it is believed that proactive awareness 
should be presented to individuals with CF regarding the adverse health effects risky 
behaviour can have upon people with CF, to reduce the occurrence of such behaviours.  
Whilst increasing an individual's awareness regarding risky behaviours is essential, it 
does have to be acknowledged that awareness regarding the adverse health effects of risky 
behaviours cannot always prevent initiation, with The Theory of Reasoned Action and The 
Theory of Planned Behaviour highlighting how a persons behavioural intention, and 
therefore their behaviour are influenced by multiple factors, such as their attitude towards the 
behaviour; their subjective norms which include their belief about important others' attitude 
towards the behaviour and their motivations to comply with others; as well as their 
behavioural control (Ajzen, 1988; Ajzen & Madden, 1986; Fishbein, 1967; Fishbein & Ajzen, 
1975). Not surprisingly The Stages of Change Model suggests that interventions to 
encourage the cessation of a risky behaviour are most successful when an individual is 
already considering that behavioural change (Prochaska & DiClemente, 1982). Therefore, to 
create an intervention within the CF population to reduce the occurrence of risky behaviours, 
it is essential that awareness is not considered in isolation to the other factors that influence 
an individual's engagement. Such interventions should allow individuals with CF to make 
more informed choices on their engagement with risky behaviours, whilst being mindful of 
the factors that can influence an individual's engagement in such behaviours, with research 
needing to investigate what influences engagement within the CF population.  
The influential roles of identity and acceptance in risky health behaviour engagement 
There are a number of possible explanations as to why chronically ill individuals 
engage in risky behaviours. Chronically ill adolescents often experience a delay in growth 
and pubertal maturation (Rosen, 1991; Singhal, Thomas, Cook, Wierenga & Serjeant, 1994; 
Turkel & Pao, 2007), often have fewer close friends (Bernhard, 2014; Boyle, di Saint, Sacks, 
Millican & Kylczycki, 1976), fewer friends of the opposite sex (Bernhard, 2014) and date less 
often (Bernhard, 2014; Orr, Weller, Satterwhite & Pless, 1984) in comparison to the general 
population. Britto et al (1998) hypothesises that these maturational challenges contribute to 
the incidence of engagement in normalised risky behaviours in order to obtain peer 
acceptance.  
 Most risky behaviours are normalised within the general population, or within an 
individual’s social group. Within the UK it is reported that 36% of smokers live in a social 
context where they are surrounded by more smokers than non-smokers, influencing an 
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individual's attitude towards this normalised behaviour (Buller et al., 2003). Similarly 
excessive alcohol consumption as a form of socialisation is often seen to be a normal 
experience during young adulthood (Seaman & Ikegwuonu, 2010), with binge drinking being 
identified as the characteristic drinking style in the UK for young adults (Martinic & 
Measham, 2008). Within some populations (particularly the student population) drug use is 
also normalised, with Price (2011) reporting that over 90% of University students have 
friends who actively take drugs. Parker, Williams and Aldridge (2002) also report that illicit 
drug use is becoming increasingly normalised within adolescents.  
 After alcohol and tobacco, marijuana is the most commonly used drug in the UK 
(Drugwise, 2016; FRANK, 2009), with 15.8% of individuals aged 16 to 24 years in England 
having used marijuana within a twelve month period, and 2.1 million people in total (aged 16 
to 59 years) in England using marijuana, again within a twelve month period (Drugwise, 
2016). Marijuana is easily accessible, and many people access it through social groups, 
therefore perceiving this being a criminal activity is low (Hathaway, 2004). Secondary school 
students report that marijuana is easy to access, and the majority of students view the 
behaviour to be recreational even if they themselves do not use it; highlighting that there is a 
high degree of social tolerance towards marijuana use (Hathaway, Comeau & Erickson, 
2011). Adolescents often believe that marijuana cannot be harmful due to it being a natural 
substance (FRANK, 2009; NIDA, 2016); this broader cultural acceptance has been catalysed 
by the media (predominantly social media) where individuals openly advocate "pro-
marijuana" perspectives (Hathaway et al., 2011; Hathaway & Erickson, 2003). Recent public 
discussions surrounding medical marijuana have also most likely had an influence upon 
adolescents’ attitudes towards marijuana, with many young people believing that marijuana 
is a "safe drug" (NIDA, 2016). 
 The normalisation of risky behaviours may increase the likelihood of people with CF 
engaging, to be seen as "normal" and to support a non-illness identity. All patients have 
illness cognitions to provide themselves with a framework for coping and understanding their 
illness (Leventhal, Benyamini & Shafer, 2007a; Leventhal, Meyer & Nerenz, 1980; Leventhal 
& Nerenz, 1985; Leventhal, Weinman, Leventhal & Phillips, 2007b), with one cognitive 
dimension of these beliefs being identity. A retaliation against the illness identity has been 
seen in previous research; Bregnballe et al (2011) indicated that one of the main adherence 
barriers in CF is an unwillingness to take medication in public, due to fear of embarrassment. 
Many adolescents with CF now attend College or University, and are therefore 
provided with the identity of being a “student”. Students are more likely than the general 
population to smoke, drink alcohol or take drugs (NHS, 2016c), often due to the occurrence 
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of cheap student bars, the freedom of living away from parents, and peer pressure (Snipes & 
Benotsch, 2013). This peer pressure may have a greater influence in CF adolescents who 
have moved away from home to attend University, due to their thriving for peer acceptance 
and to be seen as normal, potentially increasing their likelihood of engaging in behaviours 
that are not highlighting their illness identity (Withers, 2012).  
In looking at psychological factors that predict risky behaviours during adolescence, 
Withers (2012) states that adolescence is a time where teenagers are preoccupied with their 
appearance, and comparing themselves to their peers. Adolescents can suffer from 
psychological distress if they perceive themselves to be different to their peers, with this 
being most prevalent amongst chronically ill adolescents (Duff & Latchford, 2010; Withers, 
2012). Having CF may present an increased risk factor for bullying, with people keeping 
distance from individuals with CF in case they "catch" CF (Richards, 2015), causing patients 
to hide their CF from others. The notion of hiding CF is evident within the CF population, with 
individuals often having a need to not be defined by their CF, allowing them a sense of 
normalcy, with the notion of hiding one's illness identity allowing the individual to avoid the 
embarrassment they feel when their CF is on display (King, 2015). As a consequence of 
people with chronic illnesses often having a desire for normalcy and hiding their illness from 
others, Withers (2012) speculates that CF adolescents would be more likely to experiment 
with risky behaviours if their peers also engage in these behaviours. This conformity would 
be a way for CF adolescents to reduce the differences between themselves and their peers, 
and to try and forget about the burden of CF, by having fun and enjoying themselves, 
providing themselves a normal identity.  
Research shows the cognitions which predict risky behaviours within the general 
population include associating these behaviours with fun and pleasure, and the belief that 
these behaviours will reduce their stress, build up their confidence and enable them to be 
sociable (Charlton, 1984; Charlton & Blair, 1989; Ogden, 2012). Literature demonstrates 
how affective beliefs can influence an individual's motivations for engagement in risky 
behaviours, with Lawton, Conner and McEachan (2009) highlighting how negative affective 
beliefs can work to prevent initiation in a risky behaviour, whereas positive affective beliefs 
(associating the behaviour with fun and enjoyment) can influence engagement in such 
behaviours. The cognitions and affective beliefs an individual has regarding a risky 
behaviour are built through interactions with parents, siblings and peers, with these 
interactions having the ability to normalise risky behaviours (Mercken, Candel, van Osch & 
de Vries, 2011).  
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Lader and Matheson (1991) suggested that the main factor which predicts smoking is 
parental smoking, with children being twice as likely to smoke if their parents smoke, due to 
normalisation. In addition, Gutman, Eccles, Peck and Malanchuck (2011) demonstrated that 
negative family interactions are related to increased alcohol consumption and smoking in 
adolescents. Furthermore Lamb and Crano (2014) pointed out that parental beliefs about 
their child’s involvement in risky behaviours may not be accurate, however they are 
influential due to the self fulfilling prophecy, with marijuana-abstinent adolescents being 
significantly more likely to initiate use if their parents believe them to be users, conversely, 
adolescent marijuana users are significantly less likely to continue engagement if their 
parents believe they are abstinent. 
As a consequence of the increasing life expectancy within the CF population, it is not 
just an individual’s family who can influence risky behaviour engagement. Today seven out 
of ten individuals with CF are in employment or education (Saldana & Pomeranz, 2012; 
Owen, 2016); which is accompanied with psychological benefits, with there being a lower 
incidence of depression in employed individuals with CF despite variability in symptoms 
(Burker et al., 2012). These psychological benefits are due to an array of factors, such as 
providing the individual with an additional identity (a working person identity) (Winefield et 
al., 2000). However if a risky behaviour is normalised within the workplace, it may motivate 
individuals with CF to initiate in that behaviour, to provide themselves with a normal identity. 
Therefore, despite it being positive that individuals with CF are living to an age where they 
can work, it is presenting HCPs with a welcomed challenge to try and reduce the occurrence 
of risky behaviour engagement, despite an individual's exposure potentially increasing as a 
consequence of interactions with their peers at work, or within their educational experiences, 
particularly if that individual has come from a family unit where risky behaviours are not 
normalised.  
The issue with identity is closely linked with the labelling theory (Quicke & Winter, 
1994) which suggests that when individuals are provided with a “label” it is often 
accompanied with negative consequences (Telford, Kralik & Koch, 2005), which individuals 
internalise, with the labels becoming self-fulfilling prophecies (Erikson, 1964). Chronically ill 
individuals are often aware of negative stereotypes society holds about them; with 
individuals potentially believing they do not fit in with social norms, contributing to a fragile 
sense of identity (Kelly, 1992). Stigmatisation around chronic illness can be a result of 
missing schooling and being unable to participate in extra-curricular activities, therefore their 
peers may see them as “the kid who's always sick” resulting in them being treated differently 
(Bernhard, 2014, p.1). This is difficult to cope with and may lead to an increase in engaging 
in risky behaviours to reduce others perceptions of their illness identity.  
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 Laws et al (2012) states that people only become adherent to medical regimes, and 
do not retaliate against their illness when they have incorporated their illness into their 
identity and accepted their illness. The identity theory states that “the self” is constructed of 
many different identities based on an individual’s roles and relationships, with “the self” 
having to abandon some identities and incorporate others over time (Laws et al., 2012). 
Identity reformulation (Aujoulat, Marcolongo, Bonadiman & Deccache, 2008) is expected to 
occur during diagnosis of a chronic illness, requiring new behaviours within the individual, 
such as adherence; with Laws et al (2012) suggesting that it is only when this change in 
identity has occurred, and being accepted, that individuals will not engage in risky 
behaviours.  
In terms of CF and identity, individuals are born with CF, so they predominantly will 
have always been aware of their condition; therefore it may be believed that individuals with 
CF would not have to incorporate their illness into their identity. However it is reported that 
this change in self for individuals born with a chronic condition can occur during 
adolescence; this change is gradual with adolescence being a time where new questions 
regarding their chronic condition emerge (Michaud, Suris & Viner, 2007). Such questions 
often surround the cause of their condition, the nature of their condition and their prognosis, 
with this being recognised as the individual incorporating their chronic condition into their 
body image and their sense of self (Michaud et al., 2007). Consequently, the change in self 
experienced by people who have been born with a chronic condition may occur during 
transition to adult care, with Withers (2012) reporting that transition can be an upsetting 
process, due to a loss of familiarity which creates anxieties within the individual (Taylor, 
Tsang & Drabble, 2006). Transition may occur co-incidentally as non-adherence becomes 
problematic (Viner, 1999), and the adolescent may interpret this as rejection from their 
childhood clinicians as a form of punishment (Withers, 2012); causing anxiety (Pacaud & 
Yale, 2005), which could lead to a retaliation against the illness identity.  
 Transition to adult care occurs during a crucial time for identity development; with 
adolescents entering the first of three psychological stages according to Erikson’s theory 
(Santrock, 1995): identity formation, with this typically occurring during adolescence where 
an individual discovers who they are; intimacy, with this typically occurring during young 
adulthood where an individual establishes stable intimate relationships; and generativity, 
with this typically occurring during middle age where an individual has a productive lifestyle 
(Pacaud & Yale, 2005). However, for chronically ill adolescents this transition is made more 
complex due to their illness (Yates et al., 2010). Pacaud and Yale (2005) suggested that 
diabetes created issues in the process of achieving identity, intimacy and generativity; with 
Jacobson, Hauser, Powers and Noam (1982) suggesting this could be due to the delay in 
39 
 
ego development that diabetic adolescents experience, due to the threat diabetes presents 
an individual with, in terms of future complications, which may impair their ability to imagine 
their future. The issues with psychosocial maturation within diabetes may also be present in 
CF adolescents, causing them to not incorporate their illness into their identity (Laws et al., 
2012). 
Further evidence for chronically ill adolescents not incorporating their illness into their 
identity comes from Yates et al (2010), who found that chronically ill adolescents state that 
their illness does not define their identity, with these adolescents expressing a desire to be 
perceived as normal adolescents engaging in normal activities. This desire for normalcy was 
further emphasised by Higham et al (2013) who found that individuals with CF hope to live a 
normal life, where they have long-term relationships, have children, and pursue a career. 
Many of these individuals emphasised that they are normal people doing normal things, with 
one participant disclosing that 80% of him is a bloke living his normal life, and 20% of him is 
CF (Higham et al., 2013). This desire for normalcy is healthy and understandable and is not 
necessarily problematic; it would however be seen to be problematic if it involved the 
engagement in normalised risky behaviours. 
 A crucial concept within identity is image; this was demonstrated by Yates et al 
(2010) who pointed out that many chronically ill adolescents favour a degree of invisibility 
towards their illness, allowing them greater normalcy, regardless of whether this costs them 
consideration off others. With CF, individuals often appear to be physically normal, with CF 
often being referred to as an invisible impairment (Tierney, 2012). However individuals may 
believe that their illness is on display when they have to engage in medical regimens, 
therefore some individuals with CF may consciously choose to be non-adherent and / or 
engage in risky behaviours, to provide themselves again with this sense of invisibility 
(Withers, 2012). Higham et al (2013) reported how some individuals with CF avoid 
treatments that they believe makes them look different to others.  
A desire for invisibility about CF can often prevent individuals disclosing their CF 
status to others (Borschuk et al., 2014; Higham et al., 2013). Due to CF's increasing life 
expectancy, individuals with CF today are expected to disclose their illness identity to others 
(e.g. employers), with non-disclosure often having a negative impact upon an individual's 
psychological functioning (Borschuk et al., 2014; Higham et al., 2013), and providing 
individuals with a gateway to engage in risky behaviours which are normalised within their 
social group, to further provide themselves with this sense of invisibility. For instance, in 
Higham et al's (2013) research statements like “I’ve always hidden my CF”; “I don’t like 
being different” emerged, this potentially suggests that if an individual has peers who engage 
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in risky behaviours, they may be motivated to also initiate in these behaviours, to provide 
themselves with a normal identity, and to reduce the differences between themselves and 
their peers. Furthermore, Higham et al (2013) demonstrated that to be perceived as normal, 
many individuals with CF (particularly female's) hide their illness identity from their new 
partners, with the majority of females with CF only disclosing their illness when they believe 
their relationship is going to be long-term. This could involve females with CF initiating risky 
behaviours that their partners engage in, providing themselves with a sense of invisibility 
towards their CF. 
 Literature also suggests that adherence is influenced by how an individual perceives 
their illness (Audulv, Asplund & Norbergh, 2010); for instance some individuals who hold a 
life-orientated illness perspective (those who focus upon their chronic disease as only part of 
their daily lives) often focus upon their wellbeing, and therefore they may engage in non-
adherence or behaviours that are harmful towards themselves, to live a normal life (Audulv 
et al., 2010). Whereas people who possess a dominant disease-orientated illness 
perspective (where they define wellness as feeling physically well and focus on the medical 
and physiological aspects of their illness) view self-management as mandatory, regardless 
of the implications this can impose upon their social life (Audulv et al., 2010), and therefore 
they would not engage in risky behaviours that could compromise their health. 
Consequently, a desire to be perceived as normal (Higham et al., 2013; Yates et al., 2010), 
due to an individual's life-orientated illness perspective, could suggest that the patient has 
not incorporated their illness into their identity, meaning they have not accepted their 
prognosis, and therefore they cannot be expected to not engage in risky behaviours (Laws et 
al., 2012). These issues with identity and acceptance would only become a noticeable issue 
during transition to adult care; as it is only during this stage that individuals are expected to 
independently manage their treatments (Bregnballe et al., 2011).  
The influential role of unrealistic optimism in risky health behaviour engagement 
If someone has not accepted their illness then the engagement in risky behaviours 
could be a result of denial towards their CF (Telford et al., 2005). Higham et al (2013) 
suggested that people with CF can show signs of denial in an attempt to be perceived as 
normal, with denial being most predominant during adolescence, as it is during the transition 
to adult care where there may be an increased understanding of the progressive nature of 
CF and its future implications (The CF Trust, 2015; Withers, 2012). The CF Trust (2015) 
highlighted how some adolescents with CF avoid their CF, not acknowledging the severity or 
the deteriorating nature of their condition, often stating things such as: "CF doesn't impact 
my life"; "I never let it [CF] hold me back". In addition, when some CF adolescents were 
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asked about what is most stressful within their lives, their answers did not always include 
CF, instead they stated things such as "balancing social life, education and homework" (The 
CF Trust, 2015).  
Denial within CF adolescents could result in the initiation of risky behaviours. Kubler-
Ross (1969) states that individuals with chronic illnesses go through the following stages of 
emotional adjustment: denial, anger, bargaining, depression and acceptance. According to 
Laws et al (2012) acceptance is the period of time where the individual experiences identity 
reformulation, and can be expected to adhere to their medial regimens and not engage in 
risky behaviours, with denial being the first stage of the journey to acceptance. 
Closely linked with denial is optimism, which is often used as a coping mechanism, in 
order to deal with both the physical and emotional demands of CF (Abbott et al., 2008). In 
terms of coping strategies, chronically ill individuals usually use strategies which encompass 
the method of coping (cognitive and behavioural) and the focus of coping (approach or 
avoidance) (Abbott et al., 2008; Holohan & Moos, 1987; Moos & Shaefer, 1993); with 
"approach" focusing an individual's attention on their illness, and "avoidance" diverting their 
attention away from their illness (Abbott et al., 2008). Avoidance as a coping strategy may 
result in a lack of interest in CF or medical regimens, which may involve the individual 
distracting themselves away from their illness (Abbott et al., 2008). In contrast, individuals 
who focus their attention onto their CF may closely monitor their condition, and have the fight 
to "beat" CF, and this constitutes an adaptive coping mechanism (Abbott, 2003; Abbott et al., 
2008; Lazarus, 1966; Miller & Mangan, 1983; Roth & Cohen, 1986; Scheier & Carver, 1985). 
The impact of coping strategies on psychological functioning has been widely 
researched, and good psychological health is associated with more adaptive coping 
strategies (Roesch & Weiner, 2001). In addition, Abbott et al (2008) explained a role for 
coping strategies in influencing an individual's quality of life, with individuals with CF who use 
optimism as a coping strategy having a higher quality of life and greater psychological 
resilience in comparison to other patients (Abbott, 2003). However, many scholars argue 
that this may be unrealistic optimism, which is the tendency for an individual to 
underestimate their likelihood of experiencing adverse events (Weinstein, 1980). This could 
result in biased health perceptions, which may be a manifestation of denial of CF's fatal 
nature (De Ridder, Fournier & Bensing, 2004; Taylor, 1989). Unrealistic optimism could 
mean that individuals deny the presence of physical symptoms which make them appear 
vulnerable (Taylor, 1989). Research on coping within CF is limited, and there is a lack of 
research examining the effects these coping strategies have upon the engagement of risky 
behaviours within the CF population. 
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In the general population, Weinstein (1988) suggests that individuals continue to 
engage in risky behaviours due to their inaccurate perception of risk and susceptibility. 
Unrealistic optimism has been viewed as an influential factor in the initiation of a variety of 
risky behaviours. Research points out that students who are unrealistically optimistic towards 
alcohol, consume more alcohol and experience more adverse effects (e.g. hangovers, 
missed lectures), with these students often possessing a hedonistic perspective (Bissett, 
Wood, Cox, Scott & Cassell, 2011; Dillard, Midboe & Klein, 2009; Henson, Carey, Carey & 
Maisto, 2006). Unrealistic optimism is also seen in smokers from the general population, with 
smokers often believing myths such as exercise will undo most of the adverse smoking 
effects (Weinstein, Marcus & Moser, 2005). Weinstein (1988) states that individuals are 
unrealistically optimistic due to them having selective focus, meaning they ignore behaviours 
they engage in which increases a risk (e.g. “I smoke despite my CF, but that’s not 
important”), and focus on behaviours they engage in which reduces a risk (e.g. “but at least I 
take all my medication”); with this selectivity being compounded by egocentrism, with the 
individual ignoring others risk-decreasing behaviours (e.g. "everyone I know with CF takes 
all their medication, but that’s irrelevant”); focusing upon times when they engage in health-
promoting behaviours (e.g. “I always take my medication during the weekends”) and ignoring 
times they do not (e.g. “I do not take my medication during the week whilst at College”) 
(Weinstein, 1988). 
The notion of selective focus within unrealistic optimism is closely linked to the notion 
of risk compensation, where an individual believes that a risky behaviour (e.g. smoking) can 
be compensated for by another set of behaviours (e.g. adhering to all medical regimens). 
Radtke, Scholz and Keller (2011) signalled that the more compensatory health beliefs an 
adolescent has about their risky behaviour, the less likely they are to stop engaging in this 
behaviour. Risk compensation is used as a mechanism to resolve the cognitive dissonance 
than many individuals who engage in risky behaviours have (Rabiau, Knauper & Miquelon, 
2006), therefore allowing their engagement to continue by restoring a sense of cognitive 
consistency (Festinger, 1957). Consequently, in order to increase the chance of behavioural 
change, an individual's cognitive dissonance needs to be increased, creating an unpleasant 
state of tension within the individual (Festinger, 1957). 
The notion of selective focus can be seen within the general population. Many 
smokers do have smoking-related illnesses but they do not acknowledge the health risks of 
smoking, due to unrealistic optimism (Borrelli, Hayes, Dunsiger & Fava, 2010). Bock et al 
(2001) indicated that 47.6% of smokers admitted to A&E for acute respiratory care do not 
believe that their condition is made worse (or caused) by their smoking behaviour. The 
precaution adoption process model (Weinstein, 1988, 1999) focuses on the association 
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between risk perception and health protective behaviours (e.g. smoking cessation) by 
investigating risk communication (Borrelli et al., 2010). Risk perception is a multi dimensional 
construct which includes an individual’s felt vulnerability, optimism and their perceptions on 
how effective the precautions are (Borrelli et al., 2010).  
Much literature has focused on the concept of risk perception within risky behaviours, 
and how this concept involves individuals processing risk information in a way which enables 
them to continue their behaviours (Jacks & Cameron, 2003). For example, some individuals 
with CF do engage in risky behaviours despite their adverse health effects, and despite 
warnings that appear within the general population, such as pictures of damaged lungs on 
cigarette packets (Moodie, Mackintosh & Hastings, 2013). In terms of pictorial images, they 
are often not effective in preventing smoking within the general population (Moodie et al., 
2013) due to individuals managing to ignore the data or find reasons for rejecting it 
(Sherman, Nelson & Steele, 2000). Thus new interventions are required, both within the 
general population and within the CF population, in order to reduce the occurrence of risky 
behaviours despite unrealistic optimism within individuals.  
In terms of risk perception, Halpern-Felsher, Biehl, Kropp and Rubinstein (2004) 
suggested that the higher vulnerability an individual perceives, the greater their intention will 
be to attempt cessation. These results are consistent amongst chronically ill individuals (Hay 
et al., 2007) with Borrelli et al (2010) indicating that when medically-ill individuals experience 
a change in their perceived vulnerability to diseases related to their risky behaviour, it 
predicts their likelihood for cessation; whereas individuals who display unrealistic optimism 
towards their illness are likely to continue their engagement. Based on Borrelli et al’s (2010) 
findings it is plausible that individuals with CF who are unrealistically optimistic will continue 
their risky behaviour engagement until they experience a change in their perceived 
vulnerability (e.g. decrease in lung function), however this must be coupled with the 
individual perceiving that the precautions (cessation) will be effective and beneficial towards 
their health. Being unrealistically optimistic may be seen as an adaptive coping mechanism 
as it improves psychological quality of life, but it also may be seen as a maladaptive coping 
mechanism if there is an underestimation of the severity of disease, with an associated 
increase in engagement with normalised risky behaviours with detrimental physical 
consequences to health.  
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The role of motivation in risky health behaviour engagement 
 To understand why people engage in risky behaviours, we need to investigate what 
motivates individuals to initiate in risky behaviours, and what motivates cessation. Rapid 
brain changes occur between the ages of ten and twenty five years, with this transitional 
phase between the "child brain" and the "adult brain" being host to specific brain changes 
that underpin behavioural and emotional tendencies, which in turn can create problems that 
emerge during adolescence (Kuhn, 2006). These rapid brain changes include the prefrontal 
cortex being restructured resulting in the potential for poor decision making; the thinning of 
unused neural connections and pruning of synapses resulting in the potential for poor 
behavioural control; and an increase in myelination resulting in the potential for poor 
behavioural modulation (Bryon, 2015; Del Piero, Saxbe & Margolin, 2016). These brain 
changes have a number of implications for adolescents, including a reduced ability to 
consider long term consequences, and a poor understanding of what prevention means. 
Bryon (2015) states that adolescents do not intend to pursue health risk behaviours, 
however they are open to these behaviours due to their executive cognitive functioning and 
the notion of avoiding harmful outcomes not being fully developed. Instead adolescents 
possess an immature cognitive functioning where they have a high sensitivity to rewards and 
a low sensitivity to risks; motivations during adolescence are reward-seeking, and involve 
the avoidance of barriers to rewards (Bava & Tapert, 2010). 
 Bryon (2015) states that CF adolescents are seeking the same rewards as their 
peers, and have a need for strong peer identification which leads to engagement in risky 
behaviours. There is little reward in living with CF, with the pressures of managing CF often 
impinging upon the pressures of life (living with a partner, starting a family, starting an 
occupation, finding a social group) during adolescence and early adulthood. Consequently 
CF adolescents may be more motivated to conform to the pressures of life, and to not 
conform to the pressures of CF (e.g. adherence) in order to receive the rewards that 
adolescents typically strive for (e.g. peer identification). 
 Whilst adolescence is just a phase, the possibility that CF adolescents may not 
understand the need for CF treatments, or avoiding risky behaviours due their brain not 
being capable of absorbing and operationalising such information (Bava & Tapert, 2010), 
could have long-term health implications. Bryon (2015) stresses the importance of working to 
overcome the influence of peers and advocates that adolescents are to be included in 
discussions and decisions with their HCPs, with there needing to be an emphasis on 
reducing the occurrence of risky behaviours within these discussions.  
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 In terms of motivations for engagement in risky behaviours, the Self-Determination 
Theory states that there are two different types of motivations (Deci & Ryan, 1985). Firstly an 
individual can have intrinsic motivation (autonomous motivations), which would fulfil 
personally relevant goals and satisfy that individual (Deci & Ryan, 2000), with this commonly 
being associated with the individual engaging in health-related behaviours, and fulfilling the 
basic need of autonomy (e.g. independently adhering to their medical regimens) (Deci & 
Ryan, 1985, 2000). The second type of motivation is extrinsic motivation (controlled 
motivations), where an individual is driven by external factors that often make the individual 
feel less personally satisfied, an example is peer pressure, which is commonly associated 
with individuals avoiding health-related behaviours (Deci & Ryan, 1985, 2000). With 
adherence, self-determination theory proposes that research needs to investigate how 
motivation can be transformed from extrinsic to intrinsic in order to increase adherence. This 
process of shifting motivation may prove difficult given that a person with CF will have had to 
adhere to a long list of complex and time-consuming medical regimens since childhood. 
Additionally, during adolescence engaging in risky behaviours may provide alternative 
intrinsic rewards which compete with adherence as a reward, such as autonomy, self-
management and control over one's own life.  
Stress as a form of motivation 
 Engagement in risky behaviours may also provide an alleviation to stress, with risky 
behaviours potentially being central to an individual's attempt at "reconciling health keeping 
when their reserves of emotional and physical energy are seriously depleted" (Graham, 
1987, p. 55).  For some, engagement in risky behaviours promotes a sense of wellbeing, 
therefore whether an individual views a behaviour to be risky or not, is a product of both 
beliefs and an individual's social world (Ogden, 2012). 
 With the increasing life expectancy many people with CF are now attending 
University and being in employment. Work is a positive experience for individuals with CF, 
with it being associated with increasing self-esteem, and physical and mental wellbeing 
(Targett et al., 2014). However, with many individuals with CF now being in employment, it 
increases the risk of exposure to occupational stress. It is reported that 488,000 people in 
the UK suffer from occupational stress (Health and Safety Executive, 2016), with this chronic 
stress commonly being the result of psychosocial hazards found within the workplace, such 
as workload (Cohen, David, Tyrell & Smith, 1991).  
 Occupational stress may be heightened for people with CF due to an increased need 
for time off work due to ill-health. Within the general population, there is anxiety around 
taking time off work for sickness, with many workers stating that there is already not enough 
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time to complete their work, often resulting in presenteeism (Cooper, 2013; Newcombe, 
2013). People with CF may have to regularly take time off work to prevent their health 
deteriorating, with this having the potential to cause stress and anxiety within the person due 
to them becoming behind at work, and potentially needing to work overtime when they return 
due to their ever-growing workload (Newcombe, 2013). This may be made worse by some 
individuals with CF having poor energy levels, meaning they become easily tired. 
 However, not all workers with CF suffer from occupational stress, due to a variety of 
reasons such as their personality. Pessimistic individuals are more likely than optimistic 
individuals to see stimuli as hazards (Tuten & Neidermeyer, 2004). Nonetheless, if an 
individual with CF did suffer from occupational stress it could motivate them to engage in 
risky behaviours, particularly if these behaviours were normalised within their workplace, 
with such engagement being influenced by extrinsic motivations. The engagement in 
behaviours normalised by one's colleagues would allow the individual to minimise the 
differences there are between themselves and their colleagues, supporting their effort to not 
be defined by their CF. 
 The relationship between psychological distress and risky health behaviours  
 Whilst individuals may engage in risky behaviours with an aim to lessen their stress 
(Kassel et al., 2003), literature also indicates a relationship between the engagement in risky 
behaviours and psychological distress. Perkins, Karelitz, Giedgowd, Conklin and Sayette 
(2010) report that risky behaviours (predominantly smoking) are reinforced within individuals 
with a history of depression, and those with lower distress tolerance, due to the alleviation of 
stress they experience by engaging in these behaviours. Research also illustrates the effect 
that mood can have upon smoking interventions, with it being reported that a negative affect 
is related to smoking intervention failure (Breslau, Kilbey & Andreski, 1992; Hall, Munoz & 
Reus, 1994; Hall, Munoz, Reus & Sees, 1993). Similar results have been found when 
looking at excessive alcohol consumption, with people who experience psychological 
distress being twice as likely to be heavy or problem drinkers (Boden & Fergusson, 2011; 
Kavanagh et al., 2011). However, research cannot specify whether or not psychological 
distress results in the initiation of a risky behaviour, or whether psychological distress occurs 
as a consequence of engagement (Boden & Fergusson, 2011).  
Research indicates that individuals with a chronic illness are at a greater risk of 
suffering from depression in comparison to the general population (Haire-Joshu et al., 2004). 
The prevalence of depression within the CF population does vary, with Latchford et al (2010) 
reporting that 21% of adults with CF have mild depression, and 12.9% of adults with CF 
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have moderate - severe depression. Consequently, due to the relationship between 
psychological distress and risky behaviour engagement, effort needs to be employed to 
identify such individuals who may be vulnerable to initiation. The focus of this intervention 
could be about highlighting individuals who are emotionally immature, and encouraging 
those individuals to develop emotional sobriety, due to research indicating a link between 
addiction and emotional immaturity, with individuals who turn to substance abuse often 
feeling unable to deal with their feelings (Sweet & Miller, 2016). In contrast individuals who 
have developed emotional sobriety often suffer less from stressful situations due to 
developing meaningful interpersonal relationships, being optimistic, and feeling able to deal 
with tough situations without abusing substances (Sweet & Miller, 2016). Consequently, 
developing emotional sobriety could form part of an intervention to reduce the occurrence of 
risky behaviours within the CF population, whilst acknowledging the other issues discussed 
earlier. 
Research Aims 
Given the adverse health effects of smoking, excessive alcohol consumption and 
illicit drug use within the CF population, more effective health promotion measures are 
needed to reduce the occurrence of these behaviours (McEwan et al., 2012), with the 
transition evaluation highlighting the need for new proactive interventions to be integrated 
into CF care to reduce the occurrence of such behaviours. There is a lack of research 
exploring what influences engagement with risky behaviours within the CF population, with 
existing literature (Ernst, Johnso & Stark, 2011; Higham et al., 2013) not incorporating risky 
behaviours into discussions surrounding the psychological implications of CF.  
Previous research focusing on risky behaviours within the CF population has for the 
most part, taken a positivist approach, utilising questionnaires to investigate the incidence, 
prevalence and effects of risky behaviours (McEwan et al., 2012; Verma et al., 2001). 
Therefore, research is needed to progress previous work by investigating individuals’ 
reasons as to why they do or do not engage in risky behaviours, with the current research 
utilising qualitative interviews to take an interpretive perspective. Personal identity, levels of 
acceptance and managing CF as an adult were some of the themes explored, with 
participants able to discuss issues that the researcher had not anticipated, empowering 
individuals through allowing their voice to shape this research due to it being person-centred, 
in line with the guidelines provided by Owen (2016).  
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CHAPTER FOUR: METHODOLOGY - AN EXPLORATION OF RISKY HEALTH 
BEHAVIOURS WITHIN THE CYSTIC FIBROSIS POPULATION 
 Risky behaviour engagement within the CF population is an under-researched area, 
with a poor understanding of why some individuals with CF engage in risky behaviours. 
Previous research within this area has taken a positivist approach, outlining statistics on the 
incidence, prevalence and effects of risky behaviours, with the current research aiming to 
provide a narrative behind these statistics, offering greater insight as to why some 
individuals with CF engage in such behaviours. Accordingly, this research emphasised the 
perspective of the individuality of each participant in exploring reasons for risky behaviour 
engagement. To conduct this exploration it was essential to collect data that was rich in its 
descriptive attributes, which could be obtained through in-depth interviews (Denzin & 
Lincoln, 2000; Howitt, 2013). All phases of data collection within this research did not just 
acknowledge "the individual", they also acknowledge the characteristics of the everyday 
social world which impact an individual's experiences. The research reports great detail 
regarding the lives of individual participants, and how their experiences have influenced their 
behaviours, attitudes and beliefs. All of which would not have been possible to obtain without 
the utilisation of qualitative methods, with qualitative interviews being one of the most 
widespread method of inquiry across social sciences today (Brinkmann, 2016).  
Series of Events  
Figure 1. An outline of the structure of the whole study which provided a qualitative exploration of 
experiences and beliefs around risky health behaviours in a paediatric and an adult Cystic Fibrosis 
population 
 
 
 
 
 
 
 
 
Pre-Data Collection Activity 
The researcher conducted an evaluation on the information received by individuals with CF in the UK 
during their transition, to investigate whether any information is provided to patients regarding risky 
behaviours. 
 Nineteen Adult CF Units were contacted 
o Sixteen Adult CF Units replied 
 Twenty Paediatric CF Units were contacted 
o Twelve Paediatric CF Units replied 
Findings: 
All the adult and paediatric units contacted do have procedures in place when an individual engaged in a 
risky behaviour, but more emphasis should be placed on preventing initiation, and this should start when 
most of those risky behaviours start, that is, before and during transition. Therefore qualitative research is 
required to inform such interventions, by investigating individuals' beliefs and attitudes towards risky 
behaviours. 
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Phase One Data Collection 
 Twenty-four adult participants (male: 16, range 19-66 years, mean: 34 years) were recruited, with a 
median FEV1 60.77% predicted.  
 Seventeen participants disclosed during the interview that they did engage in risky behaviours 
o Four of these participants were initially identified by their multi-disciplinary team to be "non-
risky" 
This phase of data collection focused upon an individual's feelings and motives during initiation, or explored 
why they had never engaged in risky behaviours, consequently retrospective qualitative interviews were 
used. 
Findings: 
This phase of data collection successfully provided insight into the variety of reasons why some individuals 
with CF engage in risky behaviours. It became evident that the initiation in such behaviours, or at least the 
contemplation of engagement, commonly occurs during adolescence. The second phase of data collection 
was therefore driven by these findings. 
Phase Two Data Collection 
 Ten paediatric participants (male: 5, range 12-18 years; mean: 14 years) were recruited, with a 
median FEV1 69.14% predicted.  
Based upon the findings from phase one data collection the researcher considered it to be essential to talk 
with paediatric CF patients. This phase of data collection aimed to investigate paediatric participants' 
knowledge, beliefs and attitudes towards risky behaviours, at an age commonly associated with initiation. 
The semi-structured interviews conducted were prospective interviews. 
Findings: 
Overall, both phases of data collection highlight a variety of reasons why individuals may be motivated to 
initiate in risky behaviours. Within both phases of data collection some participants explained how they had 
not received awareness regarding the adverse health effects of risky behaviours from their HCPs. The 
researcher therefore deemed it essential to discuss the issue of risky behaviours with HCPs, to explore what 
awareness they provide their patients with concerning risky behaviours, and whether or not there are 
procedures in place to determine which patients receive this information. 
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Phase Three Data Collection 
 Nine CF Specialist Nurses were recruited (three paediatric Nurses, five adult Nurses, one adult and 
paediatric Nurse; range of experience: 11 months - 23 years, mean = 14 years). 
The researcher only recruited CF Specialist Nurses as both adult and paediatric participants disclosed that 
they are closest to Nurses than to other members of the multi-disciplinary team, therefore it was believed 
that Nurses would be well placed to offer valuable insights into the issue of risky behaviours and effective 
interventions. Telephone interviews were conducted due to their asynchronous communication of place. 
Findings: 
The findings from this phase of data collection coincide with the findings from the transition evaluation and 
the previous phases of data collection, with the need for new interventions being demonstrated, in order to 
reduce the occurrence of risky behaviours. As this phase of data collection only investigated how Nurses 
perceive the issue of risky behaviours, and what interventions they would like implemented, the researcher 
identified the importance of speaking to, and collaborating with other HCPs. 
Phase Four Data Collection 
 Four Dissemination Meetings were conducted 
The researcher viewed the act of dissemination to be crucial for this research, as in order for the findings to be 
used to create an intervention that has practical applications, the researcher needed to gain the views of HCPs. 
The researcher believed that dissemination was the first stage of collaboration with HCPs to create an 
intervention, allowing HCPs the opportunity to critique and evaluate the findings generated during this 
research, helping to ensure the validity of the findings. 
Findings: 
HCPs acknowledged that risky behaviours are a new and growing concern within CF care, with HCPs agreeing 
that the provision of awareness regarding the adverse health effects of risky behaviours is not embedded within 
CF care. Therefore HCPs emphasised the need for new interventions to be integrated into CF care in an 
attempt to reduce the occurrence of such behaviours. The dissemination meetings produced strong 
conclusions and recommendations regarding what interventions could work in practice to reduce the 
occurrence of risky behaviours within the CF population. 
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 The methodology used within each phase of data collection emerged following 
collaborations between the researcher and her supervisory team, as well as with HCPs who 
work within the field of CF. This has helped to ensue the validation of the methodology, with 
this research being a open and collaborative process, with the researcher welcoming 
feedback from others to help shape this research. A pre-data collection activity was 
conducted to offer insight into what information is received by individuals with CF in the UK 
surrounding the issue of risky behaviours during their transition. As discussed, this 
evaluation highlighted that despite all adult and paediatric CF units who were contacted 
having procedures in place when a patient engages in a risky behaviour, more emphasis 
should be placed on preventing initiation. It was therefore considered essential for qualitative 
research to be conducted to inform interventions aimed to reduce the occurrence of risky 
behaviours, by investigating individuals' beliefs and attitudes towards such behaviours 
(Figure 1). The researcher presented the findings from the pre-data collection activity at the 
CF Nursing Association Study Day allowing HCPs to evaluate the findings, helping to ensure 
theory triangulation. HCPs agreed with the researcher that qualitative research was needed 
within this area, pointing out that risky behaviours are often a missed area within CF care. 
Four phases of data collection were conducted to explore how best to address the issue of 
risky behaviours within the CF population.  
 Phase one data collection provided an exploration into experiences and beliefs 
regarding risky behaviours in an adult CF population. Before commencing data collection the 
researcher presented the research proposal to HCPs at each research site, allowing HCPs 
to inform this proposal ensuring the research would work in practice and would have the 
potential to generate useful findings which would have practical applications in informing 
healthcare. Adult participants were recruited for this phase of data collection as there was 
the expectation that some participants would have had experience with risky behaviour 
engagement, and therefore would be able to report what influential factors affected their 
engagement. With this phase of data collection focusing upon an individual's feelings and 
motives during initiation, or exploring why they have never engaged in risky behaviours, 
retrospective interviews were used. These interviews aimed to understand changes within 
participants over time, and to create a time dimension to the data, identifying influential 
factors which contribute to the initiation of risky behaviours within CF (De Vaus, 2006). 
Smedley et al (2015) report that retrospective interviews offer an accurate description of 
human behaviour within health research, with these interviews enabling individuals to assess 
the influence a situation had upon their identity and experiences, when they were more 
distanced from it (Taylor, 2008; Yates et al., 2010). Retrospective interviews aid participants 
in reconstructing their past, encouraging them to recall the process, choices and decision 
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making regarding risky behaviours as accurately as possible, with it being easier to disclose 
sensitive or embarrassing information when an individual is more distanced from the event 
(Gidlof, Holmberg & Sandberg, 2012).  
 Phase one data collection successfully provided insight into the variety of reasons 
why some individuals with CF engage in risky behaviours. During participant’s retrospective 
accounts, many explained how their experimentation with risky behaviours, or at least their 
contemplation of engagement commonly commenced during adolescence. This highlights 
how interventions to reduce the occurrence of risky behaviours within the CF population 
need to be introduced during adolescence, when individuals are initially making decisions 
regarding such engagement. The second phase of data collection was therefore driven by 
these findings, with the researcher considering it to be essential to talk with paediatric CF 
patients before developing an intervention. Before commencing the second phase of data 
collection, the researcher presented the findings from phase one data collection, along with 
the proposal for phase two data collection to HCPs at the research sites for phase two data 
collection. This allowed HCPs to comment on the findings generated and the new research 
proposal, with this helping to ensure theory triangulation, and again ensuring that this 
research would work in practice and would have the potential to generate useful findings 
which have practical applications. This second phase of data collection aimed to investigate 
paediatric participants' knowledge, beliefs and attitudes towards risky behaviours, at an age 
commonly associated with initiation, ensuring that any interventions created are relevant to 
all individuals with CF, particularly adolescents. The semi-structured interviews conducted 
within this phase of data collection were predominantly prospective; with the exception of 
one interview where a participant discussed previously drinking excessive amounts of 
alcohol. The use of prospective interviews gave the researcher the opportunity to determine 
what type of, and at what point in time, interventions are needed to address the issue of risky 
behaviours, within a paediatric CF population. Prospective interviews present a deep 
understanding of participants' lives (Engstrom & Forsberg, 2011), allowing this research to 
examine participants' attitudes and beliefs towards risky behaviours in real time (Lally, 
2007). 
 Overall, both phases of data collection highlight a variety of reasons why individuals 
may be motivated to initiate in risky behaviours, presenting evidence for the need to 
progress current interventions aimed to reduce the occurrence of risky behaviours within the 
CF population. Within both phases of data collection there was a reported lack of knowledge 
concerning consequences of risky behaviours, with some adult and paediatric participants 
explaining how they have not received awareness regarding the adverse health effects of 
risky behaviours from their HCPs. The researcher therefore deemed it essential to discuss 
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the issue of risky behaviours with HCPs, to explore what awareness they provide their 
patients with concerning risky behaviours, and whether or not there are procedures in place 
to determine which patients receive this information. During the course of this research, the 
researcher presented the emerging findings at a variety of national and international 
conferences, ensuring the validity of findings through the use of theory triangulation, with 
HCPs and academics agreeing that this research would benefit from direct collaborations 
with HCPs to provide practical insight into effective interventions to reduce the occurrence of 
risky behaviours. 
 Phase three data collection involved discussions with HCPs. CF Specialist Nurses 
were interviewed to gain insight into how Nurses perceive the issue of risky behaviours 
within the CF population. The researcher only recruited CF Specialist Nurses as it was 
believed that they would be responsible for delivering a new intervention regarding risky 
behaviours, in line with previous literature conducted within the general population (Cooley, 
Lundin & Murray, 2009; Fore, Karvonen-Gutierrez, Talsma & Duffy, 2014; Sarna et al., 
2016). In addition, the first two phases of data collection signalled that individuals with CF 
are closer to Nurses than to other members of the multi-disciplinary team (MDT), often 
disclosing more information to Nurses. Therefore, it was believed that Nurses would be well 
placed to offer valuable insights into the issue of risky behaviours and effective interventions. 
The researcher conducted telephone interviews due to the asynchronous communication of 
place, enabling the researcher to interview Nurses from a range of geographical locations 
within the UK (Mann & Stewart, 2000). These interviews provided insight into CF care and 
strategy used to address the issue of risky behaviours, from a wider population than face-to-
face interviews would have generated. In addition, the asynchronous communication of 
place can make individuals more willing to discuss sensitive accounts, which they may have 
been reluctant to discuss face-to-face (Mann & Stewart, 2000). For Nurses, sensitive 
accounts may have been perceived to be the identification of flaws within their service. The 
telephone interviews were synchronous communications of time, so like with the face-to -
face interviews conducted in the previous phases of data collection, the researcher could 
ensure question wording and order were contextual and in response to the participants 
developing account (Braun & Clarke, 2013; Rubin & Rubin, 1995). 
 The findings from phase three data collection coincide with the findings from the 
transition evaluation and the previous phases of data collection, with the need for new 
interventions being demonstrated, in order to reduce the occurrence of risky behaviours. 
This research therefore provides an opportunity for the implementation of research informed 
practice within the CF population. As this third phase of data collection only investigated how 
Nurses perceive the issue of risky behaviours, and what interventions they would like 
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implemented, the researcher identified the importance of speaking to, and collaborating with, 
other HCPs in order for this research to have a "real world" impact in the practice of health 
care (Henriksen, Battles, Marks & Lewin, 2005). The final phase of data collection allowed 
the researcher to disseminate the research findings, allowing HCPs to critique the findings 
and offer suggestions regarding what interventions could work in clinical practice. 
 The researcher viewed the act of dissemination to be crucial for this research, as in 
order for the findings to be used to create an intervention that has practical applications, the 
researcher needed to gain the views of HCPs. Therefore, the researcher acknowledged the 
need to make HCPs aware of the research findings, in order for those HCPs to make use of 
such findings (Freemantle & Watt, 1994), with the researcher believing that dissemination 
was the first stage of collaboration with HCPs to create an intervention (Bradley, McSherry & 
McSherry, 2010). In disseminating the research findings, the researcher was complying with 
the guidelines by the NHS Institute for Innovation and Improvement (2010), and The 
Foundation of Nursing Studies (2010), ensuring the new knowledge this research generated 
was added to the field of CF (Pellecchia, 1999). 
 This final phase of data collection was a crucial process in ensuring the issue of risky 
behaviours within the CF population will be addressed using evidence based practice, where 
HCPs will make decisions on whether to implement future interventions based upon quality 
information which derived from research (Bradley et al., 2010; Scott & McSherry, 2009). 
Through disseminating the research findings with CF HCPs it has ensured that all team 
members are research aware (Scott & McSherry, 2009; McSherry & McSherry, 2001). 
Analysis applied to each phase of data collection 
For all phases of data collection, the audio recordings were transcribed by the 
researcher utilising the Jefferson transcription coding to focus upon phonetic and 
paralinguistic features as well as spoken words, recording what was said and how it was 
said (Heath & Hindmarsh, 2002). To reduce the occurrence of omissions and mistaken 
words within the transcripts, the researcher transcribed each recording within five days of 
conducting the interview or dissemination meeting, improving the quality of the transcripts as 
the memory of what happened during data collection (e.g. body language) rapidly fades 
(Braun & Clarke, 2013). The data was analysed using thematic analysis following Braun and 
Clarke's (2006) model as this is a flexible method. Thematic analysis was used as a 
contextualist method, positioned between the two poles of essentialism and constructionism, 
characterised by critical realism (Willig, 1999). A contexualist method was used due to the 
reasons for engaging in risky behaviours being context-dependent (Brendel & Jager, 2005), 
55 
 
therefore thematic analysis acknowledged how participants made meaning of their 
experiences, alongside the impact the broader social context has upon those meanings; 
indicating that meanings and experiences are socially produced and reproduced rather than 
being inherent (Burr, 1995). This research represented an ontological realistic approach, 
acknowledging that phenomena exist independently without individuals’ perceptions, 
theories and constructions, whilst accepting a form of epistemological constructivism and 
relativism, where phenomena are inevitably a construction from an individuals own 
perspectives (Maxwell, 2012). With this research being characterised by critical realism it 
acknowledges there is no possibility of attaining a single, “correct” understanding of the 
world (Maxwell, 2012; Sims-Schouten, Riley & Willig, 2007); with this research 
acknowledging that mental states and attributes (e.g. intentions to engage in risky 
behaviours) are part of the real world despite them not being observable (Houston, 2001; 
Maxwell, 2012). Secondly, this research rejects the theory of causality and instead focuses 
on processes which influence risky behaviour engagement, in viewing these processes to be 
central to the explanation as to why some individuals with CF engage in risky behaviours 
despite their compromised health status (Maxwell, 2012; Parker, 1998).  
Within each phase of data collection thematic analysis provided a rich thematic 
description of the entire data set, as risky behaviours within CF is an under-researched area 
(Braun & Clarke, 2006), where CF patients' views surrounding risky behaviours had not 
previously been known. In addition, the themes were identified in an inductive way, 
consequently the themes are data-driven and not the researcher’s analytic preconceptions 
(Braun & Clarke, 2006; Patton, 2015). Furthermore, the themes identified were done so at 
the latent / interpretive level, meaning that this research went beyond the semantic content 
of the data, examining the underlying ideas and assumptions which shaped the semantic 
content (Burr, 1995). Therefore, the themes were not just descriptive; they were already 
theorised (Braun & Clarke, 2006).   
To conduct thematic analysis within each phase of data collection, the researcher 
firstly became familiar with the data, paying attention to any patterns that occurred. Data 
familiarisation occurred firstly during data collection and transcription of the data, where the 
researcher actively processed the data. In addition, data familiarisation occurred as a 
consequence of the researcher reading through the transcripts several times. The early 
thoughts from the researcher about what was happening in the data suggested ways in 
which the data could be coded, offering ideas about the themes apparent within the data 
(Howitt, 2013).   
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Once the researcher was familiar with the data, the researcher coded each transcript 
line by line, ensuring the researcher was working with the detail of the data (Howitt, 2013). 
Each code provided a label to describe the content of the quote selected, with each code 
representing something interesting or important about that section of data. The codes 
generated were all data-led, guided by careful analysis of what was in the data (Braun & 
Clarke, 2006). On completion of initial coding, the researcher collaborated with her director 
of studies, allowing the initial codes to be evaluated and revised to ensure they were 
representing the content of the data. At this point the director of studies and the researcher 
became two raters who were coding the qualitative data to form the themes of the data. The 
researcher then created separate documents which contained the data for each code. In 
doing this it became clear whether the code's label was accurately representing the data 
within that code; whether data which received the same code were similar, or whether a new 
code was required to represent different data that had been placed within a code; and 
whether there were similarities between the data in different codes suggesting they should 
be combined (Howitt, 2013). The researcher then presented these revised codes to her 
director of studies, allowing for the codes to again be revised based upon evaluations which 
arose from these collaborations. The validity of the codes were ensured when the researcher 
and her director of studies were in agreement regarding each code. 
Once the researcher and her director of studies were satisfied with the generated 
codes, reflecting upon and revising the initial codes, the researcher generated the themes of 
the data. To create the themes, the researcher categorised the codes into meaningful 
groups of codes, with the themes identifying major patterns which emerged from the codes 
(Braun & Clarke, 2013; Howitt, 2013). During this process the researcher collaborated with 
her director of studies, allowing the two raters to reflect and revise upon the early 
categorisation of codes, ensuring the validity of this process. When generating the themes 
the researcher created a word document for each theme, which contained each code 
represented within that theme, along with the accompanying data for each code. This 
allowed the researcher and her director of studies to review each theme, assessing whether 
each theme accurately represents the data, ensuring there is enough data to support each 
theme, and that each theme does not actually represent two different themes or sub-themes 
(Braun & Clarke, 2013; Howitt, 2013). The validity of the themes were confirmed when the 
researcher and her director of studies both agreed on the themes of the data and which 
codes should be represented within each theme. Through assessing how the themes 
support the data and the overarching theoretical perspective, the researcher defined what 
each theme was, which aspects of the data were being captured, and what was interesting 
about the themes. The process of thematic analysis was completed by hand for all phases of 
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data collection, with the collaborations between the researcher and her director of studies 
helping to ensure the inter-rater reliability of the data generated. 
Considerations by the Researcher 
 The Researcher's Identity. During this research, the researcher spent time 
reflecting on how her identity could influence the data. Whilst it is acknowledged that 
participants feel more comfortable disclosing sensitive information to an individual who is 
broadly similar to themselves, it was not practical nor possible to match the researcher with 
participants based upon major social characteristics, therefore the researcher employed 
caution and sensitivity remaining mindful that participants may have been socially 
marginalised in ways she was not (Braun & Clarke, 2013). Despite the number of differences 
that would have been present between the participants and the researcher within phase one 
data collection with adult CF patients, their age was one social characteristic that was similar 
(mid – late twenties / early thirties), potentially making participants more comfortable when 
disclosing sensitive information; this may have been a result of participants not perceiving 
the researcher to be in a position of control of the interview (Braun & Clarke, 2013).  
Nonetheless, the researcher’s role as a “researcher” may have influenced such 
power relationship, with participants potentially perceiving the researcher to be an “expert”, 
overriding other aspects of the researcher’s identity even if this was shared with participants 
(e.g. age) (Clarke, Kitzinger & Potter, 2004). Furthermore, due to the potential disclose of 
sensitive information, the researcher was prepared to deal with participant’s distress, in such 
instances the researcher would have acknowledged participants distress, asking if they 
needed a break, and if they wanted to continue (or stop); the researcher would have allowed 
participants to express such distress whilst containing it within the context of the interview. 
The researcher would have diverted from the topic that was causing distress, and sensitively 
returned to the topic later in the interview if deemed necessary, and suggested by 
participants that it was acceptable to do so (Braun & Clarke, 2013). This technique was not 
needed to be employed within any of the four phases of data collection. 
Within phase two data collection with paediatric CF patients, a major social 
characteristic that was different between the researcher and participants was age, with it 
being expected that participants viewed the researcher to be a lot older than themselves, 
potentially impacting upon the participants disclosure of information, due to the impact age 
can have upon the power relationship within interviews. The researcher’s identity as a 
"researcher" will again have influenced participants disclosure, due to participants potentially 
perceiving the researcher to be an "expert" (Clarke et al., 2004). The researcher employed 
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effort during the interview to develop a sense of rapport to reduce the power imbalance 
present. Many participants offered detailed accounts into their lives, explaining their attitudes 
and beliefs towards their CF and associated health behaviours, therefore suggesting that 
participants felt comfortable to contribute to the interview, despite the power imbalance. 
Validity 
To ensure validity during this research an interview was conducted on the researcher 
to investigate any biases the researcher had which could influence the research outcomes. 
In addition, the researcher used a reflexive diary and demonstrated triangulation.  
Interview Conducted on the Researcher. Dr Marian Crowley conducted an 
interview with the researcher to investigate the researcher’s knowledge regarding CF, and 
what the researcher was interested in within this chronic illness, to identify any biases the 
researcher may have had that could have influenced the research outcomes. The interview 
suggested that the researcher has a personal insight into CF with the researcher’s partner 
having CF. The researcher believed this insight would enable her to empathise with 
participants as she is aware of what the day to day living is like for an individual with CF. 
This interview indicated that in particular the researcher was interested in individual's views 
regarding their life with CF and the psychological implications this involves. The researcher 
has no personal experience of risky behaviours within CF (in terms of her partner). The 
researcher acknowledged the importance of individual differences in reasons for engaging in 
risky behaviours, with the researcher aiming to investigate the psychological implications 
within CF that can result in risky behaviour engagement, despite the adverse health effects. 
Reflexive Diary.  I kept a reflexive diary during this research enabling me to think in 
a critical and analytical way about the research during its progress, and enabling me to see 
how different areas of the research are related (Day, 2012). For instance, on 3rd May 2016, I 
wrote: 
"This interview was the first paediatric interview where a participant disclosed risky 
behaviour engagement. I find it interesting how individuals aged 12-15 years often report 
being very anti such behaviours, where individuals aged 18+ years often report engagement 
/ experimentation in such behaviours (from phase one data collection)." 
During the research I documented within the reflexive diary how I was constantly aware of 
my identity as a researcher, of the research process and of how each played a role in 
shaping the data (Humphrey, 2014). For instance, on 22nd March 2016 I wrote: 
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"I conducted my first paediatric interview today. The interview was a lot more challenging 
than the adult interviews in terms of encouraging the participant to 'open up' instead of 
providing closed answers. This was to be expected due to the differences in age between 
myself and the participant. However, I did provide a range of prompts to encourage 
elaboration and believe that I managed to generate some useful data." 
Within the reflexive diary I reported where the research inspiration arose from, how I 
generated new research ideas, and my awareness of the research context (O’Reilly, 2012). 
For instance, in November 2014 I wrote:  
"I have decided to broaden my research so it incorporates all risky behaviours, as opposed 
to just smoking. Quantitative research has been conducted within the CF population focusing 
upon the incidence and prevalence of smoking, excessive alcohol consumption and illicit 
drug use. Qualitative research focusing upon all these behaviours will enable me to produce 
more informative findings for CF Clinicians, which will be applicable to a range of risky health 
behaviours." 
The reflexive diary also made reference to my field notes documenting what was observed 
during the research including other’s actions, conversations and my impressions, feelings 
and tentative models (Pritchard & Whiting, 2012). The reflexive diary indicated how 
naturalism was increased during the research as I was present in the CF clinics and wards 
on a regular basis, becoming “part of the furniture”, therefore the research disturbed the 
natural clinic setting as little as possible (O’Reilly, 2012). For instance, I attended the adult 
CF clinic at the Royal Stoke University Hospital every Monday even if the Consultant had not 
identified a suitable patient to interview, providing an opportunity for individuals to be 
recruited on that day: 
"I attended clinic today at the Royal Stoke University Hospital however I did not 
manage to recruit or interview any participants. I understand that at times I will have 
"wasted" journeys, however it does mean that my face stays familiar amongst the team". 
Triangulation. Triangulation was generated to ensure that results accurately reflect 
the reasons that people gave for engaging in risky behaviours, and to be certain that the 
findings are supported by evidence, ensuring the validity of this qualitative work (Guion, 
Diehl & McDonald, 2011). This research involved data triangulation as multiple institutes 
were used to recruit participants for each phase of data collection, providing the research 
with different sources of information (Heale & Forbes, 2014). In an aim to generate theory 
triangulation, the researcher presented this research (aims and methodology to begin with, 
and then any findings as they emerged) at various national and international conferences, 
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and research meetings to use multiple perspectives to interpret the data (Guion et al., 2011). 
This enabled professionals outside of the field to comment on the theory and data 
generated, and to offer different perspectives on this data. The validity of findings was 
confirmed when professionals from different disciplines interpreted the information in the 
same way (Guion et al., 2011). These methods of triangulation demonstrate that the theories 
have been challenged and integrated to produce a clear understanding on why some 
individuals with CF engage in risky behaviours (Thurmond, 2001). Whilst presenting this 
research, the researcher reflected and acted upon points made by fellow academics and 
HCPs (Appendix A). 
Conclusions 
 The methodology used within this research generated an in-depth understanding 
regarding the factors that influence the engagement in risky behaviours within both the adult 
and paediatric CF population, with HCPs highlighting what interventions they believe should 
be integrated into CF care to reduce the occurrence of risky behaviours. The following 
chapters describe each phase of data collection in detail, highlighting how each phase of 
data collection was conducted, and how the findings from each phase of data collection 
informed the next phase of data collection. The findings generated by this research do have 
clinical and practical applications when addressing the issue of risky behaviours within the 
CF population. This doctoral research has created strong conclusions and recommendations 
on how to progress current interventions, aimed to reduce the occurrence of risky 
behaviours within the CF population. 
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CHAPTER FIVE: METHODOLOGY - AN EXPLORATION OF RISKY HEALTH 
BEHAVIOURS WITHIN THE ADULT CYSTIC FIBROSIS POPULATION 
The Research Sites 
 Participants were recruited from Birmingham Heartlands Hospital and the Royal 
Stoke University Hospital. These two research sites were chosen due to existing research 
collaborations and their geographical location. 
 Birmingham Heartlands Hospital is host to the West Midlands Adult CF Centre, who's 
MDT of HCPs includes Consultants, Registrars, Physiotherapists, Dieticians, a Social 
Worker, Psychologists and Specialist Nurses. This unit provides inpatient and outpatient 
care for adults with CF who are over the age of 16 years. A peer report concluded that this 
unit is a "large well-established centre, staffed by an enthusiastic and skilled MDT which is 
housed in a dedicated facility" (The CF Trust, 2013b, p, 1). The researcher had previously 
conducted research here investigating adherence, therefore the researcher had good 
working relationships with the MDT. In order to gain approval from the MDT for this research, 
the researcher presented the proposal and rationale during a MDT meeting. The team were 
supportive of the research aims and objectives.   
 The Royal Stoke University Hospital is host to the North West Midlands Adult CF 
Centre, who's MDT of HCPs includes Consultants, Specialist Nurses, Physiotherapists, 
Dieticians and an Arts Psychotherapist. This unit again provides inpatient and outpatient 
care for adults with CF. A peer report concluded that this unit is "a crucial resource for a 
large region that includes areas of social deprivation" (The CF Trust, 2013c, p, 3). The 
researcher had no prior research experience within this unit, however the Consultant when 
contacted was keen to be involved, believing the research is valuable. The research was 
discussed with the Consultant via email, and then following ethical approval the researcher 
was introduced to the MDT. 
Participants 
Twenty-four adult participants (male: 16, range: 19-66 years, mean: 34 years) were 
recruited, with a median FEV1 60.77% predicted (Table 1).  
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Participant 
Number 
Sex Date of Birth Age Latest Lung 
Function 
Result (FEV1) 
Late 
Diagnosis 
1 Male 20/12/1995 19 years 127%  
2 Male 21/07/1996 19 years 68%  
3 Female 14/03/1983 32 years 56%  
4 Male 11/07/1968 47 years 60% Yes - aged 
40 years 
5 Female 04/10/1995 19 years 50% Yes - aged 
10 years 
6 Female 15/05/1983 32 years 39%  
7 Male 14/02/1949 66 years 95% Yes - aged 
50 years 
8 Female 18/12/1981 33 years /  
9 Male 15/11/1989 25 years 87%  
10 Male 25/01/1983 32 years 30%  
11 Female 03/07/1986 29 years 75%  
12 Female 23/01/1958 57 years 51%  
13 Male 15/07/1981 34 years 32%  
14 Male 11/03/1982 33 years 75%  
15 Male 18/09/1981 34 years 46%  
16 Male 12/03/1972 43 years /  
17 Female 22/03/1987 28 years 81%  
18 Female 22/07/1987 28 years 65%  
19 Male 22/06/1992 23 years /  
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20 Male 28/12/1979 35 years 27%  
21 Male 26/07/1982 33 years 26%  
22 Male 27/01/1969 46 years 26%  
23 Male 16/06/1994 21 years 48%  
24 Male 13/07/1984 31 years 110%  
Table 1. Medical and Demographic Data collected for all adult participants. 
 
Seventeen participants disclosed during the interview that they did engage in risky 
behaviours, with four of these participants initially being identified by their MDT to be "non-
risky" patients during inception. Furthermore, two participants who HCPs had identified to be 
"non-risky" during inception had a history of risky behaviour engagement prior to their late 
diagnosis of CF, which was disclosed during the interview. The researcher received no 
guidance from HCPs regarding a patient’s history with risky behaviours until consent had 
been provided. 
Inclusion Criteria: All adult patients were eligible to take part in the research, however 
adults who were known to have engaged in risky behaviours were specifically targeted for 
inclusion. These patients were identified through discussions with CF Consultants. The 
researcher included “non-risky” participants for two reasons: 
1. CF Consultants may not be aware that individuals have engaged in risky 
behaviours, due to non-disclosure (this was the case for four participants; for 
some participants HCPs were not aware of the extent of participants 
engagement; the researcher did not disclose such information to HCPs). It is 
often easy for HCPs to identify individuals with CF who smoke, because of its 
respiratory implications. However, it is less easy to detect whether an 
individual with CF has engaged in drug use etc. Many participants who 
disclosed a history of drug use indicated that they had not informed HCPs of 
this behaviour (HCPs were often only aware of their smoking behaviour). 
Therefore, by including all adults with CF within the inclusion criteria, 
individuals were not excluded as a consequence of HCPs knowledge.  
2. By including adults with CF who have never engaged in risky behaviours it 
allowed the researcher to draw comparisons between their beliefs, and the 
beliefs of individuals who have engaged in risky behaviours, to inform 
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interventions aimed to reduce occurring risky behaviours within the CF 
population. 
 
Exclusion Criteria. Individuals were excluded if they had a lack of capacity (identified by 
their Consultant) and if they were non-English speakers. These individuals were identified 
through discussions with the CF Consultants and by consulting CF outpatient and inpatient 
lists.  
Where possible all adults with CF who were eligible to participate were invited to do 
so until data saturation occurred. On occasions, eligible patients may have been missed as a 
consequence of the researcher interviewing another participant, or if the Consultants had 
failed to refer an eligible patient. 
Measures 
Semi-Structured Retrospective Interview. The researcher conducted semi-
structured retrospective interviews with adults to investigate their views towards risky 
behaviours. For the purpose of the information sheet and verbal discussions with individuals 
regarding the research, the phrase "lifestyle choices" was used rather than "risky 
behaviours", as it is a less value-laden phrase and incorporates various behaviours that may 
or may not be perceived as risky by participants.  
To achieve saturation the researcher undertook all transcriptions of interviews within 
five days after each interview was completed in order to identify when "nothing new" was 
being heard. A semi-structured interview schedule (Appendix B) was developed through 
consulting the existing literature, and draft schedules were discussed with both patient 
representatives and the researcher’s supervisory team for their input. The researcher 
employed effort to ensure that the interview questions followed a logical order, in line with 
showed good practice, opening questions were less direct or probing and developed as the 
interview proceeded to explore in more detail personal lifestyle choices (Kvale & Brinkmann, 
2009). In addition, the researcher ensured the interview questions were worded to 
encourage rapport, and were not leading, providing enough information to participants so 
they understood what the area of interest was, but participants were free to respond in 
whatever way they wished (Braun & Clarke, 2013). Probes or prompts were used within the 
interview to encourage elaboration; probes consisted of either an “mm” or a specifying 
question, signalling further information was required (Fielding & Thomas, 2008; Kvale & 
Brinkmann, 2009). The researcher also was careful not to interrupt or add comment until the 
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participant had finished answering a question, leaving a short period of silence where 
appropriate in order to give participants the opportunity to elaborate further.  
The semi-structured interviews investigated participants’ beliefs about their CF and 
the impact CF has upon their life, exploring reasons for engaging and not engaging in risky 
behaviours. This research focused upon the roles of identity, acceptance and unrealistic 
optimism in influencing risky behaviour engagement within the CF population; however this 
research was qualitative, allowing for exploration of the defined areas, and also elaboration 
by participants on other topics (Gill, Stewart, Treasure & Chadwick, 2008). The researcher 
did not rigidly adhere to the interview schedule, as question wording and order are 
contextual, and should be responsive to participants developing accounts (Braun & Clarke, 
2013; Rubin & Rubin, 1995). The qualitative interviews enabled the research to take an 
interpretive perspective on risky behaviours within CF, creating humanistic research, which 
meant that individuals with CF, their pain, hopes and fears were not reduced to “technical 
guidelines about how to deal with things”, instead the research viewed participants as people 
(holism) and acknowledged the importance of individual differences (Yates et al., 2010, p. 
19). 
 The interview schedule commenced with a section of icebreaker questions which are 
important when discussing sensitive topics (e.g. life with CF), with the aim of creating a 
sense of rapport with participants, and encouraging greater depth in their subsequent 
answers (Cooley, Holland, Cumming, Novakovic & Burns, 2014), making them feel 
comfortable about contributing honestly during the interview (e.g. disclosing risky behaviour 
engagement) (Ashton, 2014). The icebreaker questions began by encouraging participants 
to discuss their views towards the research (e.g. "What were your first thoughts when you 
were asked to take part in the research?"), with the questions then becoming more personal 
by asking participants about what a typical day is like for them, however it was up to 
participants whether they discussed CF within their typical day.  
 The interview questions then invited participants to discuss the impact CF has on 
their life. The aim of these questions were to provide insight into what an individual's life is 
like with CF, with Cox (2015) demonstrating the need for research to investigate this using 
qualitative methods due to CF being a growing and a changing population. These questions 
predominantly focused upon the challenges of CF to highlight which aspects of their lives 
individuals require support with. This conversation was steered by any disclosed information 
during the ice-breaker questions, with the researcher planning to firstly focus upon treatment 
adherence, with the research framing non-adherence as a risky behaviour. The researcher 
had previously conducted research within the CF population focusing upon adherence, with 
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individuals often providing a large insight into their adherence efforts. Adherence is a topic 
that patients with CF are used to discussing on regular occasions with HCPs, therefore it 
was deemed that this would not be a sensitive topic for participants. As the interviews were 
semi-structured, participants could discuss any other ways they feel that CF impacts upon 
their life, with this section remaining broad and open-ended allowing participants to highlight 
issues that are pertinent to their life and individual circumstances (Cooley et al., 2014). 
 The interview schedule then focused upon the issue of risky behaviours specifically. 
It was expected that by this stage participants would have already disclosed whether or not 
they engage in risky behaviours, however if this was not the case the researcher asked 
participants a question to encourage disclosure: 
"Are there any behaviours that you do engage in, or have engaged in, that others may say is 
not good for your health?" 
The researcher then discussed any disclosed behaviours with participants in a non-
judgemental way, gaining insight into participants’ personal beliefs surrounding these 
behaviours. The handout that participants received alongside their consent to contact form 
illustrated that the researcher was not judgemental about the behaviours participants may 
have engaged in, and was not there to say what behaviours are "right or wrong". The 
handout stated that the research was interested in participants’ personal views and 
experiences about their lifestyle choices, and how they impact upon their health and 
wellbeing (both in a positive or negative way). The researcher was interested in investigating 
whether participants had good awareness on the health effects of risky behaviours, as the 
transition evaluation suggested that individuals with CF may have poor awareness regarding 
the possible health consequences of some behaviours. In addition, the researcher was 
interested in investigating what motivated participants initiation, or why they decided to not 
engage in such behaviours, with a focus upon identity (Withers, 2012), acceptance (Laws et 
al., 2012), and unrealistic optimism (Weinstein, 1980). The next section of the interview then 
encouraged participants to discuss support they receive from others, including family, 
friends, HCPs and others with CF, in order to investigate whether or not this support has an 
influence upon individuals' decisions regarding risky behaviours. The researcher decided to 
ask participants specifically about any relationships they have with others with CF due to this 
being identified by patient representatives as a potential issue within the CF population, with 
the first two interviews conducted also highlighting this issue; therefore due to the risk of 
cross-infection, CF patients meeting face-to-face could also be seen as a risky behaviour. 
 Whilst the interview schedule aimed to generate rapport between the researcher and 
participants, and it was essential for the researcher to empathise with participant’s potential 
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distress, the researcher had to remain professional as a researcher (Ashton, 2014; Hennink, 
Hutter & Bailey, 2011). The interview schedule aimed to make participants feel supported 
and comfortable to disclose potentially sensitive information, with the researcher 
communicating interest and concern for participants by being empathetic (Ashton, 2014; 
Patton, 2002), however the researcher acknowledged that to ensure the findings are credible 
the researcher's approach needed to be a balance between empathy and neutrality (Ashton, 
2014). The researcher therefore communicated an understanding of the "positions, feelings, 
experiences and world views" of participants (Ashton, 2014, p.28), expressing a non-
judgemental approach (Patton, 2015), whilst keeping some empathetic distance (Valentine, 
2007) by listening, recording and observing the interviews, enabling the researcher to 
engage with participants without becoming too involved (Ashton, 2014). The researcher also 
ensured that she did not interrupt participants or break silences, enabling participants to 
reflect upon the discussions (Ashton, 2014). To confirm the researcher was correctly hearing 
and receiving participants' experiences, the researcher carefully listened to participants and 
responded to their discourse (Valentine, 2007). 
 The researcher also acknowledged that whilst the interview schedule allowed the 
researcher and participant to connect, enabling disclosure of information (Hennink et al., 
2011), the researcher needed to reduce the rapport and create distance during the end of 
the interview (Ashton, 2014). Therefore, in line with Rubin and Rubin's (1995) suggestion, 
the interview schedule concluded with three questions which involved the participant 
hypothetically providing advice to a young person with CF and their family. The final 
questions allowed participants to summarise the main issues they had discussed, which 
Rubin and Rubin (1995) state allows participants to feel in control of the interview through 
providing their own narrative. The final question gave participants the opportunity to provide 
any information which they considered relevant ("Do you have anything else to add?"), 
ensuring participants felt that their contribution was valued, by portraying that their 
experiences will help others with CF (Ashton, 2014).  
 With this phase of data collection being retrospective, it is acknowledged that the 
ability to adequately detect change and identify influential factors is dependent on the 
researcher’s ability to reconstruct the past using information participants provide (De Vaus, 
2006). Therefore, the researcher conducted a series of simulated pilot interviews on 
psychology academics using role play scenarios before the study beginning, confirming the 
researcher’s ability and the effectiveness of the interview schedule, with it being amended as 
necessary. In addition, after conducting two interviews, the recordings were listened to by 
the researcher and her supervisors, again to confirm the effectiveness of the interview 
schedule. Furthermore, during the process of interviewing and transcribing, the researcher 
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constantly reflected on the interview schedule allowing it to evolve in response to 
participants' experiences (Charmaz, 2002). An amendment was made which was the 
inclusion of a discussion as to whether or not participants meet face-to-face with others with 
CF, as it appeared that this was the case for some participants, this had not been anticipated 
by the researcher previously. Being in physical contact with others with CF is clinically 
inadvisable (Lamas, 2013) because of the risk of cross-contamination. Such contact could 
therefore be construed as a risky health behaviour.    
Carrying out the Study 
Once non-eligible patients had been identified, the MDT were able to approach all 
eligible patients at each clinic or on the ward and provide them with a handout explaining the 
research (Appendix C) alongside a consent to contact form (Appendix D). All patients were 
eligible, however when clinical staff were aware that an inpatient or outpatient had engaged 
in risky behaviours they were targeted. Once individuals had provided consent to be 
contacted by the researcher, the researcher contacted them within the next 24-48 hours, via 
telephone at a time convenient for themselves (mornings, afternoons or evenings - as 
indicated by patients). Data collection methods were led by clinical staff; at the Royal Stoke 
University Hospital the researcher attended clinic every week (which was held on Monday's), 
with staff believing it to be useful for the researcher to be on site to briefly talk to patients 
after consent to contact had been provided, enabling the researcher to provide further 
information to participants about the research. At Birmingham Heartlands Hospital, the 
researcher only attended clinics, or visited the ward when an interview had been arranged. 
Once consent to contact was received the researcher explained the research verbally 
to individuals over the telephone (and face-to-face at the Royal Stoke University Hospital) 
and allowed them to ask any questions. If they were still interested in participating, the 
researcher arranged to meet patients at their CF centre at a time / date convenient for 
themselves (usually to coincide with outpatient appointments or scheduled inpatient stays). 
The MDT advised the researcher of the patient’s arrival at clinic. The researcher approached 
desired adults with CF individually and asked if they were still willing to take part in the 
research.  
The study was fully explained to patients, both verbally by the researcher and in the 
form of a written information sheet (Appendix E), to ensure patients truly understood the 
nature and purpose of the research, and patients again had the opportunity to ask any 
questions. Patients had a maximum of two weeks to decide on participation, to help facilitate 
informed consent. If patients wanted to participate they had to complete a consent form 
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(Appendix E) to ensure informed consent had been collected. Adequate records were kept of 
how, when and from whom informed consent was obtained. A coding method was used; 
participants were given a number which they wrote on their consent form with their name. 
The researcher stated this number at the beginning of the interview recording and wrote this 
number on their interview transcript (all data was anonymised and confidential; pseudonyms 
were used when writing this research up). Participants contact details (email address or 
telephone) were also collected so the researcher could contact participants at the end of the 
research to share the overall research findings. All confidential information and personal 
data was stored securely in a locked filling cabinet at the CF unit to avoid inadvertent 
disclosure. 
Once informed consent had been obtained, participants then completed a semi-
structured interview to investigate whether or not they had engaged in risky behaviours, and 
to investigate what motivated such decisions. The interview could be conducted on the same 
day as informed consent had been collected, alternatively participants could be interviewed 
on a separate day to suit their availability (twenty-two participants were interviewed on the 
same day, two participants were interviewed on a different day). The interview was 
conducted in a private room at the CF centre and lasted a maximum of 60 minutes; however 
it could be stopped earlier at participants discretion; within this research no participants 
requested for the interview to be stopped early. Participants did not have to answer any 
questions they did not want to. All participation was voluntary, and participants could 
withdraw from the research at any time without being penalised; within this research no 
participants withdrew. If participants had got distressed during the interview and expressed 
an interest to not continue, the interview would have been stopped immediately and a 
referral would have been made to their MDT; within this research no participants became 
distressed.  Due to this research examining whether participants were unrealistically 
optimistic about their health the results could have upset participants. If participants had 
have requested their results, they would have only been able to view their own interview 
transcript along with any themes that emerged (it would not have been explained what the 
interpretation of the interview was); within this research no participants requested this 
information. If participants had disclosed during the interview that they wanted to quit their 
risky behaviours they would have been advised to seek help from HCPs, within this research 
no participants disclosed a desire to quit their behaviour.  
Once the interview was complete participants were provided with a debriefing sheet 
(Appendix F), and again had the opportunity to ask any questions. The researcher then 
contacted all participants once the research had been analysed to share with them the 
overall research results and to provide the opportunity for results feedback (Appendix G).  
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Ethics Committee 
Ethical approval was obtained via the Integrated Research Application System by 
NRES Committee East Midlands – Leicester, and the R&D departments at Birmingham 
Heartlands Hospital and the Royal Stoke University Hospital. 
Analysis 
As described in the analysis section within Chapter Four, the interviews were 
transcribed utilising the Jefferson transcription coding (Heath & Hindmarsh, 2002), with the 
data being analysed using thematic analysis following Braun and Clarke's (2006) model. 
Thematic analysis generated 138 initial codes, with these initial codes being revised to form 
143 codes. An example of an initial code which was separated to form two distinct codes is 
highlighted below (see Appendix H for more examples): 
 The data within the code "Occupational Identity" was separated to form two distinct 
codes: 
o The impact Employment / Education has upon an individual’s 
Identity with CF, which explores both positive and negative impacts 
employment and education can have upon a CF patient’s identity 
o The relationship between an Occupational Identity and Risky 
Behaviours, which represents how the workplace / educational 
institute can encourage a CF patient to engage in normalised risky 
behaviours 
The researcher made inferences about what the codes meant enabling the codes to be 
combined into five overarching themes that accurately depict the data (Appendix I). The five 
themes generated are described in detail within the next chapter, utilising direct quotes and 
discussion around the reasons why some adults with CF may engage in risky behaviours. 
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CHAPTER SIX: ANALYSIS - AN EXPLORATION OF RISKY HEALTH BEHAVIOURS 
WITHIN THE ADULT CYSTIC FIBROSIS POPULATION 
 Thematic analysis was applied to the interview transcripts following the Braun and 
Clark (2006) model, which elicited key concepts that were evident when participants were 
discussing their experiences of living with CF, and their engagement with risky behaviours. 
Five themes were identified which were deemed essential when determining the 
understanding of all participants. The first theme, labelled as “All I've ever wanted is to be 
happy”, highlights how a positive outlook is highly valued by individuals, providing insight into 
the role risky behaviours can play in influencing an individual's outlook. Theme two, "Are 
they sure I haven't just got asthma?", covers an area related to avoidance of CF, highlighting 
how avoidance can provide a gateway to risky behaviour engagement and non-adherence. 
The third theme, labelled as "If you haven't got support it can be detrimental to you because 
you need that support", outlines how a lack of support within an individual's private life can 
be associated with risky behaviour engagement, highlighting the role HCPs can play to 
reduce the occurrence of risky behaviours. Theme four, "Why should I let Cystic Fibrosis 
completely dominate my life", signals how a desire to not be defined by CF is influential upon 
one's adherence behaviours and engagement in risky behaviours. The final theme, labelled 
as “The biggest challenge is coming to terms with having Cystic Fibrosis”, highlights how 
many individuals find acceptance towards their CF to be difficult, with individuals who 
demonstrated acceptance portraying how it can be associated with positive health 
behaviours. It is acknowledged that there are aspects of participants’ experiences and 
understandings that overlap across these themes; however this was to be expected, as a 
good interpretation of understandings and attitudes specify these are never made up of 
isolated concepts (Fielden, Sillence & Little, 2011). All five themes will be further examined 
in the next segment, by utilising direct quotes and discussion around this topic area.  
"All I've ever wanted is to be happy" 
 This initial theme explores how different individuals with CF view their life, and their 
future, providing insight into what influences an individual's outlook. A number of participants 
had a positive outlook towards their life and expressed optimism towards their future. James 
suggested that his positive outlook is due to his ability to lead a normal life when he is not 
experiencing exacerbations of his CF, explaining that it is only when he is ill with an infection 
that he notices his CF, James does not view himself to be ill until his symptoms become 
problematic.  
 *[James, 19 years]: "You don't no:otice you have it (.) unless:s ## you're ill" 
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It would therefore not be advantageous to encourage participants like James to incorporate 
their CF into their identity, as it was adaptive for these "healthy" participants to not view 
themselves as being ill. Whilst these participants accept that they have CF, their outlook on 
their lives and their illness is strongly influenced by symptom presentation, with James not 
possessing an illness identity when he does not notice his CF, highlighting the fluidity of an 
individual's identity which can change over time and across circumstances. 
 For some participants their positive outlook towards their life was partly as a result of 
comparing themselves favourably to others, or by comparing CF to other conditions. Sarah 
believed that there are worst things that could happen to her than CF, allowing her to be 
positive regarding her life and future, due to her understanding of common humanity, that is, 
that everyone suffers.  
 *[Sarah, 32 years]: "There's worst people off than me [...] I've got two amazing 
 children (.) a roof over my head (.) food you know (.) in my stomach # we've got an 
 NHS that (.) you know (.) makes this capable (.) there's a lot of people worst off" 
It was often the case that participants did not define themselves as being ill and appeared to 
possess a normal identity, when they were not experiencing exacerbations of their CF. 
 *[Ashley, 35 years]: "It’s [CF] not as bad as a lot of people make it out to be [...] it’s 
 not the end of the world [...] when you’ve got CF it’s not really as bad as people think" 
 Whilst many participants positive outlook was influenced by symptom presentation, 
for some participants their positive outlook was a product of engaging in behaviours which 
could be harmful towards their health, with some participants acknowledging these 
associated hazards. Matthew explained how using a steam room has a positive impact upon 
his life psychologically, improving his mood and making him feel "invigorated", despite 
acknowledging the CF-specific risks associated with this behaviour. 
 *[Matthew, 47 years]: "I shouldn't be going in there [steam room] [...] ↑ I feel good 
 after [...] I know that there is a risk # but e:every now an then I just # if it's going to 
 make me feel a bit better than what I'm feeling now then # I'll just go in" 
Matthew appears to weigh up the potential costs and benefits of using the steam room to 
inform his behaviour, with him concluding that occasional use will have more beneficial 
effects than any potential detrimental consequences. At times then, participants appear to 
value their psychological functioning above their physical health, particularly when they 
consider themselves to be "well" at present. 
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 Participants’ reasons for engaging in risky behaviours varied greatly, with some 
participants explaining that their engagement was due to psychological distress. James 
explained how he coped with his depression through smoking marijuana, with this behaviour 
helping him to forget about his problems. 
 *[James, 19 years]: "It [smoking] helped me sort of just # forget about them 
 [problems] (.) you know ## not bother with them (.) helped to (.) see the brighter 
 side".  
James was aware of the adverse health effects of smoking (both nicotine and marijuana) 
upon CF, however when suffering from depression James perceived that the psychological 
benefits of marijuana use were worth the potential risks. In addition, Nick also discussed the 
psychological benefits of engaging in risky behaviours, explaining how for years he had 
struggled with depression, regularly taking anti-depressants, however after using magic 
mushrooms his mood improved, resulting in him no longer needing anti-depressants. 
 *[Nick, 33 years]: "I love em [magic mushrooms] # I'm definitely (.) definitely going 
 to do them again (.) cause they're brilliant [...] shortly after that I stopped taking my:y 
 # antidepressants (.) and it was like pressing a (.) fa:actory reset"  
Participants greatly value the psychological benefits they experience following their risky 
behaviour engagement, and therefore the risks of such behaviours is not the predominant 
aspect, rather they focused upon the benefits such behaviours have upon their lives. 
 For some participants their psychological distress was directly due to their CF. Sarah 
explained how challenging CF is to cope with, with her deteriorating health at times meaning 
that she has no life, instead she is just existing and constantly living in fear of CF's fatal 
nature. 
 *[Sarah, 32 years]: "I'm on antidepressants [...] I do get really really down [...] I just 
 felt like I had no life [...] I wasn't living (.) I just felt like I was existing [...] it's [CF] not 
 nice (.) and it's (.) not easy to cope with"  
Many participants described how CF's fatal nature can result in anxiety, and this is 
exacerbated when individuals experience health deteriorations. Simon explained how he 
finds health deteriorations difficult to cope with both due to his diminished ability to engage in 
activities, and having to depend on others. 
 *[Simon, 33 years]: "You feel a bit (.) useless # a:and sad re:eally # you know ## 
 cause I kno:ow I used to be able to do it [e.g. make his own bed] a fe:ew years back 
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 # it's a fu:unny position to be in at thi:irty three # when you se:ee other people an 
 tha:at" 
For participants like Simon their deteriorating health means they cannot complete simple 
everyday tasks without relying on others, with their identity as grown adults being painfully 
compromised by their diminished ability. Health deteriorations can also prevent individuals 
engaging in their usual work or study related commitments. Andrew discussed the negative 
impact this has upon his life, resulting in disappointment and making it harder for Andrew to 
remain positive as his health deteriorations prevent him completing his PhD work, which had 
provided him with great enjoyment. 
 *[Andrew, 46 years]: "Fo:or the last # two yea:ars # my chest has gone do:ownhill [...] 
 PhD works got less [...] disappointed # re:eally (.) re:eally disappointed"  
Due to CF's deteriorating nature, many participants spoke about the challenge of dealing 
with frequent hospital admissions, resulting in participants not being able to see family or 
friends as frequently as they wish. Hospitalisation has a negative impact upon an individual's 
quality of life and psychological wellbeing, due to the interruptions imposed upon their 
everyday lives, with hospitalisation being a stressful time for patients and families. 
 *[Katie, 33 years]: "It's hard [hospital stays] [...] I honestly thought # as he [son] got 
 older (.) it'd get easier # but na:ah (.) seeing his face when he has to go (.) and 
 cause me and his Dad don't get on (.) I don't get to see him as much" 
 With CF's deteriorating and fatal nature, a number of participants articulated that 
CF's biggest challenge is adjusting to, and dealing with, loss. 
 *[Andrew, 46 years]: "Dealing with loss ## that's the biggest challenge (.) cause you 
 lo:ose (.) some of your independence # you lo:ose (.) some of your control (.) you 
 obviously lo:ose quality # in terms of what you can actually do # going out (.) being 
 able to eat # e::erm:m # being able to do things when you want"  
This "loss" referred to both individual loss of independence, control over their lives, quality of 
their lives and choices within their lives; as well as loss of others. For many participants, their 
fear of CF was exacerbated due to their exposure to CF's fatal nature.  
 *[Katie, 33 years]: "One of my friends died ### he was only ten at the time [...] that hit 
 me quite ha:ard # and that's when my depression started re:eally bad [...] it does 
 mentally scar you what you’re going through" 
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Katie highlighted the challenges of getting close to others and losing them through CF, with 
this indicating what her future may entail. Many individuals did struggle to cope with CF's 
fatal nature, with a number of participants demonstrating pessimism towards their future, and 
possessing a negative outlook towards their life. Matthew who received a late diagnosis of 
CF aged 40 years, was preoccupied with death, in fearing that any infection could be fatal, 
regardless of his pulmonary function.  
 *[Matthew, 47 years]: "My fear is that (.) that the next cold I catch will be the flu # 
 could be my last one (.) you know # I could end up with bronchitis (.) o:or ## 
 pneumonia" 
This fear can lead to extreme anxiety, living life fearing that it may be over at any point; with 
the desire expressed by participants to rebel against negative emotions towards CF by 
engaging in risky behaviours being easily understandable. Sam explained that as his CF 
progressively deteriorated he firstly used alcohol, followed by heroin to escape and to avoid 
CF, alleviating the stresses and anxieties that accompany his diagnosis.  
 *[Sam, 43 years]: "Things with the CF got mo:ore difficult # it [alcohol / heroin binge] 
 became an easy wa:ay just to:o # sort of esca:ape (.) some of the:e (.) e:er:r # 
 responsibilities and pressures:s [...] it's one wa:ay to ## tu:urn off (.) a:all the # 
 stresses # and anxieties of ## a:and the awa:areness of having # e:erm:m # a 
 condition to dea:al with" 
Therefore, for a number of participants their engagement in risky behaviours was clearly 
linked to their understanding of CF's fatal nature, and their experience of CF's deteriorating 
nature. Another form of this rebelling that was apparent in the data was reduced adherence 
to medical regimens. This was particularly evident when participants were experiencing 
depression, despite them often acknowledging that their non-adherence will deteriorate their 
health further, exacerbating their depressive symptoms. 
 *[Will, 21 years]: "Being a bit (.) depressed I guess (.) you know you don't # you 
 don't re:eally feel like doing your treatments to be honest # it's like a vicious circle [...] 
 when you're feeling a bit do:own (.) you're feeling ill (.) you don't want to do your 
 treatments # but then you feel wo:orse (.) an that makes you feel mo:ore down" 
For Will the only way to break the "vicious circle" was to be admitted into hospital to improve 
his health, which in turn improved his mood, providing a "boost" to continue with his 
adherence post-discharge. 
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 There was also evidence of participants using risky behaviours as a form of self-harm 
due to depression. When James spoke about his past engagement with marijuana he 
explained that although he knew this behaviour could adversely affect his CF, he continued 
his engagement as he valued the positive impact marijuana had upon his life 
psychologically, with his engagement alleviating his depressive symptoms. However, James 
also stated that his engagement was to "shunt his life span", with marijuana being used as a 
form of self-harm.   
 *[James, 19 yeas]: "I think it [smoking marijuana] was more of a::a (.) way of  
 self -harming [...] I'd start it just to # take away the depression (.) and to sort of # 
 shunt my life span a bit [...] I thought # forget about my CF [...] I'd rather live a short 
 happy life # then a lo:ong # de:epressing [...] it crossed my mind that it would really 
 damage me (.) now I can't remember if I wanted it to damage me # or I just didn't 
 care about it damaging me" 
Retrospectively James is unsure whether this was deliberate self-harm or not, however he 
strongly valued the feelings he received following his engagement. At that point in his life, 
James was not bothered about the consequences of marijuana, not viewing early death to 
be a bad thing, with the use of marijuana as a form of self-harm being advantageous as it is 
less noticeable than other forms of self-harm, therefore it was difficult for others to detect. 
 *[James, 19 years]: "I've always (.) always hated the idea of self-harming (.) cutting 
 people (.) cutting themselves [...] I chose a different (.) method # that's less sort of (.) 
 noticeable" 
 There was also evidence of participants using risky behaviours to escape their family 
circumstances, with some participants experiencing a lack of family support in helping them 
deal with their CF. Katie explained how she previously used cocaine due to her becoming 
the victim of domestic violence, where her partner physically abused her when she coughed. 
Therefore Katie explained how cocaine would stop her coughing, allowing her to escape the 
abuse. 
 *[Katie, 33 years]: "I got into a domestic violence relationship [...] if I coughed he 
 used to punch me [...] cocaine's like an anaesthetic [...] it used to like (.) stop me 
 coughing (.) so I used to take it more (.) and more (.) and more # to not get beat up"  
The long term negative health impacts of cocaine were understandably of less concern to 
Katie as she faced an immediate serious and direct threat to her health. Consequently, Katie 
focused upon the benefits cocaine was having upon her life, describing cocaine as her 
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"crutch" which she used to help her deal with any issues she encountered within her life, with 
some participants appearing to engage in risky behaviours to escape both their CF and 
family circumstances.  
 A number of participants also explained how their feelings of stress and / or 
psychological distress were as a consequence of their employment or education. Will 
explained how his University work, coupled with his complex and time-consuming medical 
regimens, resulted in him feeling stressed, with his use of ecstasy relaxing him and 
alleviating this stress. 
 *[Will, 21 years]: "When I was at uni:i (.) I was quite stressed # so # you know (.) 
 with a:all the work (.) and a:all the treatment (.) this [ecstasy] was a wa:ay (.) .hhh (.) 
 to release (.) a:all the tension" 
Will's initiation in ecstasy was due to experimenting with drugs whilst at University, a 
behaviour which Will found normal whilst at University, however his continuation was as a 
consequence of the benefits he received following his engagement, in providing him with a 
positive outlook for that period of time. 
 The presence of a positive outlook was valued by participants, with some explaining 
that when they were not experiencing enjoyment through engagement with risky behaviours 
it resulted in cessation. Sarah explained that she stopped smoking cigarettes due to 
boredom, stating that "they don't do anything", in particular smoking did not make her high 
and therefore she did not see the point in continuing her engagement, as they were costing 
her money but not doing anything. 
 *[Sarah, 32 years]: "They [cigarettes] don't make me high (.) like what's the point" 
Nonetheless, some participants suggested that if these behaviours were providing them with 
enjoyment then their engagement would have continued. Therefore despite some 
participants cessation with one risky behaviour, it may be that those participants would 
replace that behaviour with another, that would provide enjoyment. Sarah explained that 
despite stopping smoking cigarettes, she did continue smoking marijuana which she 
believed was different to cigarette smoking as it provided her with enjoyment, allowing her to 
escape from her anxieties surrounding CF's fatal and deteriorating nature.  
 *[Sarah, 32 years]: "Weed was different [to cigarettes] # weed was fun [...] that 
 [weed] was a escapism for me ### even though your problems are still there the next 
 day # you know (.) on the night time I would just be chilled out" 
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Sarah explained that if her CF was not as severe as it is today she would still smoke 
marijuana due to these psychological benefits, however she is now aware that her health 
would not be able to handle such engagement, and therefore she believes that the potential 
physical risks of marijuana use outweigh these psychological benefits. 
 Whilst a number of participants indicated that their initiation in a risky behaviour was 
to alleviate their feelings of stress, anxiety or depression, and to avoid their life, 
predominantly due to CF, some participants explained that it was not until cessation that 
they experienced a positive outlook. Katie explained that since she has stopped using drugs 
she is a lot happier within her life, and that retrospectively she can see how drug use was 
having a negative impact upon her life, causing her to be moody and at times suicidal.  
 *[Katie, 33 years]: "I'm happy now [...] instead of being cra:anky all the time [when 
 using drugs] (.) and moo:ody (.) and ti:ired # one minute I’d be alright (.) I’d be alright 
 # the next I’d be .hhh (.) drop completely # and I’d burst out crying (.) be suicidal" 
Despite Katie believing that her drug use was having a positive impact upon her life by 
allowing her to escape her problems, Katie can now appreciate that during that period of 
time she was not happy. In order to deal with her problems Katie now uses adaptive coping 
mechanisms, predominantly involving her talking with her sister and close friend. Katie, like 
other participants, indicated how her cessation has increased her self-esteem, with her 
associating her drug use with negative behaviours, whereas she now feels that she is a 
good person who is able to develop meaningful relationships, be optimistic and cope with 
challenges without using maladaptive coping mechanisms. 
 *[Katie, 33 years]: "I actually like being sober [...] I didn’t like the person I was 
 before because I was ly:ying # I was letting everybody do:own (.) I was feeling gui:ilty 
 all the time [...] I actually think I am a good person [...] my sister says to me (.) you 
 know (.) I like this Katie # even my friends say it [...] I'm happy now" 
 Whilst an individual's outlook towards their life with CF was important in influencing 
engagement with risky behaviours and non-adherence, it became evident that it is potentially 
how an individual perceives their illness which acts as a mediating factor. Some participants 
considered self-management (such as adherence) as mandatory within their lives, 
regardless of the impact it may have upon their social life. Being physically "well" was the 
primary focus underpinned by a clear understanding of the serious and even fatal 
consequences of not engaging in self-management. 
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 *[Matthew, 47 years]: "It's either # do it [medical regimens] (.) or feel lousy all day (.) 
 for not having done it [...] if I wasn't to take (.) the # the medication [...] the chances 
 are (.) I could possibly be dead" 
Viewing adherence as mandatory is then advantageous for physical health, but it can be 
disadvantageous psychologically. Andrew described how this view can cause him to be self-
critical, and to lack self-compassion during incidences of occasional non-adherence. Andrew 
appeared to be making a connection between his actions and their physical response, 
particularly when he is unwell. 
 *[Andrew, 46 years]: "I bash myself over the head for it [non-adherence] [...] whip 
 myself [laughs] [...] wh:hy did I do that # particularly when you feel bad" 
 How an individual perceives their illness can change over time and across 
circumstances. Laura explained that during the weekdays she views adherence to be 
mandatory in order to improve or maintain her current and future health, whereas during the 
weekends she is focused upon enjoying herself, valuing her psychological health above her 
physical health; believing that she can engage in risky behaviours (alcohol consumption) as 
her weekday adherence is maintaining her health.  
 *[Laura, 28 years]: "I just felt li:ike ## in the week was fo:or me to do me 
 medications (.) so Monday to Friday (.) and then Saturday and Sunday was my:y 
 time # for me:e # to go:o (.) and let me self loose # and thing # just ha:ave fun" 
Laura does not view her medical regimens to be part of "her time", instead she indicated that 
in order for her to be herself she needs to be away from CF, which she allows herself to do 
during her weekends. For other participants this change in perspective was not bound to 
certain days, instead it appeared to be determined based upon their current health status. 
Sam explained that he engages in alcohol or heroin binges until he encounters "health 
problems", which results in him becoming focused upon his medical regimens in order to 
improve his health; consequently Sam's behaviour appears to be reliant upon symptom 
presentation. 
 *[Sam, 43 years]: "Sometimes I'm focused on just doing my medication (.) my (.) you 
 know # a:all my sort of CF treatment (.) that ki:ind of thing [...] if I'm # in a:a # sta:age 
 where I'm u:using:g [alcohol or heroin] then I can # I'll be try:ying to fit that round:d # 
 doing other stuff as well" 
 Overall, this theme highlights participants quest in developing a positive outlook 
towards their life, with some participants appearing to be fighting a battle in order to 
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incorporate CF into their lives in a way which is manageable, meaningful and possible, with 
this resulting in individuals engaging in self-negotiations around adherence and risky 
behaviour engagement. 
"Are they sure I haven't just got asthma"  
 This second theme explores the role of avoidance in CF and how this provides 
individuals with a gateway to engage in both non-adherence and risky behaviours. A number 
of participants were able to ignore or to forget about the severity of their CF, particularly 
when they were feeling well, and therefore not focusing on having an illness identity. James 
clearly describes how insignificant CF is in his life when he has no symptoms, with his 
behaviour appearing to be in response to the lack of symptoms he experiences, allowing him 
to lead a "normal" life.    
 *[James, 19 years]: "I car stress enough CF has vi:irtually been (.) nothing to me [...] I 
 feel like a normal (.) healthy person" 
Many participants do not focus on their CF until they develop an infection, with Richard 
believing that his lack of symptoms exacerbated his denial towards his CF and made 
accepting CF a challenge, he explains that he was previously really healthy and was the 
same as his peers, in terms of his behaviours and identity. 
 *[Richard, 34 years]: "When I was younger I wa:as # in denial with my CF # cause I 
 (.) I was re:eally healthy [...] I:I # was the sa:ame as everyone else (.) I could do 
 everything that everyone else could [...] I was no different # so I was in denial" 
 Whilst some participants appeared to forget about their CF due to a lack of 
symptoms, other participants explained how they hate CF and the restrictions it imposes 
upon their life, resulting in these participants intentionally avoiding their CF. 
 *[Daniel, 25 years]: "As a kid you don't want to [...] I can't run with my friends # do 
 this (.) that (.) the other (.) you see the limitations:s # and then you realise wh:hy (.) 
 and then you hate it [CF] [...] it just went on (.) like # a denial stage ## like teenage 
 years” 
Daniel explained how his CF prevented him engaging in normal activities with his peers, 
causing his illness identity to be on display, resulting in Daniel avoiding his CF. When 
individuals do avoid or ignore their CF it presents a challenge in understanding treatments' 
necessity. Richard explained that when he was younger and did not experience symptoms 
he did not understand why he needed to adhere to a long list of medical regimens, as he 
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was living a normal life. Instead Richard felt that his HCPs had overestimated his diagnosis, 
and that he did not have CF.  
 *[Richard, 34 years]: "What am I doing this [physiotherapy] for (.) my chest's fi:ine # 
 o:or:r you know (.) I've ju:ust been to play football a:all afternoon # what am I doing 
 this for [...] sometimes I thought (.) I don't think I've got CF [...] o:or:r # are they 
 su::ure # are they su:ure I haven't (.) I haven't just got asthma" 
Consequently, whilst it may be psychologically adaptive to not possess an illness identity, 
this can have negative impacts upon physical health due to the impact ignoring or avoiding 
one's CF has upon adherence efforts, with the data highlighting a relationship between 
denial, or avoidance of CF, and the engagement in non-adherence.  
 Denial regarding treatments' necessity can be reinforced when there is no 
experience of adverse health effects from non-adherence, or no experience of noticeable 
benefits from adherence. Some participants talked about the lack of short-term benefits they 
receive from treatment adherence whilst they are "healthy". Jessica explained how she did 
not experience symptoms of CF when she was younger, therefore she did not see why she 
needed to be adherent, with these beliefs being reinforced when she did not experience 
symptoms following non-adherence as an adult. 
 *[Jessica, 32 years]: "I didn't see the point in them # when I was younger because I 
 was so well # I didn't understand # when I didn't take ## any of the tablets (.) I didn't 
 really get poorly (.) so I was just like well >I don't need em then< [laughs]"  
Even when participants did experience a health decline following non-adherence, they did 
not always believe that this was as a consequence of their adherence efforts. James 
explained how he recently suffered from pneumonia which he believed was due to "bad 
luck", explaining that he is frequently non-adherent however that rarely impacts upon his 
health.   
 *[James, 19 years]: "It's [pneumonia] just ## luck (.) I'd say # bad luck [...] I ha:ardly 
 (.) ever take my treatment [...] I'm not ill that often" 
 For some participants their belief that treatments are not effective was due to their 
awareness of CF's fatal nature regardless of adherence. Ben explained how he had 
witnessed his brother's CF deteriorate, resulting in his passing away, despite his excellent 
adherence efforts. 
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 *[Ben, 34 years]: "My brother did everything [adherence] (.) religiously (.) by the 
 book (.) an he just went do:ownhill like that" 
People with CF often receive little positive reinforcement following their adherence efforts, 
due to CF's deteriorating nature. To overcome this participants did discuss how HCPs try to 
aid individuals understanding that adherence will prolong their good lung function, and 
improve their life expectancy. However, a number of participants (adolescents and young 
adults) said that they did not always fully understand what prolonging good lung function 
actually means. 
 *[Jessica, 32 years]: "Even though there is someone saying it will ma:ake # this 
 better (.) or # it will (.) prolo:ong (.) your (.) good lung function (.) you don't really 
 understand what pro:olonging # good # lung functions is really" 
HCPs efforts to encourage adherence are not always successful, with these participants still 
not understanding why they need to adhere to medical regimens, particularly when their 
symptoms are not present. 
 Even when participants did understand the discourse of HCPs it did not always 
encourage their adherence efforts. Stephen explained that because adherence only 
prolongs his health, as opposed to "curing" CF, he does not value his adherence. 
 *[Stephen, 19 years]: "To Consultants and to the Professors (.) like treatment is 
 re:eally (.) really (.) it's like top priority but to me it isn't [...] why should your treatment 
 be main priority # when it's not doing anything # it's prolonging it [CF]" 
Stephen is therefore facing a dilemma where others are telling him that treatments should be 
a priority, but clearly for Stephen it is not. Stephen explained how his priority is to live his life, 
doing what "normal people do", valuing his psychological wellbeing, with lesser regard for 
physical health implications, with this appearing to be influenced by symptom presentation. 
 *[Stephen, 19 years]: "To me my treatment isn't the top priority (.) it should be (.) but 
 it isn't # because obviously I want to live my life man (.) I want to do what normal 
 people do [...] I'd rather have a laugh with my mates [...] maybe it might be my top 
 priority in a few years time when I am (.) stuck in a hospital bed and I literally can't go 
 anywhere" 
In addition, some participants’ beliefs regarding treatments lack of effectiveness were formed 
and reinforced by their childhood experiences. Emma explained how she had not adhered to 
her treatments during childhood due to her Father preventing her access to her antibiotics, 
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however she still had good health therefore Emma did not see the need for adherence 
during adulthood, as she had experienced no adverse health effects from non-adherence. 
 *[Emma, 57 years]: "I've had to grow up without it [treatments] [...] I did have a 
 poorly chest (.) so I thought I'll start taking them [antibiotics] (.) and I took the bottle 
 out (.) there was only one in the bottle (.) my °Dad had had them° [...] I was 
 fri:ightened to go to the Doctors and say my Dad's had them (.) in case they °spoke 
 to my Dad° [...] I just le:earnt to cope without them [...] I haven't grown up with a 
 regimen of:f # treatments (.) like everybody else (.) so:o # I'm a:always going to be 
 different" 
The data demonstrates the complexity of factors that contribute to adherence, with time and 
context having a large impact on adherence behaviours. Some participants adhered to their 
treatments, despite explaining that they were in a state of denial regarding their CF. Richard 
explained that his adherence, despite denial, was due to him being in a structured routine 
where adherence is integrated.  
 *[Richard, 34 years]: "I wasn't ma:ade to do them by my pa:arents but it just 
 became:e pa:art of my routine (.) from such a young age [...] for me:e doing that was 
 (.) was a no:ormal thing [...] I did them at home anyway # so:o [...] I was only doing 
 that in front of my family # so:o # that # didn't matter (.) in terms of my denial" 
 In addition to the impact avoidance of CF has on adherence efforts, the data also 
suggested a relationship between avoiding one's CF and the engagement in risky 
behaviours. A number of participants who engaged in risky behaviours did not acknowledge 
the adverse health effects associated with these behaviours. Will was raised to believe that 
drug use could have fatal consequences, he explained that following experimentation with 
illicit drugs as a form of escapism from CF he changed his attitude towards drug use. Will did 
not experience any adverse health effects of drug use, and the consequences that he had 
been taught would occur (death) did not happen, instead Will found that for him drugs 
provided him with benefits.  
 *[Will, 21 years]: "You’re a:always brought up to think >you’ll die< (.) >you’ll die< 
 stra:aight away [with drugs] [...] when you fi:irst try it you think (.) well ## it’s not 
 tha:at bad [...] no:othing's gone wrong (.) you know # an you have a re:eally good 
 time" 
In addition, some participants explained how they experienced beneficial health effects from 
their risky behaviour engagement. This was mainly amongst participants who smoked 
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marijuana, with Mark explaining how he believed that marijuana use results in a respiratory 
improvement.  
 *[Mark, 23 years]: "It [weed] can help in a lot of wa:ays as well [...] there a:are certain 
 benefits to it [...] it (.) does actually # stra:angely enough ## once you've had a bit (.) 
 re:eally # re:eally settle your chest (.) it feels re:eally (.) re:eally clear" 
Many participants believed that marijuana cannot be harmful due to it being medicinal in 
some countries, with the health improvements that participants experienced reinforcing this 
belief. 
 *[Sarah, 32 years]: "I don't feel like it [marijuana] is as bad as all the media makes 
 out (.) you know # it's a na:atural thing (.) that grows (.) it's (.) medicinal in some 
 countries" 
Some participants rationalised their engagement with risky behaviours by explaining that 
they engage in compensatory health-promoting behaviours. Sam explained how his 
engagement with illicit drugs did not have a negative impact upon his health due to his 
adherence maintaining his health. 
 *[Sam, 43 years]: "I don't think it [recreational drugs] had a particularly (.) 
 ne:egati:ive impact [...] du:uring that period I was keeping myself ve:ery healthy [...] I 
 was compliant # I was getting a lot of exercise" 
Consequently, Sam appeared to underestimate the risks of drug use, and instead focused 
upon the health-promoting behaviours which he engaged in, demonstrating evidence of 
selective focus. Further evidence of selective focus was when participants experienced 
adverse health effects of a behaviour, so they adapted that behaviour to become less 
harmful. Rob explained that when he experienced adverse health effects from smoking 
marijuana, he adapted that behaviour by vaping marijuana, to reduce the adverse health 
effects experienced in order to maintain the beneficial effects, with Rob valuing the positive 
impact marijuana has upon his life psychologically, making him feel "calmer and more 
relaxed".  
 *[Rob, 32 years]: "That [vapour marijuana] was alright [...] it's a healthier way of 
 smoking it” 
 Participants who described themselves to be in a state of denial towards their CF 
often desired a sense of normalcy, with this frequently involving the engagement in risky 
behaviours. Many participants did value the psychological benefits that avoiding one's CF 
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has upon their life, with Richard explaining that when he was in a state of denial regarding 
CF it enabled him to engage in "normal" activities and lead a "normal" life. Richard explains 
that due to accepting the true nature of his diagnosis he puts "limits" on himself, preventing 
him engaging in certain activities for the benefit of his physical health, despite the 
detrimental impact this has upon his psychological health. Such change in health beliefs 
could be due to the consequence age can have upon health within CF. 
 *[Richard, 34 years]: "Whilst being in denial (.) whi:ilst that wa:as bad [...] I used to 
 ### get on with stuff mo:ore (.) I would be like (.) well I'm ba:ad (.) but I'm going to 
 keep going cause I haven't got CF [...] now I'm mo:ore aware of what I can (.) and I 
 ca:an't do [...] with CF (.) you can fa:all into a spi:iral where ## it's not li:ike you feel 
 sorry for yourself (.) but you put limits on yourself ## an:nd stop yourself from doing 
 stuff" 
However, as discussed, while not possessing an illness identity appears to be 
psychologically advantageous, when individuals were avoiding their CF they often dismissed 
awareness provided to them from HCPs regarding risky behaviours. Sarah explained how 
she did not believe smoking would have adverse health effects despite HCPs warnings, this 
was during a period of time where Sarah did not experience symptoms of her CF and did not 
experience adverse effects from her smoking behaviour, therefore providing her with the 
belief that she was healthy and could continue her engagement.  
 *[Sarah, 32 years]: "Like later on in the future they [HCP's] said it [smoking] will (.) it 
 will affect your lungs when you're older [...] no it won't happen to me:e # I'm fi:ine" 
 In addition to risky behaviour engagement, many participants who ignored or avoided 
their CF explained how they do not disclose their illness identity to others. Nick explained 
how disclosure becomes harder with age, particularly when considering intimate 
relationships, with participants coming into contact with more people, and therefore being 
expected to disclose their CF to more people.  
 *[Nick, 33 years]: "It's got ha:arder to tell people as I've got older [...] da:ating and 
 stuff like tha:at # I don't know # when (.) is the ri:ight time to tell em (.) cause I 
 suppo:ose # you know (.) fo:or them (.) being with me is going to be (.) a new 
 experience (.) some of them might not be up fo:or it" 
Many participants explained how they did not believe others needed to be aware of their CF 
as their CF does not impact upon their life, with these participants leading a normal life and 
not possessing an illness identity.  
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 *[Andrew, 46 years]: "I didn't think it [CF] was that ba:ad you see [...] I didn't think you 
 should be aware of it because it doesn't affect me ## day to day [...] it wasn't 
 affecting my life" 
For other participants their non-disclosure was due to them not wanting to be judged based 
upon CF, therefore such participants kept CF as a separate part of their life, allowing them to 
have a normal identity in public, promoting their psychological wellbeing. 
 *[Claire, 29 years]: "Try and avoid the fact that I've got it re:eally a:and # it's the last 
 thing # you'll find out about me [...] I don't want to be judged on that # I don't want to 
 be like Claire who's poorly” 
Participants discussed how their non-disclosure enabled them to be non-adherent and 
engage in risky behaviours, as their peers were not aware that they needed to engage in 
medical regimens, and were not aware of the specific adverse health effects risky 
behaviours could have; with CF's invisible nature aiding individuals’ non-disclosure. 
 Overall this theme indicates that the avoidance of CF plays an important role in an 
individual's adherence efforts and risky behaviour engagement. However, the way in which 
this avoidance towards CF is translated into action (or non-action) in terms of adherence and 
risky behaviour engagement is influenced by a number of factors. Whilst a number of 
participants who described themselves to be in a state of denial regarding their CF engaged 
in risky behaviours, this was not always the case, with some participants who described 
themselves to be in a state of denial explaining that they have never engaged in risky 
behaviours, due to these behaviours not being normalised within their environment.  
 *[Richard, 34 years]: "I was in denial with my CF # cause I (.) I was re:eally healthy # 
 I was the sa:ame as everyone else [...]  none of me mates smoked # no one in me 
 fa:amily ## smokes:s ## e:er:r ## so I've come from an environment where # 
 smo:oking's not ## it's not done (.) I'm not exposed to it ## I've no desire to do it" 
Consequently such participants would not have been provided with a normal identity if they 
engaged in these behaviours, with group identity and social norms being influential upon 
individuals decisions to engage in such behaviours. 
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"If you haven't got any support it can be detrimental to you because you need that 
support" 
 This theme focuses upon the beneficial effect support from others can have for 
people living with CF, as well as the adverse effect a lack of support can have. The support 
this theme mainly focuses upon is that from an individual’s family, friends and HCPs, and 
suggests that in terms of providing awareness regarding risky behaviours there is an 
expectation that this is integrated into CF care. Family support was considered necessary 
and important, with a number of participants explaining how their family have prevented 
them engaging in risky behaviours by providing good awareness regarding the potential 
adverse health effects of engagement, and by protecting them from environments which 
would expose them to these behaviours. Nick explained that by being protected from 
environments where people were smoking, he understood the detrimental effect smoking 
could have upon CF. 
 *[Nick, 33 years]: "Mo:om had a:always protected me from people who smo:oked [...] 
 be:eing protected from it I have kno:own that it's bad" 
The data also indicated that some participants never engaged in risky behaviours as they 
feared the consequences from their family. Lucy acknowledged that her Mother would have 
punished her if she drank alcohol whilst underage, therefore despite this behaviour being 
normalised Lucy did not try alcohol until she was above the age of 18 years, when her 
Mother would then allow her to go to the pub with her friends. 
 *[Lucy, 28 years]: "Mum would have killed me [if drank alcohol underage] [...] 
 when me Mum was a:allowing me to start going out with my friends:s (.) when I was 
 over the pubs:s # that's when I sta:arted drinking" 
Participants explained that positive family relationships did not only prevent initiation, they 
also encouraged cessation, with James stopping smoking due to his family not being happy 
with his smoking behaviour, therefore he was aware that cessation would improve his family 
relationships, due to his family feeling cessation was important for his health.  
 *[James, 19 years]: "I did it for family [stopped smoking] [...] a lot of my family wasn't 
 happy with the fact I was smoking"  
Many participants explained how their family relationships did improve as a consequence of 
cessation, reducing the likelihood of relapse, as participants became dependent upon their 
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family to help them cope with difficult times, instead of using risky behaviours as a coping 
mechanism. 
 *[Katie, 33 years]: "I'm quite close to my sister now # e:erm I tend to talk through 
 things with her [instead of using cocaine] (.) and get things out in the open" 
 However, some participants did not disclose their engagement to their family, 
therefore their family could not encourage cessation. Will explained that his family would not 
understand why he uses drugs, therefore he has never disclosed his engagement to his 
family. 
 *[Will, 21 years]: "I don't re:eally tell my family anything [...] I don't think my Mom 
 would understand [about drug use] # my Brother wouldn't # my Brother would think 
 (.) o:oh I've got to tell Mom # so I don't re:eally have that" 
Even when a participant’s family provided awareness regarding risky behaviours it was not 
always successful. Will explained that his family is naive and are not aware of the 
substances he could access, with Will already smoking marijuana before his Mother 
provided awareness regarding the adverse health effects of marijuana use. 
 *[Will, 21 years]: "My Mom did wa:arn me when I went to uni # ↑don't do any 
 we:eed # ↓I was like yeah a:alright (.) but I'd already done it # I think my Mom's a bit 
 naive # she doesn't re:eally know there's a lot of stronger stuff (.) so rea:adily 
 available" 
In addition, some participants did not disclose their behaviours due to anticipated 
consequences, they employed effort to hide their risky behaviour engagement to avoid such 
discipline. 
 *[Stephen, 19 years]: "I was hiding it [weed] from my foster carers [...] if they'd have 
 found out I was smoking that (.) I'd have been in hell" 
 A strong family motivator to aid cessation was when participants became parents, 
with Sarah describing how once she became pregnant she stopped smoking marijuana due 
to a need to not only care for herself as a Mother, but also to care for her unborn child. 
 *[Sarah, 32 years]: "As soon as I got pregnant (.) obviously it completely changes 
 [stopped smoking marijuana] (.) you've got someone else to think about" 
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The influence of a child upon cessation was also evident within male participants, with 
Stephen and James discussing that if they were to become Fathers it would motivate their 
cessation, due to them then needing financial security and having a new focus in life. 
 *[Stephen, 19 years]: "If I had a kid [...] somat that would change your situation that 
 you wouldn't be able to do it [smoke marijuana] anymore [...] if I had a kid on the way 
 # I just wouldn't like cause you're saving your money init" 
For one participant it was not pregnancy that motivated cessation, but rather the impact their 
behaviours had upon their child. Katie explained how frightening her accidental cocaine 
overdose was for her son, motivating her cessation, with this having beneficial impacts upon 
her relationship with her son. 
 *[Katie, 33 years]: "The look on his [sons] face # worry [after accidental cocaine 
 overdose] ## I thought I'm not doing this again # that's it # just the look on his face ## 
 every time I think about coke now (.) I think about his face [...] gives me the # boost" 
 In addition to the influential role families can play in influencing risky behaviour 
engagement, the data also illustrated the beneficial impact participants families have upon 
their adherence efforts. Transition to adulthood appeared to be a challenge in terms of 
adherence efforts, with participants being expected to take on more, and have a more active 
involvement in treatment decisions. Ben explained how during his teenage years where 
independence was first encouraged his adherence "slipped", with him not looking after 
himself as well as he should have done without his Mother integrating his medical regimens 
into his life.  
 *[Ben, 34 years]: "My Mom did everything fo:or me (.) she'd la:ay my tablets out of a 
 mo:orning (.) put my nebuliser there # did my physio:o # a:an I think # when I was a 
 teenager anyway (.) everything slipped an I didn't look after myself to:oo good" 
It is not just essential for families to facilitate adherence, Nick indicated that families should 
make an individual aware of treatments' necessity, ensuring the individual will independently 
maintain their future adherence. 
 *[Nick, 33 years]: "Make them understand wh:hy they need to be doing [treatments] 
 ## why they need to be making the right decisions" 
Whilst participants discussed the challenge of independent adherence, some participants did 
still experience support with their adherence during adulthood, discussing the importance of 
personal relationships upon health. Relationships appear to have beneficial health impacts 
90 
 
both psychologically and physically, with partners being there for both practical support (e.g. 
reminding the individual to adhere to their treatments), and emotional support (e.g. providing 
encouragement to adhere to the complex and time-consuming treatment regimen). 
 *[Nick, 33 years]: "If you're in a relationship (.) you're in mo:ore of a routine [...] 
 you've got someone the:ere (.) to give you a ha:and [...] I was in a relationship for a 
 good two:o (.) or three years:s # and I suppose that was a good ti:ime for health" 
Andrew discussed how the emotional support from his wife and family motivates him to 
adhere to his treatments to prolong his life with his family. 
 *[Andrew, 46 years]: "I've got a wife # an I've got two daughters # and e:erm:m # I 
 want to be around as long as possible for them [therefore motivates adherence]" 
However, despite this motivation other factors also influence an individual's ability to fully 
adhere to their treatments, with Sarah explaining how parenthood means that she has to 
integrate her treatments into a new and disruptive life with her children, where she has less 
time for herself.  
 *[Sarah, 32 years]: "All my time and effort (.) and energy (.) and mental strength (.) 
 goes on my children (.) and trying to give them a no:ormal life" 
 Whilst being in a relationship was positive for one's health, relationship breakdowns 
were detrimental, with Simon discussing how he has engaged in risky behaviours as a way 
of coping with his multiple relationship "break ups". 
 * [Simon, 33 years]: "When I used to split up with her [girlfriend] I used to get fed up # 
 stressed and upset ### I don’t know wh:hy (.) but I did # you know (.) a:and then I 
 saw this guy (.) I said I’ll tr:ry this (.) I’ll tr:ry that (.) and then smo:oked heroin" 
The value of support was further demonstrated when some participants did not have strong 
family support, resulting in detrimental impacts upon their life. Stephen explained how his 
volatile relationship with his Mother resulted in him smoking marijuana as a form of 
escapism. 
 *[Stephen, 19 years]: "I argue with my Mom everyday [...] full blown arguments # 
 she's in my face (.) I'm in her face (.) screaming (.) an (.) you know what I mean (.) 
 she's slamming (.) banging things # that's why I smoke weed everyday [laughs]" 
As well as initiation, some participants explained how their families were aware of their risky 
behaviour engagement however they did not encourage cessation. This was often due to the 
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family normalising that risky behaviour, which in itself was often a contributing factor which 
resulted in the participants initiation. Jessica explained how she believes that her Mother did 
not try to stop her smoking due to her Mother also smoking, and therefore believing it would 
be hypocritical to encourage cessation, despite the adverse health effects this could have 
upon Jessica's CF. 
 *[Jessica, 32 years]: "Mum ju:ust said # we:ell (.) you’re sixteen # an:n (.) if you want 
 to smoke (.) then you know # what the consequences will be (.) and I think because 
 she smoked (.) she felt like she couldn’t say" 
 For some participants their negative family relationships were directly due to their CF, 
with their family not supporting their life with CF. These participants therefore explained how 
they had to deal with the physical and emotional aspects of CF on their own, with Katie 
discussing how her family did not facilitate her adherence, resulting in poor adherence as 
well as drug use as a form of escapism.   
 *[Katie, 33 years]: "I've dealt with my illness by myself for a long (.) lo:ong time [...] 
 I didn't feel like anybody ca:ared sometimes [...] that's what the drugs were about I 
 think # not having to deal with it sort of thing" 
This lack of family support was often due to participants family having negative attitudes 
towards CF, with a number of participants indicating that their family was in denial regarding 
CF, and often in regards to CF's genetic component. This denial resulted in Katie feeling 
unwanted and impacted upon her attitude towards CF, resulting in Katie not disclosing her 
illness to others ensuring her normal identity was on display to others. Consequently this 
non-disclosure enabled Katie's non-adherence and risky behaviour engagement, with CF's 
invisible nature aiding this non-disclosure. 
 *[Katie, 33 years]: "I never told anybody I had CF when I was younger [...] I was 
 ash:hamed [...] my Dad's family ## always denied that it was anything to do 
 with them [...] I think I was always being made to (.) feel unwanted" 
 A number of participants also discussed the importance of friendships and the impact 
they have upon health behaviours. Many participants spoke about the sense of belonging 
they feel from their friends, and how friendships make them feel normal by being accepted 
into a social group, providing them with a normal identity. Even when participants illness 
identity was on display in front of their friends, Andrew indicated that by maintaining these 
friendships the individual still receives a sense of normalcy and a break from CF.  
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 *[Andrew, 46 years]: "He [friend] just rang me out the blue # we was on the phone for 
 an hour an a half [...] that was re:eally good [...] it makes you feel no:ormal again # 
 even though you're hearing about their lives an thinking >I wish I could do that I wish 
 I could do that< # it's still nice to hea:ar (.) what they're doing [...] it takes you back" 
A number of participants also described how their friends would not allow them to engage in 
risky behaviours, as they are aware of the CF-specific adverse health effects, with many 
participants valuing their friendships. 
 *[Stephen, 19 years]: "They won't let me smoke fags [...] they said to me like (.) if we 
 ever see you spark up a fag (.) we'll slap it out your hand" 
 Due to individuals valuing their friendships, it was not surprising that many 
participants initiated in risky behaviours due to their friends normalising such behaviours. 
Jessica explained that for her, smoking marijuana felt normal when she was with her friends, 
with such engagement providing her with enjoyment and social acceptance.  
 *[Jessica, 32 years]: "I’d go out with my friend # and we’d go to ## our friends house 
 (.) and they’d all be smoking [marijuana] [...] it was just a # like a # social thing [...] it 
 was just the norm (.) like I just got passed it [spliff] (.) so I did it" 
When behaviours were normalised by a participants social group, many participants 
highlighted their belief that engagement in such behaviours formed part of their group 
identity, with Sam explaining that he only engaged in heroin use when he was in social 
situations with his peers. 
 *[Sam, 43 years]: "It was the:e (.) e:er:r # crowd that I was in (.) sort of # the type ## 
 the type of behaviour that wa:as going on [heroin use] (.) so it just seemed na:atural 
 to:o ## yeah # to (.) to (.) join in" 
 The behaviours of an individuals' peers strongly influence their own behaviour, with it being 
evident that a change in friendship group often resulted in cessation, as that behaviour was 
no longer normalised. 
 *[Jessica, 32 years]: "I stopped hanging around with that friend # it was just purely # 
 I used to smoke it [marijuana] when I was with her (.) and the (.) bunch of (.) people 
 (.) we used to hang with [caused cessation]"  
 Whilst the majority of friendships discussed were referring to individuals within the 
general population, some participants discussed their friendships with others with CF. Many 
of these participants viewed these friendships to be positive, despite the risk of cross-
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contamination, with Sarah explaining how she ignores in-hospital segregation because of the 
psychological benefits such friendships have upon her life, with no one else being able to 
understand the reality of CF.  
 *[Sarah, 32 years]: "I've always disregarded those # rules [...] because for me (.) 
 those people have got me through some majorly tough times [...] seeing that other 
 people know exactly what you're going through cause (.) no ot:ther person (.) on (.) 
 this (.) planet (.) knows what a CF person goes through (.) other than a CF person" 
Many participants who did mix with others with CF believed that it will not be harmful towards 
their health, with Richard explaining that he has grown up in a generation of CF care where 
he was able to mix with other individuals with CF, therefore creating his belief that such 
communication will not have adverse health effects. Such participants appear to focus on 
their psychological health rather than their physical health, particularly if they have not 
experienced any detrimental consequences to physical health. 
 *[Richard, 34 years]: "I've come through a generation whe::ere ## you used to be sat 
 in a wa:aiting room next to (.) kids with CF [...] I think tha:at as lo:ong as you meet up 
 # a:and you're res:sponsible #### the:en it's a:alright" 
Many participants talked about how in-hospital segregation is associated with increasing 
isolation, however for some participants when they were informed about the potential 
adverse health effects of cross-contamination they appeared to value their physical health 
above their psychological health, and decided to not mix with others with CF, regardless of 
their generational upbringing. 
 *[Sam, 43 years]: "I ### used to [mix with CF patients] # be:efo:ore ## infection 
 control beca:ame an issue [...] it did take a certain ## so:ocial element out [...] there 
 wa:as that ## therapeutic effect of just been able to sha:are things about # the 
 condition # with people that # understa:and it ## intuitively" 
Not all participants however found mixing with others with CF beneficial, with Sarah 
discussing how upsetting these friendships can be due to them highlighting CF's fatal nature. 
 *[Sarah, 32 years]: "I didn't want to make any mo:ore [CF] friends cause I was sick 
 of losing people [...] I couldn't cope with it" 
In addition, some participants, did not want to make friends with individuals with CF as they 
wanted to have their own friends who did not have CF, potentially in response to their illness 
identity, enabling them to possess a normal identity in public. 
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 *[Ashley, 35 years]: "I kind of # wanted to make my o:own friends [...] just because 
 they’ve got CF as well doesn’t mean I want to be friends with them" 
 With the support an individual receives in their private life (predominantly from their 
families and peers) varying between participants, an important source of support identified is 
that from HCPs. Whilst HCPs are very supportive, a number of participants believed that 
HCPs only understand textbook CF, rather than the reality of the condition, with Claire 
believing that it is impossible for anyone to understand what it is like to live with CF. 
 *[Claire, 29 years]: "Very like idealistic # and very textbo:ook # and very ## not able 
 # to # relate it to someone's real life [...] they're [HCPs] like ↑o:oh do you just want 
 to do your physio in the car when you're driving along in the morning ## ↓are you 
 having a laugh [laughs] [...] do you just want to get up ten minutes earlier and do that 
 neb ###↓ok if I turn that round would you" 
Negative views towards HCPs were often in response to HCPs focusing upon aspects of an 
individual's health which are deteriorating, instead of highlighting areas which they are 
managing well. Emma talked about the need for HCPs to focus on hope and inspiration 
during clinic appointments, to maintain an individual's psychological wellbeing and provide 
them with positive reinforcement for their self-management. 
 *[Emma, 57 years]: "It’s very very ra:are you would come to a clinic (.) and people 
 will say you’re doing well [...] they can tend to focus on # let's fix this [...] I remember 
 one ti:ime I was in clinic # a:all my results were up # apart from my FEV1 # was 
 do:own a little bit # and he (.) totally (.) focused on that" 
As well as clinic being described as a negative environment, Emma explained how it can be 
confusing due to a lack of consistency provided by different HCPs, often resulting in the 
individual not understanding what treatments they need to adhere to, and how they adhere 
to them.  
 *[Emma, 57 years]: "No two people from the clinic have ever sung from the sa:ame 
 hymn sheet [...] then you’ll get a new person and they’ll sing from a different 
 hymn sheet [...] two Consultants # one would say one thing (.) one would say the 
 other # so:o # whichever one I picked I was arguing with the other one" 
 In terms of risky behaviours, a number of participants discussed how HCPs had not 
provided CF-specific awareness. Some participants stated that they had been asked if they 
engaged in "risky" behaviours, however it was only ever a question, with awareness being 
provided on an individualised basis in response to this question.  
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 *[Stephen, 19 years]: "When I go to clinic appointments they say are you a smoker (.) 
 an I say no [...] the Nurses for the kids ward when I was a kid obviously used to say 
 well  ↑ Stephen make sure you don't start smoking [...] I didn't listen [...] it's just one 
 of them # >don't smoke<  [...] they didn't tell me any things that would happen (.) or 
 what effects it would have on me" 
Many participants believed that awareness regarding the CF-specific adverse health effects 
of risky behaviours could have prevented their initiation, by making them fear the potential 
health effects at a young age. 
 *[Stephen, 19 years]: "They tell you not to smoke but ## they don't go deep enough 
 into it [...] if they'd have shown me [...] like things # CF lungs [...] if I'd have seen 
 pictures an stuff (.) I probably would (.) have been scared to do it (.) I probably would 
 have been at that age (.) because I was only about eight when I remember starting 
 talking  about it " 
Participants suspected that HCPs do not provide this awareness regarding the adverse 
health effects of risky behaviours, as they do not have sufficient knowledge surrounding risky 
behaviour engagement. Will explained that he believes HCPs are not aware of what 
substances are readily available within the general population, therefore he believes that 
HCPs are not aware that they need to provide patients with such awareness. 
 *[Will, 21 years]: "I think they're naive to what you can get your hands on [...] I could 
 get my hands on anything [...] a:any kind of drug [...] nobody in he:ere would be 
 saying (.) o:oh Will don't do that (.) don't do that # they don't (.) re:eally expect that 
 you could do that" 
In addition, some HCPs were unaware that their patients had engaged in risky behaviours, 
as some participants did not disclose their engagement to their HCPs. Will explained that he 
did not disclose his drug use to HCPs as he did not want to be judged, or to have his 
provision of care compromised, indicating that an intervention is required to encourage 
disclosure, so HCPs can treat patients being fully aware of their personal condition. 
 *[Will, 21 years]: ">No no no< [does not disclose drug use to HCP's]  # it's only 
 because I don't want to be judged [...] if I told them (.) everything [...] I wouldn't feel 
 like I'd get the better ca:are # the best ca:are [...] they might look at me a bit 
 different" 
 Despite some participants not disclosing their engagement in risky behaviours to 
their HCPs, many participants did talk favourably about their close relationships with HCPs, 
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acknowledging that HCPs are empathetic towards adherence, shaping treatment plans 
according to an individual's lifestyle, therefore placing emphasis upon psychological factors 
as well as pharmacological, all of which is aligned to a person-centred care.  
 *[Nick, 33 years]: "With Doctors # they’re willing to meet you ha:alf wa:ay (.) to a 
 certain extent (.) just because of the nature of the beast [...] we do (.) take a:all our 
 own tablets ## it’s a:all self-medicated " 
The majority of participants spoke favourably about their Nurses, believing that they are the 
most approachable member of the MDT. Participants often valued their relationships with 
Nurses, viewing Nurses as friends or even family members, with Nurses often easing an 
individual's time during hospitalisation. 
 *[Katie, 33 years]: "I class these Nurses as my family [...] they’re the only people I 
 had at one point (.) in my life [...] that’s why I used to struggle to go ho:ome [...] 
 sometimes I would make myself ill to come in (.) cause I knew (.) that I had people to 
 talk to"  
With many participants discussing their close friendships with their Nurses, some 
participants indicated how at times these relationships were potentially not professional. 
Nicola explained how Nurses have contributed to the normalisation of excessive alcohol 
consumption, openly discussing their experiences with alcohol. In addition, Katie discussed 
how Nurses turn a "blind eye" to CF patients mixing, despite the risks of cross-
contamination. 
 *[Nicola, 19 years]: "Most of the Nurses do [drink alcohol] (.) they can't turn around 
 and tell me o:oh you can't do this # they turn round and say o:oh (.) e:erm (.) I was 
 bladdered on my Birthday" 
 *[Katie, 33 years]: "We don’t listen to that crap [cross infection] [...] it’s all bollocks 
 [...] the Nurses don’t give jack shit" 
Despite the impact such communications could have upon an individual's health, the fact 
that Nurses approach patients on a "human level" appears to foster a close patient-clinician 
relationship, with participants feeling supported by their Nurses. 
 Another source of support identified within the data is that from a participant’s 
employment or educational experiences. Some participants did demonstrate that their 
employers are understanding towards CF, however this was not the case for all participants, 
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with Matthew explaining that his managers do not care about his CF, with this having the 
potential to result in occupational stress. 
 *[Matthew, 47 years]: "Managers at work # they're just focused on one thing (.) an 
 that's getting the work out the door (.) like they aren't bothered # well I feel they aren't 
 bothered how you're feeling (.) as long as that job's getting done [...] I don't feel as if 
 I've got the confidence to go up to one of the managers an  say listen >I can't go as 
 quick as everyone else< cause I'm feeling a bit tired" 
With many participants identifying that risky behaviour engagement helps to alleviate stress, 
the presence of occupational stress could result in risky behaviour initiation. The initiation in 
a risky behaviour could also be influenced by an individual's workplace normalising that 
behaviour. Nicola explained how she is given alcohol as an incentive after work, normalising 
excessive alcohol consumption, encouraging individuals to initiate in that behaviour to 
provide themselves with a normal identity whilst at work.  
 *[Nicola, 19 years]: "After # work [barmaid in a nightclub] you always get a drink # 
 you get a free drink (.) and then you have that and then they go out after (.) so I just 
 go with them [...] when you work with alcohol you're surrounded by it" 
Educational experiences can also normalise risky behaviours, with Nick explaining how he 
viewed excessive alcohol consumption to be part of his University experience.  
 *[Nick, 33 years]: "You go to u:uni # you do a:all the drinking games [...] I was like 
 I've never re:eally done drinking ga:ames # this is quite fun [...] when I'm with my uni 
 frie:ends (.) I suppose drink is ## a pa:art of it" 
 The data does clearly illustrate the influential role of normalisation, as when risky 
behaviours were not normalised participants often did not initiate in such behaviours. 
 *[Richard, 34 years]: "None of me mates smoked # no one in me fa:amily smokes:s 
 ## I've come from an environment where it's not # smo:oking's not ## it's not 
 done (.) I'm not exposed to it ## I've no desire to do it" 
Even when participants were in an environment where typically risky behaviours are 
normalised, participants explained that if the behaviours were not normalised within their 
social group they would not conform to such behaviours, as a normal identity within that 
social group would not involve engagement. 
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 *[Richard, 34 years]: "I had mates who I knocked about with [...] none of us:s 
 we:ere:e ## that bothered about that sort of thing [...] they were a:all at uni:i to be at 
 uni (.) not to muck about and pa:arty" 
This theme therefore highlights how the role of others can be influential in promoting health 
behaviours, and preventing risky behaviour engagement; however the role of others can also 
encourage risky behaviour engagement predominantly due to normalisation. The need for 
HCPs to provide all patients with information regarding risky behaviours, regardless of an 
individual's personal condition is therefore highlighted.  
"Why should I let Cystic Fibrosis completely dominate my life?" 
 Whilst the role of others can have beneficial health effects in working to prevent 
engagement in risky behaviours, as identified this is not always the case, with some 
individuals explaining how their engagement with risky behaviours was due to such 
behaviours being normalised within their environment. When participants engaged in 
normalised risky behaviours it was often due to their effort to not be defined by their CF. 
Many participants discussed how they are more than their CF, with Emma explaining how 
she is the same as everyone else, and it is only when she attends clinic appointments that 
she feels different due to them reminding her of her CF. 
*[Emma, 57 years]: “I didn’t see myself as anything other than # everyone else (.) 
and to a certain extent that’s still how I view myself [...] it’s only when I come to clinic 
that I feel different” 
Many participants engaged in behaviours which were separate to their CF in order to just be 
themselves, rather than being them with CF. Ben explains how he behaves in a way which 
does not identify him as having CF, with others not being able to single Ben out due to him 
engaging in "normal behaviours", promoting his psychological wellbeing. 
 *[Ben, 34 years]: "You feel like you're no:ormal [when drinking alcohol] # you're not 
 isolated # you're just (.) a no:ormal person that day # a:and the thousands of people 
 around you (.) they don't know any different" 
 Some participants explained how they value this sense of normalcy above their physical 
health, with Stephen discussing how he smoked marijuana without considering the impact 
this could have upon his CF, because he cared more about social acceptance than his CF, 
in order to protect his psychological wellbeing. 
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 *[Stephen, 19 years]: "I didn’t think about my health (.) I just wanted to (.) I just cared 
 about fitting in” 
 Due to many participants valuing a sense of normalcy, they often valued CF's 
invisible nature, ensuring their normal identity in public. Daniel explained how no one ever 
questions him about his CF as it is not visible to the outside world, something which Daniel is 
appreciative of in order to allow him to lead a normal life. 
*[Daniel, 25 years]: “No one ever questions (.) o:oh you’ve got an illness # they 
wouldn’t know from looking at me (.) that’s the best thing really” 
The invisibility of CF was not always considered a positive thing though, with some reporting 
that this invisibility causes ignorance from others. Lucy explained how society often does not 
understand CF or the challenges faced, due to people with CF looking "normal" to the 
outside world. 
*[Lucy, 28 years]: “Because I look well # people (.) presu:ume I’m well # a:an when 
I’m # struggling # people don’t tend to understand that I’m struggling [...] you look (.) 
the sa:ame as everyone else # then it’s kind of (.) you’re expected to do the sa:ame 
as # everyone else” 
Visibility and invisibility of CF is situational and temporal, with it being plausible that Lucy 
may at other times be glad that her CF is not visible. The data indicates that an individual's 
perception of their identity can change as their disease progresses, with participants who 
perceived themselves to be healthy welcoming CF's invisible nature, however as health 
deteriorates individuals require more support from others, with CF's invisibility often 
preventing such support from happening. Richard explained that when he was younger he 
was healthy, therefore it was not adaptive for him to possess an illness identity (particularly 
in public), it was only when his health started to deteriorate that he accepted CF's true 
nature and incorporated his illness into his identity. 
*[Richard, 34 years]: “I was really healthy (.) I:I # was the sa:ame as everyone else (.) 
I could do everything that everyone else could # spo:orts (.) and all that sort of stuff # 
I # I was no different” 
 Whilst health deteriorations resulted in some participants accepting their illness 
identity and engaging in health promoting behaviours, others focused upon the fact that 
these health deteriorations impact upon their ability to engage in normal activities. Health 
deteriorations therefore had a negative impact upon some participants psychologically, due 
to their desire to keep up with their peers, in order to have a sense of normalcy.  
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*[Lucy, 28 years]: “As I get older I fi:ind it’s # ha:arder to keep up with them [friends] 
[...] it makes you feel a bit # crap [...] I wa:ant to do it (.) but it’s:s # you ca:an’t 
physically # do it # like everyone else ca:an”  
Consequently, it was evident that the visibility of an illness identity due to health 
deteriorations can have a negative impact upon an individual's wellbeing, with Sarah stating 
that she feels like a non-entity when using her wheelchair, due to people staring, and 
sometimes disregarding her. Therefore an individual's illness identity often prevents 
individuals living the normal life they desire. 
*[Sarah, 32 years]: “People will sta:are [when in a wheelchair] ## and just completely 
(.) dis:sregard you (.) as a human being # it’s cr:ra:az:zy [...] you just feel like you’re 
(.) a non (.) entity # you just feel like you’re not a person anymore”  
In terms of treatments, Nick spoken about the emotional aspect of adherence, with 
treatments being a continuous reminder of CF's fatal nature.  
 *[Nick, 33 years]: "It [treatments] remi:inds you of how fu:ucked you could be [...] it 
 takes you on that journey every da:ay # when you don't do it you kind of feel a bit 
 no:ormal"  
It is difficult for individuals to step away from CF even for a short time, due to the action of 
engaging in treatments every day, several times a day; therefore it is easy to see how non-
adherence can offer a temporary respite from the constancy of identifying oneself as being 
ill, providing some psychological relief and comfort in feeling "normal". Some participants did 
demonstrate how non-adherence is a way of reducing the differences between themselves 
and their peers, in order to support their efforts of acquiring a normal identity when they are 
with their peers.  
*[Emma, 57 years]: "It’s [treatment] one mo:ore thing that make me different (.) from 
the family [...] being different # and perhaps not wanting to be different comes into it a 
lot ## like not wanting to be seen taking your creon [...] you may just find a way of 
taking your creon when nobody’s looking (.) so you’re not different”  
A desire for normalcy was evident amongst many participants, however participants actions 
to acquire a normal identity varied. Some participants discussed how adherence allows them 
to possess a normal identity, with Lucy explaining how adherence improves her health, 
helping to prevent health deteriorations, allowing her to lead a normal life and to be 
perceived by others as being normal. 
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*[Lucy, 28 years]: “I don't li:ike it [CF] stopping me from doing anything [...] I look after 
myself [adherence] (.) to stop it [CF] from stopping me from doing stuff" 
This desire for a normal identity appeared to be heavily valued by participants until they 
experienced significant health deteriorations, with participants who had previously engaged 
in non-adherence, then often acknowledging treatments' necessity and valuing their physical 
health as a consequence of symptom presentation.  
*[Richard, 34 years]: “My health was very good (.) I would be able to:o ## e:erm (.) 
miss (.) the (.) odd (.) one [treatment] [...] it wouldn’t re:eally # matter” 
 In addition to adherence, many participants explained how they were provided with a 
normal identity when in public through risky behaviour engagement, with Sarah appearing to 
retaliate against her CF by engaging in risky behaviours in order receive a sense of 
normalcy. 
*[Sarah, 32 years]: “Definitely # just to (.) fit in ## to feel normal [...] that is a big part 
of it [risky behaviour engagement] [...] it's bad enough that people question you over 
your tablets at that age [...] let alone (.) not being able to go and let your hair down a 
little bit when everybody else does" 
Such participants were often conforming to their peers’ behaviours, allowing themselves to 
adopt the same identity as their peers and to be accepted by that social group. Many 
participants explained how such engagement provided themselves with enjoyment, with 
Stephen explaining that it is important for him to live his life and do what he wants to do, 
instead of letting CF rule his life, with Stephen valuing his psychological health over his 
physical health. 
 *[Stephen, 19 years]: "My main priority [...] with a life threatening illness that's going 
 to kill you (.) that should be ## living your life # doing what you want # ticking off your 
 bucket list [...] I don't let CF rule my life (.) it never has done # not a day of my life has 
 CF took over me [...] if you let your illness rule you # then you're not going to live are 
 you [...] you need to go out an live your life"  
Even when participants acknowledged the potential CF-specific adverse health effects, 
some continued their engagement as it allowed them to have a life away from CF, which was 
important to many. Ben highlighted how he needs a life away from CF to ensure his 
psychological wellbeing, despite acknowledging the adverse health effects associated with 
the behaviours that he engages in to ensure he leads a life away from CF.  
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 *[Ben, 34 years]: "If I go:o out an I have eight pints # next mo:orning my chest is 
 rubbish (.) but then I think # what do  you do ## you've got to have so:ome form of life 
 [...] su:urely you should be entitled to do (.) so:ome normal things [...] wh:hy should I 
 let it [CF] completely dominate me life [...] if I feel I want to go out (.) I'm gona go out" 
 With many participants not wanting CF to define their identity, it was not surprising 
that many participants did not want others to be aware of their illness identity, preventing 
them disclosing their CF status to others, such as their colleagues. 
 *[Jessica, 32 years] "My work colleagues don't know I've got CF [...] I don't want 
 sympathy [...] I don't want people to look # at me (.) any (.) different (.) cause some 
 people do change (.) an they're like (.) ↑oh it's alright (.) you don't have to do this [...] I 
 try an carry on # as (.) no:ormal as possible" 
There were many identified reasons as to why participants did not want to disclose their 
illness identity to others, with many participants indicating that their non-disclosure is to 
provide themselves with a normal identity in front of others. Mark explained that he does not 
disclose his CF status to others as he does not want to be treated differently, with many 
individuals viewing CF to be a disability, which Mark disagrees with. 
 *[Mark, 23 years]: "I think # as so:oon as you sta:art to talk about something serious 
 like that [CF] (.) it's a bit of a do:owner on the situation # people mi:ight ## view it as 
 a disability (.) and I definitely do not view it as a disability (.) and I don't want people 
 to be:e ## thinking me:e ## giving me any kind of:f # e:er:r # special needs (.) cause 
 they know that # a:and (.) I don't want to be treated a:any # any differently [...] there's 
 nothing which I limit myself to # so I don't think anyone else should" 
In particular participants spoken about how difficult it is to disclose their CF to people they 
are dating, fearing the relationship will end following disclosure. Therefore a number of 
participants often did not disclose their illness identity unless they perceived their 
relationship was going to be long-term. 
 *[Claire, 29 years]: "Dating people and meeting people< # >that's the last thing you 
 want to tell people< (.) and when you do (.) that's a ve:ery serious conversation [...] 
 with my ex ### I told him li:ike (.) after a few weeks (.) we'd been dating quite a lot 
 [...] I knew I was getting a bit in:nvested in him (.) and I tho:ought (.) if I tell him this 
 no:ow # he can # go:o # be:efore # I get hurt” 
 It appears that the majority of participants only allowed their illness identity to be on 
display to others when they had accepted CF's severity and deteriorating nature, with such 
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participants reporting that they no longer felt embarrassed when adhering to their treatments 
in public, with Laura then acknowledging treatments' necessity. 
 *[Laura, 28 years]: "You do:o get some funny looks [when taking tablets] sometimes 
 # but (.) the way I:I see it # well if I do:on't ta:ake these I'll be dead" 
Overall, a desire to not be defined by CF appears influential upon one's adherence 
behaviours and engagement in risky behaviours. However, a large mediating factor affecting 
engagement in such behaviours appears to be the process of accepting CF's true nature.  
"The biggest challenge is coming to terms with having Cystic Fibrosis" 
 This final theme identifies how a number of participants found accepting CF's true 
nature to be challenging, with this being particularly challenging when participants 
considered themselves to be healthy. It was often only when a participant’s health 
deteriorated that they started to accept the severity and deteriorating nature of their 
condition.  
 *[Richard, 34 years]: "The biggest cha:allenge for me (.) was ## when (.) my 
 health dipped (.) was coming to te:erms:s (.) with it # with having it [CF]" 
When participants stated that they had accepted their CF, it appeared that they were not just 
acknowledging their diagnosis, but they had accepted CF's true nature, with Katie 
highlighting that CF is a disability, and is associated with a reduced life expectancy. In 
addition, participants who appeared to have accepted their CF were keen to emphasise that 
despite CF being an invisible impairment, they are ill.  
 *[Katie, 33 years]: "You have got to realise that you have got a disability [...] you 
 have got a shorter life expectancy" 
Some participants appeared to have not just accepted their illness, but also appeared to 
have accepted treatments' necessity. However, this acceptance towards adherence did not 
always encompass all treatment modalities, with participants often categorising treatments 
based upon the benefit participants felt from treatments. James explained how adverse 
health effects following non-adherence to creon tablets ensure that he will always adhere to 
that treatment. 
 *[James, 19 years]: "My creon are the most important things (.) I'll have them [...] If I 
 don't take my creon (.) then I'll notice (.) I'll get stomach ache (.) so I've got to take 
 them # I always take them" 
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Consequently, adherence for many participants was influenced by short-term treatment 
benefits, with participants adherence decisions being based upon their immediate 
symptoms. A number of participants indicated that they self-medicate, with James only 
accepting the necessity of all his treatments when he is not well. 
 *[James, 19 years]: "When you're not ill # you don't notice that you have CF (.) so 
 you tend to just forget about the medication and ### not take it (.) but ## when I do 
 get ill # I'll do anything I can (.) to get rid of the illness" 
James explained that when his symptoms are not present he does not consider himself to be 
ill, promoting his psychological wellbeing by providing relief from CF's enduring nature, 
however this appears to be associated with poor adherence. 
 A number of participants explained how they only came to accept treatments' 
necessity due to health deteriorations as a consequence of their non-adherence, with this 
acceptance resulting in Ashley employing effort to adhere to his medical regimens in order to 
improve his health. 
 *[Ashley, 35 years]: "I was going out (.) a:all the time at uni # I kind of slipped a lot of 
 my medication [...] that’s when # the lowest of my health # and that’s kind of (.) 
 wh:hy:y # after I finished University I went back to living with my parents ## so they 
 could help me (.) bri:ing my health back up" 
Other participants discussed how they came to accept treatments' necessity with age, 
explaining that it is only at this stage in their health that they can see the benefits of their 
adherence efforts. 
 *[Ben, 34 years]: "The effort you put in no:ow (.) you won't get results until later on 
 [...] I mean I'm thirty fo:our # there's no wa:ay I thought I'd live that long (.) the wa:ay I 
 was when I was younger # a:an I'm thinking no:ow in my teenage yea:ars if I had put 
 that extra effort in ## I might have been even we:ell # even better off no:ow" 
Acceptance with age could be due to health deteriorations resulting in individuals feeling 
more of a beneficial effect from their adherence efforts. However it could also be due to 
adults having the cognitive ability to understand treatments' necessity, understanding the 
long-term benefits adherence will provide them with. When participants explained that they 
had accepted treatments' necessity it was associated with positive attitudes towards 
adherence, with participants not being embarrassed about performing medical regimens in 
front of others, and often not desiring invisibility towards their condition, as they were 
105 
 
comfortable with having their illness on display. Andrew acknowledged that without his 
adherence efforts his health would rapidly deteriorate.  
 *[Andrew, 46 years]: "They've a:all said here # that # if I hadn't adhered # to my 
 treatments [...] they don't quite put it this way # but they say you'd be six foot under # 
 and I think that's pretty true (.) having seen some of my friends who haven't # 
 adhered to it # you see people go downhill re:eally quickly" 
 Some participants also appeared to have accepted the adverse health effects 
associated with risky behaviours. This was often due to participants experiencing health 
deteriorations as a consequence of engagement, often resulting in cessation. Such 
participants often no longer desired a normal identity by engaging in these normalised 
behaviours, instead they were focused upon their physical health. 
 *[James, 19 years]: "I stopped smoking (.) my lung function got better [...] the main 
 reason I stopped is because # getting that pneumonia (.) my lungs were getting ## 
 awkward # struggling to breathe # painful # so last thing I wanted was:s (.) a fag" 
Acceptance regarding these adverse health effects was not just isolated to individuals who 
had engaged in risky behaviours, with some participants who had not engaged in such 
behaviours also accepting these adverse health effects, with this preventing their initiation. 
Claire explained that she would never smoke despite it being normalised within her 
environment, due to her experiencing the adverse health effects of passive smoke. 
Therefore Claire appeared to value her physical health above a desire for normalcy. 
 *[Claire, 29 years]: "I would just walk past someone [who was smoking] and I'd be 
 coughing [...] walking past a cloud of smoke makes you feel horrible” 
 In order for participants to accept the adverse health effects of risky behaviours, 
participants needed good awareness regarding these adverse effects, resulting in such 
participants viewing these behaviours in a negative light.  
 *[Matthew, 47 years]: "Things are bad enough with the CF (.) why are you wanting to 
 make things worse through smoking ## an what are you gaining from smoking (.) like 
 it's not enhancing your life ### it isn't making the CF any better # it's going to make it 
 worse" 
Even when risky behaviours were normalised by participants peers, their awareness 
regarding the adverse health effects often prevented their initiation. Lucy discussed how she 
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was able to make an informed choice regarding smoking due to being aware of the 
consequences of this normalised behaviour.  
 *[Lucy, 28 years]: "At hi:igh school (.) quite a few of my friends:s sta:ated smoking 
 [...] I think because I kno:ow how important it is to breathe # an breathing is 
 difficult anyway (.) I just don't know wh:hy:y people want to do that # to themselves" 
Awareness can be provided in a number of ways, with some participants stating that HCPs 
have discussed risky behaviours with them. 
 *[Ben, 34 years]: "They don't say don't smoke (.) they put it in a wa:ay where you 
 know it's bad fo:or you (.) an it's going to effect you:ur lungs even mo:ore" 
However, a number of participants reported a lack of awareness provided from HCPs, 
despite some participants believing that this awareness could have prevented their initiation. 
An example of participants who were not provided sufficient awareness regarding risky 
behaviours comes from Will and Sarah. Will explains how he is unsure whether he is allowed 
to drink alcohol whilst on antibiotics, with Sarah discussing how she was never informed that 
co-codamol can be addictive, with Sarah developing an addiction that was never detected 
until she experienced near fatal side effects.  
 *[Will, 21 years]: "I don't know if that [drinking whilst on antibiotics] affects me:e 
 health # but # they haven't told me a:any different (.) when they prescri:ibe it (.) they 
 don't sa:ay (.) right you ca:an't drink [...] I don't know if the assu:ume you kno:ow # 
 but I've never (.) ever been to:old [laughs] # so I just carry on as I am [drinking whilst 
 on antibiotics]" 
 *[Sarah, 32 years]: "I got put on it [co-codamol] without been told that they're 
 addictive:e [...] I was (.) I was getting it from he:ere (.) and my GP # so I was getting 
 double the amount [...] I got called up on it once by a Doctor (.) but I was in complete 
 denial [...] they were like look you're having too many (.) and I'd make up excuses 
 saying I've lost so:ome [...] I've kept some at my Mom's:s" 
Whilst Will and Sarah will have been informed through leaflets enclosed within the 
medication about the adverse health effects of co-codamol, and the implications of drinking 
alcohol whilst taking antibiotics, their experiences highlight the need for more specific and 
clear guidelines.  
 When participants had been provided with sufficient awareness regarding the true 
nature of their CF, and appeared to have accepted their CF, this was often associated with a 
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change in an individual's perceptions towards their illness, with acceptance commonly being 
associated with participants believing that health-orientated behaviours are mandatory. 
 *[Will, 21 years]: "You have to do it [...] if I'm out with my friends lets sa:ay (.) I sort 
 of have to sa:ay # o:oh I've got to get back tonight # I ca:an't stay over at my mates 
 house cause I've got to get back an do my stuff (.) an take my tablets" 
 Following acceptance it appeared that participants main priority was not about living their 
life how they wanted to; instead they appeared to define wellness as feeling physically well, 
and focused upon the medical and physiological aspects of their illness. Such participants 
appeared to value engagement in health-related behaviours, regardless of any restrictions 
this imposed upon their social life, with such participants being comfortable in disclosing their 
illness to others. However, for other participants awareness and acceptance regarding CF 
was associated with negative outcomes. 
 *[Stephen, 19 years]: "I came to terms with it [CF] when I was like # eight years old # 
 I remember been in primary school # crying on the toilet # cause like I actually found 
 out ## what it meant [...] I got dead upset [...] I'm going to die when I'm thirty odd" 
Awareness regarding CF resulted in anxiety amongst some participants, particularly in 
regards to CF's fatal nature, with Daniel explaining that this awareness frightened him, 
resulting in him wanting to escape and avoid his CF. 
  *[Daniel, 25 years]: "With CF it's common that you have a short life span (.) and that 
 # sca:ared me [...] I didn't wana have it [CF] # didn't wana know it” 
Some participants coped with CF's fatal nature by rebelling against HCPs guidelines, 
engaging in risky behaviours despite their awareness regarding the adverse health effects of 
such engagement. Katie explained how she focused upon living her life in the "here and 
now" as she thought she would not survive into adulthood, resulting in her engaging in risky 
behaviours. 
 *[Katie, 33 years]: "I was told I wouldn't live to see sixteen [...] so I went through 
 life:e (.) partying [...] I always thought o:oh god I'm not going to be old enough to do 
 (.) you know # so that was my theory (.) just pa:arty (.) and be happy" 
 With psychological health, some participants believed that acceptance and 
awareness about CF's true nature was not adaptive, with avoidance of one's CF providing 
participants with a better quality of life, as acceptance prevented them engaging in several 
activities. Participants portrayed how following acceptance they became mindful about 
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engaging in health-promoting behaviours, and avoiding behaviours that could negatively 
impact upon their health, with this putting restraints upon their lives, impacting upon their 
psychological wellbeing. However, acceptance and awareness did not always result in 
adherence or prevent risky behaviour engagement, highlighting that the factors which 
influence such behaviours are complex. In terms of adherence some participants spoke 
about the challenges of dealing with health deteriorations, with Claire stating that although 
she is aware of treatments' necessity, she physically cannot adhere to her treatments when 
she is ill due to her diminished energy. 
 *[Claire, 29 years]: "If (.) you're # re:ea:ally poorly # do you know when you're on  the 
 absolute wo:orst day of having the flu # flued up [...] you should (.) definitely # do 
 them [treatments] mo:ore than ever (.) but you've not got the # energy to # turn over 
 # let alo:one ## get out of bed and do it all” 
In addition some participants discussed how work can prevent adherence. Mark explained 
that due to his work commitments he sometimes does not have time to adhere to his 
treatments, with shift work making adherence even more complicated. 
 *[Mark, 23 years]: "I do:o need to take it [treatments] (.) but # it takes so:o lo:ong # 
 it's bo:oring # I just want to go to bed [...] especially # like # with some of my old 
 jobs:s # I used to come in re:eally late (.) and then I'd have to make up the vial (.) 
 wait for the vial to be ready # so I'd be fa:alling to sleep # waiting for this thing to be 
 diluted # then take it" 
Another adherence barrier identified was the role of psychological distress, with participants 
discussing how when they experience symptoms of depression they cannot adhere to their 
treatments, although non-adherence worsens their health and negatively impacts upon their 
mood. Furthermore, some participants reported non-adherence due to a dislike for 
treatments and a desire to live their life.   
 *[Stephen, 19 years]: "I'm not a big fan of treatment as it is [...] it's always going to be 
 coming faster towards me than it is to (.) these other sufferers (.) that (.) take (.) take 
 their medication [...] the more medication you can take the longer your life sort of 
 goes on (.) but you know ## for me ## I'm not a fan of it # I'm really not" 
 In terms of risky behaviours, some participants still engaged in these behaviours 
despite accepting their CF, and being aware of the potential adverse health effects. A 
number of participants discussed how psychological distress, particularly depression, had 
motivated their engagement, with James discussing how he started to smoke due to his 
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depression despite previously resenting smoking, with such engagement alleviating James' 
psychological distress and promoting his psychological wellbeing. 
 *[James, 19 years]: "Feeling a bit depressed (.) which is when I started [smoking] (.) 
 like before then (.) I was proper (.) no (.) like # anti-smoke" 
In addition, some participants acknowledged that they were aware of the adverse health 
effects associated with their risky behaviour engagement, however they had not experienced 
any adverse health effects, allowing their engagement to continue, with their experiences 
providing them with an optimistic outlook towards risky behaviour engagement. Some 
participants demonstrated unrealistically optimistic views towards their risky behaviour 
engagement, by comparing their behaviour with other uncontrollable factors. Nick compared 
his use of marijuana to car emissions present when walking down the street. 
 *[James, 19 years]: "CF affects your lungs (.) smoking affects your lungs (.) so 
 obviously it's not a good combination [...] but when I'd tried it # I realised it (.) it didn't 
 # re:eally affect me" 
 *[Nick, 33 years]: "I suppose smoking a bit of weed's not good for you (.) is it (.) 
 e:erm:m # ha:aving a lung condition (.) but you know # stuff (.) emissions come out of 
 ca:ars when you walk down the street (.) you're breathing them in (.) so it's tit for tat 
 isn't it" 
Furthermore, some participants reported engaging in risky behaviours due to their desire for 
a normal identity when in public. Nick explained that it is normal to want to smoke marijuana, 
use illicit drugs and drink alcohol even when he knows he should be adhering to his medical 
regimens, again demonstrating that such participants focus upon their psychological 
wellbeing as opposed to their physical health. 
 *[Nick, 33 years]: "If I’m feeling shit # like I’d still go out and drink lo:oads of pints (.) 
 even though I’m feeling shit [...] I should be doing (.) my inha:alers # eating some 
 good food (.) a:and maybe going for a run # get some rest [laughs] # but I’ll be like 
 na:ah (.) fuck it (.) lets go to the pub [...] it is quite natural to want to go for a 
 drink # want to smoke a bit of weed # maybe take an ecstasy pill in your twenties" 
 In addition, whilst it was indicated that acceptance can aid the cessation of a risky 
behaviour; it did not always prevent the engagement in a second risky behaviour. James 
explained how he stopped drinking excessive amounts of alcohol, as he acknowledged that 
this behaviour was harmful due to symptom presentation. However, James replaced his 
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excessive alcohol consumption with smoking marijuana, which James stated is less 
dangerous, allowing his engagement to continue. 
 *[James, 19 years]: "I used to like # proper want to get drunk all the time (.) an then 
 when I moved to weed (.) that stopped [...] there's no negative effects:s of weed [...] 
 alcohol's worse at the end of the day" 
Participants often explained how their new risky behaviour allowed them to remain in line 
with their group identity, ensuring their normal identity within that group, and on occasions 
alleviating their stress, both of which promotes an individual's psychological wellbeing. 
 *[Jessica, 32 years]: "I couldn’t drink as much (.) because ## like blue wickeds (.) I 
 think the blue in it (.) the dye (.) or whatever it is (.) used to play havoc with my 
 sto:omach [so used drugs instead] [...] that [drugs] would keep me on the same path 
 as everybody else (.) like (.) up there (.) instead of me being the sober one" 
 *[Sam, 43 years]: "It was # stre:ess:s [...] I didn't re:eally like the (.) e:er:r (.) effects of 
 # dri:inking (.) e:er:r ## there's a kind of headachy::y (.) aspect of (.) alcohol that I:I (.) 
 don't particularly enjo:oy [...] I just chose a sort of (.) single hit of (.) smo:oke (.) of 
 heroin ### yeah (.) instead of (.) e:er:r (.) drinking half a bottle of wi:ine [...] It was a 
 substitution" 
 Overall this theme identified the potential relationship between acceptance and the 
engagement in health promoting behaviours. However the factors that influence risky 
behaviour engagement are manifold; therefore an intervention to reduce the occurrence of 
risky behaviours within the CF population, and to encourage adherence, cannot just focus 
upon increasing an individual's awareness. This theme therefore aligns with the previous 
four themes in identifying another factor that can influence engagement in such behaviours. 
Acceptance and awareness should not be understood in isolation, as the data illustrates that 
engagement is potentially the result of a complex interaction between an individual's identity, 
acceptance, the support they receive from others, the challenges they experience in 
response to living with CF, and their attitude towards their life with CF. Therefore 
interventions need to be mindful of all these factors in order to attempt to reduce the 
occurrence of risky behaviours within the CF population. 
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Discussion 
 The data provides an exploration into experiences and beliefs around risky 
behaviours within an adult CF population. Participants had a range of experiences with risky 
behaviours giving a number of different reasons for engagement. The data produced is 
retrospective, which enabled older participants to talk about how things were when they 
were younger, particularly in terms of their adherence efforts, and experiences with risky 
behaviours; with participants being able to discuss how things are different now. The change 
in behaviours and beliefs that some participants discussed were dependent upon a number 
of factors, such as an individual's health status, their peer group and a change within their 
responsibilities. 
  With today’s improvement in CF treatments quality of life is improving, with many 
participants describing how they lead a “normal life” engaging in “normal activities”, 
particularly during adolescence and young adulthood when they are often relatively well 
(Götz & Götz, 2000). Being able to live a normal life was most likely to be experienced when 
participants were feeling well, allowing them to focus on other things rather than having CF, 
and experience a more positive outlook towards their life and future. Participants positive 
outlooks were often supported by comparisons to others, concluding that things could be a 
lot worse than CF. Evidence of comparing one condition with another resulting in optimism is 
demonstrated within parental attitudes towards CF, with CF parents alleviating their stress 
by comparing their child to other children they perceive “more ill” (Moola, 2012).  
 For some participants it appeared that when they were able to forget about their CF, 
due to their symptoms not being present, they did not possess an illness identity. Other 
participants explained how they retaliated against their illness identity, to embrace the same 
identity as their peers. The emphasis that many participants placed upon being normal and 
living a normal life is evident within many individuals with CF (King, 2015; Yates et al., 2010), 
with individuals often stating that they hope to live a normal life where they have long-term 
relationships, have children and pursue a career (Higham et al., 2013). For many this desire 
for normalcy was accompanied with a desire to fit in with their peers, with some explaining 
how their engagement in risky behaviours forms part of their socialisation within their social 
group, in line with previous findings within the general population (Seaman & Ikegwuonu, 
2010). Being informed about the adverse health effects did not always result in non-
engagement with risky behaviours, some participants still engaged in these behaviours in 
response to their illness identity, in order to reduce the differences between themselves and 
their peers (Higham et al., 2013; Withers, 2012). Such participants often demonstrated their 
life-orientated illness perspective explaining that they engage in such behaviours for fun and 
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enjoyment (Audulv et al., 2010), focusing upon their psychological health and wellbeing, with 
the enjoyment and pleasure individuals receive from their risky behaviour engagement 
promoting their continuation. The influential role of peers was signalled when some 
participants experienced a change in friendship group resulting in the cessation of their risky 
behaviour, demonstrating that their engagement was based upon extrinsic motivations, 
where their behaviours were heavily influenced by external factors (Deci & Ryan, 1985, 
2000).  
 Bryon (2015) explains that adolescents with CF will behave like their peers without 
CF, and will engage in normalised risky behaviours, with adolescence being a period of time 
associated with heightened risk-taking behaviours, with this being supported by the present 
research. Adolescents are less likely than adults to perceive situations as unsafe (Knoll et 
al., 2015), with the experimentation of risky behaviours being normal during adolescence 
(Cohn et al., 1995; Richmond, 2014), however the CF population does not have the same 
freedom to experiment with such behaviours (McEwan et al., 2012). This highlights the need 
for patients to be made aware of the CF-specific adverse health effects of risky behaviours 
by HCPs. Nonetheless, some participants explained how they had not been provided 
awareness by HCPs, believing that HCPs are not aware of what substances are readily 
available within the general population, with literature indicating that most Doctors know less 
about illegal drugs than their patients do (Viner & Macfarlane, 2005).  
 Some participants believed that awareness would have prevented their initiation, 
however this is questionable, with it being well established within literature that awareness 
and knowledge regarding adverse health effects generally is not enough to motivate 
cessation, or prevent initiation (Derman & Akan, 1995). In terms of cessation it is indicated 
that despite an individual's awareness regarding the adverse health effects of a behaviour, 
an individual needs to be self-motivated to cease their engagement, with health promotion 
measures being unsuccessful within individuals who do not have any intention to change 
their health behaviours (Chatwin et al., 2014). Participants indicated how their behavioural 
intention can be influenced by a number of factors.  
 As suggested by The Stages of Change Model, interventions to encourage the 
cessation of a risky behaviour are most successful when an individual is already considering 
that behavioural change (Prochaska & DiClemente, 1982). Consequently prior to an 
individual contemplating a behavioural change, effort needs to be employed to change their 
attitude towards that behaviour (Ajzen, 1988; Ajzen & Madden, 1986; Fishbein, 1967; 
Fishbein & Ajzen, 1975). To promote behavioural change it is important that the individual 
can comprehend the awareness provided, with some participants highlighting how they did 
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not have the cognitive ability to understand and operationalise health information that HCPs 
had provided them with, due to the information being too complex. This awareness did not 
result in participants experiencing a change within their behavioural intention, as they could 
not process such information. It is therefore important that health advice is age appropriate 
(Bryon, 2015), providing the opportunity for such information to have an impact upon an 
individual's attitude towards the behaviour, and therefore their behavioural intention (Ajzen, 
1988; Ajzen & Madden, 1986; Fishbein, 1967; Fishbein & Ajzen, 1975). 
 Whilst awareness and knowledge cannot always be relied upon to produce 
behavioural change, the data does show that it can have an impact on behaviours within 
some individuals. Some participants explained how they did not engage in risky behaviours 
which were normalised within their social group, due to their good awareness regarding the 
adverse health effects. Awareness can be provided in many ways, with it being apparent that 
when awareness is provided through medication leaflets, e.g. do not drink alcohol whilst 
taking antibiotics, it is not always successful, with Raynor and Knapp (2000) stating that only 
21% of individuals within the general population read all of their medicine leaflets, 
highlighting the need for awareness to be individually provided and explained to all patients, 
particularly those with distinct medical needs (Raynor, Silcock, Knapp & Edmondson, 2007). 
  Given the complex relationship between awareness and abstinence, the influence of 
external factors on engagement in risky behaviours was explored. In line with The Theory of 
Reasoned Action and The Theory of Planned Behaviour (Ajzen, 1988; Ajzen & Madden, 
1986; Fishbein, 1967; Fishbein & Ajzen, 1975), participants indicated how they greatly value 
the opinions of their peers, with participants subjective norms often encouraging their 
engagement in risky behaviours, despite their awareness regarding the adverse health 
effects. Therefore despite an adult participant retrospectively suggesting that awareness 
would have prevented initiation, when they were an adolescent this may not have been the 
case, due to their desire to comply to the behaviours of individuals within their social group. 
Consequently, with most adolescents having a desire for strong peer identification (Bryon, 
2015), their peers’ behaviour is very important in determining their engagement in order to 
receive a sense of normalcy, regardless of one's awareness.  
Many participants spoke about the importance of not being defined by CF, with 
participants explaining how they are provided with a sense of normalcy as CF is often an 
invisible impairment (Tierney, 2012). In the present study many people spoke about how 
CF's invisible nature is a positive thing, allowing them to fit in with their peers, as their peers 
cannot physically identify any differences between the individual and themselves (Withers, 
2012). Visibility of an illness identity is often difficult to cope with, with some participants 
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explaining how the stares and questions from others regarding their illness is discomforting, 
with literature explaining that this is associated with negative emotions (Withers, 2012), and 
has the potential to result in social anxiety (Burker et al., 2012; Orenstein, 2004). In order to 
maintain CF’s invisibility, many participants often fail to disclose their CF status to others, 
with CF’s invisible nature aiding this non-disclosure (Borschuk et al., 2014; Higham et al., 
2013; Tierney, 2010). Some participants explained how they do not disclose their illness to 
others as they keep CF as a separate part of their life, with participants explaining how they 
are capable of hiding their illness from a vast number of people including their partners, with 
some participants not disclosing their illness identity to their partner unless they perceive the 
relationship is going to be long-term, in line with Higham et al’s (2013) findings. 
This desire to not be defined by CF also resulted in a number of participants not 
adhering to certain treatment modalities, due to the identity adherence provides the 
individual with. One of the main adherence barriers within CF is an unwillingness to take 
medication in public (Bregnballe et al., 2011), with many participants not wanting their peers 
to see their illness identity, ensuring their normal identity in public (Yates et al., 2010), and 
allowing them to be accepted within their social group (Duff & Latchford, 2010; Withers, 
2012). An individual's desire for normalcy can be translated into different behaviours, with 
some participants explaining how they do not want to look like the traditional image of CF, 
therefore they adhere to their treatments so that they remain well and their CF is less 
obvious to others. This is in line with the social comparison theory (Festinger, 1954), with 
such participants making downward comparisons, involving them comparing themselves 
favourably to others with CF, raising their self-esteem, encouraging their adherence to 
continue so that they do not fit this traditional image of CF (O’Brien et al., 2009; Tierney, 
2012). 
Whilst many participants did highly value a sense of normalcy within their lives, the 
data demonstrated that as an individual’s disease progresses, it becomes more difficult for 
the individual to appear "normal". This shift in appearance is seen to be a very difficult time 
emotionally and psychologically, where participants explained that they were forced into a 
position of accepting an illness identity and often had to reconsider their health behaviours. 
Participants who had previously had poor adherence discussed that as their disease 
progressed they began to accept treatments’ necessity, incorporating their illness into their 
identity, with Laws et al (2012) stating that individuals only become adherent when they have 
accepted their illness. Acceptance regarding CF was often accompanied with participants 
disclosing their illness to others, aiding their adherence efforts in public. Acceptance requires 
individuals to go through the stages of identity reformulation (Aujoulat et al., 2008), which 
typically occurs during diagnosis, however with individuals with CF being born with the 
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condition some participants explained that they have never known any difference in terms of 
their CF. Nonetheless, many participants did demonstrate how they do not always possess 
an illness identity, with this being dependent upon health status, presenting symptoms, age 
and situational factors. Consequently, despite individuals being born with CF, CF is not a 
static experience as an individual's condition fluctuates, with the way an individual identifies 
themselves changing overtime and across circumstances. Many participants demonstrated 
how they only started to incorporate their illness into their identity when their health 
deteriorated, as prior to that point the participant discussed living a normal life, illustrating a 
good quality of life (Götz & Götz, 2000).  
Quality of life was important to many, with the data suggesting that participants who 
are optimistic towards their life and future posses a life-orientated illness perspective (Audulv 
et al., 2010). Participants optimistic outlook appeared to increase their quality of life, with 
such participants focusing upon the enjoyment they receive within their lives, with literature 
stating that this results in psychological resilience (Abbott, 2003; Abbott et al., 2008). A life-
orientated illness perspective did appear to result in psychological benefits, with some 
participants describing how they will engage in a behaviour despite acknowledging the 
associated risks, as they believe the psychological benefits are worth the possible risks, 
representing their intrinsic motivation (Deci & Ryan, 1985, 2000). Other participants however 
viewed self-management as mandatory, with such participants appearing to possess a 
disease-orientated illness perspective (Audluv et al., 2010) and consequently avoiding risky 
behaviours. The way an individual perceives their illness can change overtime and across 
circumstances, with participants indicating that at certain times (e.g. during weekdays) they 
can possess a disease-orientated illness perspective, where they engage in health-
promoting behaviours; however at other times (e.g. during weekends) they can focus upon 
their psychological wellbeing, engaging in behaviours which provide them with enjoyment, 
demonstrating their life-orientated illness perspective. Individuals who had good adherence 
and engaged in a risky behaviour often believed that the risky behaviour would not cause 
adverse health effects, due to their adherence protecting and promoting their current health 
status. This is evidence of risk compensation (Rabiau et al., 2006), with it being 
acknowledged that the more compensatory health beliefs an individual has regarding their 
risky behaviour, the lower their readiness is to attempt cessation, with compensatory health 
beliefs often being a mechanism to resolve cognitive dissonance (Radtke et al., 2011).  
 A further influential factor associated with risky behaviour engagement within the 
data was the occurrence of psychological distress, with research demonstrating that many 
individuals engage in risky behaviours to alleviate their stress (Boden & Fergusson, 2011; 
Kassel et al., 2003; Kavanagh et al., 2011). Depression does often worsen medical 
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prognoses, due to psychological distress playing a role in the development of substance use 
disorder (Jeppe, Szabo & Smith, 2015). Participants within the current research suggested 
that their psychological distress was a factor in their engagement, in an attempt to alleviate 
their negative emotions, with research explaining that the cognitions which predict risky 
behaviour engagement include the belief that these behaviours will reduce their stress 
(Charlton, 1984; Charlton & Blair, 1989).  
 For some participants their stress was a direct consequence of their employment or 
educational experiences. CF's increasing life expectancy means that many individuals with 
CF do work (Saldana & Pomeranz, 2012), with employment being associated with 
psychological benefits (Burker et al., 2012). However, with literature demonstrating that 
488,000 people in the UK suffer from occupational stress (Health and Safety Executive, 
2016) it is not surprising that individuals with CF may be exposed to this stress. The issue of 
occupational stress may be heightened for individuals with CF who have to frequently take 
time off work for hospitalisation, resulting in presenteeism (Cooper, 2013; Newcombe, 2013). 
Consequently, CF individuals may engage in risky behaviours to alleviate their occupational 
stress, in order to help them relax, feel happier and calmer (Kassel et al., 2003), with many 
participants explaining how the engagement in risky behaviours was associated with 
psychological benefits.  
 Psychological distress was also experienced as a direct consequence of life with CF. 
The emotional burden of living with a condition that is life limiting was discussed by a 
number of participants. Many individuals with CF do feel anxious in response to their CF and 
experience depressive feelings (Withers, 2012), which in turn can increase the possibility of 
them engaging in risky behaviours as a way to alleviate the anxiety. It was clear from the 
data that anxiety is understandably worsened when health deteriorates, as this puts a strain 
on existing coping mechanisms, and can lead people to seek or increase the use of 
additional coping mechanisms that may not be adaptive (Orenstein, 2004). Frequent 
deteriorations in health results in more frequent hospital admissions which place additional 
psychological burdens on patients and their families (Antos, Quintero, Walsh-Kelly, Noe & 
Schechter, 2014). 
 Hospitalisation impacts upon an individual's social and private life, with in-hospital 
segregation resulting in isolation and loneliness (Lamas, 2013; Visse, Abma, Oever, Prins & 
Gulmans, 2013). A number of participants discussed this and explained how they do not 
follow the in-hospital segregation rules, as they believe that the psychological benefits 
accompanied with communicating with other individuals with CF outweigh any potential 
risks. Many participants did not believe that there are any risks from communicating with 
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others with CF, with these participants potentially demonstrating unrealistic optimism 
(Weinstein, 1980), with their beliefs being influenced by their generational upbringing.  
 In addition to hospitalisation, transition to independence also presents several 
challenges for many people, and can have a particular impact on adherence. Participants 
spoke about how the decrease in family support during transition to adult care often results 
in poorer adherence, and this is a major concern during adolescence (Bregnballe et al., 
2011). Transition to adult care can be an upsetting process, due to the amount of changes 
that occur (Withers, 2012), with it being expected that individuals will become more aware 
about CF's potential future consequences as they are provided with more information from 
the adult CF team. This increase in awareness may result in identity reformulation (Aujoulat 
et al., 2008), demanding new behaviours such as independent adherence. However the 
process of identity reformulation may upset individuals as they realise CF's true implications. 
This anxiety (Pacaud & Yale, 2005) could be in response to their illness identity, with some 
participants engaging in risky behaviours and non-adherence to deal with their negative 
emotions towards CF, and to retaliate against the illness identity that they feel CF imposes 
upon their life. 
The retaliation against an illness identity due to negative emotions was also at times 
due to denial. Literature reports that individuals with CF can demonstrate denial in an 
attempt to be perceived as normal (Higham et al., 2013). The data highlighted how an 
individual can be in denial about a number of different aspects of their CF. Some participants 
were in denial regarding their diagnosis, questioning both the diagnosis and severity of their 
CF. This led them to also question treatments' necessity resulting in poor/non-adherence. 
Denial is the first stage of the journey to adherence according to Kubler-Ross's model 
(1969); with an individual being expected to go through the following stages before they 
accept their condition, and therefore accept treatments' necessity: anger, bargaining, 
depression. The questioning of one's diagnosis and the severity of their illness is a common 
experience within chronic conditions, with it having both adaptive and maladaptive 
properties. Denial can protect an individual from overwhelming feelings of anxiety, however 
despite this psychological benefit, denial can result in misunderstandings within individuals 
regarding the severity of their illness, their prognosis and their need for treatments (Vos, 
Barker, Stanley & Lopez, 2007).   
In terms of treatments' necessity, the data signalled that an individual's denial can be 
influenced by a number of factors. Childhood experiences had a big influence upon an 
individual's understanding regarding the need for treatment, with individuals who had not 
been raised in an environment which encouraged health-related behaviours, not 
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understanding why they needed to adhere to these treatments during adulthood. 
Participants good health despite non-adherence strengthened the denial stage of emotional 
adjustment (Kubler-Ross, 1969), resulting in poor/non-adherence. In addition, other 
participants explained how their denial was reinforced when they experienced no noticeable 
benefits from their adherence efforts, or no adverse health effects from non-adherence. 
Many participants focused upon the short-term treatment benefits, without consideration for 
long-term benefits, with adherence decisions being based on immediate symptoms (Abbott 
et al., 1994). Even when some participants did experience adverse health effects from their 
non-adherence they still did not always associate their behaviour with the health 
deterioration, indicating their failure to integrate their illness into their identity (Laws et al., 
2012). 
Whilst this resistance to accepting treatments' necessity may be due to denial, there 
are several other barriers to adherence. Bryon (2015) suggests that adolescents with CF 
may be less able to consider long-term consequences from non-adherence, with a  number 
of participants supporting this assertion explaining that they do not understand HCPs 
discourse. This highlights the need to ensure all interventions used are age-appropriate 
allowing individuals to process the information. Age in itself is a barrier to adherence, as 
adolescents and young adults under the age of twenty-five years possess an immature 
cognitive functioning, with these individuals often not understanding the true nature of risks 
(Bryon, 2015; Del Piero et al., 2016). Individuals under the age of twenty-five years often 
have a high sensitivity to rewards and a low sensitivity to risks (Bava & Tapert, 2010; Bryon, 
2015), with participants demonstrating that motivations during adolescence and young 
adulthood are reward seeking, involving the avoidance of barriers to rewards, such as non-
adherence. A further barrier to adherence present within the data was a lack of positive 
reinforcement (Kettler et al., 2002), with many participants demonstrating their awareness 
that their health will progressively deteriorate regardless of their adherence efforts.  
In terms of influencing risky behaviour engagement, participants who engaged in 
such behaviours often focused on the perceived benefits to their health, rather than the 
possible adverse health effects. This was particularly evident amongst participants who 
smoke marijuana, where they describe experiencing respiratory improvements following their 
engagement, with these participants focusing upon short-term effects rather than the long-
term effects of usage, demonstrating their inaccurate perception of risk and susceptibility 
(Borrelli et al., 2010; Weinstein, 1980). It is acknowledged that when individuals believe their 
"risky" behaviour offers some benefits towards their life it reduces their cognitive dissonance, 
and therefore allows them to continue their engagement, restoring a sense of cognitive 
consistency (Festinger, 1957). Consequently, in order to increase the chance of behavioural 
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change an individual's cognitive dissonance needs to be increased, creating an unpleasant 
state of tension within the individual (Festinger, 1957).  
The perceived benefit from marijuana use that participants discussed is also found 
within the general population, with many individuals perceiving marijuana to be a harmless 
substance, viewing it to be a recreational drug and not a "hard, illicit drug" (Hathaway et al., 
2011). In line with the data, many adolescents believe that marijuana cannot be harmful due 
to it being a natural substance (FRANK, 2009; NIDA, 2016), with "pro-marijuana" 
perspectives being easily available via social media (Hathaway et al., 2011; Hathaway & 
Erikson, 2004). Recent public discussions surrounding medicinal marijuana will have also 
influenced adolescents attitude towards marijuana, with many believing that marijuana is a 
"safe drug" (NIDA, 2016), which again was outlined within the data. In addition to resolving 
cognitive dissonance (Festinger, 1957), the belief that a risky behaviour is beneficial, 
demonstrates unrealistic optimism (Weinstein, 1980), which has the potential to lead to 
biased health perceptions. 
Individuals are unrealistically optimistic due to selective focus, where individuals 
ignore behaviours which increase a risk, and focus upon behaviours which reduce a risk 
(Weinstein, 1988), again demonstrating evidence of compensatory health beliefs (Radtke et 
al., 2011). Further evidence of selective focus was when a participant acknowledged the 
adverse health effects of smoking marijuana due to symptom presentation, so he adapted 
that behaviour by vaping marijuana, without acknowledging the adverse effects still present. 
Vaping is a relatively new behaviour which has also undergone a rapid normalisation 
process, with electronic cigarettes not just being used by individuals who wish to quit their 
smoking behaviour (Tan, 2015), they have provided marijuana users with a new method of 
inhaling cannabinoids, which individuals believe is less harmful (Giroud et al., 2015). 
However avoidance of CF, or even denial, did not always result in risky behaviours, 
or non-adherence, with such behaviours being influenced by a number of factors, such as 
the support an individual receives from others. A large source of support for many 
participants was family support. Participants explained that when their family members 
provide them with awareness regarding the adverse health effects of risky behaviours, and 
protect them from environments where these behaviours are present it often prevents 
initiation, with participants not wanting to upset their family members or deviate from their 
social norms. Such support also appeared to be effective from a participant’s peers, with 
individuals being more likely to listen to their peers than parents or HCPs (Bryon, 2015).  
In addition to awareness regarding the adverse health effects of risky behaviours, 
some participants explained how they never initiated in such behaviours as they feared the 
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consequences they would receive from their family (e.g. discipline), with adolescent 
substance use initiation being mediated by changes in parental monitoring within the general 
population (Dishion, Nelson & Kavanagh, 2003). Risky behaviour engagement does put 
strain upon families (Galvani, 2015), with participants often describing how their family 
relationships improved following cessation, reducing their motivation to relapse, as they 
became dependent upon their family to help them cope with difficult times, instead of using 
risky behaviours as a coping mechanism (Mathieu, 2011).  
Another family motivator which encouraged cessation and adherence was becoming 
pregnant, with many female participants stopping their engagement with risky behaviours as 
soon as they became pregnant. Male participants also explained how becoming a parent 
would motivate their cessation. However, literature does indicate that risky behaviours are 
prevalent during pregnancy, with 35% of young pregnant women in the UK smoking 
throughout pregnancy, with only 17% who smoke using "stop smoking services" (Marteau, 
Thorne, Aveyard, Hirst & Sokal, 2013). Nonetheless, pregnancy within CF is a different 
experience, with individuals feeling privileged stating things such as: "I never thought being a 
Dad would happen" (The CF Trust, 2016b). Even for females with CF who are usually fertile, 
their pregnancies are often planned, and they receive a large input from their CF teams 
during pregnancy to maintain their health, therefore experiences are different to females 
within the general population (The CF Trust, 2016b).  
Whilst family support has favourable health outcomes, a lack of support can be 
detrimental. Some participants explained that due to their negative family relationships they 
use risky behaviours to improve their mood, and escape such negativity, with literature 
demonstrating that negative family interactions are related with increased alcohol 
consumption and smoking within adolescents in the general population (Gutman et al., 
2011). In addition to negative family relationships, relationship breakdowns were also 
considered detrimental to health, with some participants engaging in risky behaviours to 
alleviate their negative emotions, with it being reported that relationship breakdowns have an 
effect upon depression, anxiety, substance use and dependency (Coleman & Glenn, 2009), 
particularly when the individual has experienced multiple relationship breakdowns (Barrett, 
2000).  
In terms of support, as well as families and peers, many participants spoke 
favourably of their HCPs, in particular their Nurses. It is commonly reported that individuals 
favour Nurses over other HCPs (Read & Mayberry, 2000), due to building patient 
relationships being central to a Nurses role (Collins, 2015; Van den Heever, Poggenpoel & 
Myburgh, 2015). Some participants did explain how despite their families and HCPs efforts, 
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they will never know what it is really like to live with CF, with HCPs themselves 
acknowledging that they cannot understand, nor imagine what it is like to live with a chronic 
condition (Lamberts, 2010). This is a barrier to effective prevention advice, with participants 
explaining how their priorities in life are different to what others believe their prioritises 
should be, with many participants focusing upon their psychological wellbeing due to their 
reduced life expectancy. Consequently, Schwartz (2016) stated that CF treatment needs to 
move away from the medical model to personalised medicine, where HCPs should 
acknowledge the whole person and be mindful of their blind spots, in the sense that they do 
not have the illness. Participants explained how emotionally difficult it can be when HCPs 
focus upon aspects of their health which are deteriorating, instead of acknowledging aspects 
which they are managing well, with parents at the UK CF Conference (2016) explaining that 
HCPs discourse needs to refer to hope and inspiration. Therefore, it is essential that CF care 
continues in its aim to provide personalised patient centred care, where HCPs focus upon 
the individual and their psychological needs, as well as their physical needs. In addition, with 
CF's improvement in life expectancy it is essential for CF HCPs to become more aware of 
the "new" challenges CF patients face (Horky, 2014), in an attempt to reduce the occurrence 
of risky behaviours within the CF population. 
Conclusions 
 Overall, this phase of data collection successfully provided insight into the variety of 
reasons why some individuals with CF engage in risky behaviours and do not engage in 
health-promoting behaviours. A desire for normalcy was seen to be important to many, with 
this desire being associated with the engagement in normalised risky behaviours, often as a 
retaliation against the illness identity. Evidence of a life-orientated illness perspective was 
also prevalent, with participants reporting that they engaged in risky behaviours for fun. 
There was also a reported lack of knowledge concerning consequences of risky behaviours, 
in line with the transition evaluation, with many participants stating they had not been 
informed of these by HCPs, despite the current research highlighting the importance of 
awareness, with patients who had good awareness of the consequences of risky behaviours 
often accepting that they cannot engage in such behaviours. 
 This research highlights the need for more effective health promotion measures to 
reduce the occurrence of risky behaviours within the CF population. The participants' 
narratives were retrospective, which provided a time dimension to the data, enabling the 
research to capture changes within participants, identifying influential factors which 
contribute to the initiation of risky behaviours within CF (De Vaus, 2006). In creating an 
intervention within the CF population, it is suggested that this intervention needs to firstly 
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raise an individual's awareness of what risky behaviours are, and what adverse health 
effects such behaviours can specifically have upon their CF. In terms of adherence, again an 
intervention needs to firstly focus upon increasing an individual's awareness regarding 
treatments' necessity, and the adverse health effects of non-adherence. It is apparent that 
this awareness needs to be provided to all individuals with CF, regardless of their personal 
condition from their HCPs, which at present appears to not be standard practice. This 
awareness would provide individuals with the opportunity of making a more informed choice 
as to whether or not they want to engage in risky behaviours and / or non-adherence in light 
of the consequences, as it has to be acknowledged that engagement in such behaviours is 
an active choice, and should be respected. In order for HCPs to provide awareness on risky 
behaviours, HCPs themselves need to be made more aware of what risky behaviours are 
current within the general population, as there was the belief amongst participants that HCPs 
are not aware of what substances their patients may have access to.  
 In addition to individuals’ awareness regarding risky behaviours and adherence, 
HCPs need to be mindful of the influence psychological distress, avoidance of one's CF and 
negative family interactions can have upon an individual's engagement; with it commonly 
being reported that all three factors are associated with engagement. Therefore whenever 
psychological distress, avoidance of CF or negative family relationships are detected or 
suspected, HCPs should be mindful of what behaviours these constructs could potentially 
result in, and again raise an individual's awareness of the adverse health effects of risky 
behaviours and non-adherence, as well as helping individuals cope with these aspects of 
their lives to reduce the occurrence of risky behaviours within the CF population. 
 Importantly, this phase of data collection highlighted that risky behaviour initiation, 
and the engagement of non-adherence commonly occurs during adolescence. The 
researcher therefore deemed it necessary for a second phase of data collection to be 
conducted within the paediatric CF population, before work on an intervention commenced. 
This second phase of data collection aimed to investigate paediatric participants’ knowledge, 
beliefs and attitudes towards risky behaviours, at an age commonly associated with 
initiation, ensuring that any interventions created are relevant to all individuals with CF, 
particularly adolescents where it is assumed interventions will be targeted. 
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CHAPTER SEVEN: METHODOLOGY - PAEDIATRIC CYSTIC FIBROSIS PATIENTS' 
ATTITUDES AND BELIEFS REGARDING RISKY HEALTH BEHAVIOURS 
The Research Sites 
 All participants were recruited from the paediatric CF population at Birmingham 
Heartlands Hospital and the Royal Stoke University Hospital. These two research sites again 
were chosen due to their geographical location, with both hospitals being used within the first 
phase of data collection, and therefore being fully informed regarding the study's aims, 
process and intended outcomes. 
 Birmingham Heartlands Hospital is host to a paediatric CF MDT of HCPs including 
Consultants, Specialist Nurses, Physiotherapists and Dieticians. This unit provides inpatient 
and outpatient care for paediatric CF patients until 17 years of age, with a report published 
by the CF Trust (2014) indicating that this unit is part of a large specialist clinical network 
compromising of hard-working, dedicated and well-established teams, which are greatly 
appreciated by patients and parents. In order to gain approval for the research off the 
paediatric MDT, the researcher presented the preliminary findings from phase one data 
collection, the research proposal and rationale to the CF MDT (Appendix J). 
 The Royal Stoke University Hospital is the location of the North West Midlands 
Paediatric CF Centre, which hosts a MDT of HCPs including Consultants, Specialist Nurses, 
Physiotherapists, Dieticians and Psychologists, providing inpatient and outpatient care for 
paediatric CF patients. A peer report concluded that despite the paediatric unit being 
"relatively small with approximately 100 full and shared care patients", it does serve a "large 
geographical area with significant socioeconomic deprivation" (The CF Trust, 2013c). To 
gain approval for the research off the paediatric MDT, the researcher presented the 
preliminary findings from phase one data collection, the research proposal and rationale at 
the North West Midlands CF Centre Regional Meeting (Appendix J). 
Participants 
 Ten paediatric participants (male: 5, range: 12-18 years; mean: 14 years) were 
recruited, with a median FEV1 69.14% predicted (Table 2).  
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Paticipant 
Number 
Sex Date of Birth Age  Latest Lung 
Function Result 
1 Male 23/11/2001 14 years / 
2 Male 15/08/2001 14 years 80% 
3 Female 03/10/2003 12 years 50% 
4 Male 01/10/2002 13 years 82% 
5 Female 24/04/2004 12 years 94% 
6 Male 10/08/1997 18 years / 
7 Female 05/04/2003 12 years 28% 
8 Female 27/12/2001 13 years 85% 
9 Male 14/09/2000 16 years 65% 
10 Female 06/06/2004 12 years / 
Table 2. Medical and Demographic Data collected for all paediatric participants. 
 
Adolescents with CF were eligible to participate regardless of whether or not they had 
experience of engaging in risky behaviours.  
Exclusion Criteria: Individuals were excluded if they had a lack of capacity (identified by 
their Consultant) and if they were non-English speakers. These individuals were identified 
through discussions with the CF Consultants and by consulting CF outpatient and inpatient 
lists.  
 Where possible all adolescents with CF who were eligible to participate were invited 
to do so until data saturation occurred. On occasions, eligible patients may have been 
missed as a consequence of the researcher interviewing another participant, or if the 
Consultants had failed to refer an eligible patient. 
Measures 
Semi-Structured Interview. The researcher conducted semi-structured interviews 
with paediatric CF patients to investigate their awareness and views towards risky 
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behaviours; with the researcher transcribing all interviews. The interview schedule (Appendix 
K) was adapted from the interview schedule used within phase one data collection through 
collaborations with the researchers supervisory team, with the interviews investigating what 
paediatric patients believe would influence their future engagement in risky behaviours (if 
anything), and why they believe some adults with CF engage in such behaviours. These 
interviews focused upon the key themes which emerged during phase one data collection. 
 The interview schedule again commenced with a section of ice breaker questions. 
Due to adolescents being less likely than adults to report engagement in risky behaviours 
(Ross-Durow, Veliz, McCabe & Boyd, 2015), these ice breaker questions were essential to 
instigate a good researcher-participant relationship, developing rapport and ensuring 
participants felt safe to disclose information and elaborate on sensitive topics (Ashton, 
2014). The ice-breaker questions were the same questions used for phase one data 
collection. It was found within phase one data collection that the final ice-breaker question 
was a good starting place for participants to provide insight into their life with CF, 
predominantly highlighting any challenges they encounter. 
 The interview then encouraged participants to discuss the impact CF has upon their 
personal life, with this discussion being responsive to participants developing accounts 
(Cooley et al., 2014; Rubin & Rubin, 1995). As with phase one data collection, this 
conversation was in line with Cox's (2015) guidelines in providing insight into what it is like to 
live with CF in the growing and changing population that CF is today. Based upon the 
findings from phase one data collection, there was a focus upon the participants’ 
experiences around telling others that they have CF, as many adult participants highlighted 
that they often do not tell others about their CF. Therefore, the researcher was interested in 
young people's experiences and decision making around telling others that they have CF, 
with literature recognising that many chronically ill adolescents favour invisibility towards 
their illness, allowing them greater normalcy (Yates et al., 2010).  
 Within this section focusing upon life with CF, the interview predominantly focused 
upon how young people view adherence. Within phase one data collection participants 
openly discussed issues surrounding adherence, highlighting factors which influence both 
adherence behaviours and the engagement in risky behaviours, with the relationsip between 
adherence and risky behaviours being highlighted within other chronic conditions (Mays et 
al., 2012), however this was the first piece of research which had investigated adherence 
and risky behaviours together within the CF population. Adolescence is a crucial time for 
adherence, with individuals becoming more responsible for their own medical regimens; 
therefore the researcher was interested in investigating how adolescents with CF cope with 
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this transition, with previous literature (Bregnballe et al., 2011), and the findings from phase 
one data collection indicating that this can be problematic. 
 The interview schedule then specifically focused on the issue of risky behaviours. 
Within the paediatric population the research was not necessarily focusing upon the 
participant’s own engagement, instead this research was investigating participants' 
awareness and knowledge on risky behaviours, and their beliefs towards such behaviours, 
as it was acknowledged that prospective interviews can be influenced by social desirability 
bias (Schwarz, 2004), despite the researcher’s effort to generate rapport. This section of the 
interview schedule also focused upon the normalisation of risky behaviours, which was 
identified to be important in influencing initiation within phase one data collection. The 
researcher was therefore interested in whether adolescents with CF are exposed to this 
normalisation, and how that impacts upon their beliefs towards risky behaviours. The 
researcher discussed these behaviours with participants in a non-judgemental way in the 
hope of gaining a true reflection of participants’ personal beliefs surrounding these 
behaviours. The researcher also gave participants the option to discuss their attitudes and 
beliefs towards risky behaviours in third person, asking participants why they think others 
(and others with CF) engage in such behaviours, potentially highlighting their intentions to 
initiate in such behaviour without personalising the discussion. 
 The next section of the interview encouraged participants to discuss any support they 
have from others. The role of others was found to be crucial in influencing adherence, and 
preventing initiation of risky behaviours within phase one data collection. Therefore, the 
researcher was interested to see how this is experienced by younger people. Within this 
section there was the opportunity to discuss the issue of cross-contamination, which for the 
adult population was often ignored. However, many adult participants highlighted that the 
disregard of such rules was due to a generational occurrence; therefore the researcher was 
interested to see how the paediatric CF population view cross-contamination, after being 
raised in a generation where HCPs employ effort to discourage patients mixing. 
 As with phase one data collection, the researcher employed effort to encourage 
elaboration within participants during the interview (Ashton, 2014; Fielding & Thomas, 2008; 
Kvale & Brinkmann, 2009; Valentine, 2007, 2014), with it again being essential for the 
researcher to reduce the rapport, and create distance during the end of the interview 
(Ashton, 2014). Therefore, the interview ended with the same three questions used for the 
adult population, allowing participants to feel their contribution to the research was valued 
(Ashton, 2014). 
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Carrying out the Study 
Discussions were held with CF Consultants at Birmingham Heartlands Hospital and 
the Royal Stoke University Hospital, to devise a list of all paediatric CF patients that did not 
meet the eligibility criteria. This list of patients was used by the MDT to identify eligible 
patients and to provide them and their legal guardians with a handout (Appendix L) 
explaining the research along with a consent to contact form (Appendix M). Once legal 
guardians had provided consent to contact, the researcher contacted them within the next 
24-48 hours via telephone at a time convenient for themselves (mornings, afternoons or 
evenings - as suggested by the guardian). The researcher explained the research verbally to 
the guardian and allowed them to ask any questions. If they were still interested in the 
research, the researcher arranged to meet the paediatric patient with their legal guardian at 
their CF centre at a time / date most convenient for themselves (usually to coincide with 
outpatient appointments or scheduled inpatient stays). The researcher was not present at 
clinic appointments or during inpatient stays until consent to contact had been received. 
The researcher was present in the waiting room of clinic or on the ward on the pre-
arranged days. A member of the MDT advised the researcher when the eligible patient along 
with their legal guardian arrived at clinic and what doctor’s cubicle they were in, or advised 
the researcher what room the patient with their legal guardian was in on the ward. The 
researcher approached the patient in the presence of their legal guardians and invited them 
to take part.  
The study was fully explained to patients and guardians, both verbally by the 
researcher and in the form of a written information sheet (See Appendix N & O), with both 
patients and guardians having the opportunity to ask any questions. The patient and 
guardian received different information sheets to aid their understanding of the research 
process and purpose. Patients and guardians had a maximum of two weeks to decide on 
participation, to help facilitate informed consent. If the legal guardian wanted their child to 
participate they had to complete a consent form (Appendix N). If the patient wanted to 
participate they either had to complete an assent form (used for patients aged 12 - 15 years) 
(Appendix P) or a consent form (used for patients aged 16 - 17 years) (Appendix Q); the 
patient could only participate if consent had been obtained from both the patient (or assent) 
and their legal guardian. 
A coding method was used so that participants' names did not appear on interview 
data ensuring all data was anonymised and confidential (pseudonyms were used for the 
write up). The researcher also collected contact details (telephone number, email address) 
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from the guardian to forward the overall results of the study. All of this personal data was 
kept strictly confidential.  
Participants then independently engaged in a semi-structured interview to investigate 
their awareness and views towards risky behaviours. Interviews were conducted in the 
absence of participants' legal guardians, unless participants explicitly expressed a desire for 
them to be present. Five interviews were conducted where guardians were present for the 
duration of the interview, one interview was conducted where the guardian was present for 
the start of the interview but left before a discussion on risky behaviours commenced. The 
interview could be conducted on the same day as informed consent, alternatively the 
researcher could interview participants on a separate day to suit their availability (nine 
participants were interviewed on the same day as consent was provided, one participant was 
interviewed on a separate day). The interview was conducted in a private room at the CF 
centre and lasted a maximum of 60 minutes, however it could be stopped earlier at the 
participants discretion; within this research no participants stopped the interview early. 
Participants did not have to answer any questions they did not want to. All participation was 
voluntary, and participants could withdraw from the research at any time without being 
penalised; within this research no participants withdrew. If participants had got distressed 
during the interview the interview would have been stopped immediately and a referral would 
have been made to their MDT; within this research no participants became distressed. Once 
the interview was complete participants were provided with a debriefing sheet (Appendix R), 
and again had the opportunity to ask any questions along with their legal guardians. The 
researcher then contacted all participants (via their legal guardians) once the research had 
been analysed to inform them of the overall research results and to ask for results feedback 
(Appendix S).  
Ethics Committee 
Ethical approval was obtained via the Integrated Research Application System by 
NRES Committee East Midlands - Leicester, and the R&D departments at Birmingham 
Heartlands Hospital and the Royal Stoke University Hospital. 
Ethical Considerations 
 Young people should be treated with the same degree of protection regarding 
confidentiality and anonymity as adults when engaging in research. Additionally, researchers 
have a duty to ensure the safety of young people, over their responsibility of guaranteeing 
confidentiality in cases of child protection (Shaw, Brady & Davey, 2011). Confidentiality can 
only be broken in exceptional circumstances where it is deemed that the risks to participants 
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(or others) health, safety or welfare, outweigh participants right to confidentiality (Royal 
College of General Practitioners [RCGP], 2011). Therefore the researcher had a protocol in 
place informed by previous safeguarding policies (Gloucestershire Confidentiality Policy, 
2005; NSPCC, 2013; RCGP, 2011; Shaw et al., 2011) to address any safeguarding issues 
that arose (Appendix T). No safeguarding issues did arise within this research, therefore 
confidentiality did not have to be broken, however this section outlines when confidentiality 
would have been broken. 
 Literature outlines that researchers have a moral obligation to break confidentiality if 
participants disclose being the victim of an unreported crime, or if the researcher feels 
participants are at risk of harm (physical or psychological) (Wiles, Crow, Heath & Charles, 
2006); such harm usually surrounds that from crime, suicidal attempts / thoughts, or self-
harm; or can refer to the harm of others. In terms of the researcher’s legal obligation, the 
researcher would have had to disclose information which suggested participants (or others) 
were in, or could be in a life-threatening situation (e.g. self-harm, suicidal attempts), or 
participants were being threatened by an abuser (Gloucestershire Confidentiality Policy, 
2005). However, the researcher did not have a duty to break confidentiality due to drug use, 
illegal or sexual activity, unless it met with the previously mentioned exceptional 
circumstances.  
 In terms of participants reporting engagement in risky behaviours the researcher, 
along with the researcher’s supervisory team devised a checklist (Appendix T), outlining 
when confidentiality would be broken. In terms of sexual activity, a researcher does not have 
to disclose sexual activity in under 13's, as this is at the discretion of the researcher, e.g. if a 
12 year old was engaging in consensual sexual activities with another 12 year old, 
confidentiality does not have to be broken (RCGP, 2011). However, if participants disclosed 
such information and the researcher had not reported it to a suitable authority, the 
researcher would have scrutinised this decision making further with the supervisory team. In 
terms of sexual activity, the researcher would only have disclosed such behaviour if it 
appeared that participants were being coerced, or if participants were under the age of 
sixteen years and engaging in sexual activity with an individual significantly above the age of 
sixteen years, with the RCGP (2011) stating that a power imbalance is indicated by an age 
gap of more than five years. In terms of consent the RCGP (2011) states that a young 
person may not have been able to provide consent to sexual activity if they were under the 
influence of drink or drugs, therefore confidentiality would have been broken. With substance 
use (smoking, drug use, or alcohol consumption) the researcher acknowledged her moral 
duty to break confidentiality if participants had not provided consent to participate in any of 
these behaviours (e.g. peer pressure); if participants were engaging in excessive amounts of 
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any of these behaviours which could cause harm to their health, and if they were unaware of 
such harm. 
 The researcher explained clearly to potential participants the limits of confidentiality 
through both the information sheet, and verbally during the consent process. If the 
researcher had felt that confidentiality needed to be broken the researcher would have 
discussed with participants the benefits of disclosing such information to HCPs, in the hope 
of gaining participants consent to break confidentiality. The researcher would have asked 
participants if there was a member of staff at their CF centre they would prefer the 
researcher to talk to first; if participants had no preference the researcher would have 
discussed the issue with the Consultant at the CF centre. However, if participants refused to 
allow disclosure of such information the researcher would have consulted the supervisory 
team in order to decide whether disclosure without consent was justified. The participant 
would have been informed before disclosure was made, if this was the decision (RCGP, 
2011).  
 The researcher acknowledged that the consent process continues for the duration of 
participation, and participants have the right to withdraw at any time. There are a variety of 
ways in which participants can withdraw their consent as outlined by Skånfors (2009); for 
instance paediatric participants may say "no" to answering some questions, may show no 
response during the interview, or ignore the researcher. The researcher was aware of these 
indicators to ensure the research was sensitive to participants' wishes (NSPCC, 2013); 
within this research no participants demonstrated these behaviours. 
 As the interviews were independent, in order to protect the researcher all interviews 
were conducted in a private room at participants CF centres, which HCPs were aware of. In 
addition, participants' legal guardians were present in the CF centre nearby (in calling 
distance), but were not able to overhear the conversations (at the participants discretion) 
(Shaw et al., 2011). 
 As this research was qualitative it had the potential to go into more depth than a 
quantitative approach, providing a platform to discuss issues which the researcher had not 
anticipated (NSPCC, 2013). Therefore to minimise the risk of personal or social harm to 
participants, the interview schedule was structured to ensure that difficult topics were given 
enough time for discussion (NSPCC, 2013). 
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Analysis 
As described within the initial analysis section within Chapter Four, the interviews 
were transcribed utilising the Jefferson transcription coding (Heath & Hindmarsh, 2002), with 
the data being analysed using thematic analysis following Braun and Clarke's (2006) model. 
Thematic analysis generated 128 initial codes, with these initial codes being revised to form 
113 codes. An example of a code that was deleted is highlighted below (see Appendix U for 
more examples): 
 Adherence is more difficult during weekends 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code: "Adherence stops the participant engaging in normal 
activities". The quote was explaining how during weekends the participant wants to be lazy 
and engage in normal activities, as opposed to waking up early to adhere to his medical 
regimens.  
 The researcher made inferences about what the codes meant enabling the codes to 
be combined into four overarching themes that accurately depict the data (Appendix V). The 
four themes generated are described in detail within the next chapter, utilising direct quotes 
and discussion around CF adolescents' attitudes and beliefs regarding risky behaviours. 
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CHAPTER EIGHT: ANALYSIS - PAEDIATRIC CYSTIC FIBROSIS PATIENTS' 
ATTITUDES AND BELIEFS ON RISKY HEALTH BEHAVIOURS 
 Thematic analysis was applied to the interview transcripts following the Braun and 
Clark (2006) model, which identified four themes within the data. The first theme, labelled as 
“The most challenging aspect of Cystic Fibrosis is getting up every morning to do your 
treatments", highlights the impact adherence has on the lives of adolescents, with many 
participants viewing non-adherence as a risky behaviour. Theme two, "Don't keep Cystic 
Fibrosis to yourself" focuses on the beneficial effect support from others can have on an 
individual living with CF, as well as the adverse effects a lack of support can have. The third 
theme, labelled as “I wish I did not have Cystic Fibrosis, that would be wicked", provides 
insight into the impact CF can have upon an adolescent's identity. The final theme, "A lot of 
people with Cystic Fibrosis do take it for granted and smoke and do stupid things", highlights 
the role knowledge has in encouraging adherence efforts and influencing engagement with 
risky behaviours. It is recognised that there are aspects of participants’ experiences and 
understandings that overlap across these themes; however this was to be expected (Fielden 
et al., 2011). All four themes will be further examined in the next segment, by utilising direct 
quotes and discussion around this topic area. 
"The most challenging aspect of Cystic Fibrosis is getting up every morning to do 
your treatments" 
 This initial theme acknowledges that for a paediatric population a risky behaviour that 
may be most prevalent is poor adherence or non-adherence, with this theme providing 
insight into the impact adherence has on the lives of adolescents with CF, signalling CF 
adolescents' views towards their treatment adherence, and the challenges associated with 
adherence, in particular on developing independence. Many participants explained how 
adherence is hard, discussing a variety of reasons as to why they find it difficult. Some 
participants believe they are prescribed too many medications, with adherence therefore 
demanding a lot of time from participants. With participants describing a large treatment 
burden, many explained how it is difficult to integrate their treatments into their everyday 
lives; with participants finding it increasingly challenging to integrate treatments within their 
lives when they have difficulty in interpreting and understanding their complex regimens. A 
number of barriers to adherence were identified by participants, with the data highlighting 
how the experience of treatment burden is due to a number of different issues, and 
fluctuates over time. 
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 At the age of 13 (approximately five years before transition), Charlotte pointed out 
how difficult she would find independent adherence, with Charlotte finding her treatment 
regimen to be confusing because of the severity of her condition resulting in her having a 
large treatment burden. 
 *[Charlotte, 13 years]: "It's [CF] too much headache [...] like I'm to:oo ill # a:and it's 
 to:oo confu:using # I have to have my medicines (.) >which one to have<" 
Due to the amount of treatments individuals with CF are expected to adhere to, many 
participants explained how adherence impacts upon every aspect of their day. 
 *[Abi, 12 years]: "I (.) get up (.) do my physio:o (.) an then (.) do my colomycin # 
 have brea:akfast (.) an then # do something # get ready and go to  school # do a:all 
 my wo:ork # have lunch (.) have break # and then (.) come back home # do my 
 dna:ase (.) and then # ha:ave dinner (.) and then (.) I wa:ait (.) like (.) I think it's an 
 hour (.) an do my physio:o an I do my (.) colomy:ycin on the night" 
Such narratives clearly illustrate the time-consuming nature of treatment adherence within 
CF. Whilst many participants viewed all treatments in a negative light, it was clear that in 
particular their negative views surrounded time-consuming treatments, with many 
participants explaining how they favour less time-consuming treatments.  
 *[Tim, 18 years]: "There a:are certain treatments that a:are # a bit mo:ore difficult # 
 just because they're mo:ore time-consu:uming" 
Participants suggested that these time-consuming treatments prevent them engaging in 
normal activities. Emily demonstrated the impact adherence has on her identity, explaining 
how her nebulised therapies prevent her engaging in normal activities with her friends after 
school, which would provide herself with a sense of normalcy. 
 *[Emily, 14 years]: "You're tr:rying to lead a (.) no:ormal life # tr:rying to (.) go out # 
 after scho:ool [...] go out (.) ska:ating (.) ska:ateboa:arding # an stuff like that [...] it's 
 ki:inda like ## ho:ow to # dea:al with it # if you know what I mea:an ## with the 
 nebuli:isers (.) an stuff ## I just want to be a no:ormal person # like I just want to go 
 outsi:ide" 
 As well as their time-consuming nature, some CF treatments are also unpleasant, 
which participants explained reduces their motivation for adherence. Charlotte discussed 
how difficult she finds being fed through her percutaneous endoscopic gastrostomy (PEG) 
feeding tube due to it commonly resulting in nausea. 
134 
 
 *[Charlotte, 13 years]: "I don't like that [being fed through PEG tube] # it takes a 
 lo:ong time [...] I feel full # to:oo full # I feel si:ick and bla:ah (.) bla:ah # I feel sick 
 toda:ay" 
 Thus because of these unpleasant symptoms, Charlotte struggles with her "feed" regularly, 
wishing that she did not have to adhere to this treatment modality. Whilst Charlotte 
described a daily struggle, other participants highlighted the impact of becoming unwell on 
the experience of treatment and adherence, with participants discussing how certain 
treatment modalities become more difficult to adhere to when they are ill with an infection. 
Tony explained that when he is feeling unwell he finds physiotherapy particularly difficult due 
to him not having the required energy to perform airway clearance.   
 *[Tony, 13 years]: "The physio # do you know (.) if you feel like ill # it just feels 
 ha:arder to do a:all the breathes" 
Due to the various challenges associated with one's adherence, many participants outlined 
how adherence does require motivation and commitment. Tony explained how he often 
"can't be bothered" to start his physiotherapy regimen due to its time-consuming, and at 
times unpleasant nature, despite recognising its effectiveness. 
 *[Tony, 13 years]: "Physio:o # that's just the lo:ongest one [...] when I'm ha:alf way 
 the:ere (.) I'm a:alright # but it's like at the beginning # like o:oh (.) I ca:an't be 
 bothered" 
 Many participants openly discussed how they believe non-adherence would have a 
positive impact upon their life psychologically, with Sophie explaining how she would be 
more relaxed within her life without having to adhere to her medical regimen. Sophie 
discussed how her CF treatments cause her to worry, and that with non-adherence she 
would be able to engage in normal activities, which her time-consuming medical regimen 
can interfere with.   
 *[Sophie, 12 years]: "I think I would be a bit mo:ore # re:ela:axed (.) about thi:ings (.) 
 and not ha:aving to worry as much [with non-adherence] [...] I'd probably just pla:ay 
 out" 
Such narratives suggest that these participants have a life-orientated illness perspective 
where they desire a sense of normalcy. This desire for non-adherence could result in future 
poor or non-adherence when they become independent over their treatments, with this non-
adherence potentially providing the individual with a sense of normalcy within their lives and 
a normal identity in front of others. Even when participants had good awareness about 
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treatments' necessity, it did not always prevent their desire for non-adherence, with it being 
completely understandable why many participants expressed this desire given the high 
demands of such treatments. Adam explained how he wishes he did not have to adhere to 
his physiotherapy regimen which would allow him to engage in normal activities, despite 
acknowledging that this non-adherence would exacerbate his symptoms causing a decline in 
his health.  
 *[Adam, 16 years]: "Researcher: Are there any treatments you wi:ish you could miss 
 out 
 Adam: [Shakes acapella device] this 
 Researcher: What is it about that then 
 Adam: It can just take a while 
 Researcher: And what is it you'd prefer to be doing 
 Adam: Probably just watching tv # on me xbox 
 Researcher: And if you didn't do that treatment ho:ow do you think it would make you 
 feel 
 Adam: I'd # probably feel # wo:orse about myself # cause # I probably wouldn't be 
 able to do as much re:eally (.) at a:all" 
 Not surprisingly, with many paediatric participants explaining that adherence is 
challenging, many emphasised that they require help with their adherence. At the age of 18 
years, where independence is encouraged, Tim explains how hard he would find 
independent adherence, valuing the support his parents provide him with to assist with his 
adherence, to keep him healthy. 
 *[Tim, 18 years]: "Pa:arents # they're quite regimental [laughs] [...] they kind of push 
 me to do everything in a certain ti:ime ## which to be honest is quite ni:ice # it keeps 
 ya hea:althy don it [...] I think it would be mo:ore difficult [without parental support] # 
 cause I know people that # pa:arents (.) don't (.) re:eally # an they do struggle mo:ore 
 # cause they haven't got the consta:ant reminder" 
Many participants recognised the need for adherence support. Charlotte explained that if her 
Mother was not there to support and to remind her to perform her medical regimens, it would 
result in unintentional non-adherence, predominantly due to forgetfulness. 
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 *[Charlotte, 13 years]: "My Mom needs to remi:ind me someti:imes to do the 
 medica:ation [...] I wouldn't take em" 
 Due to many participants emphasising their need for family support, highlighting the positive 
impact it can have upon their physical health, it is not surprising that some participants 
signalled how they come to rely upon this support, and therefore believe that when they 
enter adolescence and adulthood, independence in adherence will be challenging. Charlotte 
explained how she is fine adhering to her treatments regardless of the situation (e.g. day 
trips) as her parents are always there for support, however she acknowledges that this 
would be different without their support, highlighting how this could lead to future poor or 
non-adherence particularly when engaging in activities outside of her normal routine. 
 *[Charlotte, 13 years]: "Researcher: If you're out for the da:ay # is it mo:ore difficult to 
 do your treatments then  
 Charlotte: >Not if my Mom an Dad are going to be with me then it's okay< [...] it 
 mi:ight be ha:ard # it mi:ight be different [without parental support]" 
 Even when some participants stated that they would manage their treatments 
independently, their discourse suggested otherwise. For instance, although Chris stated that 
he would be fine with independent adherence, his hesitations, and stating phrases like "I 
guess I would be alright", suggests his uncertainty. 
 *[Chris, 14 years]: "Researcher: In terms of your treatments (.) say in the futu:ure (.) 
 when (.) ma:aybe # maybe you mo:ove out (.) o:or anything like that # ho:ow do you 
 think you'll fi:ind doing a:all your treatments by yourself # ma:aybe one da:ay  
 Chris: # O:oh ### I guess I'll be a:alright # I guess" 
In addition, the presence of participants' legal guardians within some interviews will have 
had an impact upon the information disclosed by participants, there was evidence of this 
during discussions with Mandy. During the beginning of the interview Mandy's Mother and 
Nurse were present, with Mandy explaining that adherence to physiotherapy is "quite easy" 
as she is used to her physiotherapy regimen. However, when her Nurse had left the room 
Mandy explained that in reality she is not always adherent to her physiotherapy, explaining 
that she does not have time to adhere to this treatment before school. 
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 *[Mandy, 12 years]: "Researcher: You said you do physio (.) befo:ore school # and 
 after school 
 Mandy: Well # not rea:ally # not in the mo:ornings # because I'm not really liking 
 physio [...] I literally wake up like # ten minutes before I have to leave the house in 
 the morning [laughs]" 
This highlights how individuals may present their adherence to HCPs in a way that is 
different to reality. For Mandy it appeared that she told HCPs that she was adherent to 
physiotherapy as she knew she should be adherent to this treatment modality, and 
potentially did not want to receive negative feedback from HCPs regarding her adherence 
efforts. 
 Whilst many participants did discuss how challenging independent adherence would 
be, and therefore explaining how they welcome support with their treatments, some 
participants explained how they do not welcome such support. Emily stated how she feels 
ready to become independent, but her Mother is holding her back and not recognising that 
Emily at times is being independent, and does not need reminding to adhere to her 
treatments. Emily explained how such reminders annoy her and cause her to retaliate 
against her treatments. 
 *[Emily, 14 years]: "I:I # want to [be independent] # but ## I fe:eel like I'm getting 
 he:eld back to do that # because # no o:ones letting me do it [...] say if I ne:eed to 
 take my tablets (.) I'll a:already be in the middle of doing it an Mum will be like ↓o:oh 
 take your tablets # ↑well I ha:ate being told (.) what to do:o [laughs]" 
Mandy also suggested that when her Mother and Grandmother "nag" her to adhere to her 
treatments it reduces her motivation for adherence, indicating how such nagging causes her 
to retaliate against her Mother and Grandmother, although she can appreciate that they only 
"nag" because they care.  
 *[Mandy, 12 years]: "If I'm sitting with my Mom (.) she nags me that much [to do 
 treatments] [...] then she tells my Nan (.) and the next day my Nan's like >wh:hy 
 didn't you do this< [...] I know they ca:are (.) but ## I don't like being shouted at" 
 The challenges of independence were not just discussed as future anxieties, some 
participants explained how they are independent with their treatments and recognise the 
challenges associated. One challenge that many participants discussed was forgetting to 
adhere to a certain treatment modality, demonstrating unintentional non-adherence. Despite 
Emily discussing how her Mother holds her back and is not enabling her to be independent 
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with her adherence, she also discussed how recently she has had poor adherence to her 
nebulised treatments. Emily stated that this poor adherence is due to forgetfulness, due her 
desire for a sense of normalcy, and to engage in normal activities. Emily appeared to 
actively avoid her nebulised therapy as she wants to forget about it, in line with her desire for 
normalcy. This highlights the difficulty in balancing the needs and desires of young adults to 
be independent, alongside the need for supporting and ensuring treatment adherence.   
 *[Emily, 14 years]: "My (.) nebuli:iser [laughs] # I've probably done about m::m ## 
 abou:ut # thre:ee (.) in the pa:ast (.) like # fo:our weeks:s [laughs] [...] I kinda (.) 
 fo:orget about it # because you're tr:rying to lead a (.) no:ormal life" 
Many participants, such as Sophie pointed out that to overcome forgetfulness and to aid 
their adherence efforts they use a structured routine, with participants clearly indicating how 
routine and structure support adherence. A structured treatment routine was used by 
participants who were independent (or becoming independent), and also by participants who 
still received parental support with their adherence efforts. Participants explained how this 
routine helps them (and their parents) to not forget their treatments, as such routine 
becomes integrated into their everyday lives. 
 *[Sophie, 12 years]: "<It's [adherence] ea:asy> [...] we (.) just (.) ha:ave (.) a ti:ime to 
 do it (.) sort of thi:ing # of a mo:orning we have a routi:ine" 
Besides unintentional non-adherence, Mandy highlighted how psychological distress can 
also impact on adherence, with Mandy explaining that when she experiences health-related 
stress and anxiety, often after a bad day at the hospital, it reduces her motivation for 
adherence. Mandy recognises that not doing her treatments can make her health worse and 
consequently make her more anxious, with Mandy talking about how frustrating this is for 
her. 
 *[Mandy, 12 years]: "I'm mo:ore likely to not do them [treatments] and I don't 
 understand that [...] if I'm worried I get angry with myse:elf # and then I say things I 
 don't me:ean [...] it a:all goes back to (.) because I've had a bad day at the hospital" 
 Not all participants who were independent with their adherence found it to be a 
challenge, with Sophie explaining how she felt ready to take on such independence, and 
likes to independently integrate her treatments into her life. 
 *[Sophie, 12 years]: "I have started to (.) putting together my o:own 
 medica:ations [...] Mum a:aked if:f # I was a:alright # an I said I'd quite like to do it" 
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However, with these participants being adolescents it has to be questioned whether or not 
these responses were influenced by social desirability bias. When talking with Chris in the 
presence of his Father it was acknowledged how parental and adolescent views towards 
independence vary. Chris believed that he is quite independent with his treatments, however 
his Father disagreed.  
 *[Chris, 14 years]: "I # I'm u:usually quite (.) indepe:endent (.) when it comes to 
 meds:s  
 Father: [What] you mean (.) so we:e put them out for ya (.) an you take em [...] that's 
 not independent  
 Chris: °It is:s independent°  
 Father: It's not # just cause I'm not putting it in ya mouth (.) doesn't mean I don't put 
 em out for ya an say (.) here's ya medicine (.) here's your creon # here's ya (.) 
 fe:eeding tu:ube # we do it a:all for ya" 
 Despite the potential for social desirability bias within participants responses, those 
who did report treatment independence appeared to have accepted their CF, with this 
assertion being supported by such participants not being afraid to have their illness identity 
on display. Emily explained how she does not mind publically adhering to her medical 
regimens, explaining that despite her CF she is the same as everyone else, and therefore 
possess a normal identity. 
 *[Emily, 14 years]: "I don't re:eally hide it [CF] # it's like when I've got to take my 
 tablets (.) >I take them< [...] I just see myself like (.) ano:other person # I a:am # like 
 (.) somebody else # just different # I'm not li:ike ## a sma:all person in the corner (.) 
 who:o's ## not recognisable" 
Emily clearly highlights how possessing an illness identity or a normal identity is not 
categoric or simple. Emily is able to show that she has CF in front of others, but she does 
not see herself as having an illness identity. Such participants view themselves to be normal 
and do not have a desire to hide their illness from their peers. Adam explained how CF does 
not stop him enjoying his life, with Adam being comfortable adhering to treatments in front of 
others and talking to others about his CF to raise their awareness. 
 *[Adam, 16 years]: "Researcher: Do you tell others about your CF 
 Adam: Well # yeah ## we had it in Science the other day and Miss wanted me to tell 
 everyone about it [...] I was fine with that [...] I'd tell anybody [about his CF]" 
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 Some participants did demonstrate acceptance towards their CF, with many of these 
participants also demonstrating acceptance towards treatments' necessity. Individuals can 
only accept their CF and accept treatments' necessity through awareness. Tim explained 
that despite it being a challenge to adhere to his treatments every morning, he is adherent 
because he is aware that such adherence will help to prolong his lung function. 
 *[Tim, 18 years]: "[The most challenging aspect of CF is] probably getting up every 
 mo:orning to do your treatments:s # wo:orking it out so you've got time to do them 
 [...] but because I know it's go:oing to help me in the lo:ong run (.) it doesn't re:eally 
 bother me" 
Overall, it is evident that the impact adherence has on an individual living with CF varies 
between individuals, although understandably most people did view CF to be a challenge. 
Several participants talked about the need for support from others to aid with their 
adherence efforts, and this support was not just isolated to one's adherence, but also for 
other aspects of their lives, such as providing them with awareness on the adverse health 
effects of risky behaviours.  
"Don't keep Cystic Fibrosis to yourself" 
 This second theme focuses on the beneficial effect support from others can have on 
an individual living with CF, as well as the adverse effects a lack of support can have. The 
support this theme mainly focuses on is that from an individual's family, friends and HCPs. 
Many participants underlined how support from others is a necessity to aid their life with CF, 
with Liam pointing to how individuals with CF must seek out such support and take 
advantage of it, rather than hiding their concerns which could have a negative impact on 
their psychological health. 
 *[Liam, 14 years]: "Tell someone about it [CF] if you're worried # don't keep it to 
 yourself (.) get attention [...] you must share it with someone" 
The support paediatric participants predominantly referred to originated from their family, 
with many participants understanding that CF is not just experienced by the patient, it also 
causes concern and worry for family members. Mandy explained that when she is at hospital 
she does not just worry for her health, she also worries about how her family would react to 
negative news, highlighting the emotional burden CF has upon her life, and her family's life. 
 *[Mandy, 12 years]: "I don't just worry when I go to the hospital # about # how my 
 hea:alth is # I worry about how my family will react to it" 
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Mandy highlights how her concern for her family and how her family are feeling about her 
being unwell is an additional worry for individuals with CF, which could make such 
individuals feel as if they are a burden to others, with this being an additional burden to 
having CF. 
 Participants looked favourably on family support, recognising its need. In addition to 
aiding with adherence, participants suggested that family support can be imperative in 
preventing individuals engaging in risky behaviours. Tim explained how his family have 
prevented him from smoking through providing good awareness regarding the adverse 
health effects, and through protecting him from environments which would expose him to 
second-hand smoking.  
 *[Tim, 18 years]: "Since I've been bo:orn (.) my:y Mum an Dad drilled into my head if 
 you smoke you di:ie # that's pre:etty much ho:ow they put it to me # so:o # I've kind 
 of just (.) tr:ried to keep awa:ay [...] I think that was a bi:ig thing for them to te:ell me 
 # to make sure I didn't do it" 
During the interviews where parents were present, many of them emphasised how they 
believe it is their duty to ensure their child is fully aware of the CF-specific adverse health 
effects of risky behaviours.  
 *[Chris, 14 years]: "Father: I think it's the conversations you have at ho:ome # as a 
 pa:arent you talk about stuff [regarding illicit drug use]” 
The data suggests that when an individual has good awareness regarding these adverse 
health effects it works to prevent initiation, with many participants not desiring to engage in 
these behaviours due to their awareness, and due to them appearing to have accepted their 
illness identity, and therefore accepting they cannot engage in such behaviours.  
 *[Adam, 16 years]: "I was fi:ine with it # I don't re:eally mind not smoking # >I 
 probably wouldn't smoke anyway< [...] I just think they [smokers] look like idiots really 
 # smo:oking # it's going to affect them when they get o:lder and everything" 
 Besides family members providing participants with awareness, some participants 
explained how they would never engage in such behaviours as they fear the consequences 
from their family. Tim explained how he is aware that his Mother and Father would not want 
to see him if he did smoke, particularly because of the emphasis they have placed on 
encouraging Tim not to smoke, and therefore would not want to watch Tim weaken his 
health unnecessarily. As well as punishments, some participants, such as Mandy, explained 
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how they would not engage in risky behaviours as they are aware that such engagement 
would disappoint their families. 
 *[Tim, 18 years]: "I think I would go as fa:ar as saying (.) my Mom an Dad would not 
 want to see me:e [if the participant smoked] [...] obviously they drilled it into me:e  # 
 and because they've said (.) it ca:an kill me  # they'd ki:ind of sa:ay # well (.) you're 
 ki:illing yourself # so:o (.) what's the point # I don't want to watch you ki:ill yourself # 
 an I do:o (.) true:ely believe (.) they would # just cut me o:out" 
 *[Mandy 12 years]: "I ca:an't [smoke] # not only because of my CF # but # just the 
 disappointment that my Mom would have # and my family" 
Participants who did have good awareness regarding the adverse health effects of risky 
behaviours from their families, and were aware that their family would discipline them for 
such engagement, often explained how such behaviours were not normalised within their 
family, therefore their engagement would not provide them with a normal identity. 
 However, not all participants received support from their families, with some 
participants having negative family relationships. Emily discussed how she does not seek 
support from her Mother, instead she turns to HCPs with any worries she has, due to her 
Mother making her feel unwanted. This has resulted in Emily being quite independent within 
her general life, and also in terms of managing her CF, despite only being 14 years. 
 *[Emily, 14 years]: "I'm quite indepe:endent # if I did have a:any worries I'd see my 
 Docto:or [...] I don't re:eally speak to my Mom about it [...] I've a:always being to:old 
 like # mista:ake child [...] there are some things you would say to your friends:s (.) but 
 you wouldn't say to your Mom [laughs] # some people would actua:ally say like (.) 
 a:all the things they say to their mates (.) to their Mum # because they have that (.) 
 bo:ond (.) but I don't" 
A lack of family support can have damaging effects upon an individual's life, with it being 
plausible that negative family relationships could influence an individual to engage in risky 
behaviours, as a coping mechanism to deal with such negativity. Therefore despite Chris's 
Father believing it is the role of parents to educate their child regarding the CF-specific 
adverse health effects of risky behaviours, the data illustrated how a participants family does 
not always provide such awareness, with some families normalising risky behaviours. Tony 
explained how both his parents smoke, with this exposure causing Tony to view parental 
smoking as normal.  
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 *[Tony, 13 years]: "I know that my Mom an Dad smoke [...] I do:on't (.) re:eally feel 
 anything # cause I'm (.) so:ort of used to it ## it just seems no:ormal" 
Consequently, such normalisation could have an influential role in future initiation, to hold a 
normal identity. Furthermore, when a participant’s family engaged in a risky behaviour it 
often provided access to that behaviour, with Tony explaining how he drinks alcohol at family 
parties due to both of his parents, and nearly everyone he knows drinking alcohol. 
 *[Tony, 13 years]: "My Mo:om (.) my Da:ad # nearly everyo:one that I kno:ow [drinks 
 alcohol] [...] I've tr:ried it # it was when # we was like at this (.) pa:arty (.) like wedding 
 #  >family pa:arty wedding<" 
However, the data indicates that normalisation by a participant’s family does not always 
result in a desire for initiation, it appeared that an influential factor affecting initiation was 
awareness of the CF-specific adverse health effects. Mandy indicated her anger regarding 
her Father's smoking behaviour, acknowledging the adverse health effects it will have upon 
her Father, and therefore the emotional impact it will have upon herself, and her family when 
he "suffers from his consequences". 
 *[Mandy, 12 years]: "I ha:ate it when my Dad smokes ## I feel it's unfa:air # on the 
 who:ole family # like what the bloody hell does he think # if he's smo:oking fags (.) an 
 he gets cancer (.) it's his fa:ault # and we:e'll have to suffer from his consequence ## 
 it's stu:upid" 
 The family is only one source of support identified. A number of participants 
discussed the importance of friendships, and the impact they can have on their health 
behaviours. Many participants, such as Tim and Liam, spoke favourably upon the support 
they receive from their friends, with such support being provided as a consequence of the 
participant disclosing their CF. 
 *[Tim, 18 years]: "I a:always tell a:all my close friends [about CF] (.) people I go out 
 with (.) just in case something happens # so they know (.) kind of thi:ing" 
 *[Liam, 14 years]: "Researcher: what cha:anges [after disclosure of illness identity]  
 Liam: ### They tr:ry an help me a little bit” 
Disclosure of one's CF suggests that these participants are comfortable with having their 
illness identity on display in front of their friends. It does however have to be acknowledged 
that these participants may not be comfortable in having their illness identity on display in 
other situations, as an individual's identity is not static, and is often dependent upon social 
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factors. Whilst some participants explained that they will tell anyone about their CF, being 
comfortable with having their illness identity on display in public; others explained that they 
only disclose their CF to their close friends, as in front of others they want to appear normal 
and not have their CF visible. The data did mark that disclosure appears advantageous for a 
participant’s health, with Tony talking about how disclosing his CF to his friends has enabled 
him to display his illness identity and adhere to his medical regimens in front of his friends. 
 *[Tony, 13 years]: "They [friends] don't mi:ind [the participants adherence efforts] (.) 
 cause they re:eally ## they quite kno:ow about it" 
 In addition to adherence, a number of participants described how their friends would 
not allow them to engage in risky behaviours, as they are aware of the CF-specific adverse 
health effects. Tim explained that due to him educating his friends regarding the impact 
smoking could have on his CF, he knows that his friends would never allow him to smoke.  
 *[Tim, 18 years]: "I kno:ow # friends would have a go at me:e ## I can remember (.) I 
 went to the shop for me ma:ate once:e # an e:erm:m (.) picked up cigarettes # 
 another friend se:een me wa:alking do:own the street with em # an he to:ook em off 
 me [...] I kno:ow my friends would flip [...] because I:I've dri:illed it into their head (.) 
 that I ca:an't do it" 
However, not all participants had friends who worked to prevent initiation, with some 
participants signalling how peer pressure or normalisation of a risky behaviour by their 
friends can result in a desire for initiation. Mandy explained that when her friends offered her 
a cigarette she did contemplate smoking to receive a normal identity within that social group. 
However Mandy's awareness regarding the adverse health effects of smoking prevented her 
initiation on that occasion. Nonetheless, with Mandy explaining how bad it made her feel 
when she refused to smoke, it could impact her decision if she was offered to partake in a 
risky behaviour again, with adolescents often valuing social acceptance. 
 *[Mandy, 12 years]: "I've been offered a fag [...] I was out with my ma:ates # a:and 
 they were a:all smoking # and someone (.) gave me a fag # I held it in my hand # I 
 was about to # but I just thought ### no # I ca:an't [...] if I didn't have CF (.) I think I 
 would have (.) to be honest [...] I was trying to be # co:ool [...] it ma:ade me feel so ## 
 ba:ad ## not having this fag" 
However, the data suggested that when a participant had accepted their CF, and were 
aware of the CF-specific adverse health effects of risky behaviours, it often prevented a 
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desire for initiation, with Liam explaining how he views the use of Shisha in a negative light 
and therefore would never experiment with this behaviour despite his friend's engagement. 
 *[Liam, 14 years]: "Researcher: Do you know anyone who does those behaviours:s 
 [Shisha]  
 Liam: Yeah # my friend #  
 Researcher: And what do you think of your friend who does them  
 Liam: E:erm:m ## bad # 
 Researcher: Seeing your friend (.) does it ever make you want to try it  
 Liam: No # it's bad" 
 Whilst most of the friendships discussed were referring to individuals within the 
general population, some participants discussed their friendships with others with CF. Many 
of these participants viewed these friendships to be positive, despite being aware of the risk 
of cross-contamination. Some participants explained that they ignore the rules surrounding 
in-hospital segregation because of the beneficial effects such friendships have upon their 
life, with Charlotte describing the support she receives from others with CF, and the support 
she provides them with, with them being there for any CF-related questions that she may 
have. 
 *[Charlotte, 13 years]: ">I like it< [mixing with CF patients] # reason wh:hy # cause if 
 they've got a:any questions they could a:ask me # o:or if I've got any questions I 
 could a:ask them" 
Participants who were compliant with non-contact with other CF people expressed regret 
that they could not have this contact, and recognised how valuable it could be for them, 
acknowledging that it is only others with CF who truly understand what they are going 
through. Mandy explained how she has tried to communicate with others with CF through 
emails, however that has been unsuccessful, with Mandy recognising the positive impact 
such communication could have upon her life. 
 *[Mandy, 12 years]: "I've tried emails (.) but they [others with CF] never reply [...] 
 speaking to people # it'd be rea:ally nice [...] I'd like to know someone else who has 
 the same as me [...] someti:imes I just want to let it a:all out [worries] # but # people 
 [without CF] don't understa:and # from my perspective" 
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 Whilst many participants demonstrated the benefits of communicating with others 
with CF, Tim indicated that sometimes others with CF can normalise risky behaviours, 
explaining how on one occasion individuals with CF stated that the use of marijuana is 
beneficial, stating they can smoke marijuana as their treatment adherence will maintain their 
health. 
 *[Tim, 18 years]: "I kno:ow # a lot of people [with CF] do it [marijuana] [...] they 
 a:always sa:ay (.) well I:I do it (.) beca:ause (.) >I do:o my treatments:s< (.) an I do 
 everythi:ing else (.) to keep myself hea:althy # so I think I can have my little bit on the 
 si:ide" 
These compensatory health actions could be detrimental upon the health of others with CF, 
with individuals valuing the opinions of their friends, potentially motivating individuals to also 
engage in such behaviours. Unrealistically optimistic views were also demonstrated, with 
some participants who ignored the rules surrounding in-hospital segregation, 
underestimating their likelihood of experiencing adverse events. Tim appeared to focus on 
the psychological benefits such communication has on his life, with Tim weighing up the 
risks such communication could have upon his physical health, and considering them to be 
worth the benefits. Tim appeared to value his psychological health, demonstrating his life-
orientated illness perspective.   
 *[Tim, 18 years]: "I do:on't (.) pe:ersonally (.) think it's [cross-contamination] a bi:ig 
 problem #  even though it's been pro:oven to be # I think that ## it (.) >ma:akes your 
 life ea:asier if you speak to someone with CF< # so # wh:hy # not (.) do it" 
Tim explained that despite the risks of cross-contamination been proven, he does not 
perceive cross-contamination to be a big problem, highlighting how personal experience is 
weighed as more relevant than evidence. 
 As well as the role families and friends can play in influencing an individual's attitudes 
and beliefs towards risky behaviours, the data also highlighted the role schools can play, 
illustrating that schools often provide awareness on the adverse health effects of risky 
behaviours. Emily explained how she will never smoke due to her awareness of the adverse 
health effects this can have upon individuals, with this awareness being provided through 
her education at school. 
 *[Emily, 14 years]: "I would ne:ever do tha:at [smoke] # cause I just # couldn't # get 
 my head round wh:hy:y people do that to their bo:ody # >even like hea:althy people< 
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 [...] I've done so:o many anti-smo:oking and anti-alcoho:ol campaigns with scho:ool 
 (.) an we learn about it in science:e (.) I'm like mega:a high on (.) not (.) to smo:oke" 
Although this awareness is not CF-specific, it can still play a role in preventing initiation, due 
to the suggested relationship between awareness and abstinence. In addition to school 
providing awareness, the data pointed to how some individuals become aware of the 
adverse effects of risky behaviours through television programmes, with Tony discussing 
how he became aware of the adverse health effects of illicit drug use purely through 
watching programmes which document their effect.  
 *[Tony, 13 years]: "I watch twenty four hours in NHS [laughs] # and they say how ## 
 some of them a:are like dru:uggie:es # so like # it can affect your brain an that ca:an't 
 it # an like a:all your hea:art an lu:ungs # everywhe:ere in your body" 
Not only do television programmes provide awareness on the adverse effects of risky 
behaviours, participants discussed how the television can also provide awareness to society 
regarding CF, with Abi explaining how she is fine disclosing her CF to her friends as they are 
aware of what CF is through learning about it from television programmes. 
 *[Abi, 12 years]: "Researcher: And you're fi:ine telling friends [regarding CF] ## do 
 you think they understa:and what it is:s  
 Abi: Yeah # because they've seen it on TV # so they know what it is:s" 
Such awareness will hopefully help to reduce the ignorance that some participants believe 
society has regarding CF, with Chris explaining that not many individuals within the general 
population understand what CF is, with this therefore having the potential to result in a lack 
of support or compassion from individuals within the general population, particularly due to 
CF's invisible nature. 
 *[Chris, 14 years]: "It's difficult to expla:ain (.) but I don't think many people get what it 
 [CF] is (.) exactly:y # I think the o:only thing they kno:ow (.) is that it is a lu:ung 
 disease” 
 The varied levels of support received from family and friends highlights the 
importance of consistent clear support and advice from HCPs, in influencing whether or not 
an individual will adhere to their medical regimens, and not engage in risky behaviours. 
Many participants spoke favourably about their HCPs, stating how supportive they are, with 
many participants referring to the support which derives from their Nurses. Many participants 
preferred to speak to Nurses over other HCPs as well as their parents. 
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*[Charlotte, 13 years]: "Researcher: Who do you go to if you have any questions 
about CF ## any questions:s (.) o:or concerns about CF 
Charlotte: Ask my Mom (.) o:or [Nurses name]" 
However, whilst many participants spoke favourably about their HCPs, Mandy identified a 
gap within CF care, demonstrating the need for consistent psychological support. Mandy 
explained how beneficial it was when she received psychological support from a Psychiatrist, 
explaining that it is easier to talk to someone she does not know about her worries, with 
Mandy not wanting to burden her Mother with these. However presently Mandy does not 
receive any psychological support, which as discussed is having an adverse impact upon 
her self-management, with Mandy not adhering to her treatments when she feels anxious. 
 *[Mandy, 12 years]: "I've been asking my hospital for ages if I can see my 
 Psychiatrist again (.) but they just don't get back to me # cause I seen my 
 Psychiatrist (.) I got really close to one ## I was rea:ally (.) rea:ally close to him # and 
 then he left # and then I got transferred to another one # we wasn't as close # I only 
 sa:aw her for about two months (.) and then she left # and now # I have no one ## I 
 don't like talking to my Mom about it [worries] (.) I'll be straightforward # it's easier to 
 talk to someone who has heard it a:all before" 
 In addition to general support, many participants pointed out that their awareness 
regarding the adverse health effects of risky behaviours has derived from HCPs. Tony 
explained how his Nurse informed him about the detrimental effect smoking could have upon 
his CF, with Tony stating that prior to this he was not aware of these adverse health effects, 
demonstrating the need for such awareness.  
 *[Tony, 13 years]: "When [Nurses name] came to our house (.) we had a talk about 
 (.) smo:oking an a:all that # she told me ho:ow it can be bad for your lu:ungs # and 
 how sometimes you ma:ay have to get a lu:ung transplant (.) an a:all that # like fresh 
 new lu:ungs [...] knowing me I would probably think it's a:alright [without awareness] 
 # people that I kno:ow smoke"  
However, despite this awareness appearing to have beneficial effects upon individuals, 
influencing their attitudes and beliefs towards risky behaviours, it became evident that this 
awareness is provided on an individualised basis. For instance, Tim believed that he had 
only been provided with awareness on the adverse health effects of smoking as he 
instigated the conversation.  
 *[Tim, 18 years]: "I think it [smoking] ha:as been brought up [by HCPs] befo:ore [...] 
 but # it's mo:ore me # kind of # sa:aying (.) about it ## a:asking about it [...] in 
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 ho:ospitals they don't ki:ind of # ta:alk about precautions of things # they're mo:ore 
 ta:alking about your treatments an stu:uff" 
There was also evidence of participants not being provided awareness of the adverse health 
effects of risky behaviours from HCPs, with this often causing participants to have poor 
awareness. Abi explained how her HCPs have never discussed alcohol consumption with 
her, with Abi not understanding what adverse health effects are associated with excessive 
alcohol consumption, and in particular how this behaviour can impact her CF. 
 *[Abi, 12 years]: "Researcher: Has anyone ever told you # anything (.) about 
 drinking alcohol  
 Abi: No:o [...] I don't get like # wha:at's bad about it # I know it's like alcoho:ol (.) but # 
 like wha:at's # there's something in it (.) o:or ## I dunno:o" 
Thus if participants do not have this awareness, if such behaviours were to become 
normalised within their environment they may be motivated to initiate in such behaviours to 
receive a sense of normalcy. Such participants would be unable to make an informed choice 
regarding engagement in these behaviours as they are unaware of the consequences such 
engagement could have upon their health, and specifically their CF. Due to the suggested 
relationship between awareness and abstinence, the need for HCPs to inform all individuals 
about the adverse health effects of risky behaviours, despite their personal condition is 
highlighted. Some participants demonstrated a need for such awareness at an earlier age 
than currently provided. 
 *[Tony, 13 years]: "Researcher: If you was to meet a you:unger person than you with 
 CF (.) is there anything you'd tell them  
 Tony: Yeah # like do:on't smoke an a:all that (.) cause it can make your health 
 re:eally bad # an probs the do:ocs wouldn't have told them (.) cause they're still at a 
 young a:age" 
 Overall this theme highlights the impact others can have upon a individual's life. The 
role of others can be influential in promoting health behaviours, and preventing the 
engagement in risky behaviours. However this theme identifies that on occasions the role of 
others can work to encourage initiation through normalising risky behaviours, therefore it is 
suggested that some adolescents with CF may engage in these behaviours in their future in 
order to possess a normal identity. 
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"I wish I did not have Cystic Fibrosis, that would be wicked" 
 This theme provides an understanding on how CF can have an impact upon an 
adolescent’s identity. It illustrates how adolescents with CF react to this impact upon their 
identity, focusing upon how non-adherence and the engagement in risky behaviours can 
assist individuals with CF in possessing a normal identity, particularly when in front of others. 
Many participants demonstrated a strong belief that they are not defined by CF, believing 
they are more than an individual with CF. 
 *[Emily, 14 years]: "I just see myself like (.) ano:other person"  
This emphasis on being normal demonstrated by Emily and a number of other participants 
highlights that these participants know there are differences between themselves and their 
peers, due to CF, but it is clear that CF is not what defines these individuals. Such 
participants explain that they are the same in many ways to their peers, and different in 
many other respects, which are not to do with CF. Emily explains that she views herself to 
be the same as everyone else, as she is recognisable with her own identity which does not 
include CF. 
 *[Emily, 14 years]: "I'm not li:ike ## a sma:all person in the corner (.) who:o's ## not 
 recognisable # I'm quite # a lo:oud person [laughs] most of my friends would sa:ay 
 that # an that I'm ru:ubbish with ti:ime [laughs]" 
It is clear that Emily is not the person that she thinks others might expect her to be with CF, 
she is not small, quiet, unrecognisable or a good timekeeper, with Emily not allowing 
stereotypical views of CF to define her identity. The fact that participants, such as Emily, do 
not see themselves as fitting into the stereotype of what others might expect of someone 
with CF appears to be adaptive for their psychological wellbeing, with participants describing 
that they live a normal life with their peers. To perceive living a normal life did vary between 
participants, with some participants showing the retaliation against CF allows them to lead a 
normal life, whereas other participants viewed CF to be normal, with such participants 
explaining that they are used to their condition and the everyday routine it imposes upon 
their life, with it appearing that such participants have accepted that routine. 
*[Sophie, 12 years]: "I don't re:eally mi:ind (.) because (.) I haven't like # not # had CF 
(.) sort of thi:ing (.) so ## but # I ju:ust # <thi:ink of it as (.) no:ormal>” 
Participants such as Sophie are more likely to continue adhering to their medical regimens 
independently as they enter adolescence and adulthood, due to viewing their CF to be 
normal, and not demonstrating a desire to retaliate against their illness identity.  
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 A desire for normalcy for some participants involved them discussing how they 
wished their life did not consist of CF, as they highlighted how hard it can be to live with the 
condition, which is preventing some participants living the normal life they desire. Charlotte 
explained how she is currently on the lung transplant list, consequently CF has a big impact 
upon her life, involving numerous treatments to adhere to, resulting in Charlotte not being 
able to attend school as she is too ill. Like many individuals with CF, Charlotte 
understandably explained how she does not like CF and the implications it imposes on her 
life. 
 *[Charlotte, 13 years]: "I wi:ished I never had CF (.) actually ## it would be wicked” 
Participants who had strong negative views towards their CF explained how they do not 
disclose their illness to others, in order to prevent their illness identity being on display in 
public, due to their desire for normalcy, with non-disclosure representing an individual's 
attempt to retaliate against their CF. Tim explained how he decided to not disclose his CF to 
others during his school life as he did not want to be treated differently. Tim talked about 
how he sees himself to be normal, and therefore wanted to be treated as a normal individual. 
 *[Tim, 18 years]: "Throughout scho:ool (.) a lot of people didn't know I had CF [...]  
 when people do kno:ow you've got (.) things wrong with ya ## they tend to (.) 
 cha:ange [...] I prefer to be trea:ated just # as any other individual" 
It is often easy for individuals with CF to not disclose their CF to others due to CF's invisible 
nature, with some participants valuing this invisible nature due to their negative past 
experiences when they allowed their illness to be on display. Emily explained how she was 
bullied following disclosure of her CF, which has therefore resulted in her now hiding her 
illness identity from others in order to be seen as a normal individual. 
 *[Emily, 14 years]: "Not (.) ma:any (.) people in my school kno:ow  # >that I've got 
 CF< [...] o:only (.) a couple of clo:ose friends kno:ow (.) a:and friends that I 
 used to be friends with (.) but (.) then I got bu:ullied by them [...] the school that I'm at 
 ## are quite (.) bi:itchy:y ## in that they sa:ay (.) stu:uff # an twist it [...] if I said I take 
 tablets:s # they'd change it an say that I do (.) dru:ugs" 
Negative responses towards an individual's illness can have detrimental psychological 
implications upon the adolescent. Many adolescent participants indicated how they value 
their friendships, and often employ effort to ensure there are minimal differences between 
themselves and their peers, with many adolescent participants valuing acceptance from their 
social group. 
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 Whilst the data clearly highlights how disclosure of one's CF is often not easy, with 
participants explaining how they are cautious about how and when they do disclose their 
illness identity to others; other participants discussed how they were comfortable when 
disclosing their CF to others. Mandy explained how she tells others that she has CF, with 
such disclosure often occurring due to individuals asking questions regarding health 
behaviours which Mandy engages in, such as using her inhaler or eating large portions of 
food, with Mandy discussing how she does not hide these behaviours from others, or hide 
her illness identity. 
 *[Mandy, 12 years]: "I tell them what it [CF] is:s [...] sometimes I eat a lot # and 
 they're like >how come you eat so much and never put on like a pound< " 
Whilst Mandy was comfortable with disclosing her illness identity to anyone who enquired 
about her health behaviours, some participants did highlight that their disclosure was 
predominantly to individuals who they believe needed to know, with Tim explaining that he 
only discloses his CF to individuals who he is going to be spending time with so that they are 
aware of what to do if something was to happen to him. Therefore such participants like Tim 
appear to analyse the necessity of such disclosure before disclosing their CF to others. 
 *[Tim, 18 years]: "I just don't mention it [CF] if it's not needed to be mentioned [...] I 
 a:always tell a:all my close friends (.) people I go out with (.) just in case something 
 happens # so they know (.) kind of thi:ing" 
Paediatric participants who did disclose their illness identity, viewed disclosure in a positive 
way, appearing to value their illness identity being on display due to the positive outcomes 
they experienced. Mandy explained how she likes the attention she receives from others 
when she discloses her CF, with Tony discussing how disclosure of his CF provides him with 
support from others, allowing him to adhere to his medical regimens in front of others, 
preventing his peers asking questions about his treatments, as such disclosure informs them 
about these treatments. 
 *[Tony, 13 years]: "It's better [following disclosure] (.) because # I don't have to keep 
 expla:aining # like # >wh:hy do you need to take tablets< # >wh:hy does he need to 
 do that< # >wh:hy does he need to do this<” 
Disclosure of one's CF makes public adherence easier for the individual, particularly when 
they have experienced positive responses from their peers. Chris explained how individuals 
in the general population do sometimes stare because of his nasogastric tube. This made 
Chris nervous about going to school with his feeding tube, however Chris discussed how not 
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many of his friends stared at his tube, with all his friends now being used to it, resulting in 
Chris refusing a PEG feeding tube which would not be visible to others, because, as his 
Father explained "he doesn't like the idea of having a hole in his stomach", with Chris stating 
that he became used to having his feeding tube visible. 
 *[Chris, 14 years]: "At fi:irst it was kinda like # I didn't re:eally want to go to 
 school  with it [feeding tube] ### bu:ut # after a while (.) I started getting used to it [...] 
 not many people sta:ared when I first went in [...] some people asked # what 
 happened # what's that" 
Chris points out that at first he was very unsure and anxious about going to school with his 
nasogastric tube in, but clearly he had no choice. The response from others made it less 
difficult for Chris to display his illness identity, and in time he, and others got used to his tube 
being visible. It appeared that through disclosure of one's illness, and having their illness on 
display, paediatric participants were educating their peers about CF, resulting in such 
participants often being confronted with familiarity from others regarding their CF. When 
participants were comfortable with disclosing their CF to others, it was indicated how such 
participants have integrated their CF into their life and recognise their illness identity in all 
situations, with such participants, such as Sophie, not desiring invisibility towards their CF.  
 *[Sophie, 12 years]: "Someti:imes like # at scho:ool (.) so:ome people come up to 
 me an a:ask (.) <wh:hy I'm ta:aking # mediaca:ation> # like ta:ablets [...] I  don't 
 mi:ind telling them # I don't mi:ind people kno:owing about it” 
 Many participants did desire normalcy within their lives, with participants engaging in 
different behaviours in order to receive a sense of normalcy. Some participants discussed 
their desire for non-adherence in order to be provided with a sense of invisibility towards 
their CF; whereas Tim reported that for him adherence allowed him to possess this normal 
identity. 
 *[Tim, 18 years]: "I like to be classed as no:ormal # and I won't be classed as 
 no:ormal if I don't do my treatments” 
Tim is highlighting how the beneficial health effects of adherence allow him to lead a normal 
life, and to be perceived by others as being normal, with this raising his self-esteem and 
therefore encouraging his adherence efforts to continue. A desire for normalcy was also at 
times associated with a desire to engage in risky behaviours. Tim explained how he will drink 
alcohol due to him valuing the enjoyment provided through such engagement, suggesting 
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that he possess a life-orientated illness perspective, where he acknowledges the importance 
of living his life and doing what he wants to do, instead of letting CF rule his life. 
 *[Tim, 18 years]: "A lot of people associate dri:inking (.) as a # bad behaviour # but I 
 don't # I just see that as a:a # part of fun # li:ife # cause yes it ca:an affect you # but 
 not in the sa:ame # with your lu:ungs if you smo:oke # do you know what I mean” 
Tim makes a clear distinction between risky behaviours, viewing alcohol consumption to be 
less harmful than smoking, allowing his engagement with alcohol consumption to continue. 
This could be the result of unrealistic optimism, or could be as a consequence of Tim having 
a lack of awareness regarding the CF-specific adverse health effects of excessive alcohol 
consumption. 
 Many other participants within this phase of data collection had not had experience of 
engaging in risky behaviours, with participants talking about their beliefs and attitudes 
towards such behaviours rather than their experiences. Many participants did highlight the 
importance of having a normal identity and fitting in with their peers through talking in third 
person, potentially suggesting their beliefs without confirming such assertions. Tony 
explained that he believes that some people with CF do smoke due to such behaviours 
being normalised within their environment, with Tony expressing the belief that engagement 
in such behaviours would allow the individual to conform to their groups identity. Tony had 
previously discussed how smoking is normalised within his environment by his parents, 
therefore through talking in third person Tony has potentially signalled how easy it would be 
for him to smoke.  
 *[Tony, 13 years]: "I'd say probably quite a fe:ew people (.) like te:eenagers:s (.) an 
 that # some adults:s might [smoke] with CF [...] cause probably the a:area they've 
 been brought up in # o:or some of the friends they have" 
Many participants, like Tony, believed that engagement in risky behaviours is largely 
influenced by the behaviours of individuals peers, with conformity to the groups identity 
being a way for CF adolescents to adopt the same identity as their peers, in an attempt to 
forget about the burden of CF, by enjoying themselves, ensuring their psychological 
wellbeing. 
 Many paediatric participants did speak about how various risky behaviours are 
normalised within their lives. The data provided evidence of a new risky behaviour which has 
undergone a rapid normalisation process in recent years, with the data referring to the use of 
vaping as an alternative to cigarette smoking. Adam pointed out how adolescents are not 
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always using e-cigarettes for smoking cessation, with Adam witnessing some of his friends 
smoking e-cigarettes and then progressing onto smoking "normal" cigarettes.  
 *[Adam, 16 years]: "Mo:ore of them do these e cigarettes [...] one of me mates (.) he 
 smo:oked an e-cigarette (.) and now he's started smo:oking [...] it's just 
 encouraging them to smoke" 
Adam explained how the normalisation of vaping has resulted in adolescents viewing 
engagement to be "cool", therefore encouraging other adolescents within that social group to 
initiate in that behaviour, in order to receive a normal identity and to be accepted within that 
group. 
 *[Adam, 16 years]: "They still think it's [e-cigarettes] cool [laughs] [...] like me 
 mate was making loads of little ci:ircles as he was blowing out [laughs] # they think 
 it's cool" 
 The normalisation of a risky behaviour by an individual's social group does have the 
potential to be detrimental upon the health of an adolescent with CF. However, many 
participants within the current research stated that they would not engage in such 
behaviours despite normalisation. Chris explained how smoking is normalised within his year 
group at school, however he views this behaviour in a negative light, with Chris pointing out 
that he is aware that smoking is bad for his CF and would have dramatic adverse health 
effects. 
 *[Chris, 14 years]: "Most the people in my class do [smoke]  # it's ridiculous [...] I 
 think they're re:eally (.) stu:upid  
Overall, it appeared that an influential factor affecting one's desire for initiation in a 
normalised risky behaviour is awareness regarding the CF-specific adverse health effects of 
that behaviour, and potentially the acceptance of one's CF, demonstrating that engagement 
in such behaviours is multi-factorial. 
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"A lot of people with Cystic Fibrosis do take it for granted and smoke and do stupid 
things" 
 This final theme provides an understanding on the role knowledge has in 
encouraging adolescents with CF to adhere to their medical regimens and gain 
independence for their adherence as they enter adolescence. It also displays the role 
knowledge has in working to prevent the initiation of risky behaviours amongst adolescents 
with CF, through acknowledging the CF-specific adverse health effects. This theme 
highlights however that even when an individual has good awareness regarding the adverse 
health effects of non-adherence and / or risky behaviours, it does not always prevent such 
behaviours, or prevent a desire for such behaviours.  
 Many participants signalled that the first step to engaging in health promoting 
behaviours, and not engaging in risky behaviours was to have good awareness regarding 
CF, with participants explaining how this awareness results in positive behaviours for their 
health, as they understand the detrimental impacts non-adherence or risky behaviours can 
have on their CF. Tim explained that when individuals with CF have not accepted CF's true 
nature, and consequently take their health for granted, it can result in risky behaviours, with 
such individuals not acknowledging the adverse health effects such behaviours can have on 
their CF.   
 *[Tim, 18 years]: "I believe it is tru:ue that a lot of people with CF do:o # take it for 
 gra:anted (.) a:and # smo:oke # a:and do stu:upid things:s" 
 With individuals being born with CF, some participants explain that they have always 
been aware of their CF and the implications it has upon their life. Tim stated that he has 
never know any difference in terms of his life with CF, with his adherence becoming an 
everyday routine. 
 *[Tim, 18 years]: "Because I've lived with it [CF] a:all my life # I kind of # it's 
 [adherence] just an everyda:ay routi:ine for me" 
The role of structure and routine in aiding with adherence efforts is clearly demonstrated 
within the data, with many participants highlighting how a structured routine helps to reduce 
forgetfulness within adherence, protecting and promoting their physical health. In addition to 
a structured routine, the data illustrates the importance of awareness surrounding 
treatments' necessity in encouraging adherence efforts. Charlotte demonstrated her 
awareness of CF's fatal nature without adherence, emphasising the need for adherence 
post-transplant. 
157 
 
 *[Charlotte, 13 years]: "I will get po:oorly (.) an po:oorly # a:and I will (.) end up 
 dy:ying # if I don't take em [treatments] # so I have to take em [...] so I'll have my lung 
 transplant an I'll have o:other medica:ation an I'm not even allowed to miss that # not 
 even one da:ay" 
Such awareness, and acceptance towards treatments' necessity was seen to be essential in 
encouraging individuals to adhere to their medical regimens, or at least be motivated to 
adhere to such treatments, with this acceptance meaning that even when participants 
disliked their treatments they still had the motivation for adherence, as they acknowledged 
treatments' necessity to improve or uphold their health.  
*[Sophie, 12 years]: "<I don't like ha:aving to do a:all the medica:ation> (.) but I know 
that I ha:ave to do it to sta:ay well" 
Whilst adherence for the paediatric population is heavily influenced by an individual's legal 
guardians, regardless of their beliefs and attitudes towards adherence, a personal good 
awareness of treatments' necessity does suggest that such participants would be likely to 
independently adhere to their treatments in the future. Tim explains that the most 
challenging aspect of CF is waking up every morning to do his treatments, but because he is 
aware of the health benefits he will receive from his adherence efforts he is motivated to 
overcome the challenge of early morning wakenings to adhere to his treatments.  
 *[Tim, 18 years]: "Because I know it's go:oing to help me in the lo:ong run (.) it 
 doesn't re:eally bother me" 
During this transitional period it is expected that some guardians will still be playing a big role 
in their child's adherence and this was clear from participants, with Tim stating that his 
parents still have a big involvement in aiding his adherence efforts. How treatments are 
managed as an adult may be quite different, consequently it will not be until adulthood that 
the true influence of acceptance and awareness regarding treatments' necessity will be 
visible. 
 Many participants also discussed their awareness regarding the adverse health 
effects of risky behaviours, with such awareness often causing participants to view these 
behaviours in a negative light, suggesting that such participants have accepted that they 
cannot engage in these behaviours to protect their health. Chris compared smoking to self-
harm, recognising that smoking within CF can have fatal consequences, with Chris 
explaining that he would never smoke with CF due to this awareness, despite it being 
normalised within his environment. 
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 *[Chris, 14 years]: "Smo:oking (.) drinking # that kind of thing [...] they're stupid [...] it's 
 basically like cutting yourself ain't it # it's killing yourself" 
Some participants were aware that risky behaviours are “more risky” to their health due to 
their CF, in comparison to the general population. Tony believed that risky behaviours for the 
general population are more focused upon criminal behaviours, whereas he makes the 
distinction that for an individual with CF, risky behaviours are any behaviours that can 
deteriorate their health. 
 *[Tony, 13 years]: "If it's like for CF # like (.) like # smo:oking (.) drinkin an that (.) an 
 dru:ugs [are risky behaviours] # but if it's like a no:ormal person (.) probably like 
 brea:aking in (.) o:or somat [...] they're [smoking, drinking, drugs] risky for everyone 
 (.) re:eally # but it's mo:ore risky for CF (.) cause that can make em mo:ore ill" 
Tony was recognising that while the experimentation in normalised risky behaviours is risky 
for everyone, it is "more risky" for the CF population. It did appear that when individuals had 
good awareness regarding their CF they could appreciate that any behaviour is risky which 
adversely effects their health, again acknowledging that behaviours which are risky to the CF 
population may be different to those for the general population. Tim, along with many other 
paediatric participants viewed non-adherence to also be a risky behaviour. 
 *[Tim, 18 years]: "Any ki:ind of behaviour that can affect your lu:ungs # even if it's 
 down to not doing treatments # I count that as a ri:isky behaviour" 
 A participant’s awareness on the adverse health effects of risky behaviours 
originated from a number of places. A number of participants explained how their knowledge 
provision had originated from their HCPs. Participants such as Tony reported being informed 
about the adverse health effects of risky behaviours by HCPs, however there were gaps 
within their knowledge, demonstrating the need to revisit such information on a regular basis 
with CF adolescents. 
 *[Tony, 13 years]: "I've lea:arnt (.) like # [Nurses name] told me about that [drug use] 
 as well # we spoke about a:all # like smo:oking (.) drinking # an the dru:ugs # but I 
 ca:an't # remember # like ## I know people inject themse:elves with it # an that can 
 make their bloodstrea:am # e:er:r # like # not hea:althy" 
Tony explained how alongside the conversations he had with his Nurse regarding risky 
behaviours he was also provided with standardised written information, outlining the 
consequences of such behaviours, to compliment the verbal information provided. However, 
this again was not sufficient, with Tony remembering that he has been informed regarding 
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the adverse health effects of excessive alcohol consumption, but not remembering what 
these adverse health effects are. 
 *[Tony, 13 years]: "Researcher: Has anyone ever he:ere [hospital] talked about 
 drinking lo:ots of alcohol  
 Tony: No:o ## o:oh wait (.) probably [Nurses name] when she came over to my 
 house #  
 Researcher: Yeah # do you remember what she said  
 Tony: No # I've got this like (.) folder about CF an everything # there's leaflets 
 about it  
 Researcher: O:oh so it's in there # do you rea:ad the leaflets 
 Tony: Yeah (.) >I've read em<" 
Tony's discourse (talking very fast) potentially suggests that he has not read the leaflets that 
he was provided with regarding excessive alcohol consumption. This highlights that even 
when information is provided verbally, and in written form, people may not access such 
information.  
 In addition to HCPs, many participants reported receiving awareness regarding the 
adverse health effects of risky behaviours from their families, both from discussion and 
observation. Liam explains how he would never smoke after witnessing his Grandad 
experience adverse health effects from smoking, with Liam also at times experiencing 
symptoms of passive smoking. 
 *[Liam, 14 years]: "My (.) Grandad does it [smokes] [...] [makes Liam feel] bad 
 because he is a:always coughing [...] I start to cough a little bit" 
This highlights how seeing firsthand the health impact of a risky behaviour can be a positive 
learning experience. Liam has been able to witness the long-term impact of smoking from 
his Grandad, with this impact not being evident within peer group smoking, where fitting in, 
being cool and being normal are more immediate desires, and the negatives are not 
apparent. 
 Another common way adolescents gain awareness of the adverse health effects of 
risky behaviours is through their education, mainly through lessons (PSHE, Science) and 
activities they do at school which promotes health keeping behaviours. While such 
awareness is not CF-specific, it still appears to resonate with some individuals with CF, and 
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often results in them accepting that they cannot engage in such behaviours. Another way 
participants received awareness, which was not CF-specific, was through watching 
television programmes which had documented such adverse health effects. Mandy 
demonstrated how the exposure to such adverse health effects had an impact upon her 
affect, resulting in Mandy having no motivation to engage in drug use.  
 *[Mandy, 12 years]: "I had a panic attack at school # we watched a video about what 
 drugs do to you # your face ## these people were rea:ally scaring me [...] I would 
 never do it [smoke marijuana]" 
 Whilst certain television programmes do document the adverse health effects of risky 
behaviours, the data also highlights the role television can have in promoting risky 
behaviours through advertisements. Tony explained how he understands excessive alcohol 
consumption can have adverse health effects upon an individual, with this being 
documented on Eastenders, however he acknowledged how the adverts on television 
promote alcohol consumption, making it look like a pleasant behaviour to engage in, 
encouraging initiation. 
 *[Tony, 13 years]: "I watched Eastenders:s and I seen Phil Mitchell needs a:all these 
 transpla:ants (.) so # I knew that [alcohol is bad] [...] but in the adverts:s (.) they make 
 it seem like a good thing [...] the drinks:s (.) makes it look refreshing:g [laughs]" 
Therefore the television alongside all forms of mass media can have a negative influence 
upon the engagement of risky behaviours. 
 The data did demonstrate the imperative nature of awareness, with Tony explaining 
that without the awareness his Nurse provided him with regarding the adverse health effects 
of smoking, he would have potentially engaged in that behaviour, as he was unaware of the 
harmful impacts it could have on his CF. 
 *[Tony, 13 years]: "Knowing me I would probably think it's [smoking] a:alright [without 
 awareness from HCP] # people that I kno:ow that smoke (.) they probably wouldn't 
 be in that much trouble # like (.) like with their hea:alth or anything" 
For other participants it was an experience that prevented their risky behaviour engagement 
rather than any awareness which was provided. Tim explained how he stopped drinking 
alcohol due to his liver function deteriorating. 
 *[Tim, 18 years]: "When I fi:irst tu:urned eighteen I just seen it a:as I'm eighteen now 
 (.) I can do it [drink alcohol] # but # obviously wi:ith ## my liver function went do:own 
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 # so I just said to myse:elf ## sa:ame again ## it's mo:ore my health [...] the sca:are 
 of the liver function # kind of # pu:ushed me awa:ay from drinking a bit" 
It appeared that through experiencing these adverse health effects of excessive alcohol 
consumption, Tim valued his physical health above his psychological health. 
 Consequently awareness is not always enough to prevent an individual initiating in a 
risky behaviour or encouraging their cessation. An intervention therefore cannot just focus 
upon increasing an individual's awareness regarding the adverse health effects of risky 
behaviours, with it being noted that in some cases the discourse of participants suggests 
that their awareness will not prevent their experimentation in a risky behaviour. For instance, 
the pauses made by Sophie when asked if she would find it easy to refuse a cigarette from 
her friends, suggests that her answer could be due to social desirability bias. 
 *[Sophie, 12 years]: "Researcher: What about your friends # what about if they 
 started to smoke # just hypothetica:ally # and they offered you a cigarette # do you 
 think you'd find it ea:asy to say no:o  
 Sophie: E:erm:m # I'd just ## not agree with them" 
Some participants provided reasons as to why others with CF may engage in risky 
behaviours despite their awareness. Some participants discussed how psychological 
distress could motivate individuals to engage in risky behaviours, to promote their 
psychological wellbeing, explaining how CF may encourage some individuals to engage in 
such behaviours as if their health is already bad there is nothing to stop their engagement. 
 *[Sophie, 12 years]: "Ma:aybe:e (.) if (.) something's happened (.) in their life # that's 
 (.) like (.) dri:iven em (.) to do it [alcohol/drug use] so:ort of thi:ing # like (.) they're 
 depre:essed (.) o:or something like that [...] sa:ay if ## when they were little (.) they 
 hadn't done the medication (.) so they'd be re:eally bad # they (.) mi:ight # just do it 
 [smoking/alcohol/drug use] # sa:ay # well I'm not going to get any better (.) so I 
 mi:ight as well"  
The fact that Sophie, at the age of 12 years, identified that individuals with CF do not get any 
better, clearly highlights what young people with CF are facing in dealing with the emotional 
burden of CF and its deteriorating nature. Inviting young people to discuss the reasons why 
others engage in risky behaviours, allows them to talk about this without personalising it. 
Participants could therefore say things without directly implicating themselves, with this 
being a more comfortable way of disclosing difficult issues. Some participants made no 
reference to CF when talking in third person, potentially demonstrating how they feel towards 
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their CF and their potential future engagement in risky behaviours, without confirming such 
assertion. 
 *[Sophie, 12 years]: "Someti:imes ## like (.) sa:ay # they have a ## health issue # 
 o:or something # an sa:ay # they (.) we:eren't in a (.) very (.) good # state (.) sort of 
 thing # they ma:ay think (.) well # I'm bad a:already # I mi:ight as well [smoke]"  
 Overall this theme identified the potential relationship between acceptance, 
awareness and the engagement in health promoting behaviours amongst CF adolescents. 
However as outlined within this theme the factors that predict risky behaviours are manifold; 
therefore an intervention to reduce the occurrence of risky behaviours, and to encourage 
adherence cannot just focus upon increasing a CF adolescents awareness of such adverse 
health effects. This theme therefore aligns with the previous three themes in identifying 
another factor that can influence engagement in such behaviours. Acceptance and 
awareness should not be understood in isolation, as the data illustrates that engagement is 
potentially the result of a complex interaction between how an individual is coping with the 
emotional burden of CF, the support they receive from others, and how they define 
themselves. Therefore interventions need to be mindful of all these factors in order to 
attempt to reduce the occurrence of risky behaviours within the CF population.  
Discussion: 
 The data provides an exploration into attitudes and beliefs around risky behaviours 
within a paediatric CF population. Participants had a range of different attitudes towards 
risky behaviours, suggesting a number of different reasons for why others engage in such 
behaviours. The data produced is prospective, which has presented a deep understanding 
into participants' lives, examining individuals' attitudes and beliefs towards risky behaviours 
in real time. When paediatric participants were asked about what they regard as a risky 
behaviour, many participants identified non-adherence as a risky behaviour, demonstrating 
their awareness regarding treatments' necessity. This suggests that a large amount of 
emphasis is placed upon encouraging adherence within the paediatric CF population, with 
many participants having good awareness regarding what they need to adhere to and why. 
This awareness on the adverse health effects of non-adherence appeared to have resulted 
in some paediatric participants accepting the need for adherence, which has involved them 
incorporating their illness into their identity and accepting their CF (Laws et al., 2012).  
 Whilst some participants did appear to have accepted their CF, within the paediatric 
population this may not be representative of acceptance. It is plausible that this apparent 
acceptance is due to paediatric participants having a lack of awareness towards CF's true 
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nature, and its future implications. Adult participants, within phase one data collection, 
indicated that many individuals with CF are able to live a normal life when they are younger 
and their health is relatively good, explaining that they only came to truly accept their CF 
when they experienced health deteriorations. Therefore many adolescents with CF may not 
be fully aware of CF's implications, due to them not experiencing significant health 
deteriorations, consequently it has to be questioned whether adolescents with CF are fully 
accepting their CF, particularly with many participants discussing their desire for normalcy. It 
has to be acknowledged that acceptance of CF may develop in stages, and may change 
over time, particularly in response to changes in health. Priorities are different at different 
ages, for younger people support with living a "normal" life may be more important as 
demonstrated within this research. 
 Many participants did identify the most challenging aspect of living with CF is their 
adherence to their complex and time-consuming medical regimens, with many paediatric 
participants stating that it would be difficult to independently integrate their treatments into 
their lives. There were several reasons why participants found adherence to be challenging; 
some explained how they believe they are prescribed too many medications, with Wilderman 
(2015) speculating that a decline in pulmonary function within CF can be a direct 
consequence of poor adherence, with this poor adherence being due to the individual having 
to adhere to too many medications. Due to the amount of medications individuals with CF 
are prescribed, it is not surprising that many paediatric participants indicated that they favour 
treatments which demand less time, in line with previous quantitative research (Bregnballe et 
al., 2010; Keyte et al., 2017b, 2017c). In addition, participant’s negative views towards 
adherence, and the limitations adherence imposes upon their lives appeared at times to be 
influenced by psychological distress, mainly anxiety and depression. Whilst research has 
shown that levels of anxiety and depression are similar between individuals with CF and the 
general population (Quittner et al., 2014), the impact of even slightly increased levels of 
psychological distress may be detrimental for an individual with CF, with evidence linking 
depression with inferior lung function and quality of life being reported and replicated 
(Quittner, Modi, Lemanek, Ievers-Landis & Rapoff, 2008).  
 Many participants explained that despite their awareness regarding treatments' 
necessity, they could see how non-adherence could have a positive impact upon their life 
psychologically, allowing them to lead a "normal life" by engaging in normal activities with 
their peers. Non-adherence would be a way for paediatric participants to reduce the 
differences there are between themselves and their peers, and support a normal identity 
(Withers, 2012). This emphasis on being normal despite suffering from a chronic illness is 
evident within previous literature, highlighting that chronically ill individuals perceive there to 
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be more to their identity than their illness (Higham et al., 2013; Yates et al., 2010). This 
demonstrates participants life-orientated illness perspective (Audulv et al., 2010), with such 
participants appearing to value their psychological health above their physical health. This 
desire for non-adherence therefore has the potential to result in future poor or non-
adherence when the individual becomes independent over their treatments, representing 
their efforts to avoid their CF, to be provided with a normal identity (Withers, 2012). 
However, not all participants believed that they would be provided with a normal identity 
through non-adherence, instead one participant acknowledged the engagement in 
adherence provides an individual with a sense of normalcy. This is evidence of the social 
comparison theory (Festinger, 1954), with the participant comparing himself favourably 
against others with CF, with this raising an individual's self-esteem, encouraging their 
adherence to continue so that they remain well and do not appear to fit with the traditional 
image of CF (Tierney, 2012). 
 Many participants explained how they would find independent adherence to be 
difficult, highlighting the challenges that they will have to face when they do independently 
maintain their treatment regimens. It is widely acknowledged that self-management with 
adherence amongst CF adolescents is a challenge, with individuals reporting that adherence 
is difficult predominantly due to time pressures, competing priorities and a lack of perceived 
consequences of non-adherence (Sawicki, Heller, Demars & Robinson, 2015). In order to 
improve adherence Sawicki et al (2015) highlight that adolescents with CF must accept 
treatments' necessity and become independent with their treatments, despite their anxieties 
about such independence, with successful adherence often being facilitated by a structured 
treatment routine (Horne et al., 2006). Evidence of this was found within the data, with 
participants who had been given adherence support, but were then given some 
independence reporting that they found independence to be easy, predominantly because 
they were aware of treatments' necessity, resulting in them potentially not only accepting 
their CF, but also accepting the need for adherence (Laws et al., 2012). It was apparent that 
such participants (with the help of their guardians) had created a structured daily routine to 
aid with treatment adherence (Sawicki et al., 2015), with some participants stating that 
without parental support they sometimes engage in unintentional non-adherence (Horne, 
2000), predominantly due to forgetfulness. 
 Independence with adherence is not just difficult for individuals with CF, the data 
highlighted the transfer of treatment responsibility is also difficult for parents (Filigno et al., 
2012), with some participants explaining how their parents are holding them back from 
independent adherence. The difficultly for parents is often heightened when they are 
witnessing their child's poor treatment adherence during their transition to independence 
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(Coon, 2015). However not all participants had difficulty with independent adherence, with 
some appearing to have integrated their illness into their identity, accepting treatments' 
necessity (Laws et al., 2012), with these participants often focusing upon the need for 
adherence demonstrating their disease-orientated illness perspective (Audulv et al., 2010). 
These participants often explained how they were comfortable in disclosing their CF to 
others, and publically adhering to their medical regimens, showing that they have no desire 
to hide their illness from their peers, as they do not wish to be provided with a sense of 
invisibility towards their CF. 
 With many participants having a desire for normalcy, it was not surprising that some 
found disclosure of their CF to be challenging. Literature does illustrate that many chronically 
ill individuals do desire a sense of normalcy (Keyte et al., 2017b, 2017c; Withers, 2012). 
Some participants indicated how the visibility of their illness identity is difficult which 
motivates their non-disclosure, with previous research highlighting how when adolescents 
perceive themselves to be different to their peers they often experience negative emotions 
(Withers, 2012). An example was when a participant got bullied following her disclosure of 
her CF, with this being in line with previous discussions by CF parents who stated that CF 
makes adolescents a prime candidate for bullying (Richards, 2015). Such negative 
responses to an illness identity could have detrimental psychological implications upon an 
adolescent, with adolescents often employing effort to ensure there are minimal differences 
between themselves and their peers, as adolescents often highly value the opinions of their 
social group, and desire acceptance within that group (Withers, 2012). As highlighted within 
the data it is often easy for individuals with CF to not disclose their CF to others due to CF's 
invisible nature (Tierney, 2010). Some participants explained how they will disclose their CF 
status but only to their close friends. It is widely acknowledged that disclosure during 
adolescence is a challenge within chronic illnesses, with adolescents who hide their illness 
identity often worrying about whether their friendships will continue post-disclosure (Wiener 
& Battles, 2006). Nonetheless participants did value the benefits they received post-
disclosure, even if that disclosure was only with their close friends, with this disclosure 
allowing participants to display their illness identity and adhere to their medical regimens in 
public (Wiener & Battles, 2006). 
 In addition to adherence and disclosure, when participants had good awareness 
regarding their CF they often did not have a desire to initiate in risky behaviours, regardless 
of whether or not these behaviours were normalised within their environment. Participants 
who did have good awareness regarding the adverse health effects of risky behaviours often 
recognised that these behaviours are more risky for them because of their CF than they are 
for the general population. Some participants acknowledged that although the 
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experimentation in risky behaviours is normal during adolescence, the engagement in such 
behaviours would have extreme detrimental impacts upon their CF. One participant was able 
to differentiate between risky behaviours, highlighting how excessive alcohol consumption is 
"less" harmful than smoking, with smoking being an extremely risky behaviour for his CF. 
This participant demonstrates unrealistically optimistic views towards excessive alcohol 
consumption, with this participant processing risk information regarding excessive alcohol 
consumption in a way which allows him to continue this behaviour (Weinstein, 1983). It is 
plausible that this participant felt that his sense of self-integrity was threatened when 
presented with information regarding the adverse health effects of excessive alcohol 
consumption. This may explain why the participant appeared defensive regarding his alcohol 
consumption, rejecting the associated risks by comparing such risks to the risks from 
smoking, concluding that alcohol will not have an adverse effect on his health, as alcohol is 
not as dangerous as smoking is to CF, demonstrating evidence of the self-affirmation theory 
(Sherman et al., 2000; Jacks & Cameron, 2003).  
 The experimentation of risky behaviours is "normal" during adolescence (Richmond, 
2014), with Bryon (2015) suggesting that adolescents with CF will behave like their peers 
without CF. However, within the current research there was little disclosure of engagement 
in risky behaviours, despite many participants expressing a desire for normalcy, therefore 
some narratives could have been influenced by social desirability bias. Nonetheless, within 
the data the importance of awareness regarding the adverse health effects of risky 
behaviours in preventing a desire for initiation was clearly demonstrated. Awareness 
regarding risky behaviours can originate from many individuals, predominantly parents, 
peers and HCPs. Evidence suggests that health information from peers has a greater impact 
than that from HCPs or parents (Bryon, 2015). However paediatric participants did greatly 
value their parents’ opinions, with some explaining how they would not engage in risky 
behaviours in order to avoid discipline from their families, and due to them not wanting to 
disappoint their families, with Dishion et al (2003) demonstrating how adolescent substance 
use initiation is mediated by parental monitoring in the general population. 
 It is well acknowledged within literature that awareness regarding the adverse health 
effects of risky behaviours does not always prevent initiation or encourage cessation, with 
The Theory of Reasoned Action and The Theory of Planned Behaviour highlighting how 
many factors can influence an individual's behavioural intention, and therefore behavioural 
change. These factors encompass an individual's attitude towards the behaviour, their 
subjective norms as influenced by others, and their behavioural control (Ajzen, 1988; Ajzen 
& Madden, 1986; Fishbein, 1967; Fishbein & Ajzen, 1975). The Stages of Change Model 
highlights that interventions to prevent risky behaviour engagement are more successful 
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when an individual is already contemplating that behavioural change (Prochaska & 
DiClemente, 1982), with awareness not always being enough to encourage such change in 
behaviour.  
 Within the data it appeared that personal experience is weighed more heavily than 
knowledge, with participants continuing to mix with others with CF as they have not 
experienced any adverse health effects, despite being aware of such potential effects. 
Similarly one participant explained that he would never smoke due to witnessing the adverse 
health effects of smoking within his Grandad. This highlights how experiencing first-hand the 
health impact of a risky behaviour can be a positive learning experience, with these long-
term impacts not being evident within peer group risky behaviour engagement. Witnessing 
such adverse health effects can result in participants not valuing normalcy, or desiring to 
conform to these normalised behaviours, accepting that they cannot engage in such 
behaviours due to their health (Laws et al., 2012). Exposure to the adverse health effects of 
risky behaviours can also be provided through television programmes, with participants 
signalling that this exposure prevents their desire to initiate in these normalised behaviours. 
This is supported by previous research in the general population, demonstrating that 
visualisation interventions are more effective than language based messages, with it being 
believed that these images have an impact upon one's affect, motivation and therefore 
behaviour, with these images being more memorable than words (Karamanidou, Weinman & 
Horne, 2008; Lee, Cameron, Wunsche & Stevens, 2011). Affective beliefs are often 
described within literature to be significant predictors of risky behaviours. When an individual 
has a negative affect regarding a behaviour they are less likely to engage in that behaviour, 
with individuals being more likely to engage in a behaviour when they have a positive affect 
about that behaviour (Lawton et al., 2009; Rhodes, Fiala & Conner, 2010).   
 Whilst the television can provide awareness regarding the adverse health effects of 
risky behaviours, some participants explained how it can promote risky behaviour 
engagement, mainly through advertisements and programmes documenting the positive 
impact such behaviours can have upon an individual's mood.  "The Only Way Is Essex" is a 
reality series which often appeals to adolescent viewers, the show was previously sponsored 
by "WKD" and often contains scenes where the cast are on nights out, displaying the 
positive effects of alcohol use. Research within the general population indicates that such 
exposure is associated with the likelihood of adolescents starting to drink alcohol, and will 
increase the alcohol consumption of those who already drink (Anderson, de Brujin, Angus, 
Gordon & Hastings, 2009). 
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 Because of the awareness an individual receives within their private life varying 
between participants, it is acknowledged that CF-specific awareness needs to be provided to 
all individuals with CF from their HCPs. The data highlighted that awareness from HCPs 
regarding the adverse health effects of risky behaviours is often provided on an 
individualised basis, however due to the suggested relationship between awareness and 
abstinence within this research there is a need for this awareness to be provided to all 
patients regardless of their personal condition. Nonetheless, even when participants 
received awareness from their HCPs it was not always sufficient. Awareness was often 
provided on a verbal basis, thus different patients could receive different amounts of 
information. Participants were often able to remember that they have been informed 
regarding the adverse health effects of a behaviour, however they had gaps within their 
knowledge regarding why these behaviours are risky. It is acknowledged that due to CF's 
improvement in life expectancy, individuals with CF are now faced with "new" issues, such 
as a vulnerability to engage in risky behaviours, which CF HCPs may overlook (Horky, 
2014). Consequently it appears that new interventions are needed to be integrated into CF 
care on a proactive basis. These findings are in line with phase one data collection and the 
transition evaluation, illustrating that more emphasis needs to be placed on reducing the 
occurrence of risky behaviours due to the CF population not having the freedom to 
experiment with such behaviours (McEwan et al., 2012). 
Conclusions 
 Both phases of data collection provide insight into the variety of reasons why 
individuals with CF may be motivated to initiate in risky behaviours, and engage in poor/non-
adherence. Overall it is concluded that a desire for normalcy was seen to be important to 
many adolescents and adults with CF, with literature acknowledging that this desire for 
normalcy can be accompanied with the engagement of normalised risky behaviours, and 
non-adherence in response to the illness identity. Evidence of a life-orientated illness 
perspective was also prevalent, with some adult participants reporting that they engage in 
risky behaviours for fun. The role of affective beliefs was clearly demonstrated within both 
phases of data collection, with adults explaining how enjoyment and pleasure increases the 
continuation of a behaviour, whereas adolescents explain how a negative affect reduces 
their motivation for a behaviour. In general amongst both adult and paediatric participants 
there was a reported lack of knowledge concerning consequences of risky behaviours. 
Through the researcher’s reflections it was highlighted that different participants from the 
same CF centre did not have the same awareness regarding risky behaviours. Some 
participants reported not being informed by HCPs regarding risky behaviours, whereas other 
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participants had been informed, suggesting that HCPs approach the issue of risky 
behaviours on an individualised basis. Some paediatric participants reported that they 
received leaflets informing them about risky behaviours, whereas other paediatric 
participants from the same CF centre did not make reference to such leaflets. This 
demonstrates the need for more effective health promotion measures in order to reduce the 
occurrence of risky behaviours within the CF population, by approaching the issue on a 
proactive basis, where all individuals receive standardised information regarding the CF-
specific adverse health effects of such behaviours regardless of their personal condition.  
 Another area of interest identified within the researcher’s reflections is that only one 
paediatric participant reported engagement with a risky behaviour, the participant was 18 
years old and reported previously drinking alcohol excessively. It was found that the majority 
of other paediatric participants (all under the age of 18 years) were very "anti" such 
behaviours, whereas many individuals aged 18 years and above (from phase one data 
collection) appeared to have experimented in risky behaviours, or at least considered such 
experimentation. It is therefore interesting to think what happens during these years which 
changes an individual's attitude towards such behaviours, often resulting in initiation or 
experimentation. Paediatric participants may have been reluctant to discuss any desires to 
initiate in risky behaviours with the researcher due to the differences in age between the 
participants and the researcher impacting upon the power relationship within the research 
(Braun & Clarke, 2013; Descombe, 2014). Due to the researcher being a lot older than 
participants, the researcher was interviewing across differences, which can be difficult when 
trying to establish rapport. Such differences in age, alongside the researcher’s identity as a 
researcher would have caused participants to view the researcher as an "expert", affecting 
their disclosure of sensitive issues, potentially due to fearing the researcher would pass on 
such information to HCPs, despite the researcher explaining the bounds of confidentiality. 
With paediatric participants rarely discussing any desire to initiate in such behaviours to the 
researcher, who is outside of their health care team, it is expected that adolescents with CF 
are less likely to discuss any desires, intentions or engagement in risky behaviours with 
HCPs. Therefore work needs to be done in order to encourage such disclosure, or to provide 
individuals with an alternative route of disclosure. 
 Overall, this research highlights the juxtaposition between clinical recommendations, 
and personal life strategies undertaken by individuals with CF to support their identity, with 
this representing a challenge for individuals with CF, their families and HCPs alike. To 
reduce the occurrence of risky behaviours within the CF population, more information needs 
to be provided to patients by HCPs about the engagement in such behaviours. Individuals 
would then be free to make a more informed choice in light of the consequences regarding 
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engagement. Understanding the dilemma highlighted within this research will aid the 
development of interventions, with both phases of data collection providing an interpretative 
perspective on the reasons why some individuals with CF engage in risky behaviours and 
non-adherence. With many participants within both phases of data collection reporting a lack 
of awareness regarding the adverse health effects of risky behaviours provided by HCPs, 
the researcher deemed it essential to talk with HCPs regarding what awareness they provide 
patients with, and which patients they provide this awareness to. The researcher decided to 
recruit CF Specialist Nurses for the next phase of data collection, due to participants within 
both phases of data collation describing Nurses to be the most approachable member of the 
MDT, disclosing more information to Nurses. Therefore, it was believed that Nurses would 
be well placed to offer valuable insights into the issue of risky behaviours and effective 
interventions. In addition it was believed that Nurses would be responsible for delivering a 
new intervention regarding risky behaviours in line with previous literature conducted within 
the general population (Cooley et al., 2009; Fore et al., 2014; Sarna et al., 2016). The third 
phase of data collection therefore involved conducting semi-structured interviews with CF 
Specialist Nurses, to investigate how they perceive the issue of risky behaviours within the 
CF population, and to gain insight into what interventions they believe would work in practice 
to reduce the occurrence of such behaviours.  
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CHAPTER NINE: METHODOLOGY - CYSTIC FIBROSIS SPECIALIST NURSES’ 
PERCEPTIONS OF RISKY HEALTH BEHAVIOURS 
Participants 
 Nine CF Specialist Nurses were recruited, all of whom worked in different UK CF 
units (three paediatric Nurses, five adult Nurses, one adult and paediatric Nurse; range of 
experience: 11 months - 23 years, mean = 14 years). 
Measures 
Telephone Interviews. The researcher conducted semi-structured interviews via 
telephone with CF Specialist Nurses to gain insight into how they perceive the issue of risky 
behaviours within the CF population. One face-to-face interview was conducted with a 
participant who expressed a wish for this methodology, this was an option to all Nurses. 
To achieve saturation the researcher transcribed all interviews. A semi-structured 
interview schedule (Appendix W) was developed through collaborations with the 
researcher’s supervisory team and through consulting existing literature, and the previous 
two phases of data collection. These interviews aimed to progress the findings from the 
transition evaluation which indicated the issue of risky behaviours is often neglected within 
CF care. The researcher therefore investigated CF Specialist Nurses’ awareness about risky 
behaviours within the CF population, and how Nurses currently address this issue. This 
research was qualitative, allowing the methodology to explore the defined areas, while 
allowing elaboration on other topics (Gill et al., 2008), providing an interpretive perspective 
on how CF Specialist Nurses perceive risky behaviours, creating humanistic research (Yates 
et al., 2010). 
 The interview schedule commenced with a section of ice breaker questions to 
generate rapport (Ashton, 2014; Cooley et al., 2014), with the interview then encouraging 
Nurses to discuss what it is like to work within the CF population, mainly focusing upon the 
challenges of CF, such as its deteriorating and fatal nature. Literature reports that the most 
challenging aspect of being a CF Specialist Nurse is when a patient becomes ill and passes 
away. Nurses often state that when they lose a patient they feel like they've lost a family 
member as a consequence of developing strong relationships with CF patients, due to their 
high patient contact (Rhys, 2011). It is reported that CF Nurses deal with this loss through 
accepting that they did their best for that patient (Rhys, 2011). Research shows that CF 
HCPs are competent in helping patients adjust to decreased health, however they are less 
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well prepared to assist patients whose health has improved (Horky, 2014), therefore the 
researcher also investigated this assertion. 
 The semi-structured interviews also focused upon the issue of disclosure, 
investigating whether Nurses believe patients tell them the truth. This is based upon the 
findings from phase one data collection, which showed that with risky behaviours many 
patients either fail to disclose engagement to HCPs, or they do not disclose the extent of 
their engagement; in line with previous research (Viner & Macfarlane, 2005). The interviews 
therefore focused upon how a Nurse would respond if they suspected a patient was not 
disclosing information to them. This information may not necessarily be about risky 
behaviours, as this section remained broad and open ended (Cooley et al., 2014). It was 
speculated that CF Specialist Nurses would highlight the issue of adherence, with literature 
marking that poor adherence is a major concern within the CF population (Barker et al., 
2012; Daniels et al., 2011; Keyte et al., 2017b, 2017c), with this also being highlighted 
during the previous phases of data collection. Therefore, the next section of the interview 
specifically focused on poor adherence, to investigate CF Specialist Nurses’ views on 
whether they perceive poor adherence to be a major concern as reported within literature, 
and what new interventions they believe would work to encourage adherence. 
 The interview schedule then focused upon CF Specialist Nurses’ views on risky 
behaviours. This section firstly aimed to progress the transition evaluation by investigating 
how Nurses inform patients about risky behaviours, which patients they inform (e.g. are all 
patients informed, or only those who engage in such behaviours), and what behaviours they 
provide awareness on; with the findings from the previous phases of data collection 
suggesting that many CF patients are not informed regarding the adverse health effects of 
such behaviours specific to CF. This section then investigated Nurses’ views regarding 
whether risky behaviours are an issue within the CF population, and whether they are aware 
of how prevalent such behaviours are, as the findings from phase one data collection 
suggested that many patients do not disclose engagement to HCPs. This section then ended 
by investigating Nurses’ views on what new interventions would work to address this issue. 
 As with the previous phases of data collection, the researcher's approach was a 
balance between empathy and neutrality (Ashton, 2014). In order to make participants feel 
their contribution was valued the interview ended by asking participants to describe an 
intervention they would like to see implemented to address the issue of risky behaviours, 
discussing barriers and enablers to such intervention.   
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Carrying out the Study 
 The researcher contacted the CF Nursing Association (CFNA) via email, informing 
them about this study and providing them with an information sheet (Appendix X). The CFNA 
then emailed all CF Specialist Nurses informing them about the research via an information 
sheet (Appendix Y) (the email had been generated via the researcher), and if a CF Specialist 
Nurse was interested in participating they were asked to email the researcher. The 
researcher was available to meet with Nurses at their CF unit at a date / time convenient for 
themselves, or would communicate via email or telephone, further explaining the research 
(and again providing them with the written information sheet) and answering any questions. 
If Nurses still wished to participate they were required to complete a written consent form 
(Appendix Y), to ensure informed consent had been collected; Nurses were given a 
maximum of two weeks when deciding on participation.  
The Nurses then completed a semi-structured interview, investigating how they 
perceive the issue of risky behaviours within the CF population. A coding method was used 
during this research; Nurses were given a number which was written on their consent form 
with their name. The researcher stated this number at the beginning of the interview 
recording and wrote this number on the transcript (pseudonyms were used for the write up). 
This enabled the Nurses to disclose accurate information representing the reality of practice 
within their CF unit to address risky behaviours, without their colleagues knowing what they 
had disclosed. The interview was arranged at a time / date convenient for the Nurses, with 
the interview lasting a maximum of 60 minutes; however the interview could be stopped 
earlier if Nurses wished this to be the case. No Nurses requested the interview to be stopped 
early. The Nurses did not have to answer any questions they did not wish to. All participation 
was voluntary, and the Nurses could withdraw from the research without being penalised; 
within this research no Nurses withdrew their participation. Once the interview was complete 
the Nurses received a debriefing sheet (Appendix Z), and again had the opportunity to ask 
questions. The researcher then contacted all Nurses via email once the research was 
complete to inform them of the overall research results and to ask for results feedback 
(Appendix AA).  
Ethics Committee 
Ethical approval was obtained by the Business, Law and Social Sciences Ethics 
Committee at Birmingham City University. 
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Analysis 
As described in the initial analysis section within Chapter Four, the interviews were 
transcribed utilising the Jefferson transcription coding (Heath & Hindmarsh, 2002), with the 
data being analysed using thematic analysis following Braun and Clarke's (2006) model. 
Thematic analysis generated 72 codes. The researcher made inferences about what the 
codes meant enabling the codes to be combined into three overarching themes that 
accurately depict the data (Appendix BB). The three themes generated are described in 
detail within the next chapter, utilising direct quotes and discussion around CF Nurses' 
perceptions towards risky behaviours.  
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CHAPTER TEN: ANALYSIS - CYSTIC FIBROSIS SPECIALIST NURSES’ PERCEPTIONS 
OF RISKY HEALTH BEHAVIOURS 
 Thematic analysis was applied to the interview transcripts following the Braun and 
Clark (2006) model, which identified three themes within the data. The first theme, labelled 
as “Cystic Fibrosis care as a changing environment", highlights CF Specialist Nurses’ views 
towards CF care, and how CF care has changed over time. Theme two, "Cystic Fibrosis 
Specialist Nurses knowledge regarding a patient's life", focuses upon the awareness CF 
Specialist Nurses have regarding what influences their patients’ decisions surrounding 
health behaviours. The final theme, labelled as "Effective health promotion advice: What 
works?”, demonstrates what interventions CF Specialist Nurses believe need to be 
implemented to encourage health promoting behaviours, and reduce the occurrence of risky 
behaviours within the CF population. It is acknowledged that there are aspects of the 
Nurses’ ideas and understandings that overlap across these themes; however as with the 
previous two phases of data collection this was to be expected (Fielden et al., 2011). All 
three themes will be further examined in the next segment, by utilising direct quotes and 
discussion around this topic area. 
Cystic Fibrosis Care as a changing environment 
 This initial theme focuses upon CF Specialist Nurses’ views towards CF care, and 
how that care has changed over time. CF Nurses demonstrated a passion for their role, with 
them pointing out that they are more than a Nurse, being there for more than the medical 
needs of individuals with CF. Many Nurses such as Sharon indicated that their role involves 
them being a "patient advocate", and attending to all needs of their patients, encompassing 
their psychological and medical needs. 
 *[Sharon, 8 years, Paediatric Nurse]: "My:y role is # ce:ertainly as a patient 
 advoca:ate (.) as well [...] it's a unique position to be in" 
With being a "patient advocate", many Nurses agreed the most enjoyable part of their role is 
forming relationships with their patients over a long period of time, with Natalie explaining 
how CF Nurses meet with their patients regularly throughout their lives, being able to support 
patients through the lifespan. 
 *[Natalie, 15 years, Adult Nurse]: "It's very nice to have relationships over a lo:ong 
 time # some of the patients (.) are very # admira:able (.) in ho:ow they manage 
 everything # a:and (.) it's quite rewa:arding being able to suppo:ort (.) e:erm:m # 
 patients in their li:ife # e:erm:m # in that respect" 
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CF Nursing is a demanding role, which can be emotionally draining when supporting an 
individual with CF throughout their whole life. Nurses explained that the hardest part of their 
role is accepting CF's fatal nature, with many Nurses explaining how they found it difficult to 
deal with death when they first entered their position, after forming strong relationships with 
their patients who they got to know personally. This was most difficult when the Nurses were 
of a similar age to the individuals with CF who passed away, with Natalie explaining how she 
could identify with these patients and their lives. Nurses explained the way in which they 
individually deal with death does change over time, in order to cope with CF's fatal nature. 
 *[Natalie, 15 years, Adult Nurse]: "At fi:irst it [death] was very hard for me (.) because 
 I was at a simila:ar age (.) to a lot of the patients who I'd built rela:ationships with (.) 
 and you could associa:ate with the same a:age group as yourself ve:ery ea:asily [...] I 
 suppose no:ow (.) I still ha:ave relationships with the patients (.) but [...] I've 
 cha:anged with ho:ow I deal with it [...] I deal with it in a different wa:ay" 
Natalie found it difficult to verbalise how she now deals with death stating "I can't re:eally 
explain it very well to you:u". Her narrative suggests that now she is not of a similar age to 
patients it has become slightly easier to deal with death, potentially due to the relationships 
she forms with patients being different due to this age gap, nonetheless it is very clear and 
understandable that death is still an area of Natalie's job in which she struggles with.  
 In terms of CF care as a whole, Nurses pointed out that it is not standardised across 
all CF units, with this being most apparent to Nurses who have worked in multiple centres, 
such as Alice who has been a CF Specialist Nurse for 21 years and worked in three different 
centres. As a consequence of Alice's experience within different CF centres, she expressed 
the opinion for the need for certain things to become standardised, such as the use of 
medications, and how to deal with exacerbations. 
 *[Alice, 21 years, Adult Nurse]: "I've worked in thre:ee different centres (.) and it's 
 interesting ho:ow ## differently (.) clinicians operate across country [...] we really 
 should start standardising what we do # in terms of ## imuno-imodulator drugs [...] 
 prophylaxis # preventions # ho:ow we (.) manage (.) exacerbations [...] it's interesting 
 how differently the Europeans work to us # in terms of ho:ow they approach CF" 
In addition to standardised care, Nurses also value the use of individualised care, believing 
this is the most successful form of care. Nurses, such as Michelle expressed their belief that 
working with patients and listening to what patients want, results in positive health outcomes, 
such as adherence. 
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 *[Michelle, 4 years, Paediatric Nurse]: "Everyone is so:o # so:o ## positive # in 
 te:erms of the professionals [...] wo:orking for that individual patient # so I'm very 
 much in a tea:am that # it's a:all for the patient" 
 The importance of psychological factors was also portrayed within this phase of data 
collection. Many Nurses, such as Jayne, indicated how it is important to talk to individuals 
with CF on a human-to-human basis, whilst remaining professional. This develops a strong 
sense of rapport, and a positive relationship between the patient and HCP, with Nurses 
believing this encourages patients to be more honest regarding their CF and health 
behaviours, and is therefore associated with positive health outcomes.  
*[Jayne, 11 months, Adult Nurse]: "I tr:ry and take off the Nu:urses cap a little (.) and 
speak one (.) on (.) one # as a human be:eing [...] they tend to open up (.) and give 
me something ba:ack" 
In addition, with CF care now having a focus upon psychological factors, Nurses explained 
how important it is to attend to their patients’ emotions, due to CF providing individuals with 
challenges such health deteriorations. Kirstie explained how CF care also focuses upon 
increasing an individual's quality of life, and helping them enjoy their life by making their CF 
easier to manage e.g. by administering home intravenous antibiotics. 
 *[Kirstie, 22 years, Paediatric Nurse]: "We know it's a life limiting condition [...] I think 
 you can do a lot with that ## so you can put the qua:ality there:e" 
It is well acknowledged that optimism can increase a patient’s quality of life, therefore it is 
not surprising that CF care tries to provide patients and families with future hope and 
optimism. CF Nurses do this in a variety of ways, with Kirstie explaining how in her centre 
they show adolescents with CF the "normal" life that some adults with CF live. 
 *[Kirstie, 22 years, paediatric nurse]: "We fo:or example # have a (.) fo:older of 
 which CF adults contribu:ute to (.) obviously if they consent to it # where they take 
 photogra:aphs of what they've been up to (.) and then we give tha:at to the fa:amilies 
 in o:our clinic to have a look through to see what people a:are up to # to give them a 
 sense of ho:ope" 
Nurses explained that to provide individuals with CF and their families with optimism, it is 
essential for Nurses to also be optimistic for CF's future, with Michelle discussing how she is 
optimistic due to the research, money and recognition which is presently being invested into 
CF. 
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 *[Michelle, 4 years, Paediatric Nurse]: "If I wasn't positive fo:or them (.) ho:ow can I 
 expect them to be positive fo:or themselves # and ho:ow can you live with CF and 
 not tr:ry to be positive" 
Remaining positive and optimistic for patients is a huge demand on Nurses, however 
Michelle recognises the need for this in order to maintain patients’ optimism, due to the 
emotional burden CF does present individuals with. 
 In addition to this focus upon optimism and quality of life, CF care is also changing in 
its delivery method, with many Nurses identifying a role for technology (such as a Skype 
Triage) in caring for individuals with CF at home, instead of regularly bringing them into 
clinic. This would reduce the risk of cross infection, and potentially have an impact upon an 
individual's quality of life.  
*[Jayne, 11 months, Adult Nurse]: "There's new things on the horizon # we're no:ow 
looking into (.) e:erm:m # sort of # test a (.) Skype like Tria:age # that's already in 
progress in (.) in clinics (.) in Wa:ales [...] some patients ne:eed to come to clinic 
mo:ore than others:s # so it's to se:ee whether o:or not (.) we can tria:al # mana:age 
(.) them (.) from ho:ome [...] we a:are looking for wa:ays to (.) to keep them 
hea:althier for lo:onger # we don't a:always have to bring them to clinic if they're not 
feeling very well # perha:aps we could have a look at them at ho:ome and see ho:ow 
they get on" 
 
A reduction in the number of hospital visits would not just reduce the risk of cross-
contamination, it would also result in less reminders for patients regarding their disease and 
how they may deteriorate. CF care is also changing through medical advances, with many 
Nurses excited by the new emerging medications, providing CF Nurses with optimism for the 
future of CF. 
 *[Sharon, 8 years, Paediatric Nurse]: "I think we:e (.) are a:almost (.) getting into an 
 exciting e:era of (.) next genera:ation treatments [...] I don't know whe:ere it'll lead up 
 (.) but (.) it'll ce:ertainly lead us to the next step up from CF modula:ators (.) a:and 
 correctors # so it'll be the next genera:ation of CF ca:are" 
Hope and optimism towards this new era of personalised medicine within CF is not just 
experienced by Nurses, it is experienced by everyone involved within an individual's care; 
patients, families and HCPs alike. Nurses however did point out that particularly within the 
short-term, when a new treatment is introduced it increases a patient’s treatment burden, 
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demanding more time from individuals, which is identified as a major barrier to adherence 
within CF. 
 Whilst Nurses predominantly focused upon the large number of positive changes 
within CF care, they did also identify some issues. Firstly, a major issue surrounded funding, 
with many of the new medications not currently being funded by the NHS. In addition, with 
CF entering an era of personalised medicine, it is resulting in increased longevity, with 
Nurses explaining that they believe their job will become more complex, due to individuals 
with CF being vulnerable to more complications with their increasing life expectancy. 
*[Debbie, 23 years, Adult Nurse]: "With our patients living lo:onger (.) their li:ives 
a:aren't # particularly # ea:asier # because they're getting mo:ore and mo:ore (.) CF 
related issues [...] I would say it's (.) it's made the job mo:ore complex" 
In addition to complications, Dawn explained how the role of a CF Specialist Nurse does not 
just involve dealing with classic CF patients anymore, with Nurses often seeing patients who 
are in the "CF-spid" category, where they screened positive for CF but have a indeterminate 
diagnosis as a consequence of the nationwide newborn screening implemented in 2007. 
Dawn also explains how HCPs now have to deal with patients who have two identified CF 
genes but have a normal sweat test, with Dawn identifying that currently CF care does not 
know how best to care for such patients, as they do not know what their future will hold, 
acknowledging how CF care is a changing environment. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "We don't (.) know (.) what the 
futu:ure holds fo:or them # there's a who:ole host of different pa:atients # we have 
some who sit in the gre:ey area (.) where their sweat chlo:oride sits between fo:orty 
and si:ixty (.) so they're pro:obably pancreatic sufficient # possibly:y (.) you kno:ow (.) 
genera:ally we:ell # but so:ome can have quite problema:atic chest disease # so I 
thi:ink there a:are (.) va:ariences no:ow # I think proba:ably (.) twenty yea:ars ago:o 
(.) I would have never thought there we:ere patients who we:ere pancreatic sufficient 
(.) I just tho:ought they were a:all the sa:ame [laughs]" 
 
 Furthermore, many CF Nurses explained that with life expectancy increasing, and 
with many individuals with CF entering adolescence and adulthood being relatively well, CF 
care now needs to address the issue of risky behaviours. Michelle explained how risky 
behaviours have only recently become an issue within her CF centre, however she identifies 
that it is a "real concern" that needs to be actively addressed.  
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*[Michelle, 4 years, Paediatric Nurse]: "There are a few patients (.) who have just got 
# a lot (.) go:oing on # and pote:entially (.) da:abbaling in thi:ings # a:and for us (.) 
that's obviously a re:eal conce:ern with trea:atments (.) a:and their health (.) a:and 
everything else # it's only ju:ust becoming an issue in more recent yea:ars # we're 
only no:ow starting to think # this # this could happen to a:any of our patients actually 
## we're re:eally trying to focus in on it with our Psychologist" 
Whilst many Nurses did acknowledge that risky behaviour education needs to be a focus of 
CF care, in order to reduce the occurrence of such behaviours, not all CF units are 
addressing this issue. Nurses suggested that psychology could play a role in reducing the 
occurrence of risky behaviours within the CF population, pointing out that psychology is 
being integrated more and more within CF care. Nurses are very aware of CF's 
psychological implications, and welcome psychological support within their CF MDT's.  
*[Michelle, 4 years, Paediatric Nurse]: "We've got a Psychologist now full ti:ime # and 
that’s bri:illiant (.) cause she would see them quite a bit # for e:everythi:ing  # and 
that's crucial # that's getting bi:igger (.) and bi:igger (.) and bi:igge:er aspect of CF (.) 
that it ever used to be" 
 Overall this theme indicates that CF care is a changing environment, and now is an 
environment where pharmacological and psychological factors are equally considered.  In 
addition, Nurses appreciate the need to actively address risky behaviours within the CF 
population, with the effectiveness of such interventions being dependent upon HCPs 
knowledge on what risky behaviours are current within the general population, as well as the 
reasons why individuals with CF may engage in such behaviours. 
Cystic Fibrosis Specialist Nurses knowledge regarding a patient's life 
 This second theme provides insight into CF Specialist Nurses knowledge regarding 
their patients’ lives, and how much awareness they have regarding what influences their 
patients’ decisions regarding health behaviours. Some Nurses admitted that they do not 
know their patients very well, as predominately they focus upon their medical condition, 
rather than focusing upon their patients’ lives, however Kirstie did explain that there is a 
need for this to happen. 
*[Kirstie, 22 years, Paediatric Nurse]: "I probably don't know my patients as well as I 
ought to [...] natura:ally we're going to focus on that [medical side] mo:ore # but [...] 
it's good to look at the (.) bi:igger picture:e" 
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While some Nurse stated that they do not focus upon the "bigger picture" of their patients’ 
lives, the majority of Nurses did have insight into what an individual's life is like with CF, and 
often demonstrated strong relationships with their patients. Dawn explained how she is able 
to detect patients’ anxieties, despite patients often not vocalising these, with Debbie 
explaining how she can predict how different patients will cope with different aspects of their 
disease.  
*[Dawn, 20 years, Adult and Paediatric Nurse]: "Some of the te:eena:agers (.) ca:an 
(.) displa:ay behaviour (.) that reflects their stress and anxiety [...] they ma:aybe:e (.) 
a:aren't able to voca:alise it # >I'm really worried about my future< # >I know I'm 
sick< (.) >am I going to die:e< [...] none of that comes out (.) different behaviours 
come out" 
*[Debbie, 23 years, Adult Nurse]: "We do know patients so:o well that we can # 
actually # guess in a way (.) ho:ow they're going to cope with each situation # so we 
can actually ## ta:alk to them (.) and advi:ise them and gu:uide them # using the best 
way fo:or that patient" 
 An area where Nurses demonstrated a good insight into their patients' lives was 
regarding adherence, and what motivates adherence decisions. In particular, Nurses 
acknowledged the difficulties for individuals with CF during their transition to adult care, with 
Kirstie explaining that Nurses expect trouble during adolescence, as they appreciate how 
hard independence with adherence is, especially alongside the other challenges that 
adolescence presents. 
*[Kirstie, 22 years, Paediatric Nurse]: "Young people are expected to kno:ow about 
their treatment (.) ri:ight at the very time they're getting their head arou:und (.) 
rela:ationshi:ips (.) sexua:ality # everything that comes in their teenage yea:ars" 
Nurses also identified other barriers to adherence such as a desire for a normal identity and 
wanting to live a normal life, therefore suggesting how a life-orientated illness perspective 
can result in poor adherence. Due to Nurses being aware of adherence barriers, which are 
more prevalent within certain treatment modalities (e.g. pancreatic enzymes), some Nurses, 
such as Kirstie, explained how they address these issues with all patients on a proactive 
basis, in an attempt to encourage adherence. 
*[Kirstie, 22 years, Paediatric Nurse]: "Some thi:ings which are a:always there [...] 
people say (.) not ta:aking creon at school because they're embarrassed [...] so we 
address that (.) when they first go to school [...] kno:ow it's going to be a hu:urdle for 
some people (.) a:and address it for everyo:one" 
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Nurses also pointed out that acceptance plays a role within adherence, suggesting that if an 
individual has not integrated their illness into their identity then they may be in a state of 
denial regarding their CF. Jayne demonstrated her belief regarding the negative impact 
denial can have upon one's adherence efforts. 
*[Jayne, 11 months, Adult Nurse]: "I think a lot of it comes down to (.) denial a lot of 
the ti:ime # they think things a:aren’t that bad (.) well actually they a:are" 
In addition to the psychological implications, Nurses also explained that an individual's poor 
adherence can be due to a lack of time, therefore Nurses suspect that individuals prioritise 
their treatments based upon their short-term consequences. Michelle explained that if 
Nurses understand what treatments an individual struggles with, they can manipulate their 
treatment plan to fit within their lifestyle and encourage adherence. 
 *[Michelle, 4 years, Paediatric Nurse]: "It ma:ay be a time issue (.) it may be a 
 socialising issue # it may be a body conscious issue # there's different wa:ays you 
 can (.) almost (.) manipula:ate medication" 
 Within this research Nurses clearly identified that they are fully aware of the 
difficulties that patients face, and how these difficulties differ between treatments and 
between different people's needs. Nurses employ a great deal of effort to support their 
patients, often on an individualised basis, and to understand what life is like for them. To 
encourage an individual's adherence efforts, Nurses illustrated how they provide awareness 
to patients. Some Nurses believe this works best using case study examples of how non-
adherence can result in health deteriorations. To encourage adherence through awareness, 
Nurses acknowledged the need to identify patients who struggle with their adherence, in 
order to provide those patients with the most support. However, Natalie explained that the 
way in which Nurses question patients regarding adherence influences patients’ honesty, 
with Nurses needing to communicate a non-judgemental approach.  
 *[Natalie, 15 years, Adult Nurse]: "I don't think they tell the truth # but I don't think we 
 ask a:always the ri:ight questions ## so fo:or example # I would maybe sa:ay # a:are 
 you on >so and so drug< #  they'll say yes:s (.) and I won't go on to say ## ho:ow 
 many ti:imes have you managed to take it this we:eek ## but if I was to [...] then (.) I 
 think I'd get the honest answe:er" 
Nurses have highlighted the importance of fitting care to each individual patient, therefore 
there may be a reason why Nurses do not push certain patients when asking about 
adherence efforts. However, the importance of Nurses being aware of the reality of an 
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individual's adherence efforts should be acknowledged. It is possible that when a patient 
experiences a health deterioration, a HCP who is not informed about the patient’s adherence 
efforts would prescribe additional treatments to improve the patient’s disease progression, 
which of course would not be successful if the patient is already struggling with their 
adherence efforts.  
 In addition to adherence, Nurses also discussed their knowledge regarding risky 
behaviours, highlighting their awareness that these behaviours are prevalent within the CF 
population, describing such behaviours as a growing concern. However, despite many 
Nurses recognising this issue, not all CF units fully address the issue of risky behaviours. 
Michelle, explained that Nurses require more education to be able to provide such 
awareness. 
 *[Michelle, 4 years, Paediatric Nurse]: "I want to be a bit mo:ore knowledgeable # 
 because [...] it will affect them so:o much (.) if we don't get to the bottom of it"  
While it is well acknowledged that some HCPs know less about illegal substances than their 
patients do, it should be expected that when HCPs know a patient engages in risky 
behaviours, awareness is provided, nonetheless Jayne explains that this is not always the 
case.    
 *[Jayne, 11 months, Adult Nurse]: "We do:o # have a fe:ew pa:atients (.) who we 
 kno:ow # dabble (.) in a few things (.) they shouldn’t # but there’s no:othing # we 
 don’t give a:any information # we don’t have (.) e:er:r # leaflets here (.) from an 
 infectious control point of view # we don’t keep a sta:and or anything" 
This demonstrates the need to implement standardised interventions within the CF 
population to address the issue of risky behaviours, both on a reactive and proactive basis. 
Nurses did demonstrate the need for interventions after witnessing the detrimental, and on 
occasions, fatal nature of risky behaviours within CF patients. Dawn explained that risky 
behaviour engagement is a new thing that CF Nurses are witnessing, and therefore they 
have only recently realised the need for such interventions, both to raise their awareness, 
and patients’ awareness regarding the adverse health effects of risky behaviours specifically 
within CF. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "There was a death (.) in adults # in 
CF services (.) from a young man (.) who:o ## extre:eme risk ta:aking behaviour # he 
died # not as a result of his Cystic Fibrosis # but of the substance he took […] that 
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ha:ad an impact on a:all of us # to think that wa:as (.) ha:appening # and if it is:s 
happening # ho:ow can we identify it" 
 It is acknowledged that Nurses already do an incredibly complex and difficult job 
within CF, therefore adding preventative education to Nurses current role presents an 
additional task for Nurses. Many Nurses were able to offer their insight into potential 
predictors of risky behaviour engagement within the CF population. Nurses were aware of 
the pressures on young people to behave like their peers, and how this might result in 
engaging in risky behaviours.  
*[Michelle, 4 years, Paediatric Nurse]: "They think wh:hy (.) why not (.) when 
everyone else is [engaging in risky behaviours] […] if they're hanging around with 
that sa:ame group that do:oes (.) you don't want to feel different (.) when you 
probably (.) already do:o feel different" 
In addition to identity, Nurses also identified the issue of stress, believing that CF imposes 
more stress upon individual’s lives, and therefore alongside family, employment, study 
issues, patients may be motivated to initiate in such behaviours in order to alleviate their 
stress. Some Nurses did discuss the importance of providing awareness to CF patients 
regarding the adverse health effects of risky behaviours, with Dawn identifying that this 
would allow patients to make a more informed choice about their engagement. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "I do:o think it's impo:ortant [to raise 
awareness on risky behaviours] […] I do:o feel it is:s a valu:ue to do it ## but you 
kno:ow [laughs] what they do with the informa:ation is up to them # as long as I'm 
confident that I've gave them the best informa:ation that I ca:an" 
 Nurses did acknowledge that awareness they provide a patient with will not 
necessarily prevent their engagement with a risky behaviour, with Dawn explaining that 
HCPs cannot take responsibility for patients’ actions outside of their care. However, Dawn 
believed it was important that HCPs provide patients with all the awareness they can do 
regarding the adverse health effects of risky behaviours, allowing patients to make a more 
informed choice as to whether or not they want to engage in such behaviours in light of the 
consequences. Some Nurses gave examples where they had provided awareness, but 
patients appeared to retaliate against such advice and engage in normalised risky 
behaviours, which on occasions had health implications. Nurses were often aware as to why 
patients retaliated against their advice, with Kirstie identifying young adults inability to 
consider long-term consequences. 
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*[Kirstie, 22 years, Paediatric Nurse]: "Sometimes understa:anding the effects on 
your liver (.) on your medica:ation is difficult (.) difficult to get their heads round [...] 
what's happening in ten yea:ars time (.) doesn't seem to ## hit them" 
While many Nurses identified the need for interventions to be integrated into CF care to 
address the issue of risky behaviours, they highlighted that a barrier to such intervention is 
the fact that risky behaviours are a changing environment. Alice acknowledged that smoking 
is becoming less prevalent within the general population, and other behaviours (such as 
drug use and the use of e-cigarettes) are gaining popularity. Nurses were therefore 
highlighting how they require education on what behaviours their patients may be exposed 
to, and how they may impact their CF, in order for Nurses to be able to educate patients.  
*[Alice, 21 years, Adult Nurse]: “One of the Respiratory Consultants was commenting 
on the fact (.) that you know # in another (.) sixty years:s (.) they won't have anything 
to do:o # because (.) the amount of cigarette smoking is dropping […] I think 
teenagers now are mo:ore likely to take a pill (.) than to smoke […] we have to now 
change our mindset # about what that [risky behaviours] mea:ans to CF"  
 While many Nurses identified that risky behaviours are a concern within the CF 
population, some Nurses explained how difficult it is to imagine their patients engaging in 
such behaviours.  
*[Michelle, 4 years, Paediatric Nurse]: "I guess you can't even ima:agine that they're 
going to think about it [risky behaviours] […] I don't think it's very common […] they're 
a:all (.) so:o aware of ho:ow much it ca:an (.) impact upon your breathing (.) and 
shortness of breath # and that's (.) >sca:ary and horrible and frightening<" 
This did result in some Nurses, such as Jayne, not perceiving there to be a need for 
interventions to be implemented to address the issue of risky behaviours within the CF 
population.  
*[Jayne, 11 months, Adult Nurse]: "A lot of them # do:on't re:eally do (.) a:all the bad 
thi:ings […] there's not re:eally room for us to then introdu:uce mo:ore ways to keep 
them on the right track (.) because a lot of them are a:already o:on it” 
Whilst Nurses indicated that risky behaviours are not as prevalent within the CF population 
as they are within the general population, this research does demonstrate that risky 
behaviours are still a major concern for those who do engage in such behaviours, and 
therefore interventions do need to be implemented to reduce the occurrence of such 
behaviours, with this intervention firstly needing to involve staff training.  
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*[Michelle, 4 years, Paediatric Nurse]: "Support fo:or us […] what to look out fo:or # 
and ho:ow to address it [...] there is so:o much that ca:an happen # probably ha:alf of 
it we're unawa:are of (.) what ki:inds of risky behaviours they could enga:age in # I 
wouldn't even have a clu:ue about [laughs]" 
Overall, this theme highlights the need to raise Nurses’ awareness regarding what risky 
behaviours are prevalent within the general population, as well as to increase their 
awareness as to what impact such behaviours can have upon CF. In addition, this theme 
highlights the need for interventions to be implemented within CF care to provide awareness 
to patients on a proactive and reactive basis. 
Effective health promotion advice: What works? 
 This final theme provides insight into what interventions Nurses believe need to be 
implemented to encourage health promoting behaviours, and reduce the occurrence of risky 
behaviours within the CF population. All three phases of data collection suggest a role for 
the avoidance of one's CF in engaging in risky behaviours, and non-adherence. Therefore a 
potential avenue CF care could focus on is to encourage acceptance regarding CF, whilst 
instilling a sense of hope and optimism within patients. This is currently not addressed within 
all CF units, with Dawn explaining that they do not have an active process within their centre 
to address CF's true nature, including its fatal nature. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "We don't have a a:active process (.) 
to sit young people do:own and sa:ay (.) >do you realise you've got a life limiting 
disea:ase< [...] we wouldn't # avo:oid it (.) if pa:atients (.) so:ort of # a:asked us about 
it # but it isn't something we make a po:oint out of discussing with them" 
It does have to be considered whether it is a Nurses role to advise patients regarding CF's 
fatal nature, especially if parents do not want these discussions to be had with their children. 
Nurses did discuss how they often go to great lengths to provide a positive outlook for 
patients, with Kirstie explaining how at her CF unit they provide patients with photographs of 
adult CF patients enjoying an active life. Therefore, the process of accepting one's CF is 
complex, and it is recognised that acceptance is not always in a patient’s best interests, with 
acceptance regarding CF's fatal nature potentially having negative implications upon an 
individual's psychological wellbeing. Nonetheless, with HCPs not providing awareness to 
patients regarding the true nature of their CF, it is possible that patients do not have this 
knowledge, potentially fostering a sense of denial within patients, which as recognised can 
result in non-adherence, and the engagement in normalised risky behaviours. Consequently 
through informing patients about CF's true nature, it would highlight to patients the 
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importance of adherence and the avoidance of risky behaviours to prolong their good lung 
function; however it is essential that such awareness is provided whilst instilling a sense of 
hope and optimism within patients. It is possible that this awareness could focus upon the 
practicalities of life with CF, highlighting what an individual can and cannot (or should not) do 
with their CF in order to protect their health. 
   Nurses also acknowledged the need for interventions to specifically encourage 
adherence. As outlined previously, interventions targeting adherence are now changing, with 
room for technology, such as Skype Triages. In addition, some Nurses, such as Kirstie, 
identified a potential role for mentoring to encourage adherence, in order to take the 
emphasis off Nurses providing an intervention due to the lack of time HCPs have to spend 
with each individual patient. 
*[Kirstie, 22 years, Paediatric Nurse]: "We could do a lot mo:ore [to encourage 
adherence] # if we had ti:ime fo:or # for individual patients a bit mo:ore […] mento:or 
# somebody who ca:an help them on a da:ay to da:ay basis […] you need to pick out 
tho:ose individua:als (.) where they ne:eed that bit of mentorship # be able to wo:ork 
with them a bit mo:ore in-depth"  
Mentoring would involve CF patients communicating with one another via technology to 
encourage positive health behaviours, with this having the potential to reduce isolation 
amongst patients, allowing patients to ask questions which they may not be comfortable 
asking HCPs.  
 In addition to adherence, Nurses identified the need for interventions on risky 
behaviours to be implemented within CF care. Nurses explain that it is only recently that 
interventions have started to be implemented to address risky behaviours, with not all units 
currently addressing such issue. Consequently, Nurses acknowledge that they are missing 
patients who are engaging in such behaviours, and therefore such patients are not receiving 
the awareness required to encourage cessation. It was explained by Michelle that some CF 
units rely on patients instigating a conversation regarding risky behaviours, or disclosing 
engagement before awareness is provided, indicating that many interventions used at 
present are reactive. 
*[Michelle, 4 years, Paediatric Nurse]: "With transition that [risky behaviours] 
becomes one of the:e areas we discuss (.) but # e:erm:m # no:ormally it's them 
a:asking us (.) you know # o:or we hear they've been out dri:inking (.) so we have 
that conversa:ation" 
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This outlines a gap for proactive interventions, to provide awareness before initiation, 
engagement or experimentation has occurred. Proactive interventions do currently exist, with 
one intervention being identified within both the transition evaluation, and by Nurses within 
this phase of data collection. The intervention identified was the “ready, steady go” 
questionnaires (University Hospital Southampton, 2014) which are administered three times 
prior to transition, and contain two questions relating to risky behaviours, to identify whether 
or not individuals understand the risks associated with such behaviours. Within this phase of 
data collection Kirstie and Dawn, who are both from different CF units, reported using this 
intervention, believing it allows them to have a platform to instigate such discussions with 
patients. 
*[Kirstie, 22 years, Paediatric Nurse]: "We use it [ready, steady, go] as a forum to 
discussing the issues:s (.) which is brilliant (.) cause actua:ally having something (.) 
piece of paper in front of you:u # you don't have to have that embarrassing (.) eye 
balling conversa:ation [laughs] # which young people ha:ate […] it's a standa:ard 
thing # so you know what to discuss […] we <go through # sexual hea:alth> # 
>recreational drugs< # smo:oking" 
The ready, steady, go intervention is not without its flaws, with Kirstie and Dawn both fearing 
that this intervention could become a “tick box exercise”, believing that some Nurses do not 
have the "conversation" regarding the adverse health effects of risky behaviours with their 
patients. Furthermore, the ready, steady, go paperwork has an accompanying set of 
paperwork to be used at the adult unit after transition (hello paperwork), however Kirstie 
indicated that the adult unit at her hospital have not taken this intervention on board. 
 Kirstie and Dawn also discussed the verbal information they provide their patients 
with, as well as using the ready, steady, go intervention, in an attempt to prevent initiation of 
risky behaviours, therefore being proactive.  
*[Dawn, 20 years, Adult and Paediatric Nurse]: "When they get to thirte:een (.) pa:art 
of that consulta:ation [annual review] (.) will inclu:ude # not a va:ast amount (.) but we 
will refer to >drugs and alcohol< (.) and the wa:ay tho:ose # can affect (.) Cystic 
Fibrosis" 
It is positive to see that some CF units do approach the issue of risky behaviours on a 
proactive basis with all patients regardless of their personal condition, providing patients with 
the opportunity to make a more informed choice about their engagement in such behaviours 
in light of the consequences. However, Nurses did highlight that verbal information is 
associated with limitations, with information not being standardised and being dependent 
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upon the HCP who provides the information, and the clinic environment. HCPs have less 
time to spend with individual patients during busy clinics, therefore it may be considered less 
important to discuss risky behaviours with patients who HCPs believe are not engaging in 
such behaviours. Consequently, Nurses recognised the need to accompany verbal 
information with written information. Kirstie and Dawn, who did use the ready, steady, go 
intervention, explained how beneficial it would be to have resources to support the verbal 
discussions, whether that is on paper or via technology.  
 There was evidence within two different CF units of patients being provided with 
supplementary written information on risky behaviours. Dawn explained how when she 
discusses fertility and safe sex with adolescent CF patients, she also uses written and visual 
information (in the form of a fact sheet) to aid patients understanding, with patients being 
able to take this information home. The use of written information to accompany verbal 
information ensures standardisation, with all patients receiving and having access to the 
same information. In addition to the use of a fact sheet, Alice explained how patients have 
access to leaflets which they can pick up within their clinic rooms regarding risky behaviours. 
Alice also explained how her CF unit uses newsletters again to raise awareness of specific 
risky behaviours, especially if HCPs suspect a number of patients are engaging in that 
behaviour. 
*[Alice, 21 years, Adult Nurse]: "If a patient hadn't disclosed their engagement # but 
you (.) hi:ighly suspected they were experimenting (.) or engaging in such behaviours 
we put it in the newsletter # as things come up (.) we tend to say (.) right # this ma:ay 
become an issue across the board […] sometimes we just try to get patients to talk 
about what they did and why it was a bad idea" 
In addition to the written information that all patients have access to, Alice explained that 
there is a conversation with patients regarding these behaviours as well, to try and increase 
their awareness, in an attempt to prevent initiation. Alice explained how these discussions 
are often on a reactive basis, in response to HCPs suspicions that those patients are 
contemplating engagement, or have experimented with that behaviour.  
 Many Nurses did identify the need to use technology to provide this written 
information, as it was well recognised that adolescents and young adults commonly 
communicate online and through various mobile apps, therefore many Nurses stressed the 
importance of fostering such communication style in order to reach their patients.  
*[Alice, 21 years, Adult Nurse]: "Online is so ke:ey # every teenage I meet is 
su:urgically attached to their phone # it's such an ea:asy way to # provide information 
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(.) cause that's what they want to look at # they don't want to be talked at # they want 
to fi:ind this information # so whether you could put it on things like Facebook # 
Twitter # CF apps […] I think the only way you're going to grab their attention is in the 
media form they're used to" 
The use of social media was identified as a potential avenue to explore, with this being a 
familiar platform for patients to communicate over. Many individuals with chronic illnesses do 
seek advice through communicating with individuals with the same condition as them via 
social media. The use of social media therefore could be applied to addressing the issue of 
risky behaviours, as well as adherence within the CF population. However, social media 
does have barriers, such as safeguarding issues, and whether online patient communication 
will encourage face-to-face communication. Online communication would need to be closely 
monitored by HCPs. In addition to the use of social media, other Nurses expressed a need 
to improve their websites, to again provide a platform to raise CF patients’ awareness 
regarding risky behaviours. This again would fit in with adolescents and young adults’ 
communication style, and would eliminate some safeguarding issues associated with the use 
of social media. Not only would the use of technology potentially be favoured by patients, it 
would also be less time demanding for HCPs, with many Nurses explaining that they do not 
have time for in-depth conversations regarding risky behaviours with "non-risky" patients, 
due to how busy the clinic environment is. 
 Nonetheless, despite there being a need for technology based interventions, the data 
indicated that this should not replace the verbal discussions that HCPs have with patients, 
particularly those who they suspect are engaging in such behaviours, or those who have 
disclosed such engagement. This suggests that technology could be used on a proactive 
basis, whereas predominantly verbal discussions could be used on a reactive basis. Nurses 
explained that when they suspect a patient is experimenting in risky behaviours, the verbal 
discussions need to be individualised, with Nurses needing to demonstrate a non-
judgemental approach. Besides providing an individualised approach, Nurses also stressed 
the importance of revisiting information on risky behaviours to ensure patients have not 
forgotten the information. Nurses believe revisiting information should be a combination of 
verbal and written information, even though in reality Dawn explains that within her CF unit 
this information is only revisited on a verbal basis. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "It's not just a one off at thi:irteen (.) 
because (.) you know (.) two years do:own the line (.) you ask them # ↑>can you 
remember that conversation we had about such and such< # ↓ they will inva:ariably 
say no:o" 
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 Furthermore, Nurses also emphasised the need to integrate psychology within such 
interventions, due to them acknowledging the connection between a patient’s psychology 
and their behaviours, with Nurses explaining that any psychological issues firstly need to be 
addressed in order to encourage cessation. Dawn acknowledges that CF Specialist Nurses 
are not competent in helping patients deal with their psychological issues, and therefore 
acknowledges the need for Psychologists to be integrated into the CF MDT. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "I'm not a:always good at the psycho-
social stuff # but when we have the people [Psychologist and Social Worker] in 
pla:ace (.) I think (.) that re:eally helps # we can start to dea:al with the psyche:e" 
Nurses emphasised the need for psychological interventions to be employed on a reactive 
and proactive basis, potentially by using screening. Due to Nurses being aware of possible 
predictors of non-adherence and risky behaviours, they recognised the role of a psycho-
social team screening patients for such “predictors”, and providing "at risk" patients with 
awareness on a proactive basis. However, Dawn explained how not all CF units have a 
Psychologist at present. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "We've not got a Psychologist # we've 
not had one for an a:awful long ti:ime # and I:I think (.) if we had a Psychologist # 
within o:our service # who was (.) scre:eening patients and picking things up # I:I 
think ## it would be mu:uch better [...] we should be looking fo:or that [mental health 
issues] on an annual ba:asis # and we should be scre:eening that out [...]  we're 
doing absolu:utly no:othing" 
 When discussing Nurses’ ideas surrounding future interventions they emphasised the 
need to target these interventions at the right population, with emphasis firstly needing to be 
placed on “the right age group”. The data coincided with the previous phases of data 
collection, in indicating that discussions, and awareness regarding risky behaviours need to 
be provided to patients from a younger age than present practice. However, while Nurses 
acknowledged the lowering age of initiation, they commonly suggested that awareness 
should be provided from age fourteen years and above, whereas the results from phase one 
data collection suggest that experimentation, or at least contemplation starts in some 
individuals from the age of twelve years; therefore for some individuals fourteen may be “too 
late” to provide a proactive intervention. In addition, Nurses explained that more effort needs 
to be placed on providing interventions to the “hard to reach patient group”, who HCPs know 
are engaging in such behaviours and not adhering to their medical regimens, however they 
rarely attend clinic appointments.  
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*[Jayne, 11 months, Adult Nurse]: "We don’t re:eally have patients who would come 
every six we:eeks (.) who we kno:ow have a drug problem (.) o:or a drink problem (.) 
o:or smo:oke" 
Potentially interventions delivered using technology could be a way of providing such 
awareness to this “hard to reach group”, without them physically being present within the 
hospital setting; it would then be up to the individual as to whether they engaged with such 
resources. In addition, Nurses also believed that future interventions need to be developed 
through patient input, with many Nurses identifying a role for the results of the previous two 
phases of data collection to shape such interventions. 
*[Dawn, 20 years, Adult and Paediatric Nurse]: "It'd be re:eally interesting to hear (.) 
what the young people a:are saying [about risky behaviours] (.) beca:ause I think #  
that would then # info:orm # ho:ow you (.) tr:ry (.) to identify it (.) I suppo:ose" 
 In terms of ideas for future interventions, Nurses identified two possible interventions. 
Firstly, as with adherence, some Nurses believed mentorship could be used to address the 
issue of risky behaviours, with Kirstie explaining how it would provide young CF patients with 
a platform to discuss issues with individuals who are away from their family and HCPs. 
*[Kirstie, 22 years, Paediatric Nurse]: "Something like the mento:oring (.) would be 
the best approach # I think […] so you've got somebody (.) e:erm:m (.) that you can 
tu:urn to (.) to ask sort of (.) life questions:s to" 
In addition, four Nurses emphasised the need to have some form of staff training to raise 
HCPs awareness as to what risky behaviours are “current” within the general population, 
how they could identify those within their patients, and what impact such substances have 
upon CF. 
*[Alice, 21 years, Adult Nurse]: "I think # it would be useful # for people # mo:ore 
knowledgeable than me (.) about what the current tre:endy things a:are # it's tough 
enough to keep up to date on a:all the things that are changing # without having to 
read up on # the latest ecstasy # designer drug is [laughs]" 
By providing such awareness it would allow HCPs to share that awareness with patients 
through whatever platform the CF unit desired, both on a proactive and reactive basis. Lee 
also acknowledged that staff training would increase HCP’s confidence in raising the topic of 
risky behaviours with patients, believing that currently not all HCPs are comfortable with 
confronting the issue due to their limited knowledge regarding the adverse health effects of 
risky behaviours. 
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*[Lee, 14 years, Adult Nurse]: "I'm not sure if a:all team members are confide:ent (.) 
when assessing patients # risky behaviour # to dea:aling with any issues that ma:ay 
come up […] I think it'd be:e (.) useful # for there to be mo:ore (.) tra:aining (.) more 
educa:ation for the staff # more CF team members should be comforta:able (.) 
a:aksing the questions:s # identify:ying the issues (.) and dea:aling with them as well" 
However, whilst these Nurses stressed the need for such education, they did identify some 
barriers, such as the limited amount of time HCPs have to attend staff training. Therefore 
Lee explained how such training could potentially be integrated into regional meetings etc, 
instead of making a separate occasion for HCPs to attend. 
*[Lee, 14 years, Adult Nurse]: “To identify:y risky beha:aviours (.) and to talk to 
patients about that ## they're soft ski:ills (.) but they can take ti:ime (.) for (.) 
professionals to beco:ome proficient to tho:ose ski:ills # so I think those would be the 
ba:arriers re:eally" 
 Overall, this theme identifies that many Nurses do acknowledge the need for new 
interventions to be implemented into CF care regarding risky behaviours, with it appearing 
necessary to provide awareness to all patients on a proactive basis, through both verbal 
information and supplementary written information. Nurses believe that technology based 
interventions would be most successful for patients, due to it fostering the communication 
style of adolescents and young adults. In addition, Nurses also expressed a need for staff 
training, due to them having gaps within their knowledge regarding risky behaviours, in terms 
of which behaviours are current within the general population, and what impact such 
behaviours could have upon CF patients. 
Discussion 
 The data provides an exploration into how CF Specialist Nurses perceive the issue of 
risky behaviours within the CF population, providing insight into what interventions they 
believe would work. Nurses had a range of different experiences with risky behaviours within 
their patient group, influencing their attitudes and beliefs regarding the need for an 
intervention. The data was produced using telephone interviews, with the asynchronous 
communication of place encouraging Nurses to discuss sensitive issues, which they may 
have been reluctant to discuss face-to-face (Mann & Stewart, 2000). Nurses were positive 
about their role, enjoying their job and their high patient contact. Adult and paediatric 
participants within the previous phases of data collection highlighted the strong relationships 
they have with their Nurses, viewing Nurses to be the most approachable member of the 
MDT; this is in line with previous literature within the general population (Collins, 2015; Read 
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& Mayberry, 2000; Van den Heever et al., 2015). These close patient-Nurse relationships 
mean that many Nurses have a good insight into what an individual's life is like with CF, 
being able to detect anxiety within patients, and predict how different patients will cope with 
different aspects of their disease.  
 Working within the CF population is challenging when faced with CF's fatal nature, 
with many Nurses explaining how dealing with death is the most challenging part of their 
role, especially when Nurses were of a similar age to patients. This is in line with previous 
literature where CF Specialist Nurses discuss the challenge of dealing with death, with many 
Nurses stating that the only way they can deal with this continuous loss is the acceptance 
that they did their best for each patient who passes away (Rhys, 2011). CF's fatal nature is 
an emotional burden for patients, therefore Nurses explained that in order to help patients 
cope with their CF they encourage patients to be optimistic towards their life and future. 
Optimism can increase a patient’s quality of life (Abbott et al., 2008), with optimism being 
evident within both the first and second phase of data collection, with participants who did 
demonstrate optimism towards their life and future often leading a "normal" and enjoyable 
life despite their CF, and the challenges that imposes upon their life (Abbott et al., 2008; 
Götz & Götz, 2000). In order for patients to be optimistic, Nurses explained how they also 
needed to be optimistic towards the future of CF care. Nurses optimism can help encourage 
positive changes in a patients attitude and beliefs towards their condition (Goodwin, Curry, 
Naylor, Ross & Duldig, 2010), however remaining positive can be difficult for Nurses, and 
can be an additional pressure of their job, especially when faced with upsetting and 
distressing events, but having to remain positive for other patients. 
 Not surprisingly a major focus of CF care is adherence, with many Nurses explaining 
how the use of individualised care helps to promote an individual's adherence efforts. The 
use of individualised care was favoured by adult participants within phase one data 
collection, with participants explaining how HCPs meet patients "half way" with their 
adherence, recognising that it is patients who have to administer the medication themselves. 
Adult participants explained how HCPs allow patients to shape their treatment plan to a 
certain extent, sympathising with occasional non-adherence, highlighting the importance of 
shaping treatment plans according to an individual's lifestyle, placing emphasis on 
psychological as well as pharmacological factors (Horne, 2000). In order to encourage 
patients to be open about their adherence efforts, Nurses explained how they need to talk to 
patients on a human-to-human basis, developing rapport with patients. Nurses believe that a 
strong patient-clinician relationship is associated with positive health outcomes, in terms of 
encouraging patients to be open regarding their adherence efforts, enabling HCPs to 
structure the patient’s treatment plan around their lifestyle. This is in line with previous 
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literature which demonstrates the positive impact the patient-clinician relationship has upon 
health outcomes within the general population (Kelley, Kraft-Todd, Schapira, Kossowsky & 
Riess, 2014). 
 Nurses demonstrated their clear understanding on the barriers patients face towards 
their adherence, in particular acknowledging the difficulties individuals with CF face during 
their transition to adult care. Previous literature (Barker et al., 2012; Bregnballe et al., 2011), 
along with the previous two phases of data collection, highlight how difficult independence 
with self-management is, with this having the potential to result in poor adherence. When 
discussing what reduces an individual's adherence efforts, many Nurses identified how 
individuals with CF desire a sense of normalcy, with this being in line with the previous 
phases of data collection, in highlighting how a life-orientated illness perspective can result 
in poor adherence (Audluv et al., 2010). In addition to identity, Nurses also explained how an 
individual's poor adherence can be due to denial either regarding their CF, or regarding 
treatments' necessity, with this being highlighted by adult participants within phase one data 
collection, and being in line with previous research (Laws et al., 2012). Nurses also 
explained that an individual's poor adherence can be due to a lack of time, which Bregnballe 
et al (2011) and a number of adult and paediatric participants highlighted to be a major 
barrier to adherence. Therefore Nurses suspect that individuals focus upon the short-term 
consequences of treatment as suggested by previous literature (Abbott et al., 1994; Keyte et 
al., 2017b, 2017c), with adult participants within this research explaining how they are more 
likely to adhere to a treatment if they experience an immediate benefit. In order to encourage 
an individual's adherence efforts, Nurses explained how they provide awareness to patients 
regarding treatments' necessity, with the previous phases of data collection suggesting that 
awareness and acceptance towards CF and treatments' necessity is influential within 
adherence efforts. 
 CF care is a changing environment, with many Nurses explaining how their CF units 
are exploring how they could use technology (e.g. Skype Triage) to reduce the number of 
hospital visits patients have. This would not just save time for HCPs, it would also be 
advantageous for patients to not keep having reminders of their CF, and how their health 
may deteriorate. Adult participants within phase one data collection explained how 
emotionally difficult it is to see others with CF who have deteriorated more than themselves, 
as it serves as a reminder of what their future may entail. Individuals with CF have reported 
health benefits following the use of technology to monitor their health, due to them being 
able to actively view changes in their e.g. weight, and act accordingly (The UK CF 
Conference, 2016). CF care is also changing in terms of what needs to be addressed with 
patients, with Nurses identifying how risky behaviours are a growing concern within the CF 
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population. While previous research indicates that risky behaviours are not as prevalent 
within the CF population as they are within the general population (McEwan et al., 2012; 
Verma et al., 2001), this research signals that risky behaviours are a major concern for those 
who do engage in such behaviours, highlighting the need for more effective health promotion 
measures to reduce the occurrence of such behaviours. Nurses did indicate that they do lack 
awareness regarding risky behaviours, in terms of what behaviours are prevalent within the 
general population and what impact they could have upon CF patients, with this being 
suspected by adult participants within phase one data collection. It is well acknowledged that 
some HCPs know less about illegal substances, than their patients do (Viner & Macfarlane, 
2005), with Nurses identifying the need to have some form of staff training to raise their 
awareness regarding risky behaviours, allowing them to then pass on this knowledge to their 
patients. 
 Nurses did have good awareness regarding what influences the engagement in risky 
behaviours within the CF population, highlighting how a desire for normalcy could lead to the 
engagement in risky behaviours, in order to adopt the same identity as one's peers, with this 
being identified within previous literature (Bryon, 2015; Duff & Latchford, 2010; Withers, 
2012), and within the previous phases of data collection. Nurses also identified the issue of 
stress, believing that the stress of living with a chronic condition, coupled with the stress an 
individual experiences within their private life could motivate an individual to engage in risky 
behaviours, with previous literature (Boden & Fergusson, 2011; Kassel et al., 2003; 
Kavanagh et al., 2011) and adult participants explaining how risky behaviour engagement 
can alleviate feelings of stress and anxiety. 
 With risky behaviours not being as prevalent within the CF population as the general 
population, some Nurses did not perceive there to be a need for interventions to be 
implemented, explaining how most patients are already "on the right path" and are not 
engaging in risky behaviours, as found within the paediatric population. However, the adult 
population clearly explained the need for awareness, stating that this could have prevented 
their initiation with risky behaviours. Many Nurses did recognise the need for awareness due 
to the severe adverse health effects risky behaviours can have upon an individual with CF, 
however they correctly identified that awareness does not always prevent initiation, as 
demonstrated within the previous phases of data collection. Nurses believed that adolescent 
patients sometimes engage in risky behaviours despite health advice from HCPs, due to 
their inability to consider long term consequences (Bryon, 2015), with such Nurses 
demonstrating the need to progress current interventions. 
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 Within this research some Nurses highlighted how they do not make patients aware 
of the true nature of their CF. The process of accepting one's CF is complex, and it is 
recognised that it is not always in a patients best interests. Nonetheless, with HCPs not 
providing this awareness to patients regarding the true nature of their CF, it is possible that 
patients do not have this knowledge, potentially fostering a sense of denial within patients, 
which a recognised by Laws et al (2012) can result in non-adherence and risky behaviour 
engagement (Withers, 2012). Whilst phase one data collection identified that for some 
patients it is advantageous for them to not possess an illness identity, Goodwin et al (2012) 
highlights the importance of patients being informed about the true nature of their chronic 
condition, in order to be empowered to carry out self-management of their condition. 
Goodwin et al (2012) explains the importance of providing information that gives a realistic, 
but positive outlook on an individual's condition, explaining what their condition is, what 
might happen in their future, and who they can contact for help and support. The importance 
of raising one's awareness regarding CF was identified by Toth (2016), who explained how 
in the USA some CF units have an additional annual assessment to help young adults take 
ownership of their CF, and understand CF's true nature. It is believed that such intervention 
would be most successful if it focused upon the practicalities of CF, explaining what CF is, 
and what it means for an individual's life. This could focus upon what behaviours that 
individual can or cannot engage in, with emphasis being placed on the importance of 
adherence and the avoidance of risky behaviours. Such acceptance could focus on the 
challenges that adolescents with CF face in terms of lifestyle choices, helping them decide 
what choices are adaptive for their health, rather than focusing upon CF's fatal and 
deteriorating nature, which as highlighted can be associated with psychological implications. 
 A further suggestion regarding a new intervention was the use of mentoring to 
promote adherence, and reduce the occurrence of risky behaviours. Online Patient Advisory 
Groups and adult mentoring have been successfully set up within the USA, to allow CF 
patients to communicate and encourage positive health behaviours amongst one another. 
Moog (2016) highlights how these groups reduce isolation amongst patients, and allow 
patients to ask each other questions which they would not ask HCPs. In order for all CF 
patients within the unit to benefit from the discussions the Patient Advisory Group has, Moog 
(2016) explains how a newsletter is distributed to all patients based on these discussions. In 
considering the transcripts from the previous two phases of data collection, it is believed that 
this suggestion would be welcomed by patients, due to them often desiring to communicate 
with other CF patients, and feeling isolated due to patient segregation (Lamas, 2013). 
 Within all phases of data collection the need for proactive interventions to address 
the issue of risky behaviours was recognised. Some Nurses did explain that their units do 
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currently use proactive interventions; two Nurses referred to the use of the ready, steady, go 
questionnaires (University Hospital Southampton, 2014). While it is positive that these units 
are addressing the issue of risky behaviours, Nurses acknowledged that this intervention is 
not without its flaws. As highlighted within the transition evaluation, just because a patient 
has indicated they understand the risks of a behaviour does not mean they do not engage, 
or do not desire to engage in that behaviour. It also has to be questioned whether patients 
disclose their true attitudes and beliefs towards such behaviours, with it being plausible that 
patients respond in a positive way to be viewed favourably by their clinicians’ due to social 
desirability bias (Krumpal, 2013; Lippitt et al., 2014; Sanzone et al., 2013). Some Nurses 
also discussed the use of verbal information to provide proactive awareness regarding risky 
behaviours. However, again while this is positive, the use of verbal information alone can be 
criticised. Literature indicates that patients within the general population forget up to half of 
the verbal information/advice that has been given within five minutes, and recall only 20% of 
the information (Entwistle & Watt, 1998; Little et al., 1998). Nurses also acknowledge the 
limitations of these proactive interventions, and therefore identify the need to accompany 
verbal information with written information, with literature illustrating that patient retention of 
information can be improved with supplemental written information (MacFarlane et al., 
2002).  
 Many Nurses did identify the need to use technology to provide this written 
information, as it was well recognised that adolescents and young adults commonly 
communicate online and through various mobile apps (Peacock & Sanghani, 2014). The use 
of social media has started to be explored within CF care, for instance Smith and Gouick 
(2015) used a closed Facebook group to encourage CF patients to exercise and support one 
another, with half the participants reporting that the use of social media maintained their 
motivation to exercise. The use of social media therefore could be applied to addressing the 
issue of risky behaviours, as well as adherence within the CF population. Many Nurses 
identified that the awareness provided to patients regarding risky behaviours needs to be 
revisited on several occasions, with the need for this being emphasised by paediatric 
participants within the second phase of data collection. Paediatric participants often 
discussed that HCPs have provided awareness regarding risky behaviours, however 
participants could not describe what the adverse health effects of risky behaviours are. Best 
practice does need to be employed when revisiting such information, as some adult 
participants within phase one data collection explained that they were frequently asked 
about their awareness on e.g. smoking, however information was not disclosed to raise their 
awareness.  
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Conclusions 
 Overall this phase of data collection points out that whilst the majority of CF 
Specialist Nurses acknowledge that risky behaviours are becoming a major concern within 
the CF population, the way CF units address the issue of risky behaviours varies greatly. 
Some Nurses explained that it is only recently that their unit has started to address this 
issue, however Nurses often identified flaws within their unit’s interventions. For instance, it 
appeared that some units rely upon patients disclosing their engagement with risky 
behaviours, or instigating a conversation before any awareness is provided. In addition, the 
majority of CF units who do provide awareness only provide verbal information, with many 
Nurses stating that this now needs to be progressed to provide patients with accompanying 
written information, whether that is on paper or via technology.  
 This phase of data collection does coincide with the findings from the transition 
evaluation and the previous phases of data collection, in indicating that risky behaviours 
within the CF population are predominantly approached on an individualised basis. 
Consequently, within all phases of data collection the need for new interventions is 
demonstrated, in order to reduce the occurrence of risky behaviours within the CF 
population. This research therefore provides an opportunity for the implementation of 
research informed practice within the CF population, in terms of addressing the issue of risky 
behaviours in a standardised way through listening to patients' and Nurses' beliefs regarding 
current practice, and how they believe such practice should be progressed. 
 However, this third phase of data collection only investigated how Nurses perceive 
the issue of risky behaviours within the CF population, and what interventions they would like 
implemented. The researcher therefore identified the importance of speaking to, and 
collaborating with other HCPs, in order for this research to have a "real world" impact in the 
practice of health care (Henriksen et al., 2005). This final phase of data collection allowed 
the researcher to disseminate the research findings, allowing HCPs to critique the findings 
and offer suggestions regarding what interventions would work. 
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CHAPTER ELEVEN: METHODOLOGY - DISSEMINATION MEETINGS 
Participants 
 HCPs who work within the CF MDTs (adult and paediatric teams) at Birmingham 
Heartlands Hospital and the Royal Stoke University Hospital were recruited. Both hospitals 
were research sites for the first two phases of data collection, illustrating their invested 
interest within this research. Three dissemination meetings were conducted:  
 07/11/2016 - Birmingham Heartlands Hospital adult CF team 
 09/11/2016 - Royal Stoke University Hospital adult and paediatric CF teams 
 06/12/2016 - Birmingham Heartlands Hospital paediatric CF team 
 
Measures 
 Dissemination Meeting. The researcher followed the guidelines outlined by 
Henriksen et al (2005) and Lakhanpaul et al (2014) in order to create a dissemination plan. 
The researcher disseminated the overall research findings from the previous three phases of 
data collection, believing that these findings would be of interest to CF HCPs as they were 
outlining an issue related to safety in patient care. 
 The researcher delivered the dissemination meetings to various MDT members at 
each research site, as the researcher believed that different MDT members would have 
different ideas for future interventions, and bring different sources of knowledge to the 
meetings. For instance, phase one data collection suggested that patients disclose different 
information to Nurses than they do to Doctors, which could therefore influence Nurses and 
Doctors views towards suitable interventions. In addition, when designing each phase of 
data collection the researcher had discussed ideas with all members of the MDT at each 
research site, therefore it made sense to disseminate findings to all MDT members.  
 The researcher disseminated these findings face-to-face with HCPs by asking for 
time during MDT meetings at the CF units. The researcher disseminated the findings 
through utilising a PowerPoint presentation, thoroughly explaining each finding to HCPs. 
Once the researcher had presented the findings, the researcher encouraged HCPs to 
discuss the research using a plan (Appendix CC) in line with Henriksen et al's (2005) 
guidelines. It was hoped this plan would encourage HCPs to critique the findings and offer 
their suggestions for interventions that could work. 
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 Although the findings from this doctoral research remained static, the way in which 
these findings will be presented for publication have been influenced by the outcome of the 
dissemination meetings. These meetings have illustrated what findings are relevant to CF 
HCPs, allowing the researcher to present the findings for publication which meet the needs 
of these professionals, supporting the application of findings in practice (Bradley et al., 
2010). 
Carrying out the Study 
 The researcher contacted the lead Consultant from each CF unit (Birmingham 
Heartlands Hospital adult and paediatric units; The Royal Stoke University Hospital adult and 
paediatric units) who had been liaising with the researcher during the first two phases of data 
collection via email or telephone, informing them about this phase of data collection. The 
researcher forwarded the CF units an information sheet (Appendix DD), and if the unit 
required further information the researcher was available to discuss the research further 
either via telephone, email or in person. If verbal consent was provided by the CF unit, the 
researcher then proceeded to arrange a suitable date / time for the dissemination meeting 
(this was often during MDT meetings). 
HCPs then attended the dissemination meeting, where they were informed of the 
overall findings from the doctoral research utilising a PowerPoint presentation (Appendix 
EE). The researcher invited HCPs to critique the findings and offer their views on which 
findings were of interest to them. The researcher asked HCPs to provide their views on 
whether they believe an intervention is required to reduce the occurrence of risky behaviours 
within the CF population, and offer suggestions on what interventions they believe would 
work in practice. 
The dissemination meetings were conducted in a private room at the CF units and 
lasted a maximum of 60 minutes, however they could be stopped earlier if the MDT wished 
this to be the case; within this research no meetings were stopped early. HCPs did not have 
to answer any questions they did not wish to. All participation was voluntary, and HCPs 
could withdraw from the research at any time without being penalised; within this research 
no HCPs withdrew. Once the dissemination meeting was complete, HCPs again had the 
opportunity to ask questions.  
Ethics Committee 
Ethical approval was obtained by the Business, Law and Social Sciences Ethics 
Committee at Birmingham City University. 
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Analysis 
As described within the initial analysis section within Chapter Four, the dissemination 
meetings were transcribed utilising the Jefferson transcription coding (Heath & Hindmarsh, 
2002), with the data being analysed using thematic analysis following Braun and Clarke's 
(2006) model. Thematic analysis generated 15 codes. The researcher made inferences 
about what the codes meant enabling the codes to be combined into two overarching 
themes that accurately depict the data (Appendix FF). The two themes generated are 
described in detail within the next chapter, utilising direct quotes and discussion around CF 
HCPs ideas regarding future interventions to address the issue of risky behaviours.  
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CHAPTER TWELVE: ANALYSIS - DISSEMINATION MEETINGS 
 Thematic analysis was applied to the interview transcripts following the Braun and 
Clark (2006) model, which identified two themes within the data. The first theme, labelled as 
“Awareness is already provided to adolescent Cystic Fibrosis patients regarding risky health 
behaviours", demonstrates the awareness CF patients already have access to on risky 
behaviours, mainly from the NHS and their educational experiences. Theme two, "HCPs 
ideas regarding future interventions to address the issue of risky health behaviours”, points 
out the practical applications of this research, highlighting what interventions CF HCPs 
would like to see integrated into CF care. Both themes will be further examined below, by 
utilising direct quotes and discussion around this topic area. 
 Overall all HCPs within the dissemination meetings recognised that risky behaviours 
are becoming a major concern within the CF population, with many HCPs acknowledging 
that they could do more on the issue of risky behaviours, both in adult and paediatric units, 
illustrating that the provision of awareness regarding the adverse health effects of risky 
behaviours is not embedded within their practice. HCPs agreed that best practice regarding 
risky behaviours does not always happen, explaining that not all patients are being 
approached regarding this issue. 
*[Paediatric Nurse (1)]: "There's a fo:orm they put in the notes # that the outpatient 
staff are meant to ask [includes risky behaviours] # I haven't se:een that for a lo:ong 
time 
 [Paediatric Consultant (1)]: No:o it is still around actually" 
Even when best practice is employed with written information being provided, HCPs often 
acknowledged that they are aware that the majority of patients do not read this information.  
 *[Paediatric Nurse (2)]: "I used to give them booklets ## about # sex and dru:ugs ## 
 but (.) I kno:ow they probably wouldn't read it ## we haven't stopped giving them out" 
This demonstrates the need to progress current interventions in order to place more 
emphasis on the issue of risky behaviours, in an attempt to reduce the occurrence of such 
behaviours within the CF population, with some HCPs identifying that their CF units do not 
use any interventions to address risky behaviours. 
 *[Paediatric Nurse (2)]: "I kno:ow when I used to do Asthma clinic ## I a:always used 
 to ask about smo:oking (.) and I don't do it within CF clinic" 
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 Nonetheless, not all HCPs initially identified the need to have an intervention 
implemented within CF care, with some HCPs suggesting that patients receive awareness 
regarding the adverse health effects of risky behaviours from elsewhere, and therefore it is 
not necessary for HCPs to provide such information. A common belief was that adolescent 
CF patients receive awareness regarding smoking, excessive alcohol consumption, illicit 
drug use and risky sexual behaviour from their school. 
 *[Paediatric Consultant (1)]: "They get educa:ated at scho:ool ## they get quite a lot 
 of information about these things at scho:ool # which # the drug information for 
 instance at scho:ool is mo:ore up to date than what I kno:ow" 
While it is often the case that education about risky behaviours is provided within schools, 
this education is not always successful, with Chowdry, Kelly and Rasul (2013) reporting that 
there is little consensus between schools regarding which approach is most effective to 
reduce occurring risky behaviours, and what age group should be targeted, with the current 
generation of prevention programmes typically using a range of different techniques. It was 
concluded that when schools just focus upon the consequences of such behaviours the 
intervention is not successful, with interventions needing to be interactive as opposed to 
passive in order to have more success (Chowdry et al., 2013). HCPs may have 
overestimated the quality of the awareness individuals receive from their school, and 
therefore may not have realised the need to have this awareness implemented into CF care, 
with some HCPs believing that their role should potentially be to reinforce the message from 
school, therefore not focusing too much time upon risky behaviours. 
 *[Paediatric Consultant (1)]: "I'd have thought o:our role was mo:ore to ## briefly 
 reinfo:orce what school is # and also ma:aybe emphasise if there a:are significant 
 increased risks because of the:eir health ## ra:ather than doing a:all of their sex ed" 
With HCPs reinforcing the message provided by schools it would reduce the amount of time 
HCPs need to dedicate to providing awareness on risky behaviours, allowing them to 
continue with the many other aspects there are to their role. However, if schools cannot 
provide awareness on risky behaviours effectively, it does have to be questioned how HCPs 
can be expected to do this as well, alongside all their other pressures. According to Chowdry 
et al (2013) the information provided by schools, and reinforced by HCPs would need to 
move away from focusing on just the outcomes of risky behaviours through passive 
information. 
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 Some HCPs did notice that they should not rely on schools providing awareness, as 
the awareness a school provides, and the technique used by that school is all dependent 
upon the school's curriculum and values. 
 *[Paediatric Consultant (2)]: "If they [the school] don't si:ign up to # some of those 
 lessons [PSHE] # then # they won't get access to sex education # which other kids 
 ma:ay have 
[Paediatric Nurse (1)]: It depends if they go to a Catholic school" 
In addition, some HCPs acknowledged that regardless of the effectiveness of school-based 
interventions for the general population, this awareness is not CF-specific, therefore it may 
not resonate with CF patients as it does not inform them about the health effects they could 
personally experience. Predominantly it is expected that risky behaviour education in 
schools will focus upon the elevated risk of cancer associated with such behaviours, with 
some HCPs pointing out that again this may not resonate with CF patients, due to cancer 
predominantly occurring in individuals at an age which is above the life expectancy for CF. 
 *[Dietician]: "At school they're not going to be focused on that [CF risks] are they # 
 they're going to be focusing on the cancer risk [...] there's a difference # CF patients 
 thinking life expectancy wise # cancer risk # it doesn't matter" 
 In addition to school-based interventions, some HCPs believed that sufficient 
awareness regarding the adverse health effects of risky behaviours would be provided 
through the NHS, targeted at adolescents, predominantly provided online. 
 *[Adult Consultant (1)]: "You would hope so that somewhere ## in the NHS there 
 must be some teeniebob information on (.) sex drugs and rock and roll I would have 
 thought" 
Whilst NHS choices (2017) does provide sufficient information online regarding smoking, 
excessive alcohol consumption, illicit drug use and risky sexual behaviours, as with the 
education provided through schools, this information is not CF-specific, therefore this 
information would potentially not resonate with CF patients. In addition, no one provides this 
information to adolescents with CF, it is up to the individual to search for this information 
online, with HCPs acknowledging that patients are competent in doing this. Nonetheless, 
without this information being CF-specific an individual cannot make an informed choice 
about whether or not they want to engage in such behaviours in light of the consequences. 
In terms of CF-specific awareness, there is limited awareness provided online, with the CF 
Trust not providing advice regarding smoking or illicit drug use, and only providing minimal 
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information about excessive alcohol consumption (The CF Trust, 2010), with this information 
appearing to be targeted to adults with CF, despite it being acknowledged that initiation 
commonly occurs during adolescence.  
 During the dissemination meetings, many HCPs began to recognise the need for an 
intervention to be implemented within the CF population, to address the issue of risky 
behaviours. Many HCPs felt that initially an intervention needs to target HCPs, in order to 
raise their awareness on risky behaviours. Many HCPs responded that they do not know the 
impact risky behaviours can have upon CF (excluding smoking), resulting in them not being 
confident in addressing the issue of risky behaviours with their patients. 
*[Paediatric Consultant (1)]: "I suppo:ose the question is # is the risk grea:ater then if 
you've got CF [...] what about # alcoho:ol # it's ## you know (.) drinking to excess is a 
bad idea:a ## is it wo:orse because you've got CF" 
Consequently, many HCPs recognised that they often only discuss smoking within their CF 
unit, as they feel confident regarding the CF-specific adverse health effects, nonetheless 
they do appreciate that patients are potentially subject to other risky behaviours. 
 *[Paediatric Consultant (1)]: "I think other than # ho:ow it affects you:ur treatment # I 
 think we know # very little # about whether there is health impacts (.) fo:or # non 
 smo:oked marijuana"  
Many HCPs did emphasise the need for staff training to raise their awareness regarding the 
CF-specific effects of risky behaviours (particularly excessive alcohol consumption and illicit 
drug use), which they could then inform patients about. In addition, many HCPs 
acknowledged the need to have general training regarding risky behaviours, in order to be 
aware of what risky behaviours are prevalent within the general population, and how they 
may identify such behaviours within their patients, with many HCPs accepting that their 
patients are likely to know more about risky behaviours than they do, as identified within the 
previous phases of data collection. 
 *[Adult Nurse]: "They know mo:ore about what drugs are out there than we do [...] it's 
 often an education to us when they do admit what drugs they're taking ## haven't got 
 a clue rea:ally about what effect they're going to carry ## rea:ally" 
HCPs identified that they are unsure on how they should address the issue of risky 
behaviours with patients, with some HCPs emphasising that they simply do not have the 
training to effectively reduce the occurrence of such behaviours within the CF population. 
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 *[Adult Consultant (2)]: "Is it that we are badly trained to promote this health 
 behaviour [...] I know I am # I've never been trained on this" 
In addition to reducing the occurrence of these behaviours, HCPs explained that without 
sufficient training they do not feel confident in dealing with information that patients disclose, 
often not being aware of when confidentiality should be broken. 
 *[Physiotherapist]: "Sometimes it's not knowing what to do with that info:ormation as 
 well when you get it # cause then you've got the a:awkward do I tell the pa:arents # 
 o:or not ## it depends what it is # is it sa:afeguarding # isn't it safeguarding [laughs]" 
Thus, HCPs were agreeing that staff training is required within the CF population, to not just 
provide HCPs with CF-specific awareness, but also to inform their practice as to how to 
approach the issue with all patients regardless of their personal condition, as well as issues 
such as confidentiality and safeguarding.  
 HCPs believed that with this training they would then be able to provide sufficient 
awareness to patients, with HCPs being in agreement that such awareness should be 
provided in absence of parents or guardians. This would establish a trusting relationship 
between the patient and HCP, providing a safe environment for disclosure, ensuring 
confidentiality, with HCPs stating this awareness should start before adult care, in line with 
the findings from the previous phases of data collection. 
 *[Adult Consultant (1)]: "I think by the time they come to us # if they haven't had 
 some kind of intervention # we've missed ## how many of them haven't we # cause 
 we get them at what # nea:arer seventeen now # sixteen [...] it's probably a little bit 
 after the horse has bolted" 
In addition, HCPs stated that such awareness needs to be revisited on several occasions to 
ensure its effectiveness. Consequently, many HCPs agreed that an opportunity to provide 
regular awareness could be during annual reviews, with this providing HCPs the opportunity 
to provide standardised proactive awareness. 
 *[Paediatric Consultant (1)]: "I think actually we should be mo:ore proactive shouldn't 
 we # we ca:an't ask every single time we see them ## but annual reviews" 
The use of annual reviews was emphasised during all three dissemination meetings, with the 
researcher receiving an email following the second dissemination meeting by an Adult 
Consultant stating that the research has practical applications, and therefore that CF unit 
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was adding a section onto their Annual Review form for risky behaviours, ensuring the adult 
team at least enquires about this on regular intervals. 
 HCPs were keen to emphasise the need to provide more than verbal awareness, in 
line with previous literature, with Chowdry et al (2013) stating that awareness should be 
interactive as opposed to passive. Consequently, many HCPs agreed that effort should be 
employed to use technology to provide such awareness, with this being the platform that 
adolescents commonly use to communicate through. HCPs believed that technology would 
provide adolescents the opportunity to access CF-specific information regarding risky 
behaviours, without asking HCPs for advice and guidance, ensuring confidentiality. HCPs 
believed that patients are less likely to instigate a conversation regarding risk behaviours 
with HCPs, due to patients being aware that such behaviours are possibly not good for their 
health, however they do not know the CF-specific adverse health effects of such behaviours. 
In addition, HCPs explained how difficult it is to instigate a conversation regarding risky 
behaviours with adolescent patients who they have known for a long period of time, and 
formed strong relationships with. 
*[Paediatric Consultant (2)]: "Whenever we do our initial assessments (.) there's 
questions on the:ere ## risks to self and others:s # through self-h:arm # but also 
drinking (.) alcohol ## drugs etc # which feels ea:asy to ask when you're meeting 
someone for the fi:irst time (.) getting a lot of info:ormation from them 
 [Paediatric Nurse (1)]: Yes # rather than kno:owing them for yea:ars and yea:ars  
 [Paediatric Consultant (1)]: That's pa:art of the problem I think ## it makes it 
 ha:arder" 
This highlights the nature of nursing and caring for a population of people long-term, with 
HCPs highlighting how the close, personal relationships they form with patients can impinge 
upon their ability to ask personal or sensitive questions to patients, potentially due to 
embarrassment and not wanting to damage the strong patient-clinician relationship. 
Therefore HCPs believe the use of technology could overcome these awkward 
conversations. 
Conclusions 
 The dissemination meetings provide the researcher with clinical and practical insight 
into how these doctoral findings can inform current advice and practice in addressing the 
issue of risky behaviours within the CF population. Overall, HCPs acknowledge that they 
have limited awareness regarding the impact risky behaviours (predominantly excessive 
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alcohol consumption and illicit drug use) have upon CF patients, therefore they do not feel 
confident in instigating conversations regarding such behaviours. Consequently proactive 
awareness regarding risky behaviours appears to be rarely incorporated within CF care, with 
all CF units who the researcher contacted identifying procedures they have in place when a 
patient engages in a risky behaviour, but rarely discussing attempts to prevent initiation. 
HCPs were keen to identify that awareness regarding risky behaviours should not just be 
provided on a reactive basis, therefore they identified the need to have some form of staff 
training to raise HCPs awareness regarding these behaviours, allowing them to then 
correctly and confidently provide awareness to all patients on a proactive basis.  
 In providing awareness to patients, many HCPs identified that this should not just be 
done through verbal discussions, with it commonly being emphasised that technology should 
be used to provide such awareness. HCPs identified how technology could be used by 
presenting links on the CF unit's website which would provide standardised information 
across all CF units. In addition HCPs also identified the role that smart-phone apps could 
play to raise patients' awareness regarding risky behaviours. The use of smart-phone apps 
has been implemented into CF care in order to encourage adherence amongst patients 
(Smith, 2013).  
 It is documented that CF patients do see the benefit of smart-phone apps (such as 
Cystix) to assist with self-management, allowing them to set reminders to take their 
medication, providing dietary advice and also promoting psychological wellbeing by allowing 
them to communicate with other CF patients (Hilliard et al., 2014). Consequently if apps do 
exist which are aimed at the CF population, potentially work could be done to integrate 
education regarding risky behaviours into these apps, through working with experts who can 
provide CF-specific awareness about the adverse health effects of risky behaviours. It is 
believed that this information would need to be continually reviewed due to new risky 
behaviours which emerge on a regular basis, such as new legal highs, or vaping which has 
undergone a rapid normalisation process in recent years. In addition these apps could also 
contain tools to help patients avoid engagement in risky behaviours, with an obvious 
example being the use of an alcohol tracker. This would enable individuals to track how 
many units of alcohol they are consuming, to try and motivate them to only drink moderate 
amounts of alcohol, and to avoid excessive alcohol consumption and binge drinking 
(Change4Life, 2017). Overall the dissemination meetings, along with all previous phases of 
data collection do highlight a missed area within CF care, with this research demonstrating 
how best to inform current advice and practice to reduce the occurrence of risky behaviours 
within the CF population. 
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CHAPTER THIRTEEN: OVERALL SUMMARY 
 Before commencing this doctoral research, the researcher conducted a transition 
evaluation to investigate what information is provided to patients on risky behaviours, with 
this evaluation demonstrating that different CF services address risky behaviours in different 
ways, with many units not incorporating risky behaviours as a formal part of their transition 
process. All units contacted had procedures in place for when a patient is actively engaged 
in a risky behaviour, however there appeared to be missed opportunities in aiming to prevent 
initiation in risky behaviours. It was concluded from this transition evaluation that more 
emphasis does need to be placed on proactive interventions, with the researcher identifying 
the need for qualitative research to inform interventions, by exploring individuals' beliefs and 
attitudes towards risky behaviours (See Figure 2 for a visualisation of the overall findings of 
the four studies). 
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Figure 2. A mind map representation outlining the overall findings of the studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase One Data Collection Phase Two Data Collection 
Within both phases of data collection it was clear to see how many individuals with CF are not defined by their CF, 
instead they view themselves to be a "normal" person, engaging in "normal" activities. 
Transition Evaluation 
All units contacted had procedures in place for when a patient is actively engaged in a risky behaviour, 
however there appeared missed opportunities in aiming to prevent initiation in risky behaviours. It was 
concluded that more emphasis does need to be placed on proactive interventions. 
With many placing emphasis on their desire for normalcy, it was not surprising that many adult and paediatric 
participants discussed the challenge of disclosing their CF status to others, due to them not wanting their illness 
identity to be visible to society. 
In order to possess a normal identity and to appear normal in front of others, many participants within both phases 
of data collection explained how non-adherence and the engagement in normalised risky behaviours (pto for 
insight into the identified influential factors) can provide them with a sense of normalcy. 
Barriers and Enablers to adherence: 
 Many participants favoured less 
time-consuming treatments, with 
time-consuming treatments 
preventing individuals engaging 
in normal activities. 
 Ill health can result in periods of 
poor adherence or non-
adherence due to the individual 
not have the required energy to 
complete their medical regimens. 
 Psychological distress also 
reduces an individual's 
motivation to adhere to their 
medical regimens.  
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What influences the engagement in risky behaviours? 
Awareness: 
Participants highlighted the importance of awareness to help individuals understand why they cannot engage in such 
behaviours. This awareness originated from a number of sources: 
 Family (providing awareness, protecting their child from environments where risky behaviours are 
normalised, discipline) 
o Not all families provide this support, with some families normalising risky behaviour engagement 
 Friends (this is often successful as adolescents and young adults value social acceptance) 
o When friends normalise risky behaviours it can result in initiation due to a desire for social 
acceptance, with participants then seeing that risky behaviour as part of their group identity 
 HCPs  
o This awareness is provided on an individualised basis, with some participants explaining they have 
not received any awareness (pto for insight into how this informed phase three and phase four). 
Awareness is not enough to prevent an individual initiating in a risky behaviour 
Individuals can engage in risky 
behaviours to improve their 
quality of life and 
psychological wellbeing. 
Psychological distress can 
result in an individual 
engaging in a risky behaviour, 
to alleviate their feelings of 
stress and anxiety despite 
their awareness regarding the 
associated risks. 
Denial regarding CF can 
provide an individual with 
a gateway to engaging in 
risky behaviours. Even 
when participants reported 
awareness regarding the 
adverse health effects of 
risky behaviours, some 
participants still engaged 
in risky behaviours due to 
compensatory health 
promoting beliefs and 
selective focus. 
Negative 
relationships (e.g. 
domestic violence, 
arguments) can 
result in risky 
behaviour 
engagement to 
escape these 
negative 
relationships and 
improve an 
individual's 
psychological 
wellbeing. 
Not wanting to be 
defined by CF can 
motivate individuals to 
engage in behaviours 
which are away from 
their CF, these are 
often normalised 
behaviours, which 
could include risky 
behaviours normalised 
within an individual’s 
environment. 
Whilst acceptance often results in health promoting behaviours, it was indicated that individuals may still engage in risky 
behaviours despite accepting their CF due to: 
 Psychological Distress 
 A desire for normalcy 
 Not experiencing any of the adverse health effects 
 Unrealistic Optimism 
Pto for insight into how this has informed the recommendations for future interventions. 
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Phase Three Data Collection Phase Four Data Collection 
With adult and paediatric participants demonstrating that the issue of risky behaviours is approached on an 
individualised basis, the researcher identified the importance of speaking with HCPs to investigate how the 
issue of risky behaviours is approached in reality.  
HCPs identified that risky behaviours are a new issue within the CF population which are a major concern, 
having fatal consequences upon some patients. HCPs acknowledged that they do need to do more to 
address the issue of risky behaviours as the provision of awareness regarding the adverse health effects of 
such behaviours is not embedded within their practice. 
 
Despite HCPs identifying the need 
for interventions to be embedded 
within practice, it was identified that 
HCPs themselves have poor 
awareness regarding what risky 
behaviours are present within the 
general population, what impact they 
can have upon CF patients and how 
to address this issue with patients. 
Firstly an intervention needs to 
target HCPs to provide them with 
awareness regarding risky 
behaviours, HCPs will then be able 
to provide this awareness to 
patients.  
It was identified that awareness regarding the adverse 
health effects risky behaviours can specifically have upon 
CF  needs to be provided to patients on regular occasions 
by HCPs.  It was believed that this awareness should be 
delivered using the communication style preferred by 
adolescents and young adults, therefore HCPs identified 
the role a smartphone app could play in providing this 
awareness. This would allow patients to access 
confidential information regarding risky behaviours, 
allowing them to make a more informed choice about 
whether or not they want to engage in such behaviours in 
light of the consequences. 
The research identified that awareness is not always enough to prevent the initiation or aid the cessation of 
risky behaviours within the CF population. Therefore HCPs identified the need to have screening tools 
embedded within CF care on regular occasions (e.g. during annual reviews) to identify patients who may be 
vulnerable to engaging in such behaviours. It is believed that these screening tools should focus upon 
psychological distress and avoidance of CF, to help individuals cope with these aspects of their lives which in 
turn has the potential to reduce the occurrence of risky behaviours within the CF population. 
A screening tool would also be helpful to identify individuals engaging in risky behaviours. A new screening 
tool would be able to focus on new risky behaviours present within the general population (e.g. the use of 
vaping). 
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 The first phase of data collection within this doctoral research involved the researcher 
conducting qualitative interviews with adult CF patients, to gain insight into their reasons as 
to why they do or do not engage in risky behaviours. This phase of data collection did 
successfully highlight a variety of reasons as to why some individuals with CF engage in 
risky behaviours, and do not engage in health-promoting behaviours, demonstrating the 
need for more effective health promotion measures, to reduce the occurrence of such 
behaviours. The participants' narratives were retrospective which provided a time dimension 
to the data, and created a more comfortable environment for participants to disclose 
sensitive and embarrassing information, when they were more distanced from the event (De 
Vaus, 2006). 
 Importantly, phase one data collection highlighted that risky behaviour initiation, and 
the engagement of non-adherence commonly occurs during adolescence. The researcher 
therefore deemed it necessary for a second phase of data collection to be conducted within 
the paediatric CF population, before work on an intervention commenced. This second 
phase of data collection was both current and prospective, exploring paediatric participants' 
knowledge, beliefs and attitudes towards risky behaviours, at an age commonly associated 
with initiation. There were a number of common findings within these two phases of data 
collection. 
 Within both phases of data collection it was clear to see how many individuals with 
CF are not defined by their CF, instead they view themselves to be a "normal" person, 
engaging in "normal" activities. With many placing emphasis on their desire for normalcy, it 
was not surprising that many adult and paediatric participants discussed the challenge of 
disclosing their CF status to others, due to them not wanting their illness identity to be visible 
to society. In order to possess a normal identity and to appear normal in front of others, 
many participants within both phases of data collection explained how non-adherence and 
the engagement in normalised risky behaviours can provide them with a sense of normalcy. 
In terms of barriers and enablers to adherence, it was clear that many adult and paediatric 
participants favour less time-consuming treatments, with time-consuming treatments 
preventing individuals engaging in normal activities. Many adult participants explained how 
they would engage in occasional non-adherence in order to engage in normal activities that 
they did not want to miss out on, demonstrating their life-orientated illness perspective. This 
was also demonstrated within the paediatric population, with many participants explaining 
how they wish they could engage in normal activities instead of adhering to their complex 
and time-consuming medical regimens. Within both phases of data collection it was 
highlighted how ill health can result in periods of poor adherence or non-adherence, due to 
the individual not having the required energy to complete their medical regimens, with this 
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predominantly impacting on physiotherapy regimens. In addition, psychological distress also 
reduces an individual's motivation to adhere to their medical regimens in both populations.
 In terms of risky behaviours, participants within both phases of data collection spoke 
about how important awareness is regarding the adverse health effects of risky behaviours, 
to help patients understand why they cannot engage in such behaviours. This awareness 
originated from a number of sources. Both adult and paediatric participants explained that 
this awareness can be provided by their families, with participants often stating that their 
family have made them aware of the adverse health effects, and they are also aware that 
their family would discipline them if they engaged in such behaviours. It was also clear within 
both phases of data collection that when an individual has disclosed their CF status to their 
friends, their friends often work to prevent the individual initiating in a risky behaviour, with 
their peers’ efforts often being successful. However, families and friends do not always 
provide this support, with some participants explaining how their family and friends have 
normalised risky behaviour engagement, with participants in phase one data collection 
demonstrating how normalisation can result in initiation, often due to a desire for normalcy. 
Participants did point out that when they had been provided awareness regarding the CF-
specific adverse health effects of risky behaviours and accepted that awareness, they did 
not engage in risky behaviours despite this normalisation. Therefore, with the data 
demonstrating that the support an individual receives in their private life varies between 
individuals, the importance of awareness originating from HCPs on the CF-specific adverse 
health effects of risky behaviours was emphasised within both phases of data collection. It 
was clear that the adult and paediatric CF population receive awareness regarding risky 
behaviours from HCPs on an individualised basis, with some participants explaining that 
they have not received this awareness. This highlights the need for standardised 
interventions to be implemented into CF care to provide patients with awareness on risky 
behaviours on a regular proactive basis, regardless of an individual's personal condition.  
 Within both phases of data collection it was clear that awareness is not always 
enough to prevent an individual initiating in a risky behaviour. Psychological distress can 
result in an individual engaging in a risky behaviour, to alleviate their feelings of stress and 
anxiety despite their awareness regarding associated risks. Adult participants provided 
several examples of this, with paediatric participants highlighting the role of psychological 
distress through talking in the third person. In addition, some participants within phase one 
data collection, and one participant within phase two data collection, demonstrated 
compensatory health beliefs enabling their engagement in risky behaviours to continue, 
despite their awareness that these behaviours can be harmful towards their health. Some 
participants also demonstrated the role affective beliefs can have in influencing their 
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engagement in risky behaviours, with adult participants highlighting how enjoyment of a 
"risky" behaviour often results in continuation of that behaviour, regardless of an individual's 
awareness of the risks. Within the paediatric population it was clear that when interventions 
produced a strong negative affect within an individual, it resulted in the individual having 
negative views towards that behaviour, and not desiring initiation. Information regarding a 
risky behaviour needs to be accurate, clear and not over fearful. Participants within phase 
one data collection explained that when the experience of risky behaviour experimentation 
was not as bad as they had been told, they mistrusted and did not believe all other 
information they had been given, resulting in the continuation of their behaviour despite the 
awareness they had been provided.  
 With many participants reporting a lack of awareness regarding the adverse health 
effects of risky behaviours provided by HCPs, the researcher deemed it essential to talk with 
HCPs regarding what awareness they provide patients with, and which patients receive this 
awareness. The researcher recruited CF Specialist Nurses for phase three data collection, 
due to participants within both phases of data collection describing Nurses to be the most 
approachable member of the MDT, disclosing more information to Nurses than other HCPs. 
Therefore it was believed Nurses would be well placed to offer valuable insights into the 
issue of risky behaviours and effective interventions. The telephone interviews with Nurses 
did generate an in-depth understanding on how Nurses perceive the issue of risky 
behaviours within the CF population, and what interventions they believe would work. Before 
work started on creating an intervention the researcher did identify the importance of 
speaking to, and collaborating with other HCPs, in order for the research to have "real world" 
impact in the practice of health care. The final phase of data collection allowed the 
researcher to disseminate the research findings, allowing HCPs to critique these findings 
and offer suggestions regarding what interventions would work in reality. Phase three and 
phase four data collection both provide recommendations for how a new intervention should 
look within the CF population, to reduce the occurrence of risky behaviours, highlighting the 
practical applications of this research. 
Recommendations 
 While all CF units contacted reported having procedures in place if a patient engages 
in a risky behaviour, a common finding highlighted within the transition evaluation, and by 
HCPs within phase three and phase four data collection, is the lack of proactive awareness 
CF patients are provided with regarding the CF-specific adverse health effects of risky 
behaviours. Without this awareness patients are not able to make an informed choice as to 
whether or not they wish to engage in such behaviours, which are commonly normalised 
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within their environment. HCPs identified that risky behaviours are a missed area within CF 
care, with awareness regarding risky behaviours not being embedded within practice. 
Consequently it was identified that individuals with CF often seek awareness regarding such 
behaviours from elsewhere, such as the internet, where inaccurate information can be 
displayed. It was evident within this doctoral research that the issue of risky behaviours is 
approached on an individualised basis, with different patients (within the first two phases of 
data collection) at the same CF unit not always having the same awareness regarding risky 
behaviours. This research therefore highlights the need for proactive interventions to be 
integrated into CF care in order to reduce the occurrence of risky behaviours.   
 In order to provide awareness, HCPs within phase three and phase four data 
collection identified that they firstly require some form of staff training, to raise their 
awareness as to what risky behaviours are current within the general population, what 
impact they can have upon CF patients, and how HCPs should approach the issue of risky 
behaviours, whilst being in line with safeguarding and confidentiality policies. The need for 
staff training was also raised by the adult CF population, with some participants expressing 
their beliefs that HCPs are naive and are not aware of what risky behaviours are present 
within the general population. In terms of providing awareness to CF patients, all phases of 
data collection, along with the transition evaluation demonstrate that this awareness needs 
to go beyond verbal awareness, in order to provide standardised information to all patients 
regardless of their personal condition. HCPs identified that verbal information could be 
implemented on a reactive basis, where the information does need to be individualised, 
whereas technology could administer a proactive intervention.  
 HCPs identified the role smart-phone apps could play in presenting such information, 
with this intervention having the potential to reach hard to reach groups (e.g. those who do 
not attend clinic appointments, who HCPs suspect engage in risky behaviours), and 
fostering the communication style used by individuals at an age where initiation in risky 
behaviours commonly occurs. The use of technology would allow individuals with CF to seek 
accurate information regarding risky behaviours in a confidential way, with this doctoral 
research indicating that such awareness needs to be administered to individuals from the 
age of 12 years and above. It was also highlighted that this awareness needs to be revisited 
on several occasions, with patients within phase one and phase two data collection often 
remembering that the provision of awareness was implemented into their care, but not being 
able to recall what awareness was provided. In order to revisit such information HCPs 
identified a role for the annual review. As well as awareness implemented into one's care by 
their CF unit, proactive awareness could be provided online via the CF Trust, which currently 
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does not offer any awareness regarding smoking or illicit drug use, and only distributes 
minimal awareness regarding excessive alcohol consumption. 
 All phases of data collection highlight how awareness administered to patients would 
need to be revised on regular occasions due to the emergence of new risky behaviours, in 
order to accurately document to patients what behaviours are risky for the CF population, 
and what impact they can have upon their CF. For instance, a new risky behaviour that has 
emerged is the use of e-cigarettes, with paediatric participants explaining how some 
individuals engage in this behaviour despite never smoking conventional cigarettes. 
Research is required to investigate the respiratory complications associated with this 
behaviour, to see whether or not this could have an impact upon one's CF. Quantitative 
research would also be useful to investigate the incidence and prevalence of "vaping" within 
a CF population, to investigate whether an intervention does need to specifically focus upon 
this new "risky behaviour". 
 As well as this doctoral research highlighting the need for proactive awareness to be 
embedded within CF care regarding the adverse health effects of risky behaviours, this 
research did also highlight factors that can influence engagement in such behaviours. All 
phases of data collection highlighted the role psychology can play within an intervention, in 
terms of screening patients for these "potential predictors". Adult and paediatric participants 
identified the role psychological distress, avoidance of CF and negative family interactions 
can play in influencing engagement in such behaviours, with HCPs also identifying these 
factors as influential within risky behaviour engagement. Consequently a screening tool 
could be created to identify these "at risk" groups; with HCPs then having the opportunity to 
help such patients cope with these aspects of their lives, in order to attempt to reduce the 
occurrence of risky behaviours within the CF population. In terms of avoidance of one's CF, 
a proactive intervention could be introduced which would encourage all individuals with CF 
to take ownership of their CF, by highlighting CF's true nature whilst instilling a sense of 
hope and optimism within patients. In terms of highlighting CF's true nature to individuals, 
this should focus upon the practicalities of their condition, and what that means for their life. 
For example, with adolescent patients this could involve providing awareness on what 
behaviours an individual can and cannot (or should not) engage in, in order to protect their 
health. It is acknowledged that making individuals aware of the fatal nature of CF is not 
always advantageous, therefore as explored within previous chapters, awareness within this 
intervention should just focus upon the practical aspects of the condition. HCPs also 
identified the role mentoring could play as a way to reduce the occurrence of risky 
behaviours within the CF population, by offering patients online support from individuals who 
truly understand their condition, reducing feelings of isolation. 
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Limitations 
 Overall, this research has highlighted to CF HCPs within the Midlands a missed area 
which could have detrimental impacts upon some patients. This research provides practical 
insight into policy change for the prevention and reduction of risky behaviours within the CF 
population, by informing current advice and practice. Nonetheless, limitations of this 
research do need to be acknowledged. For the majority of the research two CF units were 
used (Birmingham Heartlands Hospital and the Royal Stoke University Hospital); whilst 
qualitative research does not aim to generalise findings to the wider population, the aim of 
this research is to create an intervention to reduce the occurrence of risky behaviours within 
the UK CF population, in part by providing standardised information across all UK CF units. 
However an individual's attitudes and beliefs regarding risky behaviours is likely to partly be 
influenced by their environment, with research acknowledging that economic distress can 
play a big role in the initiation of risky behaviours within the general population (Board on 
Children, Youth and Families, 2011). Therefore the effectiveness of an intervention is likely 
to vary depending upon the location of the CF unit, and potentially would need to be 
modified depending upon that area to maximise its effectiveness. Consequently further 
research could be conducted to gain an insight into the incidence and prevalence of risky 
behaviours (smoking, excessive alcohol consumption and illicit drug use) across all UK CF 
units, to identify where emphasis needs to be more thoroughly placed. 
 Limitations of data collection methods also need to be acknowledged. Within the first 
phase of data collection retrospective interviews were used. While this study design enables 
participants to assess the influence a situation had upon their identity and experiences, 
when they are more distanced from it (Taylor, 2008; Yates et al., 2010), it is not without its 
limitations, and can contain several sources of bias. Retrospective interviews can result in 
selective memory, where the participant remembers, or does not remember, certain events 
which happened in their past which could have been an influential factor affecting their 
initiation in risky behaviours (Wittrock & Foraker, 2001). Retrospective interviews can also 
result in telescoping, where an individual recalls an event that happened at one time, as if it 
happened at another time e.g. recalling that suicidal thoughts occurred prior to initiation, 
whereas in reality such thoughts occurred after the individual had initiated in risky 
behaviours (Johnson & Schultz, 2005). Attribution is also an issue within retrospective 
accounts, where individuals will attribute positive events to one's own agency, but attribute 
negative events to external forces (Aguinis & Edwards, 2014). Furthermore, exaggeration is 
another form of bias which can occur during retrospective accounts, where an individual 
represents outcomes as more significant than reality (Aguinis & Edwards, 2014). 
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Nonetheless, while these limitations do need to be acknowledged, the whole purpose of 
qualitative research is to recognise what is important to each individual participant, rather 
than establish honesty, reliability and validity, therefore this research did accept what 
participants said during the interviews as their stories, with all participants offering great 
insight into their lives with CF and their decisions regarding risky behaviour engagement.  
 During the retrospective interviews it was deemed necessary to conduct prospective 
interviews in the following phase of data collection with adolescent CF patients, to explore 
their knowledge, awareness and attitudes towards risky behaviours at an age commonly 
associated with initiation. Prospective interviews can work to overcome the above mentioned 
biases with retrospective accounts, allowing the research to examine participants' attitudes 
and beliefs towards risky behaviours in real time (Lally, 2007). However, again this phase of 
data collection is not without its limitations. Firstly, during five interviews guardians were 
present for the entire interview, with it being accepted that their presence will have had an 
impact on what information was disclosed during the interview; adolescents were unlikely to 
disclose experimentation with risky behaviours while their legal guardians were present 
(Economic and Social Research Council, 2017). Even in the absence of legal guardians, a 
limitation of prospective interviews is the likelihood of social desirability bias. The researcher 
was aware that participants were unlikely to report current experimentation or engagement in 
risky behaviours to the researcher regardless of whether or not their guardians were present, 
due to participants being likely to believe that these behaviours are "undesirable" (Schwarz, 
2004), despite the researcher’s effort to generate rapport and demonstrate a non-
judgemental approach. For this reason, the research was not investigating engagement with 
risky behaviours within this phase of data collection, instead it was focusing upon one's 
attitudes, beliefs and awareness towards risky behaviours, with the researcher paying 
attention to the discourse of participants to try and identify accounts that had been 
influenced by social desirability bias.  
 Another data collection limitation that should be highlighted is the use of telephone 
interviewing within phase three data collection. With few qualitative studies employing 
telephone interviews (Sturges & Hanrahan, 2004), literature has reported that it can be 
viewed as "the less attractive" alternative to face-to-face interviewing (Novick, 2008). It is 
argued that the absence of visual cues via telephone results in a loss of contextual and 
nonverbal data, and can also influence the rapport generated during the interview, and the 
researcher’s ability to probe and truly interpret the responses of participants (Garbett & 
McCormack, 2001; Novick, 2008; Smith, 2005; Sturges & Hanrahan, 2004). Whilst this data 
collection method does not contain nonverbal information, it does have to be acknowledged 
that this data is not always essential, with nonverbal cues not always being used extensively 
221 
 
in analyses that heavily rely on transcripts rather than field notes (Novick, 2008). In addition 
there is always the possibility that nonverbal data has been misinterpreted (Burnard,1994; 
Chapple, 1999; Sturges & Hanrahan, 2004). The researcher did consider these limitations, 
however valued the anonymous nature of telephone interviewing, believing that it would 
allow the Nurses to relax and feel able to disclose sensitive information about their CF unit's 
practice (Sweet, 2002). This data collection method also decreased the travel required by 
the researcher, allowing this research to reach geographically dispersed participants 
(Novick, 2008). 
Conclusions 
 Overall this research does provide practical insight into policy change for the 
prevention and reduction of risky behaviours within the CF population nationally and 
internationally, by informing current advice and practice. Throughout this research HCPs 
have acknowledged that they require awareness and tools around risky behaviours, with the 
provision of awareness regarding risky behaviours not appearing to be implemented into CF 
care on a proactive basis. Standardised, easily implemented and evidence-based practice is 
therefore required throughout UK CF centres, to provide awareness to patients from the age 
of 12-years, with this awareness needing to be revisited on several occasions. This research 
identifies a role for technology in administering this awareness. Awareness regarding risky 
behaviours would allow individuals with CF to make a more informed choice on engagement 
with such behaviours. However, as discussed, an intervention needs to go beyond providing 
awareness, with this research making a useful contribution to literature in highlighting factors 
that influence the engagement in risky behaviours within the CF population.  
 Consequently, as explored in previous chapters, an intervention firstly needs to 
inform HCPs regarding risky behaviours; both in terms of why patients may engage in such 
behaviours, along with the CF-specific adverse health effects these behaviours can have 
upon CF patients. It is then identified the intervention needs to focus upon patients. This 
research demonstrates the need for an intervention to screen for psychological distress and 
avoidance of CF as influential factors affecting initiation in risky behaviours, as well as 
identifying those who have negative relationships within their lives. Identified patients should 
then be offered assistance to cope with these aspects of their lives, which in turn would have 
the potential to reduce the occurrence of risky behaviours within the CF population, 
potentially through encouraging such patients to develop emotional sobriety (Sweet & Miller, 
2016). This support could in part involve the use of patient advisory groups, or mentoring, 
which have been successfully set up within the USA to allow CF patients to communicate 
and encourage positive health behaviours amongst one another (Moog, 2016). 
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 In addition, this doctoral research points out that all patients should be informed on 
the adverse health effects of risky behaviours regardless of their personal condition, and this 
awareness should be administered on a proactive basis, through the use of technology. It is 
therefore believed that the researcher now needs to take this research further afield, to 
ensure an intervention would be welcomed into all UK CF units. In terms of designing the 
intervention, the researcher proposes to collaborate with patients, HCPs, as well as the UK 
CF Trust, providing the possibility of impact at national and international levels by 
dissemination of findings and reporting standardised practices. 
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Appendix A 
Extracts from the Researcher's Reflexive Diary 
 The researcher presented this research (aims and methodology to begin with and 
then findings as they emerged) at the following conferences and research meetings: The 
North American Cystic Fibrosis Conference 2014, RESCON14, The National Cystic Fibrosis 
Nursing Association Study Day 2015, The European Cystic Fibrosis Conference 2015, BLSS 
Faculty Research Conference 2015, The North West Midlands Cystic Fibrosis Regional 
Meetings 2015, 2016; RESCON 15; Birmingham Heartlands Hospital CF Multi-Disciplinary 
Team Meeting 2016; The International CF Conference 2016; Well-Being Conference 2016; 
The North American CF Conference 2016; RESCON 17; The European Cystic Fibrosis 
Conference 2017. 
 Through presenting this research the researcher was able to reflect and act upon 
points made by fellow academics and HCPs: 
Postgraduate Certificate in Research Practice: 
 During a presentation as part of the PgCert in Research course the researcher was 
asked two questions: 
1) Are "risky behaviours" a negative thing or are they just a normal process within 
adolescence? 
2) Can you prevent "risky behaviours" 
The researcher reflected upon these questions and concluded (as taken from the 
researcher's reflexive diary and incorporated into the literature review) that: 
"Adolescence is a time characterised by the experimentation of risky behaviours (Suris & 
Parera, 2005). However despite literature acknowledging that risky behaviours within 
adolescence is quite common, there is a line which causes these normal experimental 
behaviours to escalate to behaviours that put the individual at risk (Richmond, 2014) e.g. 
smoking for adolescents in the general population may be viewed as just an experimental 
behaviour, however for an adolescent with CF it is an extremely risky behaviour. In addition 
it is considered normal in the general population for adolescents to go out and socialise with 
alcohol after the age of 18 years, but for a CF patient there is the risk of hypoglycaemia and 
pancreatitis.  
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Furthermore the existing discussion on adherence has accepted that increasing adherence 
(and decreasing risky behaviours) is a positive outcome (Abbott et al., 1996), without 
acknowledging that avoidance of regimens and the initiation in risky behaviours may be 
rational and represent an active choice (Mitchell & Selmen, 2007) which should be 
respected. However patients cannot make a rational choice if they have not been presented 
with enough information on the consequences of such behaviours (as found in the transition 
evaluation).  
By providing patients with information on risky behaviours it would not necessarily prevent 
the initiation of these behaviours, but it would allow CF patients to make a more informed 
choice on whether or not they want to engage in those behaviours in light of their knowledge 
of the consequences." 
 
Cystic Fibrosis Nursing Association Study Day 2015: 
 Through speaking to Nurses about the transition process at different CF regional 
units the researcher was provided with some very interesting feedback (taken from the 
researchers reflexive diary). The researcher presented the transition proforma that a UK 
Hospital stated they use to guide the conversation that HCPs have with patients, including a 
discussion on risky behaviours. However a Nurse from the same hospital informed the 
researcher that he had never seen that document, indicating that in best practice the hospital 
uses this document to guide the conversation, but in reality the document is not used. 
 
European Cystic Fibrosis Conference 2015: 
 [Taken from the researchers reflexive diary]  
"It was a really valuable experience to attend the European Cystic Fibrosis Conference in 
Brussels. My supervisor and I agreed that there is a gap within the current research within 
CF where my research can sit. Whilst there is research focusing upon the psychological 
implications of this disease, there is virtually no mention of risky behaviours within the 
current research. I was delighted to receive the Young Investigator Award during the closing 
ceremony. This is a fantastic recognition for my work and demonstrates that my work is both 
current and relevant." 
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UK Cystic Fibrosis Conference 2015: 
 [Taken from the researchers reflexive diary] 
"This was a fantastic experience for me to network with professionals within the field of CF, 
and to have an insight into the most current research being conducted within this area. I was 
particularly pleased to see an emphasis on adolescence by Dr Bryon and the behaviours 
they may engage in to seek 'rewards'. However no solutions were provided on how to 
overcome this issue - this is something my PhD research will hopefully provide". 
 
North West Midlands Cystic Fibrosis Regional Meeting: 
 [Taken from the researcher's reflexive diary]  
 The researcher presented the preliminary findings from phase one data collection to 
the MDT at their regional meeting, allowing the researcher to reflect upon the MDT's views 
on these findings: 
"It was stated that the aim of the intervention should not be to prevent risky behaviours, but 
to provide more education. I agree with this (and should change the discourse of this) as it 
has to be acknowledged that the engagement in such behaviours is an active choice which 
may be rational and should be respected - however patients should have enough information 
to make a more informed choice on their engagement." 
 
Support from Participants and HCPs: 
 [Taken from the researcher's reflexive diary] 
"Participants have also acknowledged the need for my research, with participant 11 (phase 
one data collection) stating that my information sheet made sense - it made sense that 
someone should investigate this. Furthermore, participant 9 (phase one data collection) 
stated that my research was great and that more people should look into CF to raise 
awareness for the condition. 
As well as patients seeing the relevance of my research, HCPs have also been very 
supportive. HCPs have encouraged me during the research process, and state that the 
interviews (both adult and paediatric interviews) have been a success as I am an 
approachable individual. They also stated that my interviews are useful to help patients 
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acknowledge the reasons behind their behaviours. Again the reactions from staff and 
patients illustrate the relevance of my research". 
 
North American Cystic Fibrosis Conference 2016: 
 [Taken from the researchers reflexive diary] 
"I attended the NACFC in Orlando, Florida and presented my research as a poster 
presentation. This was a fantastic opportunity and I was pleased that my poster generated a 
large amount of interest with a lot of researchers / practitioners questioning me regarding the 
research. Everyone was very supportive of my research and findings, acknowledging its 
practical applications, increasing the validity of these findings. 
In addition, I was asked during my time at the conference if I would be interested in 
conducting a qualitative analysis for the UK Cystic Fibrosis Trust. This involved me analysing 
open ended responses from the patient preference response survey, and I got the 
opportunity to present these findings at the European Cystic Fibrosis Conference 2017 in 
Seville." 
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Appendix B 
Adult Interview Schedule 
Ice Breakers Question’s: 
 Thank you for taking part 
 What were your first thoughts when you were asked to take part in this research? 
 Did you have any hesitations about agreeing to take part? 
 So to begin with, can you tell me a bit about your life? 
o What do you do in your spare time? 
o Do you work / study? 
o Live with your family? 
 
Impact of Cystic Fibrosis on the patient’s personal life: 
 Could you tell me about some of the challenges in terms of living with Cystic 
Fibrosis? 
 Has it always been this, or were other aspects / things more difficult to cope with 
when you were younger? 
 How do you find it sticking to your treatment regimen? Are there any aspects that are 
more difficult? 
 Has this changed over time / circumstances? 
 What treatments do you tend to “miss out”? 
 At the end of the day if you have missed a treatment how does it make you feel? 
 When you wake up in a morning do you plan to do all your treatments? 
 Are there some days when you wake up and you know you're just not going to do 
everything? 
 
Barriers to Adherence: 
 What things make it difficult to stick to the regimen?  
Areas for further elaboration may include: 
 
o Not enough time in the day with their job etc 
o The belief that the medical regimen is not benefitting them 
o The fear of antibiotic resistance 
o Are they self-prescribing according to their symptoms 
o Ask whether this is of a weekday / weekend 
 
 Are there any situations where you are less likely to take your medication / complete 
your physiotherapy? 
Areas for further elaboration may include: 
o At college / work 
o At a friend’s house 
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 What makes it harder to complete your regimen in these situations? 
 
o An area for further exploration may include the identity the medical regimen 
provides them with 
 
Risky Health Behaviours: 
 Are there things that you think are “not good” for your health?  
Examples may include: 
o Smoking 
o Drugs 
o Drinking alcohol 
 Do you feel that these behaviours have an impact on your Cystic Fibrosis? 
 Is there anything else in your life that you may not do if you were being "really 
healthy"? 
 
Smoking (CAN BE ADAPTED TO ANY RISKY BEHAVIOUR): 
 Did you think about Cystic Fibrosis when you started smoking? 
 About how old were you when you started smoking? 
 Can you remember why you started smoking, what were the triggers, what did you 
think about at the time? What was happening? 
 Some people with health problems say that they engage in behaviours that are not 
good for their health because these behaviours give them a sense of being “normal". 
What do you think about that? 
 Have you ever tried to stop smoking? Why? How did you find it? 
 What do you hope for your future in terms of smoking? 
 
Family and Friends: 
 Are you open with family and friends about your smoking? What do they think about 
it? What is their reaction? 
  “Other” may include:  
o Parents 
o Siblings 
o Partner 
 
 Are you open with your friends about your Cystic Fibrosis? What do they think about 
your Cystic Fibrosis? What is their reaction? 
 
 Who do you go to with any concerns regarding your Cystic Fibrosis?  
Example may be: 
o Consultants 
o Family 
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o Friends 
o Online forums 
o Do you speak to Cystic Fibrosis patients face to face? 
 
Conclusion: 
 What would you want to tell a young patient with Cystic Fibrosis? 
 What would you tell a family who had just had a child with Cystic Fibrosis, or who 
have a young adult with Cystic Fibrosis? 
 Honestly if you were to have this discussion with another person who has Cystic 
Fibrosis, outside of this research, would this conversation be the same? 
 Do you have anything else to add? 
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         Appendix C - Adult Handout 
Title of study: The role of health beliefs in predicting and explaining lifestyle choices 
within Cystic Fibrosis patients 
Researchers: Rebecca Keyte, Dr Helen Egan, Dr Anna Regan, Dr Angela McGowan. 
 
What is the research about? 
We are investigating Cystic Fibrosis (CF) patients' views about their current or past lifestyle 
choices. We are interested in your personal views and experiences about your lifestyle 
choices, and how they impact upon your health and wellbeing (both in a positive way or 
negative way).  
What are lifestyle choices? 
We are interested in hearing your experiences of living with CF; and hearing about choices 
you have made both in the past and now around smoking, drinking alcohol and taking drugs.  
Who can take part? 
Anybody who has CF and is 18 years or over can take part in this research. It does not 
matter if you have never smoked, drank alcohol or taken drugs, we would still like to talk to 
you and hear your experiences of living with CF and the reasons why you made decisions 
about certain lifestyle choices.  
What will this research involve? 
It is completely up to yourself whether or not you want to take part in this research. If you do 
decide to take part, you will be interviewed by Rebecca Keyte to investigate your personal 
views and experiences about your lifestyle choices. This interview will be audio recorded so 
the researcher can listen back over the interview again and analyse the material; this 
recording will not be listened to by anyone outside of the research team. This interview will 
take a maximum of 60 minutes and will take place at Birmingham Heartlands Hospital on a 
date suitable for yourself. None of the information collected about you during this study will 
be seen by anyone including the staff treating you. You do not have to answer any questions 
that you do not want to during the interview, and you can leave the interview at any time 
without providing a reason. You will be given the opportunity to read through your interview 
and ask for anything to be taken out if you wish to do so. 
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Appendix D 
ADULT CONSENT TO CONTACT FORM 
 
Title of Study: The role of health beliefs in predicting and explaining lifestyle choices within 
Cystic Fibrosis patients. 
 
Name of Researcher: Rebecca Keyte 
 
Please complete this form if you are happy for the researcher to contact you to discuss this 
study. 
   Please initial 
the box 
 
1. I confirm that I have read the research information sheet for the above study. 
 
2. I agree that my care co-ordinator can inform the above researcher of my medical 
condition in order to assess my eligibility to participate in the above study.   
 
3. I understand that my personal contact details below will be stored securely, in 
line with the data protection act. 
 
4. I agree that the researcher can contact me to discuss my participation in the 
above study using my contact details below. 
 
Full Name:  _________________________________________________________ 
Address:  ___________________________________________________________ 
 
 
Telephone:  ______________________ Mobile:  ________________________ 
Email:  _________________________________ 
Preferred Time to be contacted: Morning Afternoon Evening (please circle) 
Preferred Method of contact: Home  Mobile  Email (please circle) 
Many thanks for expressing interest in this study. You will be contacted, as per your stated 
preferences within 24-48 hours to discuss the research further. As previously explained, there is no 
obligation to commit to the study at this time and whether you participate or not, this will not affect 
the care or treatment you receive under normal routine care. 
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Appendix E 
Adult Information Sheet and Consent Form 
 
 
 
Title of study: The role of health beliefs in predicting and explaining lifestyle choices 
within Cystic Fibrosis patients 
 
You are being invited to participate in a research study. Before you make a decision 
on whether to take part, it is important for you to understand why the research is 
being done and what it will involve. Please read the following information carefully 
and discuss it with others if you wish. Please feel free to ask us any questions if 
there is anything that is not clear or you would like more information on before you 
decide whether to participate or not. Thank you for reading.  
 
Introduction to the research and invitation to take part 
This study aims to investigate Cystic Fibrosis (CF) patients' views about their current or past 
lifestyle choices. Participants are being recruited from the West Midlands Adult Cystic 
Fibrosis Centre at Heartlands Hospital, and at the North West Midlands Adult Cystic Fibrosis 
Centre at the Royal Stoke University Hospital. You are identified as potentially suitable to 
take part in this study. The members of the research team are: Rebecca Keyte (Psychology 
Graduate), Dr Helen Egan (Health Psychologist), Dr Anna Regan (Clinical Psychologist) and 
Dr Angela McGowan (Consultant Respiratory Physician). 
 
What is the purpose of the study? 
We are interested in your personal views and experiences about your lifestyle choices, and 
how they impact on your health and wellbeing. There is very little research which asks 
people with CF directly how they feel about their choices and about what factors might 
influence the health choices that they make. The findings from this research will be useful for 
health professionals to help support people with CF, particularly young people who are 
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beginning to make independent decisions around their own health and lifestyle. If we 
understand more about why people make choices that may not be good for their health, we 
can offer more effective support to encourage positive health and lifestyle choices. 
 
Do I have to take part? 
It is up to you whether to take part or not. You will be approached, and will complete this 
study in a private room at your Cystic Fibrosis Centre; you will not be expected to complete 
any part of this study in the public waiting room. To help you decide if you want to 
participate, we will first describe the study and if you express an interest, we will give you 
this information sheet. If after reading this sheet and having any questions answered, you 
are still keen to participate, we will ask you to sign the consent form. You are free to 
withdraw from this research at any time without giving a reason. This would not affect the 
care that you receive in any way. 
 
Why have I been asked to participate? 
You have been asked to consider participating in this study because you have Cystic 
Fibrosis, and are cared for either at the West Midlands Adult Cystic Fibrosis Centre or the 
North West Midlands Adult Cystic Fibrosis Centre. 
 
What will I have to do if I participate? 
If you decide to participate, you will be interviewed by Rebecca Keyte to investigate your 
personal views and experiences about your lifestyle choices, and how they impact on your 
health and wellbeing both positively and negatively. This interview will be audio recorded so 
the researcher can listen back over the interview again and analyse the material; this 
recording will not be listened to by anyone outside of the research team. This interview will 
take a maximum of 60 minutes. None of the information collected about you during this study 
will be seen by anyone including the staff treating you. We will also record your latest lung 
function results from your medical notes. 
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What are the possible risks of participating? 
There are no risks from participating in this study as the information that you provide in this 
research will be strictly confidential. The information will be anonymised, which means that 
all identifying information will be removed and will not be seen by anyone including the staff 
treating you.   
 
Are there any possible benefits? 
There are likely to be no direct benefits to you by participating in this study. The findings 
from this research will be useful for health professionals to help support people with CF, 
particularly young people who are beginning to make independent decisions around their 
own health and lifestyle. 
If you do become distressed during the interview you will be referred to Dr Anna Regan 
(Clinical Psychologist at Heartlands Hospital) or Dr Angela McGowan (Consultant at the 
Royal Stoke University Hospital). 
 
What do I do now? 
Once you have read this information sheet and have had any questions answered to your 
satisfaction, we will ask you if you are still keen to participate in the study. If so, we will ask 
you to sign a consent form, and arrange a date / time of when we will conduct the interview 
(possibly on the same day as you consenting depending on your availability). We will also 
obtain the information about your lung function from your medical notes.  
 
What if there are any problems? 
We do not anticipate there to be any problems in taking part in this study. Participants will be 
given the option of results feedback with the researcher to talk through any issues raised 
during this research. 
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What if I have a complaint? 
In the unlikely event of you having any complaints about any aspects of the study, we will do 
our best to answer these complaints. If you would prefer to speak to someone independent 
of the research team about your complaint then you can contact your local Patient Advice 
Liaison Service (PALS) Team: 
Heartlands Hospital: Telephone 0121 424 1212 or email pals@heartofengland.nhs.uk 
Royal Stoke University Hospital:  Telephone 01782 676450 or 01782 676455 or email 
patient.advice@uhns.nhs.uk   
However, we do not expect any harm to come to you during the course of this study. If you 
are harmed by taking part in this research project there are no special compensation 
arrangements outside that of the NHS. 
 
Will my taking part in the study be kept confidential? 
Yes, we will follow ethical and legal practice and all information about you will be handed in 
confidence. However if you were to disclose some information within the interview that 
indicated the potential harm to either yourself or others then the researcher may have to 
report this information to a suitable authority. 
 
What happens at the end of the study? 
Throughout the study, and when it ends, your hospital Doctor and General Practitioner will 
continue to monitor you as usual. 
 
What happens if I have more questions? 
If you do not understand something in this leaflet, or have further questions you may ask the 
researcher now. Or you can contact the researcher via email or telephone on: 
Rebecca.Keyte@mail.bcu.ac.uk / 07957157974; or Dr Helen Egan on: 
Helen.Egan@bcu.ac.uk ; or Dr Anna Regan on: anna.regan@heartofengalnd.nhs.uk ; or Dr 
Angela McGowan on: Angela.McGowan@uhns.nhs.uk  
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What happens now if I decide to participate? 
If you decide to participate you will be asked to read, sign and date the written consent form 
attached to this sheet. By signing it you acknowledge that you have understood the aims of 
the research, and what you are being asked to do. 
 
Will my General Practitioner (GP) be informed? 
We do not plan to inform your GP about your participation in the study, but can do if you 
wish. 
 
What happens if I change my mind during the study? 
You are free to withdraw your participation at any time, and it will not affect your future care. 
 
Who is organising and funding the study? 
The study has been organised by Rebecca Keyte, Dr Helen Egan, Dr Anna Regan and Dr 
Angela McGowan at Birmingham Heartlands Hospital and The Royal Stoke University 
Hospital. These will not be paid for including you in this study. In addition unfortunately we 
are unable to pay for travel expenses.   
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity. This study has been 
reviewed and given favourable opinion. 
 
Who can I contact about the study? 
In the first instance any concerns or questions should be addressed to Rebecca Keyte 
(Rebecca.Keyte@mail.bcu.ac.uk / 07957157974) or Dr Helen Egan 
(Helen.Egan@bcu.ac.uk) or Dr Anna Regan (anna.regan@heartofengalnd.nhs.uk) or Dr 
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Angela McGowan (Angela.McGowan@uhns.nhs.uk). If you have further concerns you can 
contact your Patient Advice Liaison Service (PALS) 
Heartlands Hospital: Telephone 0121 424 1212 or email pals@heartofengland.nhs.uk 
Royal Stoke University Hospital:  Telephone 01782 676450 or 01782 676455 or email 
patient.advice@uhns.nhs.uk   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
275 
 
 
 
REC Number: 14/EM/1183    Enrolment Number: 
Title: The role of health beliefs in predicting and explaining lifestyle choices within Cystic Fibrosis 
patients 
I ................................................................................. (Name in BLOCK CAPITALS)  
        
1. Have read the attached information concerning my participation in this study and have had 
the opportunity to discuss it and ask any questions. All my questions have been answered in 
a satisfactory way. 
 
2. Understand my participation is voluntary and I will not be paid for my participation. 
 
3. Know that at any time, and without giving a reason, I can withdraw my participation in the 
study and that my future care and management will not be affected. 
 
4. Understand that audio-taping will be used to record my interview which will only be listened to 
by members of the research team. 
 
5. Understand that I will have a copy of this patient information leaflet and written consent to 
keep. 
 
6. Understand that relevant sections of my medical notes and data collected during the study 
may be looked at by individuals from regulatory authorities or from the NHS Trust, where it is 
relevant to my taking part in this research. I give permission for these individuals to have 
access to my records.  
 
7. Understand that the researcher will not identify me by name in any reports using information 
obtained from this study, and that my confidentiality as a participant in this study will remain 
secure.  
 
8. Understand that if I were to disclose some information during the interview which indicated 
the potential harm to either myself or others then the researcher may have to report this 
information to a suitable authority. 
I hereby give my consent to take part in this study.  
My Signature ....................................................................Date ........................... 
Initials 
 
Name Printed .................................................................... Signature of Researcher ............................. 
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Appendix F 
Adult Debriefing Sheet 
 
 
 
 
Dear Participant , 
 
The purpose of this study was to investigate your views behind your lifestyle choices. 
This study was conducted due to research indicating that some lifestyle choices have a 
negative impact upon a CF patient’s health. It is hoped that this research will identify ways to 
prevent CF patients from engaging in risky behaviours; which in turn will benefit patients as it 
will contribute to increasing their health, as they will not be engaging in a behaviour that can 
compromise their health. 
The information that was collected about you during the course of this study will be 
kept strictly anonymous and will be destroyed when the study is completed. If you require 
any further help or discussion after taking part in the study; or if you would like to know 
anything about the results or information of the study then please feel free to contact me: - 
(Rebecca.Keyte@mail.bcu.ac.uk / 07957157974), or Dr Helen Egan on:- 
Helen.Egan@bcu.ac.uk , or Dr Regan on:- anna.regan@heartofengland.nhs.uk , or Dr 
Angela McGowan on:- Angela.McGowan@uhns.nhs.uk 
Thank you again for participating in this study.  
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Appendix G 
Results Feedback 
 
 
 
 
 I conducted 24 interviews with adults with Cystic Fibrosis. During these interviews we 
spoke about what life is really like with Cystic Fibrosis, and I listened to your reasons about 
why you make certain lifestyle choices. We are really grateful to all of you who contributed to 
this research and I was pleased to hear that so many of you valued the research, saying 
things such as: 
 "It made sense that someone should investigate this" 
 "It is great, more people should look into CF to raise awareness for the 
condition" 
 The results of the research do indicate that some adults with Cystic Fibrosis do 
engage in certain behaviours like smoking, drinking excessive amounts of alcohol, and drug 
use, despite these behaviours being negative for their health. Individuals provided a variety 
of reasons for engaging in such behaviours.  
 By understanding why some adults with Cystic Fibrosis do engage in these "risky 
behaviours", Health Care Professionals will now be able to identify adults who may be at risk 
of engaging in these behaviours to try and prevent their engagement. As many individuals 
emphasised the need for more information to be provided to patients about the negative 
health effects of these behaviours, we will work to create a way of providing patients with this 
information at an age where they may be considering engagement in such behaviours. 
 All of this would not be possible without yourselves giving up your time to contribute 
to this research, so again I would like to say a big thank you to you all. 
 
Rebecca Keyte 
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Appendix H 
Revising the Codes 
Taken from the Researchers Reflexive Diary: 
3rd March 2016: 
 After a supervision meeting where we looked at my themes and accompanying 
codes I have made some slight changes. 
 Occupational Identity: 
Firstly I have incorporated a new code “occupational identity” into the “Identity” theme. 
The material was represented already within my analysis, however we acknowledged that 
the identity provided to an individual through employment and education is very important 
and therefore needed to be more clearly signposted within my analysis. 
EXAMPLE: 
Participant 3 [F, 32years]: “I wasn’t going out with any of my holiday repping friends (.) it 
[drug use] wasn’t re:eally (.) the sa:ame (.) sort of night" 
 Within my new code “Occupational Identity” I decided that the data would be 
better represented if this code was separated into two distinct codes: 
 
 The impact Employment / Education has upon an individual’s Identity with CF 
which explores both positive and negative impacts employment and education can 
have upon a CF patient's identity 
 The relationship between an Occupational Identity and Risky Behaviours which 
represents how the workplace / educational institute can encourage a CF patient to 
engage in normalised risky behaviours 
4th March 2016: 
 Based upon my supervision meeting I decided to include an additional three codes 
within the theme focusing upon “Acceptance and Awareness” to indicate patients' 
awareness regarding adherence and risky health behaviours which had originated from 
HCPs. Firstly there was the code: 
 Lack of Awareness from HCPs regarding the need for adherence 
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This included data which had predominantly originated within the theme that focuses upon 
“Support from Others” and still features within that theme. This data highlights how HCPs 
can provide a lack of awareness regarding the need for adherence despite the data 
documenting that awareness / acceptance can result in adherence. 
EXAMPLE: 
Participant 19 [M, 23years]: "I think a lot is re:eally underrated ## when I come to hospital 
[...] they ask (.) o:oh have you done much exercise # o:oh maybe try and do some more # 
[...] there should be mo:ore than taking medication # they're hot on giving you medication (.) 
but not on lifestyle choices [...] there's mo:ore value than is being lead on to in hospitals 
anyway (.) fo:or exercise" 
Secondly there was the code: 
 Lack of awareness from HCPs regarding risky health behaviours 
This included data which had predominantly originated within the theme that focuses upon 
“Support from Others” and still features within that theme. This data highlights how HCPs 
can provide a lack of awareness regarding the adverse effects of risky health behaviours to 
their patients despite the data documenting that awareness of such adverse effects can 
prevent initiation / aid cessation 
EXAMPLE: 
Participant 11 [F, 29years]: “I'm pa:artial to a glass when I # you know (.) if I've had a bad 
day at work (.) o:or:r just of a weekend [...] they've [HCP] never said (.) don't (.) drink # but 
they've also said # obviously don't ## no they've never told me not to drink" 
Thirdly there is the code: 
 Awareness provided by HCPs regarding risky health behaviours 
This included data which had predominantly originated within the theme that focuses upon 
“Support from Others” and still features within that theme. This data highlights the 
information HCPs had provided participants with regarding risky health behaviours.  
EXAMPLE: 
Participant 9 [M, 25years]: “It weren't until I got to # he:ere [Hospital name] [...] as an adult 
they explained mo:ore  [about alcohol] # crunch down on you # that's the effect it had on it 
then ## I realised what it's doing [...] when you're not having your drugs and your drinking as 
well ## or:r (.) not having your creon right (.) your bowels are everywhere ## your lungs hurt” 
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7th March 2016: 
Support from Others: 
 Within the theme that focuses upon "Support from Others" I created a new code to 
indicate the importance of friendship from participants’ perspectives. The new code is: 
 "The importance of friendship, providing patients with a sense of belonging" 
This data was already displayed within this theme, however the new code better displays the 
role of friendship alongside the existing codes illustrating the support or lack of support 
participants receive from their friends, and the influence such friendships have upon the 
engagement in risky behaviours.  
EXAMPLE: 
Participant 1 [M, 19 years]: "It's good that I have mates that care [...] I haven't got a (.) strong 
(.) relationship with my family like (.) so my friends are all I've got to be honest" 
 In addition within the theme that focuses upon "Support from Others" I also added 
more data under the code "Society has a lack of awareness regarding CF" to illustrate the 
impact of this lack of awareness.  
EXAMPLE: 
Participant 11 [F, 29years]: “A lot of people go # °I've heard that° # but nobody knows wha:at 
it is:s [...] it's ve:ery hard then when you have to explain to someone (.) it's ve:ery tricky # 
be:ecause ## I don't even know where to start [...] >don't go home and google it< [laughs] (.) 
because it looks # on paper (.) it's horrendous [...] can you just look at the re:eality in front of 
you” 
 Finally, within the theme that focuses upon "Support from Others" I combined the 
codes "Lack of support from work / University" and "Work / University as a source of 
support" as both codes did not have a lot of data under them, and all the data was 
representing the same thing. The new code was called: 
 The support a patient receives from work / university 
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Appendix I 
Example Theme 
Theme: "Why should I let Cystic Fibrosis completely dominate my life?" 
Codes: 
 Not defined by a CF identity 
 Normalcy / normal identity provided through non-adherence 
 Normalcy / normal identity provided through risky health behaviour engagement  
 Normalcy / normal identity provided by engaging in normal activities  
 Desire to fit in 
 Adherence allows normalcy / normal identity 
 Adherence prevents normalcy 
 Response to the CF identity 
 The invisible impairment allows normalcy 
 The invisible impairment causes ignorance off others 
 Life-orientated illness perspective 
 Risky health behaviours were normalised by friends 
 A change in friendship group resulting in cessation 
 Peer pressure and risky health behaviours 
 Risky health behaviours were normalised by friends 
 Risky health behaviours were not normalised, thus preventing initiation 
 Risky health behaviours were normalised by the environment 
 Risky health behaviours were normalised by educational and employment 
experiences 
 The impact employment / education has upon an individual's identity with CF 
 The relationship between an occupational identity and risky health behaviours 
 Illness identity physically on display 
 The impact of the illness identity being on display 
 Hiding the illness identity to provide oneself with a normal identity 
 Incorporated CF into their identity 
 Non-disclosure to partner 
 Non-disclosure to hide the illness identity 
 Non-disclosure to escape sympathy 
 Disclosure of CF 
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Appendix J 
Approval from the Paediatric CF MDTs at the Royal Stoke University Hospital and 
Birmingham Heartlands Hospital 
[Taken from the Researcher's Reflexive Diary] 
The Royal Stoke University Hospital: 
"I did an oral presentation on the aims of my current and proposed research within the CF 
population (Investigating the role of health beliefs in predicting lifestyle choices). It was great 
to receive feedback from professionals within the field. The paediatric team stated that the 
inclusion criteria should be from 12 - 18 years to coincide with secondary school, and 
because literature states that individuals start to contemplate risky behaviour engagement at 
that age (11+ years). In addition the paediatric Clinical Psychologist stated I should look at 
patients awareness / beliefs about their life expectancy as this can influence risky 
behaviours (she suspects). Furthermore it was stated that the aim of the intervention should 
not be to prevent risky behaviours, but to provide more education. I agree with this (and 
should change this / the discourse I use) as it has to be acknowledged that the engagement 
in such behaviours is an active choice which may be rational and should be respected - 
however patients should have enough information to make a more informed choice on their 
engagement. 
After my talk the paediatric team stated that they want to be involved in my research. The 
team seemed very keen to be on board. This is fantastic news as I have struggled to recruit 
research sites. However now I can progress with phase two data collection!! 
Overall this indicates that professionals within the field of Cystic Fibrosis see my research to 
be relevant and valuable; believing it has the potential to have an impact upon NHS 
practice." 
Birmingham Heartlands Hospital: 
"I presented my research proposal for phase two data collection to the CF MDT at 
Birmingham Heartlands Hospital. The presentation went well with the paediatric team stating 
they are keen to be involved within the research. The team have ten patients at the moment 
aged 12 years and above and are happy to start handing out consent to contact forms (I am 
just waiting for R&D approval). 
Through my discussions with the paediatric CF MDT it did indicate that risky health 
behaviours are a missed area - patients are provided a booklet on drugs etc but there is no 
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discussion encouraged. The CF MDT stated that they are aware the booklet ends up under 
the patients bed etc. The CF MDT also stated how they ask if patients smoke but not about 
alcohol or drug use. 
The CF MDT suspect that the majority of patients will not have engaged in any risky health 
behaviours, however they did say they may be naive to believe that! We did discuss about 
confidentiality and at what point I would need to break that (e.g. what is risky? - Is one 
cigarette risky? Is parental smoking risky? Is drinking with family risky? Is under-aged sex 
risky?). This is something I need to discuss with my supervisors before I conduct my first 
interview. 
Hopefully I should be starting data collection again shortly" 
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Appendix K 
Paediatric Interview Schedule 
Ice Breakers Question’s: 
 Thank you for taking part 
 What were your first thoughts when you were asked to take part in this research? 
 Did you have any hesitations about agreeing to take part? 
 So to begin with, can you describe what you do in a typical day? 
 
o Weekday / Weekend difference 
o Spare time 
 
Impact of Cystic Fibrosis on the patient’s personal life: 
 Could you tell me what it is like to live with Cystic Fibrosis 
 
o Discuss the challenges of living with Cystic Fibrosis 
o Has it always been this or were other aspects / things more difficult to cope 
with when you was younger? 
 
 Do you tell others about your Cystic Fibrosis? 
 
o Who do you tell? 
o What do you tell them? 
o How do you find telling others about your Cystic Fibrosis? 
o Why don't you tell others about your Cystic Fibrosis? 
 
 How do you find it sticking to your treatment regimen?  
 
o Does anyone help you stick to your regimen? (Who?) 
o Are there any aspects that are more difficult to stick to? 
o Has this changed over time? 
o Does it change depending on the situation / circumstances? 
o Are there any treatments you tend to "miss out"? 
o Are there any treatments you wish you could "miss out"? 
o How do you think it would make you feel if you did miss those treatments out? 
 
Barriers to Adherence: 
 What things make it difficult to stick to the regimen?  
Areas for further elaboration may include: 
 
o Not enough time in the day with school etc 
o The belief that the medical regimen is not benefitting them 
o Are they self-prescribing according to their symptoms? 
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o Weekday / weekend difference 
 
 Are there any situations where you are less likely to take your medication / complete 
your e.g. physiotherapy? 
Areas for further elaboration may include: 
o At school 
o At a friend’s house 
 
 What makes it harder to complete your regimen in these situations? 
 
o An area for further exploration may include the identity the medical regimen 
provides them with 
 
Risky Health Behaviours: 
 When I say "risky behaviours" what does that make you think of? 
 Do you think that some things are more risky for you because of your Cystic 
Fibrosis? 
 What things would “not be good” for your health?  
Examples may include: 
 
o Smoking 
o Drugs 
o Drinking alcohol 
 
 Do you feel that these behaviours would have an impact on your Cystic Fibrosis? 
 Have you ever been told that any of these behaviours would be bad for your Cystic 
Fibrosis? 
 
o Who has provided you with this awareness? 
o How does it make you feel towards these behaviours? 
 
 Do you know anyone who takes part in these behaviours? 
 
o Who? 
o How does that make you feel? 
 
 Have you / would you ever be motivated to try one of these behaviours?  
 
o What would motivate you? 
o What would stop you? 
 
 Why do you think people do engage in these behaviours? 
 Do you think any Cystic Fibrosis patients engage in risky behaviours? 
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o Why do you think a Cystic Fibrosis patient would engage in these 
behaviours? 
o Why do you think a Cystic Fibrosis patient would not engage in these 
behaviours? 
 
Family and Friends: 
 If you did (e.g. smoke) would you be open with family and friends about your (e.g. 
smoking?) What do you think they would think about it? What would their reaction 
be? 
 “Other” may include:  
o Parents 
o Siblings 
o Partner 
 
 Who do you go to with any concerns regarding your Cystic Fibrosis?  
Examples may be: 
 
o Consultants 
o Family 
o Friends 
o Online forums 
 
 Do you ever speak to any other Cystic Fibrosis patients? 
 
o Is this online? 
o Is this face to face? 
 
Conclusion: 
 What would you want to tell a younger patient with Cystic Fibrosis? 
 
o e.g. about going to school with Cystic Fibrosis 
o e.g. about telling others about their Cystic Fibrosis 
 
 What would you tell a family who had just had a child with Cystic Fibrosis? 
 Honestly if you were to have this discussion with another person (e.g. someone who 
has Cystic Fibrosis), outside of this research, would this conversation be the same? 
 Do you have anything else to add? 
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Appendix L - Paediatric Handout 
Title of study: The role of health beliefs in predicting and explaining lifestyle choices 
within Cystic Fibrosis patients 
Researcher: Rebecca Keyte 
Contact Details: Rebecca.Keyte@mail.bcu.ac.uk; 07957157974 
About the Researcher: 
 I am PhD student in the Psychology department at Birmingham City University. I 
have recently completed a piece of research with adult Cystic Fibrosis patients (at 
Birmingham Heartlands Hospital and the Royal Stoke University Hospital) which was looking 
at their lifestyle choices. Now I would like to conduct a similar piece of research with 
paediatric Cystic Fibrosis patients. 
What is the research about? 
 I am interested in hearing your experiences of living with Cystic Fibrosis and hearing 
your thoughts about the lifestyle choices made by you and by other people. These lifestyle 
choices may include smoking, drinking alcohol and taking drugs.  
 I would like you to take part in this research as you are aged 12 years or above. It 
does not matter if you have never smoked, drank alcohol or taken drugs, I would still like to 
talk to you and hear your experiences of living with Cystic Fibrosis.  
What will the research involve? 
 It is completely up to yourself whether or not you want to take part in this research. If 
you do decide to take part, you will be interviewed by Rebecca Keyte to investigate your 
personal views and experiences about your lifestyle choices. This interview will be audio 
recorded so the researcher can listen back over the interview again and analyse the 
material; this recording will not be listened to by anyone outside of the research team. This 
interview will take a maximum of 60 minutes and will take place at Birmingham Heartlands 
Hospital on a date suitable for yourself. None of the information collected about you during 
this study will be seen by anyone else including the staff treating you. You do not have to 
answer any questions that you do not want to during the interview, and you can leave the 
interview at any time without providing a reason. However, if you were to tell the researcher 
some information during the interview which indicated the potential harm to either yourself or 
others then the researcher may have to report this information to a suitable authority. 
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Appendix M 
PAEDIATRIC CONSENT TO CONTACT FORM 
 
Title of Study: The role of health beliefs in predicting and explaining lifestyle choices within 
Cystic Fibrosis patients. 
 
Name of Researcher: Rebecca Keyte 
 
Please complete this form if you are happy for the researcher to contact you to discuss this 
study. 
 Please initial 
the box 
 1. I confirm that my son/daughter has read the research information sheet for  
 the above study. 
 
 
2. I agree that my son/daughter's care co-ordinator can inform the above 
researcher of their medical condition in order to assess their eligibility to 
participate in the above study.   
 
3. I understand that my personal contact details below will be stored securely, in 
line with the data protection act. 
 
 
4.I agree that the researcher can contact me to discuss my son/daughter's 
participation in the above study using my contact details below. 
 
Full Name:  _________________________________________________________ 
Address:  ___________________________________________________________ 
 
 
Telephone:  ______________________ Mobile:  ________________________ 
Email:  _________________________________ 
Preferred Time to be contacted: Morning Afternoon Evening (please circle) 
Preferred Method of contact: Home  Mobile  Email (please circle) 
Many thanks for expressing interest in this study. You will be contacted, as per your stated 
preferences within 24-48 hours to discuss the research further. As previously explained, there is no 
obligation to commit to the study at this time and whether you participate or not, this will not affect 
the care or treatment you receive under normal routine care. 
 
 
 
 
289 
 
Appendix N 
Parental Information Sheet and Consent Form 
 
 
 
Title of study: The role of health beliefs in predicting and explaining lifestyle choices within 
Cystic Fibrosis 
 
Researchers: Rebecca Keyte, Dr Helen Egan, Dr Anna Regan, Dr Angela McGowan. 
Institutions name and location: Birmingham City University, School of Social Sciences 
Birmingham City University, Perry Barr, Birmingham B42 2SU 
Email: Rebecca.Keyte@mail.bcu.ac.uk (07957157974) 
 
Introduction to the research and invitation for your son / daughter to take part 
We are researchers at Birmingham City University carrying out a research project 
investigating what adolescents with Cystic Fibrosis think about “risky” health behaviours (e.g. 
smoking, excessive alcohol consumption, illicit drug use). This study is interested in 
adolescents' personal views about risky health behaviours and the impact they believe they 
have upon an individual’s life. The findings of these interviews, alongside interviews with 
adult Cystic Fibrosis patients, will highlight to professionals why some individuals with Cystic 
Fibrosis do engage in risky health behaviours, and what could be done to motivate patients 
to not engage in these behaviours to improve their health status. Participants are being 
recruited from Birmingham Heartlands Hospital and the Royal Stoke University Hospital. 
 
Does your son / daughter have to take part? 
It is up to you whether or not you want your son / daughter to participate in this research. 
Cystic Fibrosis patients aged 12 years and above are being recruited for this research. Your 
son / daughter will complete this study in a private room at their hospital; they will not be 
expected to complete any part of this study in the public waiting room. To help you and your 
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son / daughter to decide about participation, we will first describe the study and if you both 
express an interest we will give you both an information sheet. If after reading your 
information sheets and having any questions answered, you are both still keen on 
participation, we will ask you both to sign a consent form. Your son / daughter would be free 
to withdraw from this research at any time without giving a reason, this would not affect the 
care they receive in any way.  
 
What will your son / daughter have to do if they participate? 
If you and your son / daughter decide to provide written consent, your son / daughter will 
participate in a semi-structured interview conducted by Rebecca Keyte to investigate their 
views towards risky health behaviours, and their views on why some adolescents engage in 
risky health behaviours. The interview will take place in a private room at their hospital. The 
interview will be audio recorded so the researcher can listen back over the interview again 
and analyse the material; this recording will not be listened to by anyone else outside of the 
research team. The interview will take a maximum of 60 minutes, but can be stopped earlier 
if your son / daughter wishes this to be the case. None of the information collected about 
your son / daughter during this study will be seen by anyone else including the staff at their 
hospital, and the interview data (including recordings) will be destroyed at the end of the 
study. However, if your son / daughter were to tell the researcher some information during 
the interview which indicated the potential harm to either themselves or others then the 
researcher may have to report this information to a suitable authority. We will also record 
your son / daughters latest lung function results from their medical notes. The interviews are 
designed to be independent, however if your son / daughter wishes you to be present this 
can be arranged. 
 
What are the possible risks of participating? 
There are no risks from participating in this study as the information that your son / daughter 
provides in this research will be strictly confidential. The information will be anonymised, 
which means that all identifying information will be removed and will not be seen by anyone 
including the staff at your son / daughter's hospital. I want to assure you that I have had a full 
criminal record check done and this is clear, a copy of which can be produced upon request. 
If you have any questions regarding this research then please feel free to contact me using 
the information given above.  
291 
 
Are there any possible benefits? 
There are likely to be no direct benefits to your son / daughter by participating in this study. It 
is not expected for your son / daughter to become distressed during the interview, however if 
this was to happen your son / daughter will be referred to Dr Anna Regan or Dr Francis 
Gilchrist. 
The findings from this research will highlight to professionals ways to encourage CF patients 
not to engage in risky behaviours; which in turn will benefit patients as it will contribute to 
increasing their health, as they will not be engaging in a behaviour that can compromise their 
health status. 
 
What do I do now? 
Once you have read this information sheet and have had any questions answered to your 
satisfaction, if you are still keen for your son / daughter to participate in the study we ask you 
to sign the attached consent form. If your son / daughter also consents to participating in this 
study we will arrange a date / time of when we will conduct the interview (possibly on the 
same day as you and your son / daughter consenting depending on your availability). We will 
also obtain the information about your son / daughters lung function from their medical 
notes.  
 
What if I have a complaint? 
In the unlikely event of you having any complaints about any aspects of the study, we will do 
our best to answer these complaints. If you would prefer to speak to someone independent 
of the research team about your complaint then you can contact your local Patient Advice 
Liaison Service (PALS) Team:  
 
Heartlands Hospital: Telephone 0121 424 1212 or email pals@heartofengland.nhs.uk 
 
Royal Stoke University Hospital:  Telephone 01782 676450 or 01782 676455 or email 
patient.advice@uhns.nhs.uk   
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Will my son / daughters taking part in the study be kept confidential? 
Yes, we will follow ethical and legal practice and all information about your son / daughter 
will be handled in confidence.  
 
What happens at the end of the study? 
Throughout the study, and when it ends, your son / daughters hospital Doctor and General 
Practitioner will continue to monitor them as usual. 
 
What happens if I have more questions? 
If you do not understand something in this leaflet, or have further questions you may ask the 
researcher now. Or you can contact the researcher via email or telephone on the contact 
details provided above. 
 
What happens now if I decide my son / daughter should participate? 
If you decide to allow your son / daughter to participate you will be asked to read, sign and 
date the written consent form attached to this sheet. By signing it you acknowledge that you 
have understood the aims of the research, and what your son / daughter is being asked to 
do. Your son / daughter will then be asked to read, sign and date a separate consent form if 
they wish to participate. 
 
Will my son / daughters General Practitioner (GP) be informed? 
We do not plan to inform your son / daughters GP about their participation in the study, but 
can do if you wish. 
 
What happens if my son / daughter changes their mind during the study? 
Your son / daughter is free to withdraw their participation at any time without providing a 
reason. 
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Who is organising and funding the study? 
The study has been organised by Rebecca Keyte and Dr Helen Egan at Birmingham City 
University. These will not be paid for including your son / daughter in this study. In addition 
your travel expenses will not be paid.  
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity. This study has been 
reviewed and given favourable opinion by NRES Committee East Midlands - Leicester. 
 
Who can I contact about the study? 
In the first instance any concerns or questions should be addressed to Rebecca Keyte (see 
above for contact details). If you have further concerns you can contact your Patient Advice 
Liaison Service (PALS) team:  
 
Heartlands Hospital: Telephone 0121 424 1212 or email pals@heartofengland.nhs.uk 
 
Royal Stoke University Hospital:  Telephone 01782 676450 or 01782 676455 or email 
patient.advice@uhns.nhs.uk   
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REC Reference: 14/EM/1183     Enrolment Number: 
Title: The role of health beliefs in predicting and explaining lifestyle choices within Cystic 
Fibrosis 
I ................................................................................. (Name of parent / guardian)  
     
1. Have read the attached information sheet (Version 2; 26/1/2016) concerning my son / 
daughters participation in this study and have had the opportunity to ask any questions. All 
my questions have been answered in a satisfactory way. 
 
2. Understand my son / daughters participation is voluntary and they will not be paid for their 
participation. 
 
3. Know that at any time, and without giving a reason, my son / daughter can withdraw their 
participation in the study. 
 
4. Understand that audio-taping will be used to record the interview which will only be listened to 
by members of the research team. 
 
5. Understand that I will have a copy of this patient information leaflet to keep. 
 
6. Understand that relevant sections of my son / daughters medical notes and data collected 
during the study may be looked at by individuals from regulatory authorities or from the NHS 
Trust, where it is relevant to my son / daughters taking part in this research. I give permission 
for these individuals to have access to my son / daughters records.  
 
7. Understand that the researcher will not identify my son / daughter by name in any reports 
using information obtained from this study, and that their confidentiality as a participant in this 
study will remain secure.  
 
8. Understand that if I my son / daughter was to disclose some information during the interview 
which indicated the potential harm to either themselves or others then the researcher may 
have to report this information to a suitable authority. 
 
I hereby give my consent for my son / daughter to take part in this study.  
My Signature ....................................................................Date ........................... 
Name Printed ...................................................................Signature of the Researcher ........................ 
Initials 
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Appendix O 
Paediatric Information Sheet 
 
 
Title of study: The role of health beliefs in predicting and explaining lifestyle choices 
within Cystic Fibrosis patients 
Researchers: Rebecca Keyte, Dr Helen Egan, Dr Anna Regan and Dr Angela McGowan. 
 
What is the research about? 
We are investigating Cystic Fibrosis (CF) patients views about their lifestyle choices. We are 
interested in what you think about lifestyle choices made by you and by other people, and 
how you think they impact upon your health and wellbeing (both in a positive way or 
negative way).  
What are lifestyle choices? 
We are interested in hearing your experiences of living with CF; and hearing your thoughts 
around smoking, drinking alcohol and taking drugs.  
Who can take part? 
Anybody who has CF and is 12 years or over can take part in this research. It does not 
matter if you have never smoked, drank alcohol or taken drugs, we would still like to talk to 
you and hear your experiences of living with CF and the reasons why you make decisions 
about certain lifestyle choices.  
What will this research involve? 
It is completely up to yourself whether or not you want to take part in this research. You will 
not be paid for taking part in the research. If you do decide to take part, you will be 
interviewed by Rebecca Keyte to investigate your personal views and experiences about 
your lifestyle choices. This interview will be audio recorded so the researcher can listen back 
over the interview again and analyse the material; this recording will not be listened to by 
anyone else outside of the research team. This interview will take a maximum of 60 minutes 
and will take place in a private room at your Cystic Fibrosis Centre on a date suitable for 
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yourself. None of the information collected about you during this study will be seen by 
anyone else including the staff treating you, and the interview data (including recordings) will 
be destroyed at the end of the study. However, if you were to tell the researcher some 
information during the interview which indicated the potential harm to either yourself or 
others then the researcher may have to report this information to a suitable authority. You do 
not have to answer any questions that you do not want to during the interview, and you can 
leave the interview at any time without providing a reason. It is not expected that you will get 
upset during the interview, however if you was to get upset you will be referred to Dr Anna 
Regan (Clinical Psychologist at Heartlands Hospital) or Dr Francis Gilchrist (Consultant at 
the Royal Stoke University Hospital). The researcher will also take a record of your latest 
lung function result. 
 
What happens if I have more questions? 
If you do not understand something, or have further questions you may contact the 
researcher via email or telephone on: Rebecca.Keyte@mail.bcu.ac.uk (07957157974). 
If you have further concerns you can contact your local Patient Advice Liaison Service 
(PALS) on:  
Heartlands Hospital: Telephone 0121 424 1212 or email pals@heartofengland.nhs.uk 
Royal Stoke University Hospital:  Telephone 01782 676450 or 01782 676455 or email 
patient.advice@uhns.nhs.uk   
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Appendix P 
Paediatric Assent Form 
 
 
REC Reference: 14/EM/1183      Enrolment Number: 
  
Title: The role of health beliefs in predicting and explaining lifestyle choices within Cystic Fibrosis 
I ................................................................................. (Name in BLOCK CAPITALS)  
        
1. Have read the information sheet (Version 2; 26/1/2016) about taking part in this study and 
have had the chance to ask any questions about this study. All my questions have been 
answered. 
 
2. Understand that I do not have to take part in this study if I do not want to and that I will not be 
paid for taking part. 
 
3. Know that I can quit the study at any time, and I do not have to give a reason for this. 
 
4. Understand that audio-taping will be used to record the interview which will only be listened to 
by members of the research team. 
 
5. Understand that I will have a copy of this patient information leaflet to keep. 
 
6. Understand that my medical notes will be looked at by the researcher to record my lung 
function.  
 
7. Understand that the researcher will not write my name in any reports written about the study, 
so that only the researcher will know what I said during the study.  
 
8. Understand that if I were to tell the researcher some information which indicated that myself 
or others may be at risk of harm, then the researcher may have to report this information to a 
suitable authority. 
I would like to take part in this study:  
My Signature ..................................................My Name ......................................................................... 
Date ...............................................................Signature of Researcher .................................................. 
Initials 
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Appendix Q 
Paediatric Consent Form 
 
 
REC Reference: 14/EM/1183      Enrolment Number: 
  
Title: The role of health beliefs in predicting and explaining lifestyle choices within Cystic Fibrosis 
I ................................................................................. (Name in BLOCK CAPITALS)  
        
1. Have read the information sheet (Version 2; 26/1/2016) about taking part in this study and 
have had the opportunity to discuss it and ask any questions. All my questions have been 
answered. 
 
2. Understand that I do not have to take part in this study if I do not want to and that I will not be 
paid for taking part. 
 
3. Know that at any time, and without giving a reason, I can quit the study. 
 
4. Understand that audio-taping will be used to record the interview which will only be listened to 
by members of the research team. 
 
5. Understand that I will have a copy of this patient information leaflet to keep. 
 
6. Understand that my medical notes will be looked at by the researcher to record my latest lung 
function result.  
 
7. Understand that the researcher will not identify me by name in any reports of this study, and 
that my confidentiality as a participant in this study will remain secure.  
 
8. Understand that if I were to tell the researcher some information during the interview which 
indicated the potential harm to either myself or others then the researcher may have to report 
this information to a suitable authority. 
I hereby give my consent to take part in this study.  
My Signature ....................................................................Date ........................... 
Name Printed .................................................................... Signature of Researcher ............................. 
Initials 
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Appendix R 
Paediatric Debriefing Sheet 
 
 
Dear Participant, 
 
The purpose of this study was to investigate your views on risky health behaviours 
(e.g. smoking), and your views on why some individuals with Cystic Fibrosis smoke etc. It is 
hoped that this research will identify ways to stop Cystic Fibrosis patients engaging in these 
behaviours; which in turn will benefit patients as it will increase their health status. 
The information that was collected about you during this study will be kept strictly 
anonymous which means that no one (other than the researchers) will know what you said 
during your interview. If you have any questions after taking part in the study; or if you would 
like to know anything about the results then please feel free to contact me: - 
(Rebecca.Keyte@mail.bcu.ac.uk; 07957157974). 
Thank you again for participating in this study. 
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Appendix S 
Paediatric Results Feedback 
 
 
 
 
 I conducted 10 interviews with adolescents with Cystic Fibrosis. During these 
interviews we spoke about what life is really like with Cystic Fibrosis, and I listened to 
participants' beliefs about certain lifestyle choices. We are really grateful to all of you 
(parents and adolescents) who contributed to this research. 
 The results of the research indicate the attitudes and beliefs that some adolescents 
with Cystic Fibrosis have regarding engagement in certain behaviours like non-adherence, 
smoking, drinking excessive amounts of alcohol, and drug use. Individuals provided a variety 
of reasons for why some individuals with Cystic Fibrosis may engage in such behaviours.  
 By understanding the factors that may influence engagement in these "risky 
behaviours", Health Care Professionals will now be able to identify patients who may be at 
risk of engaging in these behaviours to try and prevent their engagement. As many 
participants emphasised the need for more information to be provided to patients about the 
negative health effects of these behaviours, we will work to create a way of providing 
patients with this information at an age where they may be considering engagement in such 
behaviours. 
 All of this would not be possible without yourselves giving up your time to contribute 
to this research, so again I would like to say a big thank you to you all. 
 
Rebecca Keyte 
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Appendix T 
Breaking Confidentiality in Paediatric Participants 
 In regards to this research ("The role of health beliefs in predicting and explaining 
risky behaviours within the paediatric Cystic Fibrosis population"), the researcher has 
created this document to clearly illustrate when confidentiality should be broken. 
The researcher would have no option to break confidentiality if: 
[In brief] it is deemed that the risks to the participants (or others) health, safety or welfare, 
outweigh the participants right to confidentiality (RCGP, 2011).  
Specifically this means that confidentiality would have to be broken if: 
 The participant discloses being the victim of a unreported crime (Wiles et al., 2006) 
 The researcher feels the participant is at risk of harm (Wiles et al., 2006); such harm 
usually surrounds issues such as that from crime, suicidal attempts / thoughts, or 
self-harm (but includes both physical and psychological harm) 
 The researcher feels others are at risk of harm e.g. through criminal activities 
(includes both physical and psychological harm) (Wiles et al., 2006) 
 The  participant disclosed that they (or others) was in, or could be in a life threatening 
situation (e.g. self-harm, suicidal attempts) (Gloucestershire Confidentiality Policy, 
2005) 
 The participant was being threatened by an abuser (Gloucestershire Confidentiality 
Policy, 2005) 
 The participant requested the release of information themselves (the researcher 
would get written evidence of this) 
 There were court orders for confidential information 
 It appeared that the participant had not provided consent for sexual activities (e.g. 
they were being coerced) (RCGP, 2011) (this would also be the case if the 
participant was under the influence of drugs or alcohol) 
 The participant was under the age of sixteen years and engaging in sexual activity 
with an individual significantly above the age of sixteen years, the RCGP (2011) 
states that researchers should be alert if there is a power imbalance indicated by an 
age gap of more than five years 
 The participant was engaging in substance use (e.g. smoking, excessive alcohol 
consumption, illicit drug use) and had not provided consent to engage in such 
behaviours (e.g. peer pressure) 
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The procedure which would be followed if confidentiality needed to be broken: 
[Devised through discussions with the researcher's supervisory team] 
1) Identify the dilemma of concern: Is it ethical, legal, or moral? 
2)  Identify potential issues: evaluate rights and responsibilities of all involved (researcher, 
participant, parents, healthcare team) 
3)  Look at the relevant ethics code for guidance 
4)  Consider applicable laws 
5)  Consult others with experience 
6) Brainstorm various courses of action before doing anything 
7)  Identify the consequences of each action for all parties 
8) Decide on the best possible course of action bearing above process in mind.  
Specifically in regards to this research, if the researcher felt that confidentiality needed to be 
broken (after completing the above checklist), the following actions would be taken: 
1) The researcher would discuss with the participant the benefits of disclosing such 
information to their HCPs, in the hope of gaining the participants consent to break 
confidentiality  
2) The researcher would ask the participant if there was a member of staff at their CF centre 
they would prefer the researcher to talk to first; if the participant had no preference the 
researcher would discuss the issue with the Consultant at the CF centre.  
However if the participant refused to allow disclosure of such information to their HCPs the 
researcher would: 
1) Consult the research supervisory team in order to decide whether or not disclosure 
without consent was justified 
2) The participant would be informed before disclosure was made, if this was the decision 
(RCGP, 2011).   
The researcher would have discussions with the research supervisory team if: 
 The participant had reported engagement in risky behaviours (e.g. smoking, 
excessive alcohol consumption, illicit drug use, risky sexual behaviour) but the 
303 
 
researcher had not broken confidentiality, the researcher would discuss the case with 
the research supervisory team and record her decision and reasons for not disclosing 
such information. 
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Appendix U 
Revising the Codes 
Taken from the Researchers Reflexive Diary 
5th August 2016 
Upon completion of my initial codes, I left my data for one month until revising the codes in 
order to allow me to look at the codes with "fresh eyes". I have made some slight changes to 
the codes within each of the four themes.  
Identity Theme 
 Within the theme focusing upon identity I added four new codes. Firstly, there was 
the code: 
 Illness identity on display aids adherence 
 
This code includes data which had originated within that theme, within the code "Illness 
identity on display due to acceptance", however by representing this data within another 
code it clearly outlined the impact displaying an illness identity can have upon one's 
adherence to medical regimens. 
EXAMPLE: 
Participant 3 [F, 12 years]: "Sister: when you're out with your friends an you don't mi:ind 
taking your tablets (.) an stuff like that  
Participant: Yeah # I don't mi:ind [...] they just ask (.) what's that"  
 Secondly, two new codes were added to support the code "desires normalcy". The 
first codes was: 
 A desire for normalcy can result in non-adherence 
 
This code included data which had originated within that theme, within the code "desires 
normalcy", however by representing this data within the new code it clearly outlines the 
impact a desire for normalcy can have upon one's adherence to medical regimens. 
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EXAMPLE: 
Participant 3 [F, 12 years]: “Researcher: Is there any other treatments that you think o::oh (.) 
I don't wana do this toda:ay  
Participant: ## E::er:r # dna:ase  [...] because like # I go to school (.) and when I get back 
I've got to do it like stra:aight away # but sometimes they sa:ay # my friends ask me to >go 
the park< or something (.) but I ca:an't # I've got to do that fi:irst” 
The second code was: 
 A desire for normalcy can result in risky behaviour engagement 
 
This code included data which had originated within that theme, within the code "desires 
normalcy", however by representing this data within the new code it clearly outlines the 
impact a desire for normalcy can have upon one's engagement with risky health behaviours. 
EXAMPLE: 
Participant 6 [M, 18 years]: “I just see drinking alcoho:ol (.) a:as:s # you do it fo:or fun [...] I 
just see it a:as # you go out an ha:ave fun an do it” 
 Thirdly, one new code was added to support the code "disclosure of illness identity": 
 Disclosure of illness identity assists with adherence: 
 
This code includes data which had originated within that theme, within the code "disclosure 
of illness identity", however by representing this data within the new code it clearly outlines 
the impact disclosure of one's illness identity has upon their adherence. 
EXAMPLE: 
Participant 5 [F, 12 years]: “Someti:imes like # at scho:ool (.) so:ome people come up to me 
an a:ask (.) <wh:hy I'm ta:aking # mediaca:ation> # like ta:ablets [...] I don't mi:ind telling 
them # I don't mi:ind people kno:owing about it” 
 In addition to adding new codes to this theme, I also renamed two codes to better 
represent the data embedded within these codes. Firstly I renamed the code "peers can 
result in individuals engaging in risky health behaviours" to: 
 Group norms can result in risky health behaviours 
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The reason for this change in name is because the data represented by this code 
demonstrates how the normalisation of a risky health behaviour by an individual's social 
group can result in initiation, in an attempt to conform to the group norms and to be accepted 
within that group.  
 Secondly, I renamed the code "awareness of adverse health effects can prevent the 
influence peer pressure has upon the engagement of risky health behaviours" to: 
 Awareness of adverse health effects can prevent the engagement in risky 
health behaviours despite group norms 
 
The reason for this change in name is because the data represented by this code does not 
just refer to peer pressure, it also outlines how some individuals' social group has 
normalised the engagement in risky health behaviours. Therefore this code outlines how 
awareness of the adverse health effects of risky behaviours can prevent individuals 
conforming to their group norms (whether or not such conformity is influenced by peer 
pressure). 
Adherence 
 Within the theme focusing upon adherence I deleted 9 codes: 
 1) I deleted the code: 
 Adherence is boring 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Adherence requires willpower", as the 
participant was explaining how difficult it is to adhere to their medical regimens due to how 
boring their treatments are, therefore such adherence requires willpower.  
 2) I deleted the code: 
 Adherence is more difficult during weekends 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Adherence stops the participant 
engaging in normal activities", as the participant was explaining how during weekends he 
wants to be lazy (engage in normal activities) as opposed to waking up early to adhere to his 
medical regimens. 
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 3) I deleted the code: 
 Adherence is more difficult during the mornings 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Adherence is time consuming", as the 
participant was explaining how she has to wake up early to complete her time consuming 
treatments which is difficult due to tiredness etc. 
 4) I deleted the code: 
 Hospital stays prevent the participant engaging in normal activities 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Adherence stops the participant 
engaging in normal activities", as the participant was discussing the impact IV antibiotics has 
upon her life, with hospital admissions being an additional form of adherence. 
 5) I deleted the code: 
 Patient and parents perspective on independence vary 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Participant is independent with 
adherence", as the participant was explaining that he feels he is independent, however his 
Father disagreed, suggesting that a patients perspective of independence may not be 
accurate, with some participants' responses potentially being influenced by social desirability 
bias. 
 6) In terms of independence, I also deleted the code: 
 Parents acknowledge independence will decrease adherence 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Independence will be a challenge", as 
the quote was from a Father who agrees that independence will be difficult, and that he 
expects that the participant will struggle with their adherence when they become 
independent. 
 7) I also deleted the code: 
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 Adherence due to support from others 
 
The reason for deleting this code is because it only contained one quote which did not 
clearly illustrate the impact support from others has upon an individual's adherence efforts. 
This concept is more clearly outlined within the theme focusing upon support from others. 
 8) I also deleted the code: 
 No routine results in non-adherence 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Routine aids with adherence", as the 
quote was illustrating how a structured routine can improve one's adherence efforts. 
 9) Finally, I deleted the code: 
 Adheres despite illness identity 
 
The reasons for deleting this code is because the data was all illustrating how patients had 
appeared to have accepted their illness identity (and were not afraid to display their illness 
identity) due to them having good awareness of their CF and the need for adherence, 
therefore the data was added to the code: "Independence due to awareness". 
Awareness  
Within the theme focusing upon one's awareness I deleted two codes. Firstly, I deleted the 
code: 
 Lack of awareness regarding CF 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Awareness regarding CF", as it was 
indicating the impact a lack of awareness can have upon an individual's health behaviours, 
which will be opposite to the data represented within this code, and outline the imperative 
nature of awareness regarding one's illness to promote health keeping behaviours. 
 Secondly, I deleted the code: 
 Awareness of the adverse effects of risky health behaviours does not always 
prevent initiation due to habit 
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The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme "Awareness of adverse effects of risky 
health behaviours does not always prevent initiation", as the quote was indicating how 
awareness alone cannot prevent an individual engaging in such behaviours due to a variety 
of reasons (in this case habit). 
The role of others 
 Within the theme focusing upon the role of others I deleted six codes:  
 1) I deleted the code: 
 Friends do not normalise risky health behaviours 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Friends prevent the initiation of risky 
health behaviours", as the participant was indicating that by their peers not normalising such 
behaviours it prevents their initiation as such engagement would not provide the individual 
with a normal identity. 
 2) I deleted the code: 
 Friends would not prevent the initiation in risky health behaviours 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Peer pressure can result in the 
initiation of risky health behaviours", as the participant was indicating how their friends all 
smoke so their friends would not prevent the participants initiation, instead they may 
encourage such initiation (through peer pressure). 
 3) I deleted the code: 
 Awareness prevents the initiation of risky health behaviours despite peer 
pressure 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Awareness prevents the initiation of 
risky health behaviours despite normalisation", as the participant was explaining that even if 
a friend was to have normalised a risky behaviour and told the participant to engage in that 
behaviour, her awareness of the adverse health effects would prevent such initiation. 
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 4) I deleted the code: 
 Hospital cannot prevent the engagement in risky health behaviours 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Hospital works to prevent the initiation 
of risky health behaviours", as although the participant was explaining how hospital cannot 
prevent such initiation, he did illustrate the hospitals effort to try and prevent such behaviours 
amongst patients. 
 5) I deleted the code: 
 Cross Contamination rules have a negative impact upon a patient's life 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Cross Contamination rules are seen in 
a negative light", as the participant was explaining how he views such rules in a negative 
way due to the negative impact they have upon his life. 
 6) Finally, I deleted the code: 
 Lack of support from school 
 
The reason for deleting this code is because it only contained one quote which could be 
represented by another code within the same theme: "Support from school is important", as 
the participant was explaining how he has to manage his own adherence at school, which is 
difficult, due to a lack of support; highlighting the imperative nature of such support. 
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Appendix V 
Example Theme 
Theme: "I wish I did not have Cystic Fibrosis, that would be wicked" 
Codes: 
 CF is normal 
 Disclosure of the illness identity 
 Disclosure of the illness identity assists with adherence 
 Disclosure due to necessity 
 Disclosure provides patients with support off others 
 Illness identity being on display is positive 
 Illness identity being on display allows adherence 
 Illness identity is on display due to acceptance 
 Illness identity is on display due to society accepting the illness identity 
 Non-disclosure to prevent illness identity being on display 
 Desires normalcy 
 A desire for normalcy can result in risky health behaviours 
 A desire for normalcy can result in non-adherence 
 Normalcy is provided through adherence 
 Group norms can result in risky health behaviours 
 Awareness of adverse health effects can prevent the engagement of risky health 
behaviours despite group norms 
 Risky health behaviours are not normalised for the participant which results in 
negative views towards such behaviours   
 Risky health behaviours are normalised for the participant  
 Normalisation results in initiation 
 Normalisation causes the participants to view the behaviour in a positive light 
 Awareness of the adverse health effects prevents initiation in risky health behaviours 
despite normalisation of such behaviours   
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Appendix W 
CF Specialist Nurses Interview Schedule 
Ice Breakers Question’s: 
 Thank you for taking part 
 What were your first thoughts when you were asked to take part in this research? 
 Did you have any hesitations about agreeing to take part? 
 
Working within the Cystic Fibrosis population: 
 Could you tell me what it is like to work within the field of Cystic Fibrosis 
 
o Discuss the rewards of working within the field of Cystic Fibrosis 
 
 Many Cystic Fibrosis patients I have spoken with have discussed some challenges in 
terms of living with Cystic Fibrosis, these include the deteriorating nature of Cystic 
Fibrosis and the uncertain future patients face, how do you find working within that 
environment? 
 
o How do you cope? 
o How do you help patients cope? 
 
 Do you believe that patients tell you everything during their clinic appointments (are 
they truthful to their HCPs)?  
 
o Do you ever feel when a patient has left the room that they have not told you 
the truth / told you everything? 
o What do you think they are not truthful about? 
o What do you do if you suspect a patient is not being truthful? 
 
Adherence: 
 What are some of the barriers you are faced with in terms of successfully treating 
Cystic Fibrosis?  
It is believed HCPs will identify the issue of adherence 
 
o Do you believe adherence is a major concern within the Cystic Fibrosis 
population? 
o What treatments do you believe patients find most difficult to adhere to? 
o Do you believe patients tell the truth regarding their adherence? 
o How do you help patients improve their adherence? 
o Is there anything else you could do / wish you could do to help patients 
improve their adherence? 
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Risky Health Behaviours: 
 What procedures do you have in place to inform patients about risky health 
behaviours? 
o Which behaviours do you inform them about? 
o Do you think this is effective? 
o What else would you like to do to prevent these behaviours within the Cystic 
Fibrosis population? 
 
 Do you believe many Cystic Fibrosis patients do engage in risky health behaviours? 
 
o What behaviours? 
o If a patient disclosed their engagement in that behaviour what would you do? 
o If you suspected a patient engaged in that behaviour what would you do? 
o Do you believe that this is effective? 
o Is there anything else you wish you could do if you had the time / resources? 
 
 Do you think a new intervention is required to prevent Cystic Fibrosis patients 
engaging in risky health behaviours? 
 
o What would you like this intervention to look like? 
 
 
Conclusion: 
 Do you think the intervention you have just described would work in reality? 
o What is preventing such intervention being implemented into Cystic 
Fibrosis care? 
 Do you have anything else to add? 
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Appendix X  
Handout provided to the Cystic Fibrosis Units 
Title of study: The role of health beliefs in predicting and explaining lifestyle choices within 
Cystic Fibrosis patients 
Researcher: Rebecca Keyte Contact Details: Rebecca.Keyte@mail.bcu.ac.uk; 07957157974 
About the Researcher: 
 I am PhD student in the Psychology department at Birmingham City University. I 
have recently completed two pieces of research with adult and paediatric Cystic Fibrosis 
patients (at Birmingham Heartlands Hospital and the Royal Stoke University Hospital) which 
were investigating the factors associated with risky health behaviour engagement within the 
Cystic Fibrosis population  
What is the research about? 
 I am interested in hearing the views of Cystic Fibrosis Specialist Nurses surrounding 
the issue of risky health behaviours. I am interested in hearing whether or not Cystic Fibrosis 
Specialist Nurses perceive risky health behaviours to be a major concern within the Cystic 
Fibrosis population, and whether or not they feel an intervention needs to be integrated into 
Cystic Fibrosis care to prevent the engagement of these behaviours.  
What will the research involve? 
 If Cystic Fibrosis Nurses provide written consent, they will participate in a semi-
structured interview conducted by Rebecca Keyte to investigate their views regarding 
whether or not risky health behaviours are a major concern within the Cystic Fibrosis 
population, and whether or not an intervention needs to be integrated into Cystic Fibrosis 
care. The interview will take place in a private room at the Cystic Fibrosis unit in which they 
work at, or will be conducted via telephone (depending on your preference / availability). The 
interview will be audio recorded so the researcher can listen back over the interview again 
and analyse the material; this recording will not be listened to by anyone else outside of the 
research team. The interview will take a maximum of 60 minutes, but can be stopped earlier 
if the Cystic Fibrosis Specialist Nurse wishes this to be the case. None of the information 
collected about the Nurses during this study will be seen by anyone else outside of the 
research team, and the interview data (including recordings) will be destroyed at the end of 
the study. 
315 
 
Appendix Y 
Information Sheet and Consent Form 
 
 
 
Title of study: How Health Care Professionals perceive the issue of risky health behaviours 
within the Cystic Fibrosis population. 
 
Researchers: Rebecca Keyte, Dr Helen Egan, Dr Michael Mantzios, Prof. Craig Jackson. 
 
Institutions name and location: Birmingham City University, School of Social Sciences 
Birmingham City University, Birmingham B4 7BD 
Email: Rebecca.Keyte@mail.bcu.ac.uk (07957157974) 
 
Introduction to the research and invitation for you to take part 
We are researchers at Birmingham City University carrying out a research project 
investigating what predicts risky health behaviours (e.g. smoking, excessive alcohol 
consumption, illicit drug use, non-adherence) within the Cystic Fibrosis population. This 
study (phase three data collection) is interested in hearing the views of Specialist Nurses 
who work within the field of Cystic Fibrosis surrounding the issue of risky health behaviours. 
The researchers are interested in hearing whether or not Specialist Nurses perceive risky 
health behaviours to be a major concern within the Cystic Fibrosis population, and whether 
or not they feel an intervention needs to be integrated into Cystic Fibrosis care to prevent the 
engagement of these behaviours.  
 
Do you have to take part? 
It is up to you whether or not you want to participate in this research. Specialist Nurses who 
belong to a Cystic Fibrosis Multi-Disciplinary Team are being recruited. You will complete 
this study in a private room at the Cystic Fibrosis unit you work at, or via a telephone 
interview (depending on your preference / availability). To help you decide about 
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participation, we will first describe the study and if you express an interest we will give you 
an information sheet. If after reading your information sheet and having any questions 
answered, you are still keen on participation, we will ask you to sign a consent form. You 
would be free to withdraw from this research at any time without giving a reason.  
 
What will you have to do if you participate? 
If you decide to provide written consent, you will participate in a semi-structured interview 
conducted by Rebecca Keyte to investigate your views regarding whether or not risky health 
behaviours are a major concern within the Cystic Fibrosis population, and whether or not an 
intervention needs to be integrated into Cystic Fibrosis care. The interview will take place in 
a private room at the Cystic Fibrosis unit you work at, or will be conducted via telephone 
(depending on your preference / availability). The interview will be audio recorded so the 
researcher can listen back over the interview again and analyse the material; this recording 
will not be listened to by anyone else outside of the research team. The interview will take a 
maximum of 60 minutes, but can be stopped earlier if you wish this to be the case. None of 
the information collected about you during this study will be seen by anyone else outside of 
the research team, and the interview data (including recordings) will be destroyed at the end 
of the study.  
 
What are the possible risks of participating? 
There are no risks from participating in this study as the information that you provide in this 
research will be strictly confidential. The information will be anonymised, which means that 
all identifying information will be removed and will not be seen by anyone including the staff 
at the Cystic Fibrosis unit you work at. If you have any questions regarding this research 
then please feel free to contact me using the information given above.  
 
Are there any possible benefits? 
There are likely to be no direct benefits to you by participating in this study. However the 
findings from this research will highlight whether or not Specialist Nurses view risky health 
behaviours to be a major concern within the Cystic Fibrosis population, and will hopefully 
highlight potential interventions which could work in reality aimed to prevent the initiation and 
aid the cessation of such behaviours within the Cystic Fibrosis population.  
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What do I do now? 
Once you have read this information sheet and have had any questions answered to your 
satisfaction, if you are still keen to participate in the study we ask you to sign the attached 
consent form. We will then arrange a date / time of when we will conduct the interview. 
 
What if I have a complaint? 
In the unlikely event of you having any complaints about any aspects of the study, we will do 
our best to answer these complaints. If you would prefer to speak to someone independent 
of the research team about your complaint then you can contact the relevant Research & 
Development Department [Insert contact details]: 
 
Will my taking part in the study be kept confidential? 
Yes, we will follow ethical and legal practice and all information about you will be handled in 
confidence.  
 
What happens if I have more questions? 
If you do not understand something in this leaflet, or have further questions you may ask the 
researcher now. Or you can contact the researcher via email or telephone on the contact 
details provided above. 
 
What happens now if I decide to participate? 
If you decide to participate you will be asked to read, sign and date the written consent form 
attached to this sheet. By signing it you acknowledge that you have understood the aims of 
the research, and what you are being asked to do.  
 
What happens if I change my mind during the study? 
You are free to withdraw your participation at any time without providing a reason. 
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Who is organising and funding the study? 
The study has been organised by Rebecca Keyte, Dr Helen Egan, Dr Michael Mantzios and 
Prof. Craig Jackson at Birmingham City University. These will not be paid for including you in 
this study.  
 
Who has reviewed the study? 
This study has been provided favourable ethical opinion by Birmingham City University. 
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Enrolment Number: 
Title: How Health Care Professionals perceive the issue of risky health behaviours within the 
Cystic Fibrosis population. 
 
I ................................................................................. (Name of participant)  
       
1. Have read the attached information sheet concerning my participation in this study and have 
had the opportunity to ask any questions. All my questions have been answered in a 
satisfactory way. 
 
2. Understand my participation is voluntary and I will not be paid for my participation. 
 
3. Know that at any time, and without giving a reason, I can withdraw my participation in the 
study. 
 
4. Understand that audio-taping will be used to record the interview which will only be listened to 
by members of the research team. 
 
5. Understand that I will have a copy of this information leaflet to keep. 
 
 
6. Understand that the researcher will not identify me by name in any reports using information 
obtained from this study, and that my confidentiality as a participant in this study will remain 
secure.  
 
I hereby give my consent to take part in this study.  
 
My Signature ....................................................................Date ........................... 
Name Printed ...................................................................Signature of the Researcher  
         ........................ 
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Appendix Z 
Debriefing sheet 
 
 
 
Dear Participant, 
 
The purpose of this study was to investigate your views on whether or not risky 
health behaviours are a major concern within the Cystic Fibrosis population. This is in light of 
the two previous phases of data collection I have conducted, which have illustrated that 
some Cystic Fibrosis patients (predominately adults) engage in risky health behaviours, but 
do not disclose their engagement to their Health Care Professionals. It is hoped that all 
phases of this doctoral research will help in reducing the occurrence of risky health 
behaviours (e.g. smoking, excessive alcohol consumption, illicit drug use, non-adherence) 
within the Cystic Fibrosis population, by informing interventions aimed to prevent the 
initiation and aid the cessation of such behaviours, predominantly by increasing patient 
awareness regarding the adverse effects of such behaviours specific to Cystic Fibrosis.  
The information that was collected about you during this study will be kept strictly 
confidential which means that no one (other than the researchers) will know what you said 
during your interview. If you have any questions after taking part in the study; or if you would 
like to know anything about the results then please feel free to contact me: - 
(Rebecca.Keyte@mail.bcu.ac.uk; 07957157974). 
Thank you again for participating in this study. 
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Appendix AA 
Results Feedback to CF Specialist Nurses 
 
 
 I conducted nine interviews with Cystic Fibrosis Specialist Nurses to see how you 
perceive the issue of risky health behaviours within the Cystic Fibrosis population, and to 
gain an insight into how you would like to progress current interventions aimed to reduce the 
occurrence of risky behaviours.  
 Overall the majority of Nurses who I spoke to did acknowledge that risky health 
behaviours are becoming a major concern within the Cystic Fibrosis population, however 
you indicated that not all Cystic Fibrosis units address the issue of risky health behaviours. 
Some Nurses explained that it is only recently that their unit has started to address this 
issue, however Nurses often identified flaws within their unit's interventions. For instance it 
appeared that some units rely upon patients disclosing their engagement with risky health 
behaviours, or instigating a conversation before any awareness is provided. In addition, the 
majority of Cystic Fibrosis units who do provide awareness provide verbal information, with 
many Nurses stating that this now needs to be progressed to provide patients with 
accompanying written information, whether this is on paper or via technology. Furthermore, 
some Nurses expressed an interest in having some form of staff training to raise Health Care 
Professionals awareness as to what risky health behaviours are current within the general 
population, and how they may identify those within their patients. 
 Through conducting research within the adult and paediatric Cystic Fibrosis 
population to investigate patients' awareness and beliefs towards risky health behaviours, 
and by understanding how you perceive the issue of risky health behaviours within the 
Cystic Fibrosis population, I now aim to work with Health Care Professionals to design an 
intervention aimed to reduce the occurrence of such behaviours within this population. All of 
this would not be possible without yourselves giving up your time to contribute to this 
research, indicating what interventions would have practical applications to address the 
issue of risky health behaviours specifically within the Cystic Fibrosis population, so again I 
would like to say a big thank you to you all. 
 
Rebecca Keyte 
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Appendix BB 
Example Theme 
Theme: Effective health promotion advice: What works? 
Codes: 
 No intervention to raise patients' awareness regarding CF's true nature 
 Improve adherence through awareness on non-adherence 
 Improve adherence through awareness via case studies 
 Awareness does not always result in adherence  
 Improve adherence through individualised care 
 Do not blame patients for poor adherence 
 Adherence interventions are now starting to use technology 
 Future interventions for adherence could involve mentoring 
 Time is key for any intervention 
 Interventions for risky health behaviours are new 
 Not all units have interventions for risky health behaviours 
 No standardised interventions for risky health behaviours 
 Risky health behaviour interventions often rely on patients instigating the 
conversation - reactive rather than proactive 
 Risky health behaviour interventions and adherence interventions need to involve 
psychology  
 Interventions need to allow patients to make an informed choice regarding risky 
health behaviours 
 Interventions for risky health behaviours involve increasing a patients awareness 
through verbal information 
 Intervention does not just use verbal information 
 Interventions for risky health behaviours involve increasing a patients awareness 
(Ready, Steady, Go) 
 Flaws with Ready, Steady, Go 
 Awareness does not prevent initiation or aid cessation in all cases 
 Intervention to encourage cessation is individualised 
 Intervention to encourage disclosure is individualised 
 Intervention encourages patients to disclose risky heath behaviours to parents 
 Interventions for risky health behaviours are revisited on several occasions 
 Interventions are not successful when parents are present 
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 Verbal information needs to be progressed and accompanied by written information 
 Verbal information needs to be progressed and accompanied by information via 
technology / online 
 Future risky health behaviour interventions need to target the right age group 
 Future risky health behaviour interventions need to target hard to reach group 
 Future interventions need to be designed with patient input 
 Future risky health behaviour interventions could involve mentorship 
 Mentorship interventions would not just be for non-adherence and risky health 
behaviours 
 Barriers to implementing a mentorship intervention 
 Future interventions need to involve staff training 
 Barriers to staff training intervention 
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Appendix CC 
Dissemination Meeting Plan 
 What would HCPs like to see in place to address the issue of risky behaviours within 
Cystic Fibrosis patients? 
 Do HCPs currently use an intervention to address the issue of risky behaviours? 
o What does this involve e.g. Cystic Fibrosis specific risky behaviour 
material, input from psychologist? 
o Could this intervention be improved? If so, how? 
 Do HCPs believe an intervention is required to address the issue of risky 
behaviours? 
 What would be an "ideal" way to address the issue of risky behaviours in the Cystic 
Fibrosis population? 
 What do HCPs believe would work in reality to address the issue of risky behaviours? 
 Which members of the MDT should be involved in delivering an intervention to 
address the issue of risky behaviours? 
 What are the potential benefits of the intervention HCPs have described? 
 What are the practical applications of the intervention HCPs have described? 
 What future events may help or hinder HCPs implementing such intervention to 
address the issue of risky behaviours? 
 What barriers may HCPs face in implementing such intervention to address the issue 
of risky behaviours? 
o What suggestions do HCPs have for overcoming these potential barriers? 
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Appendix DD  
Handout for the Dissemination Meetings 
Title of study: Dissemination Meeting: What predicts risky health behaviours within 
the Cystic Fibrosis population. 
Researcher: Rebecca Keyte 
Contact Details: Rebecca.Keyte@mail.bcu.ac.uk; 07957157974 
About the Researcher: 
 I am PhD student in the Psychology department at Birmingham City University. I 
have recently completed two pieces of research with adult and paediatric Cystic Fibrosis 
(CF) patients (at Birmingham Heartlands Hospital and the Royal Stoke University Hospital) 
which were investigating the factors associated with risky health behaviour engagement 
within the CF population. I have also conducted a piece of research with CF Specialist 
Nurses investigating their views towards risky health behaviours within the CF population.  
What is the research about? 
 I aim to disseminate the research findings to Health Care Professionals (HCPs). I am 
interested in hearing the views of HCPs who work within the field of CF about the research 
findings. I want to hear which findings HCPs believe are relevant to practice, and ideas they 
have about an intervention which could work in reality aimed to prevent the initiation and aid 
the cessation of risky health behaviours within the CF population. HCPs are being recruited 
from both Birmingham Heartlands Hospital and the Royal Stoke University Hospital. 
What will the research involve? 
 If HCPs provide verbal consent, they will participate in a dissemination meeting 
conducted by Rebecca Keyte to investigate their views regarding the research findings, and 
what interventions they believe could be integrated into CF care. The dissemination meeting 
will take place in a private room at the CF unit in which the HCPs work at. The meeting will 
be audio recorded so the researcher can listen back over the meeting again and analyse the 
material; this recording will not be listened to by anyone else outside of the research team. 
The dissemination meeting will take a maximum of 60 minutes, but can be stopped earlier if 
the HCPs wish this to be the case. None of the information collected about the HCPs during 
this study will be seen by anyone else outside of the research team, and the dissemination 
meeting data (including recordings) will be destroyed at the end of the study. 
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Appendix EE 
Presentation used for the Dissemination Meetings 
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Appendix FF 
Example Theme 
Theme: HCPs ideas regarding future interventions to address the issue of risky health 
behaviours 
Codes: 
 Interventions are required to address risky health behaviours 
 Staff training is required 
 Awareness should be provided during annual reviews 
 Interventions are required prior to adult care 
 Interventions should be delivered in absence of parents 
 Interventions for risky health behaviours need to emulate those used for non-
adherence 
 Interventions could provide awareness to adolescents via technology 
 
 
 
 
 
